{"idx": 43, "pair_id": "30045370", "src": "This study was performed to determine whether between 2015 and 2017 there has been a change in the preferred method of treatment of Dupuytren disease by German hand surgeons, especially with respect to percutaneous needle fasciotomy. In 2015 and 2017, 530 members of the German Society for Surgery of the Hand were invited to take part in an online survey, asking for their preferred treatment for Dupuytren disease, including decision criteria and in relation to Tubiana stages. 110 and 101 responders, respectively, took part. In both surveys, 86 surgeons stated that they treated up to 100 patients per year (Group A), while 24 and 15 surgeons, respectively, treated more than 100 Dupuytren patients annually (Group B). In both surveys, limited fasciectomy was found to be the preferred method (82.9\u2005% and 87.7\u2005%). Treatment with clostridial collagenase is performed only sporadically (1.3\u2005% or 1.4\u2005%). Percutaneous needle fasciotomy is of minor relevance in stage I (19.1\u2005% or 10.9\u2005%) and II (16.4\u2005% or 9.9\u2005%) and is performed mainly by surgeons who treat more than 100 patients per year.The most important criterion for the decision on what treatment should be chosen was 'best outcome' (54.3\u2005% and 68.6\u2005%). Between 2015 and 2017, there was no great change in the choice of treatment for Dupuytren disease in Germany. In particular, there was no increase in PNF procedures.", "tgt": "ZIEL: Die vorliegende Untersuchung pr\u00fcft, ob es zwischen 2015 und 2017 zu einem Wandel der von deutschen Handchirurgen zur Behandlung der Dupuytren\u2019schen Kontraktur bevorzugten Therapie kam, insbesondere ob ein Anstieg der Perkutanen Nadelfasziotomie zu verzeichnen ist. Jeweils 530 Mitglieder der Deutschen Gesellschaft f\u00fcr Handchirurgie (DGH) wurden 2015 und 2017 eingeladen an einer Online-Umfrage teilzunehmen, bei der stadienbezogen nach der jeweils bevorzugten Therapie des M. Dupuytren und den entsprechenden Entscheidungskriterien gefragt wurde. 110 bzw. 101 Befragte nahmen teil. Jeweils 86 gaben an, im Jahr bis 100 Patienten zu behandeln (Gruppe A), 24 bzw. 15 behandeln mehr als 100 Dupuytren-Patienten (Gruppe B). In beiden Umfragen wurde die Limitierte Fasziektomie als bevorzugte Therapie am h\u00e4ufigsten genannt (82,9\u2005% und 87,7\u2005%). Die Behandlung mit clostridialer Kollagenase wird nur sporadisch durchgef\u00fchrt (1,3\u2005% bzw. 1,4\u2005%). Die Perkutane Nadelfasziotomie hat nur in den Stadien I (19,1\u2005% und 10,9\u2005%) und II (16,4\u2005% und 9,9\u2005%) eine gewisse Bedeutung und wird vor allem von Kollegen durchgef\u00fchrt, die mehr als 100 Dupuytren-Patienten pro Jahr behandeln. Das Kriterium \u201eBestes Ergebnis\u201c wurde als wichtigstes Motiv bei der Entscheidungsfindung/Indikationsstellung genannt (54,3\u2005% und 68,6\u2005%). Eine nennenswerte Verschiebung bei der Therapiewahl der Dupuytren\u2019schen Kontraktur ist zwischen 2015 und 2017 in Deutschland nicht erfolgt. Insbesondere ist kein Anstieg der PNF zu verzeichnen.", "term_pairs": [{"src": {"text": "Dupuytren disease", "char_start": 132, "char_end": 149, "token_start": 23, "token_end": 25}, "tgt": {"text": "Dupuytren\u2019schen Kontraktur", "char_start": 138, "char_end": 164, "token_start": 23, "token_end": 27}}, {"src": {"text": "percutaneous needle fasciotomy", "char_start": 202, "char_end": 232, "token_start": 34, "token_end": 37}, "tgt": {"text": "Perkutanen Nadelfasziotomie", "char_start": 223, "char_end": 250, "token_start": 36, "token_end": 38}}, {"src": {"text": "German Society for Surgery of the Hand", "char_start": 271, "char_end": 309, "token_start": 47, "token_end": 54}, "tgt": {"text": "Deutschen Gesellschaft f\u00fcr Handchirurgie", "char_start": 298, "char_end": 338, "token_start": 46, "token_end": 50}}, {"src": {"text": "limited fasciectomy", "char_start": 740, "char_end": 759, "token_start": 138, "token_end": 140}, "tgt": {"text": "Limitierte Fasziektomie", "char_start": 756, "char_end": 779, "token_start": 130, "token_end": 132}}, {"src": {"text": "clostridial collagenase", "char_start": 833, "char_end": 856, "token_start": 161, "token_end": 163}, "tgt": {"text": "clostridialer Kollagenase", "char_start": 866, "char_end": 891, "token_start": 153, "token_end": 155}}, {"src": {"text": "percutaneous needle fasciotomy", "char_start": 906, "char_end": 936, "token_start": 179, "token_end": 182}, "tgt": {"text": "Perkutane Nadelfasziotomie", "char_start": 949, "char_end": 975, "token_start": 173, "token_end": 175}}, {"src": {"text": "PNF", "char_start": 1363, "char_end": 1366, "token_start": 287, "token_end": 288}, "tgt": {"text": "PNF", "char_start": 1485, "char_end": 1488, "token_start": 281, "token_end": 282}}]}
{"idx": 46, "pair_id": "30045382", "src": "Beh\u00e7et's disease is a multi-system disease with inflammatory infestations, in particular of the small and middle arteries and veins. Histologically, the disease presents with the image of leukocytoclastic vasculitis. The etiology of Beh\u00e7et disease is unknown, but genetic factors are discussed of playing a role in its pathogenesis. There is no known autoantibody, which could serve as a diagnostic tool. The disease usually affects patients in the 3. life decade and is rare in pediatrics. A very rare clinical form of Beh\u00e7et's disease occurs during neonatal period. In this form life-threatening courses of the disease have been described. In this report a family with a diagnosed disorder of the mother, where the second child presented with ulcerations in the mucous membrane area during the first week of life, will be discussed. In this case, the question of a transfer of autoantibodies from the mother, which triggers the disease in the child, must be raised. The clinical progress will be compared to known cases in the literature in order to derive recommendations for a therapeutic procedure. In our patient, ANAs were transiently detected, which correlated to the mother's. Fortunately, the course of the disease was mild, so that no further treatment was necessary. But, potential life-threatening events should be always held in consideration. Here, steroids seem to be the treatment of choice. In the wake of the increasing immigration of pregnant Morbus Beh\u00e7et patients from Mediterranean and from countries with higher prevalence of Morbus Beh\u00e7et-positive mothers should be considered.", "tgt": "Der Morbus Beh\u00e7et ist eine Multisystemerkrankung mit entz\u00fcndlichem Befall, v. a. der kleinen und mittleren Arterien und Venen. Histologisch zeigt sich das Bild einer leukozytoklastischen Vaskulitis. Die Ursachen des Morbus Beh\u00e7et sind unbekannt. Genetische Faktoren werden in der Pathogenese diskutiert. Ein \u201eklassischer\u201c Autoantik\u00f6rper als Diagnostiktool ist nicht bekannt. Die Erkrankung betrifft normalerweise Patienten in der dritten Lebensdekade und ist in der P\u00e4diatrie selten. Eine sehr seltene klinische Form des Morbus Beh\u00e7et tritt bereits in der Neonatalperiode auf. Hier sind bei einer Manifestation lebensbedrohliche Verl\u00e4ufe beschrieben. Vorgestellt werden soll eine Familie mit bekannter Erkrankung der Mutter, bei der bereits das zweite Kind in der ersten Lebenswoche mit Ulzerationen im Schleimhautbereich auffiel. Die Frage einer \u00dcbertragung von Autoantik\u00f6rpern, die dieses beim Kind triggert, muss in diesem Zusammenhang diskutiert werden. Dieser klinische Verlauf wird mit Verl\u00e4ufen aus der Literatur verglichen, um Empfehlungen zum therapeutischen Procedere ableiten zu k\u00f6nnen. Bei unserem Patienten lie\u00dfen sich vor\u00fcbergehend ANAs, die mit den m\u00fctterlichen korrelierten, nachweisen. Trotzdem zeigte sich ein milder Verlauf, der keine weiteren Interventionen bedurfte. An m\u00f6gliche potentielle lebensbedrohliche Symptome sollte aber immer gedacht werden. Hierbei scheinen Steroide das Mittel der Wahl zu sein. Im Zuge der zunehmenden Immigration schwangerer Morbus Beh\u00e7et-Patientinnen aus dem Mittelmeerraum und aus L\u00e4ndern mit h\u00f6herer Pr\u00e4valenz, wie z.\u2009B. auch Japan, nach Deutschland sollte bei der Betreuung von Neugeboren Morbus Beh\u00e7et-positiver M\u00fctter an die M\u00f6glichkeit eines transienten neonatalen Morbus Beh\u00e7et gedacht werden.", "term_pairs": [{"src": {"text": "Beh\u00e7et's disease", "char_start": 0, "char_end": 16, "token_start": 0, "token_end": 4}, "tgt": {"text": "Morbus Beh\u00e7et", "char_start": 4, "char_end": 17, "token_start": 1, "token_end": 3}}, {"src": {"text": "multi-system disease", "char_start": 22, "char_end": 42, "token_start": 6, "token_end": 10}, "tgt": {"text": "Multisystemerkrankung", "char_start": 27, "char_end": 48, "token_start": 5, "token_end": 6}}, {"src": {"text": "inflammatory infestations", "char_start": 48, "char_end": 73, "token_start": 11, "token_end": 13}, "tgt": {"text": "entz\u00fcndlichem Befall", "char_start": 53, "char_end": 73, "token_start": 7, "token_end": 9}}, {"src": {"text": "small and middle arteries and veins", "char_start": 96, "char_end": 131, "token_start": 18, "token_end": 24}, "tgt": {"text": "kleinen und mittleren Arterien und Venen", "char_start": 85, "char_end": 125, "token_start": 15, "token_end": 21}}, {"src": {"text": "leukocytoclastic vasculitis", "char_start": 188, "char_end": 215, "token_start": 34, "token_end": 36}, "tgt": {"text": "leukozytoklastischen Vaskulitis", "char_start": 166, "char_end": 197, "token_start": 28, "token_end": 30}}, {"src": {"text": "Beh\u00e7et disease", "char_start": 233, "char_end": 247, "token_start": 40, "token_end": 42}, "tgt": {"text": "Morbus Beh\u00e7et", "char_start": 216, "char_end": 229, "token_start": 34, "token_end": 36}}, {"src": {"text": "genetic factors", "char_start": 264, "char_end": 279, "token_start": 46, "token_end": 48}, "tgt": {"text": "Genetische Faktoren", "char_start": 246, "char_end": 265, "token_start": 39, "token_end": 41}}, {"src": {"text": "pathogenesis", "char_start": 319, "char_end": 331, "token_start": 56, "token_end": 57}, "tgt": {"text": "Pathogenese", "char_start": 280, "char_end": 291, "token_start": 44, "token_end": 45}}, {"src": {"text": "autoantibody", "char_start": 351, "char_end": 363, "token_start": 62, "token_end": 63}, "tgt": {"text": "Autoantik\u00f6rper", "char_start": 322, "char_end": 336, "token_start": 51, "token_end": 52}}, {"src": {"text": "diagnostic tool", "char_start": 388, "char_end": 403, "token_start": 69, "token_end": 71}, "tgt": {"text": "Diagnostiktool", "char_start": 341, "char_end": 355, "token_start": 53, "token_end": 54}}, {"src": {"text": "pediatrics", "char_start": 479, "char_end": 489, "token_start": 87, "token_end": 88}, "tgt": {"text": "P\u00e4diatrie", "char_start": 466, "char_end": 475, "token_start": 71, "token_end": 72}}, {"src": {"text": "neonatal period", "char_start": 551, "char_end": 566, "token_start": 101, "token_end": 103}, "tgt": {"text": "Neonatalperiode", "char_start": 556, "char_end": 571, "token_start": 86, "token_end": 87}}, {"src": {"text": "ulcerations", "char_start": 745, "char_end": 756, "token_start": 137, "token_end": 138}, "tgt": {"text": "Ulzerationen", "char_start": 787, "char_end": 799, "token_start": 120, "token_end": 121}}, {"src": {"text": "mucous membrane area", "char_start": 764, "char_end": 784, "token_start": 140, "token_end": 143}, "tgt": {"text": "Schleimhautbereich", "char_start": 803, "char_end": 821, "token_start": 122, "token_end": 123}}, {"src": {"text": "autoantibodies", "char_start": 879, "char_end": 893, "token_start": 164, "token_end": 165}, "tgt": {"text": "Autoantik\u00f6rpern", "char_start": 863, "char_end": 878, "token_start": 130, "token_end": 131}}, {"src": {"text": "therapeutic procedure", "char_start": 1081, "char_end": 1102, "token_start": 200, "token_end": 202}, "tgt": {"text": "therapeutischen Procedere", "char_start": 1052, "char_end": 1077, "token_start": 159, "token_end": 161}}, {"src": {"text": "ANAs", "char_start": 1120, "char_end": 1124, "token_start": 207, "token_end": 208}, "tgt": {"text": "ANAs", "char_start": 1146, "char_end": 1150, "token_start": 171, "token_end": 172}}, {"src": {"text": "steroids", "char_start": 1364, "char_end": 1372, "token_start": 254, "token_end": 255}, "tgt": {"text": "Steroide", "char_start": 1390, "char_end": 1398, "token_start": 207, "token_end": 208}}, {"src": {"text": "Morbus Beh\u00e7et patients", "char_start": 1463, "char_end": 1485, "token_start": 272, "token_end": 275}, "tgt": {"text": "Morbus Beh\u00e7et-Patientinnen", "char_start": 1476, "char_end": 1502, "token_start": 221, "token_end": 225}}, {"src": {"text": "Mediterranean", "char_start": 1491, "char_end": 1504, "token_start": 276, "token_end": 277}, "tgt": {"text": "Mittelmeerraum", "char_start": 1511, "char_end": 1525, "token_start": 227, "token_end": 228}}, {"src": {"text": "prevalence", "char_start": 1536, "char_end": 1546, "token_start": 282, "token_end": 283}, "tgt": {"text": "Pr\u00e4valenz", "char_start": 1554, "char_end": 1563, "token_start": 233, "token_end": 234}}]}
{"idx": 282, "pair_id": "33748867", "src": "The challenges posed by the COVID-19 pandemic face different institutional structures and traditions of action in the European health systems. This article uses the example of the public health services in Sweden, France and Austria to address the question of the similarities and differences in the measures taken to combat the pandemic (status: November 2020).Among the countries presented in this article, Austria is the least affected by the pandemic and France is the most affected. In all analysed health systems there is a\u00a0tension between national and regional responsibilities. France's healthcare system is particularly centralized, while Sweden's is strongly regional and municipal. Governments in the nation states are striving to obtain pandemic containment powers independent of parliamentary decisions. Sweden differs from Austria and France in that its pandemic containment strategy is based primarily on recommendations and appeals rather than directives and bans. The sequences of action during the pandemic and, apart from Sweden, the instruments used to contain the pandemic are similar. The course of the pandemic and the measures taken in Austria and France show clear parallels with those in Germany. The protection of particularly vulnerable groups has not been sufficiently successful in all countries and remains a\u00a0challenge to be met.", "tgt": "Die Herausforderungen der COVID-19-Pandemie sto\u00dfen in europ\u00e4ischen Gesundheitssystemen auf unterschiedliche institutionelle Strukturen und Handlungstraditionen. Dieser Beitrag befasst sich am Beispiel der \u00f6ffentlichen Gesundheitsdienste (\u00d6GD) Schwedens, Frankreichs und \u00d6sterreichs mit der Frage nach den Gemeinsamkeiten und Unterschieden bei den Ma\u00dfnahmen zur Pandemiebek\u00e4mpfung (Stand: November 2020).\u00d6sterreich ist das unter den Vergleichsl\u00e4ndern am wenigsten, Frankreich das am st\u00e4rksten von der Pandemie betroffene Land. In allen analysierten Gesundheitssystemen existiert ein Spannungsverh\u00e4ltnis zwischen nationalstaatlichen und regionalen Zust\u00e4ndigkeiten. Frankreichs Gesundheitssystem ist besonders zentralistisch ausgerichtet, das schwedische stark regional und kommunal organisiert. Die Regierungen in den Nationalstaaten sind bestrebt, von Parlamentsentscheidungen unabh\u00e4ngige Kompetenzen zur Pandemieeind\u00e4mmung zu erhalten. Schweden unterscheidet sich bei der Pandemieeind\u00e4mmung von \u00d6sterreich und Frankreich durch eine vornehmlich auf Empfehlung und Appelle statt auf Ge- und Verbote st\u00fctzende Strategie. Dabei \u00e4hneln sich die Handlungssequenzen im Pandemieverlauf und, abgesehen von Schweden, auch die zur Pandemieeind\u00e4mmung eingesetzten Instrumente. Der Verlauf und die getroffenen Ma\u00dfnahmen in \u00d6sterreich und Frankreich zeigen deutliche Parallelen zu denen in Deutschland. Der Schutz besonders vulnerabler Gruppen ist in allen L\u00e4ndern nur unzureichend gelungen und bleibt eine best\u00e4ndige Herausforderung.", "term_pairs": [{"src": {"text": "COVID-19 pandemic", "char_start": 28, "char_end": 45, "token_start": 5, "token_end": 9}, "tgt": {"text": "COVID-19-Pandemie", "char_start": 26, "char_end": 43, "token_start": 3, "token_end": 8}}, {"src": {"text": "health systems", "char_start": 127, "char_end": 141, "token_start": 20, "token_end": 22}, "tgt": {"text": "Gesundheitssystemen", "char_start": 67, "char_end": 86, "token_start": 11, "token_end": 12}}, {"src": {"text": "public health services", "char_start": 180, "char_end": 202, "token_start": 30, "token_end": 33}, "tgt": {"text": "\u00f6ffentlichen Gesundheitsdienste", "char_start": 205, "char_end": 236, "token_start": 26, "token_end": 28}}, {"src": {"text": "pandemic containment", "char_start": 749, "char_end": 769, "token_start": 129, "token_end": 131}, "tgt": {"text": "Pandemieeind\u00e4mmung", "char_start": 904, "char_end": 922, "token_start": 116, "token_end": 117}}, {"src": {"text": "vulnerable groups", "char_start": 1254, "char_end": 1271, "token_start": 210, "token_end": 212}, "tgt": {"text": "vulnerabler Gruppen", "char_start": 1410, "char_end": 1429, "token_start": 187, "token_end": 189}}]}
{"idx": 429, "pair_id": "33752718", "src": "In this study we examined to what extent members of a best-practice integrated healthcare model in Germany discussed their subjective future work ability with their general practitioner (GP); furthermore, we examined independent variables which explain whether future work ability is discussed. In a cross-sectional survey, 1168 (out of 3218 invited) integrated healthcare members responded to a standardized questionnaire. This study includes n\u2009=\u2009475 employed respondents who were at most 65\u2009years old. We determined the (relative) frequency of employed members up to 65\u2009years who had already discussed their subjective future work ability with their GP. By means of logistic regression analysis, explanatory variables were identified which statistically explained the discussion of future work ability with their GP. N\u2009=\u200980 (16.8%) respondents stated they had discussed their future work ability with their GP. A multiple logistic regression analysis showed the following results: The odds ratio for discussing future work ability is increased the more satisfied respondents are with their general practitioner, the worse they assess their current work ability in relation to the physical demands of the job, and when respondents suffer from one or more chronic diseases (Nagelkerke's pseudo-R<sup>2</sup>\u2009=\u20090.13). Even in this healthcare setting, employees up to the age of 65 rarely discussed their subjective future work ability with their GP. This suggests that the issue 'future work ability' is even less commonly discussed in other community-based care settings in Germany. It seems that health care providers involved in acute care only sporadically take this issue into consideration - despite the great importance of maintaining work ability.", "tgt": "ZIELSETZUNG: In dieser Studie untersuchten wir, wie h\u00e4ufig Mitglieder eines Best-Practice-Modells der Integrierten Versorgung in Deutschland ihre subjektive k\u00fcnftige Arbeitsf\u00e4higkeit mit ihrem Hausarzt (GP) besprechen; dar\u00fcber hinaus untersuchten wir unabh\u00e4ngige Variablen, die erkl\u00e4ren, ob die k\u00fcnftige Arbeitsf\u00e4higkeit thematisiert wird. In einer Querschnittserhebung beantworteten 1168 (von 3218 Eingeladenen) Mitglieder der Integrierten Versorgung einen standardisierten Fragebogen. Diese Studie umfasst n\u2009=\u2009475 berufst\u00e4tige Befragte, die h\u00f6chstens 65 Jahre alt waren. Wir ermittelten die H\u00e4ufigkeit von erwerbst\u00e4tigen Mitgliedern bis 65 Jahre, die ihre subjektive k\u00fcnftige Arbeitsf\u00e4higkeit bereits mit ihrem Hausarzt besprochen hatten. Mit Hilfe einer logistischen Regressionsanalyse wurden Pr\u00e4diktoren ermittelt, die erkl\u00e4ren, ob die k\u00fcnftige Arbeitsf\u00e4higkeit mit dem Hausarzt besprochen wird. N\u2009=\u200980 (16,8%) der Befragten gaben an, ihre k\u00fcnftige Arbeitsf\u00e4higkeit mit ihrem Hausarzt besprochen zu haben. Eine multiple logistische Regressionsanalyse ergab folgende Ergebnisse: Die Odds Ratio f\u00fcr die Besprechung der k\u00fcnftigen Arbeitsf\u00e4higkeit ist umso h\u00f6her, je zufriedener die Befragten mit ihrem Hausarzt sind, je schlechter sie selbst ihre derzeitige Arbeitsf\u00e4higkeit in Bezug auf die k\u00f6rperlichen Arbeitsanforderungen einsch\u00e4tzen und wenn die Befragten chronisch krank sind (Nagelkerke-Pseudo-R<sup>2</sup>\u2009=\u20090,13). Selbst im hier vorliegenden Versorgungskontext besprachen Erwerbst\u00e4tige bis zum Alter von 65 Jahren ihre k\u00fcnftige Arbeitsf\u00e4higkeit nur selten mit ihrem Hausarzt. Dies deutet darauf hin, dass das Thema \u201ck\u00fcnftige Arbeitsf\u00e4higkeit\u201d in anderen populationsbezogenen Settings der Gesundheitsversorgung in Deutschland noch seltener besprochen wird. Es scheint, dass in der Akutversorgung t\u00e4tige Leistungserbringer dieses Thema nur sporadisch ber\u00fccksichtigen - trotz der gro\u00dfen Bedeutung des Erhalts der Arbeitsf\u00e4higkeit.", "term_pairs": [{"src": {"text": "general practitioner (GP)", "char_start": 165, "char_end": 190, "token_start": 27, "token_end": 32}, "tgt": {"text": "Hausarzt (GP)", "char_start": 193, "char_end": 206, "token_start": 28, "token_end": 32}}, {"src": {"text": "future work ability", "char_start": 134, "char_end": 153, "token_start": 22, "token_end": 25}, "tgt": {"text": "k\u00fcnftige Arbeitsf\u00e4higkeit", "char_start": 157, "char_end": 182, "token_start": 24, "token_end": 26}}, {"src": {"text": "subjective future work ability", "char_start": 610, "char_end": 640, "token_start": 106, "token_end": 110}, "tgt": {"text": "subjektive k\u00fcnftige Arbeitsf\u00e4higkeit", "char_start": 658, "char_end": 694, "token_start": 98, "token_end": 101}}, {"src": {"text": "cross-sectional survey", "char_start": 300, "char_end": 322, "token_start": 50, "token_end": 54}, "tgt": {"text": "Querschnittserhebung", "char_start": 349, "char_end": 369, "token_start": 53, "token_end": 54}}, {"src": {"text": "logistic regression analysis", "char_start": 668, "char_end": 696, "token_start": 117, "token_end": 120}, "tgt": {"text": "logistische Regressionsanalyse", "char_start": 1024, "char_end": 1054, "token_start": 156, "token_end": 158}}, {"src": {"text": "odds ratio", "char_start": 987, "char_end": 997, "token_start": 171, "token_end": 173}, "tgt": {"text": "Odds Ratio", "char_start": 1086, "char_end": 1096, "token_start": 163, "token_end": 165}}, {"src": {"text": "chronic diseases", "char_start": 1256, "char_end": 1272, "token_start": 216, "token_end": 218}, "tgt": {"text": "chronisch krank", "char_start": 1362, "char_end": 1377, "token_start": 202, "token_end": 204}}, {"src": {"text": "Nagelkerke's pseudo-R<sup>2</sup>", "char_start": 1274, "char_end": 1307, "token_start": 219, "token_end": 233}, "tgt": {"text": "Nagelkerke-Pseudo-R<sup>2</sup>", "char_start": 1384, "char_end": 1415, "token_start": 206, "token_end": 219}}, {"src": {"text": "integrated healthcare", "char_start": 68, "char_end": 89, "token_start": 14, "token_end": 16}, "tgt": {"text": "Integrierten Versorgung", "char_start": 102, "char_end": 125, "token_start": 18, "token_end": 20}}, {"src": {"text": "acute care", "char_start": 1631, "char_end": 1641, "token_start": 296, "token_end": 298}, "tgt": {"text": "Akutversorgung", "char_start": 1791, "char_end": 1805, "token_start": 278, "token_end": 279}}]}
{"idx": 501, "pair_id": "33780988", "src": "The functional gastrointestinal disorders (FGIDs) have a high prevalence and are associated with high healthcare costs. The diagnosis of these diseases could be difficult and require func-tional tests such as high-resolution manometry (HRM) of the esophagus, anorectal manometry and H2-Breathtests. Due to the COVID-19 Pandemic and the fear of infections there was a marked reduction in the number of performed exams in the last months - nevertheless some exams are necessary, in order to exclude or to diagnose important and dangerous diseases like Achalasia. Goal of this article is to present some new and relevant developments in the field. The HRM of the esophagus is the diagnostic standard for Achalasia, a rare clinical condi-tion associated to dysphagia - new European guidelines suggests a safe strategy in perform-ing the pneumatic dilatation.The intestinal methanogen overgrowth (IMO) is a clinical condition caused by a high production of methane in the small intestine due to overgrowth of Methanobrevibacter smithii, this condition could be in some patients associated with irritable bowel syndrome.", "tgt": "In den letzten 2 Jahren wurden mehrere Leitlinien unterschiedlicher Fachgesellschaften publiziert. Zur interventionellen Behandlung der Achalasie kommen die pneumatische Dilatation, die POEM sowie die Heller-Myotomie zur Anwendung. Bei der Durchf\u00fchrung der pneumatischen Dilatation ist ein sequenzielles Vorgehen empfohlen (1. Dilatation bis 30\u200amm, 4 Wochen sp\u00e4ter 2. Dilatation auf 35\u200amm). SIBO: \u2002Die bakterielle Fehlbesiedlung des D\u00fcnndarms ist ein klinisches Syndrom mit einem breiten Spektrum an Symptomen. Goldstandard ist die Kultur aus Duodenalsaft mit einem Cut-off von >\u200a1000CFU/ml laut der neuen amerikanischen Leitlinie. Mit einer geringeren Sensitivit\u00e4t, aber hohen Spezifit\u00e4t ist der H<sub>2</sub>-Atemtest mit Glukose geeignet. Der Laktulose-Atemtest ist eher skeptisch zu bewerten. IMO: \u2002Als intestinal methanogen overgrowth (IMO) bezeichnet man eine \u00dcberwucherung von Methan-produzierenden Prokariota, welche mittels Durchf\u00fchrung eines Atemtests mit Messung des Methans in der Ausatemluft nachgewiesen werden kann. Diese Kondition ist teilweise mit einem Reizdarmsyndrom vom Obstipationstyp assoziiert. COVID-19 UND FUNKTIONSDIAGNOSTIK: \u2002Aufgrund der COVID-19-Pandemie hat in den letzten Monaten die Zahl an Untersuchungen in der gastroenterologischen Funktionsdiagnostik abgenommen \u2013 es wurden allerdings Empfehlungen zur Priorisierung ver\u00f6ffentlicht.", "term_pairs": [{"src": {"text": "COVID-19 Pandemic", "char_start": 310, "char_end": 327, "token_start": 56, "token_end": 60}, "tgt": {"text": "COVID-19-Pandemie", "char_start": 1167, "char_end": 1184, "token_start": 191, "token_end": 196}}, {"src": {"text": "Achalasia", "char_start": 550, "char_end": 559, "token_start": 99, "token_end": 100}, "tgt": {"text": "Achalasie", "char_start": 136, "char_end": 145, "token_start": 16, "token_end": 17}}, {"src": {"text": "pneumatic dilatation", "char_start": 833, "char_end": 853, "token_start": 151, "token_end": 153}, "tgt": {"text": "pneumatische Dilatation", "char_start": 157, "char_end": 180, "token_start": 19, "token_end": 21}}, {"src": {"text": "intestinal methanogen overgrowth (IMO)", "char_start": 858, "char_end": 896, "token_start": 155, "token_end": 161}, "tgt": {"text": "intestinal methanogen overgrowth (IMO)", "char_start": 807, "char_end": 845, "token_start": 140, "token_end": 146}}, {"src": {"text": "irritable bowel syndrome", "char_start": 1089, "char_end": 1113, "token_start": 192, "token_end": 195}, "tgt": {"text": "Reizdarmsyndrom", "char_start": 1071, "char_end": 1086, "token_start": 178, "token_end": 179}}]}
{"idx": 622, "pair_id": "32412533", "src": "This article explores diverse views on both the current challenges and limits as well as the reforms and innovations of existing democracies at the beginning of the twenty-first century. First, it argues that socioeconomic inequality, new populism, new forms of communication, and globalization have stimulated a\u00a0renewal of interest in analyzing the 'frontiers of democracy.' Democracies have reacted with different innovations and reforms in order to meet these challenges. The authors trace the phases of respective research from studies on singular, standalone instances to normative as well as empirical work on participatory (direct democratic and deliberative) systems. Finally, they advocate for combining the conceptual approach of defining democracy by the fulfillment of democratic values with rigorous empirical evaluation of the contributions (old and new) that institutions and procedures provide in order to fulfill these values and meet the mentioned challenges.", "tgt": "Dieser Artikel untersucht unterschiedliche Ansichten \u00fcber die aktuellen Herausforderungen und Grenzen sowie auch \u00fcber Reformen und Innovationen der bestehenden Demokratien zu Beginn des 21.\u00a0Jahrhunderts. Er verdeutlicht, dass die sozio\u00f6konomische Ungleichheit, der neue Populismus, die neuen Kommunikationsformen und die Globalisierung zu einem neuen wissenschaftlichen Diskurs \u00fcber die \u201eGrenzen der Demokratie\u201c gef\u00fchrt haben. Demokratien haben mit unterschiedlichen Innovationen und Reformen auf diese Herausforderungen reagiert. Die Autoren zeichnen die Phasen der Demokratische-Innovationen-Forschung nach \u2013 von der Fokussierung auf einzelne Innovationen bis zu normativen und empirischen Studien zu partizipativen (direktdemokratischen und deliberativen) Systemen. Der Beitrag endet mit einem Pl\u00e4doyer f\u00fcr zuk\u00fcnftige politikwissenschaftliche Forschung. Notwendig ist die Kombination eines konzeptuellen Zugangs, bei dem Demokratie anhand der Verwirklichung demokratischer Werte definiert wird, mit gr\u00fcndlicher empirischer Evaluation der Beitr\u00e4ge (neuer und alter) Institutionen und Verfahren zur Erf\u00fcllung dieser Normen sowie zur Bew\u00e4ltigung der genannten Herausforderungen.", "term_pairs": [{"src": {"text": "socioeconomic inequality", "char_start": 209, "char_end": 233, "token_start": 37, "token_end": 39}, "tgt": {"text": "sozio\u00f6konomische Ungleichheit", "char_start": 230, "char_end": 259, "token_start": 32, "token_end": 34}}, {"src": {"text": "new populism", "char_start": 235, "char_end": 247, "token_start": 40, "token_end": 42}, "tgt": {"text": "neue Populismus", "char_start": 265, "char_end": 280, "token_start": 36, "token_end": 38}}, {"src": {"text": "new forms of communication", "char_start": 249, "char_end": 275, "token_start": 43, "token_end": 47}, "tgt": {"text": "neuen Kommunikationsformen", "char_start": 286, "char_end": 312, "token_start": 40, "token_end": 42}}, {"src": {"text": "globalization", "char_start": 281, "char_end": 294, "token_start": 49, "token_end": 50}, "tgt": {"text": "Globalisierung", "char_start": 321, "char_end": 335, "token_start": 44, "token_end": 45}}, {"src": {"text": "frontiers of democracy", "char_start": 351, "char_end": 373, "token_start": 60, "token_end": 63}, "tgt": {"text": "Grenzen der Demokratie", "char_start": 388, "char_end": 410, "token_start": 53, "token_end": 56}}, {"src": {"text": "innovations and reforms", "char_start": 416, "char_end": 439, "token_start": 70, "token_end": 73}, "tgt": {"text": "Innovationen und Reformen", "char_start": 467, "char_end": 492, "token_start": 64, "token_end": 67}}, {"src": {"text": "participatory", "char_start": 616, "char_end": 629, "token_start": 103, "token_end": 104}, "tgt": {"text": "partizipativen", "char_start": 703, "char_end": 717, "token_start": 98, "token_end": 99}}, {"src": {"text": "direct democratic", "char_start": 631, "char_end": 648, "token_start": 105, "token_end": 107}, "tgt": {"text": "direktdemokratischen", "char_start": 719, "char_end": 739, "token_start": 100, "token_end": 101}}, {"src": {"text": "deliberative", "char_start": 653, "char_end": 665, "token_start": 108, "token_end": 109}, "tgt": {"text": "deliberativen", "char_start": 744, "char_end": 757, "token_start": 102, "token_end": 103}}, {"src": {"text": "democratic values", "char_start": 781, "char_end": 798, "token_start": 128, "token_end": 130}, "tgt": {"text": "demokratischer Werte", "char_start": 961, "char_end": 981, "token_start": 131, "token_end": 133}}, {"src": {"text": "empirical evaluation", "char_start": 813, "char_end": 833, "token_start": 132, "token_end": 134}, "tgt": {"text": "empirischer Evaluation", "char_start": 1014, "char_end": 1036, "token_start": 138, "token_end": 140}}, {"src": {"text": "institutions and procedures", "char_start": 874, "char_end": 901, "token_start": 143, "token_end": 146}, "tgt": {"text": "Institutionen und Verfahren", "char_start": 1068, "char_end": 1095, "token_start": 147, "token_end": 150}}]}
{"idx": 795, "pair_id": "32252119", "src": "The present study examines dimensionality, reliability and convergent validity of the German Beck Scale for Suicidal Ideation (BSS) in a clinical sample. 308 inpatients after suicide attempts/acute suicidality participated in the study (53,6% female). Of those, 224 completed the full BSS and self-report questionnaires assessing depression (DESC), hopelessness (BHS), interpersonal variables (INQ) and defeat (DS-d)/entrapment (ES-d). Dimensionality was investigated by confirmatory factor analysis (CFA, models with 1, 2, 3 and 5 factors) and convergent validity was investigated by correlational analysis (Pearson). In total, the 5-factor model achieved the best fit. Yet, model fit is comparable between all tested models without considering the RMSEA model. The multidimensional models result in similar subscales. Subscales reflecting passive death wishes (\u03b1>0,80), active suicidal ideation (\u03b1>0,73) and suicide-related behaviors (\u03b1>0,70) achieve acceptable internal consistency. The BSS sum score and the subscales assessing passive and active suididal thoughts correlate moderately positive with DESC, BHS, INQ and DS-d/ES-d (r between 0,25 and 0,66) while the behavior-related scale shows smaller (r between 0,14 und 0,27) or no associations (INQ, thwarted belongingness). The CFAs do not provide clear evidence for either an uni- or a multidimensional structure of the BSS. In the light of this finding, use of the BSS score is limited despite evidence supporting its reliability and convergent validity.", "tgt": "Dimensionalit\u00e4t, Reliabilit\u00e4t und konvergente Validit\u00e4t der deutschsprachigen Beck Scale for Suicidal Ideation (BSS) sollen erstmalig in einer klinischen Stichprobe untersucht warden. 308 station\u00e4re Patienten nach Suizidversuch/mit akuter Suizidalit\u00e4t wurden rekrutiert (53,6% weiblich); 224 f\u00fcllten die vollst\u00e4ndige BSS sowie weitere Frageb\u00f6gen f\u00fcr Depression (DESC), Hoffnungslosigkeit (BHS), interpersonale Variablen (INQ) und Defeat (DS-d)/Entrapment (ES-d) aus. Neben konfirmatorischen Faktoranalysen (CFA, Pr\u00fcfung von Modellen mit 1, 2, 3 und 5 Faktoren) zur Dimensionalit\u00e4tspr\u00fcfung wurden Pearson-Korrelationen zur Bestimmung der konvergenten Validit\u00e4t berechnet. Insgesamt erzielt das 5-Faktoren-Modell den besten Fit; ohne Ber\u00fccksichtigung des RMSEA-Wertes ist der Modell-Fit zwischen den verschiedenen Modellen allerdings vergleichbar. Im Rahmen der mehrfaktoriellen Modelle entstehen inhaltlich vergleichbare Subskalen. Akzeptable interne Konsistenzen zeigen sich nur f\u00fcr die Subskalen, die passive Todesw\u00fcnsche (\u03b1>0,80), aktive Suizidgedanken (\u03b1>0,73) und suizidhandlungsbezogene Items (\u03b1>0,70) erfassen. Der BSS-Summenscore sowie die Subskalen, die passive bzw. aktive Suizidgedanken abbilden, korrelieren moderat mit DESC, BHS, INQ und DS-d/ ES-d (r zwischen 0,25 und 0,66), w\u00e4hrend die handlungsbezogene Subskala keine (INQ, Thwarted Belongingness) bzw. geringe Assoziationen zeigt (r zwischen 0,14 und 0,27). Die CFAs liefern keinen eindeutigen Hinweis f\u00fcr eine ein- oder mehrdimensionale Struktur der BSS. So ist die Auswertung \u00fcber den BSS-Summenwert trotz Hinweisen auf dessen Reliabilit\u00e4t und konvergente Validit\u00e4t aus empirischer Sicht kritisch zu bewerten.", "term_pairs": [{"src": {"text": "Beck Scale for Suicidal Ideation", "char_start": 93, "char_end": 125, "token_start": 13, "token_end": 18}, "tgt": {"text": "Beck Scale for Suicidal Ideation", "char_start": 78, "char_end": 110, "token_start": 8, "token_end": 13}}, {"src": {"text": "BSS", "char_start": 127, "char_end": 130, "token_start": 19, "token_end": 20}, "tgt": {"text": "BSS", "char_start": 112, "char_end": 115, "token_start": 14, "token_end": 15}}, {"src": {"text": "DESC", "char_start": 342, "char_end": 346, "token_start": 62, "token_end": 63}, "tgt": {"text": "DESC", "char_start": 362, "char_end": 366, "token_start": 55, "token_end": 56}}, {"src": {"text": "BHS", "char_start": 363, "char_end": 366, "token_start": 67, "token_end": 68}, "tgt": {"text": "BHS", "char_start": 389, "char_end": 392, "token_start": 60, "token_end": 61}}, {"src": {"text": "INQ", "char_start": 394, "char_end": 397, "token_start": 73, "token_end": 74}, "tgt": {"text": "INQ", "char_start": 421, "char_end": 424, "token_start": 66, "token_end": 67}}, {"src": {"text": "DS-d", "char_start": 411, "char_end": 415, "token_start": 78, "token_end": 81}, "tgt": {"text": "DS-d", "char_start": 438, "char_end": 442, "token_start": 71, "token_end": 74}}, {"src": {"text": "ES-d", "char_start": 429, "char_end": 433, "token_start": 85, "token_end": 88}, "tgt": {"text": "ES-d", "char_start": 456, "char_end": 460, "token_start": 78, "token_end": 81}}, {"src": {"text": "confirmatory factor analysis", "char_start": 471, "char_end": 499, "token_start": 94, "token_end": 97}, "tgt": {"text": "konfirmatorischen Faktoranalysen", "char_start": 473, "char_end": 505, "token_start": 85, "token_end": 87}}, {"src": {"text": "CFA", "char_start": 501, "char_end": 504, "token_start": 98, "token_end": 99}, "tgt": {"text": "CFA", "char_start": 507, "char_end": 510, "token_start": 88, "token_end": 89}}, {"src": {"text": "Pearson", "char_start": 609, "char_end": 616, "token_start": 120, "token_end": 121}, "tgt": {"text": "Pearson", "char_start": 596, "char_end": 603, "token_start": 106, "token_end": 107}}, {"src": {"text": "RMSEA", "char_start": 750, "char_end": 755, "token_start": 149, "token_end": 150}, "tgt": {"text": "RMSEA", "char_start": 753, "char_end": 758, "token_start": 131, "token_end": 132}}]}
{"idx": 807, "pair_id": "26633901", "src": "The current standard therapy to treat myomas in women wishing to have children consists of minimally invasive surgical myomectomy. Uterine artery embolisation (UAE) has also been discussed as another minimally invasive treatment option to treat myomas. This review evaluates the literature of the past 10 years on fibroid embolisation and its impact on fertility and pregnancy. Potential problems associated with UAE such as radiation exposure of the ovaries, impairment of ovarian function and the impact on pregnancy and child birth are discussed in detail. Previously published reports of at least 337 pregnancies after UAE were evaluated. The review concludes that UAE to treat myomas can only be recommended in women with fertility problems due to myomas who refuse surgery or women with an unacceptably high surgical risk, because the evaluated case reports and studies show that UAE significantly increases the risk of spontaneous abortion; there is also evidence of pathologically increased levels for other obstetric outcome parameters. There are still very few prospective studies which provide sufficient evidence for a definitive statement on the impact of UAE therapy on fertility rates and pregnancy outcomes.", "tgt": "Aktueller Therapiestandard bei Frauen mit Kinderwunsch zur Behandlung von Myomen ist die m\u00f6glichst wenig invasive, operative Myomenukleation. Die Uterusarterienembolisation (UAE) zur Myomtherapie wird immer wieder als ebenfalls minimalinvasive Therapiem\u00f6glichkeit diskutiert. Die \u00dcbersichtsarbeit wertet die Literatur der letzten 10 Jahre zum Thema \u201eMyomembolisation \u2013 Einfluss auf Fertilit\u00e4t und Schwangerschaft\u201c aus, wobei sowohl eine m\u00f6gliche, mit der Intervention verbundene Strahlenbelastung der Ovarien, m\u00f6gliche St\u00f6rungen der Ovarialfunktion infolge der UAE als auch m\u00f6gliche Auswirkungen auf Schwangerschaft und Geburt auf der Basis der vorliegenden Literatur ausf\u00fchrlich diskutiert werden. Die bisher publizierten mindestens 337 Schwangerschaften nach UAE wurden ausgewertet. Als Reviewergebnis kann die UAE von Myomen nur f\u00fcr Frauen mit myomassoziierten Fertilit\u00e4tsproblemen empfohlen werden, die chirurgischen Ma\u00dfnahmen ablehnen oder die ein inakzeptabel hohes chirurgisches Risiko aufweisen, denn vorliegende Fallserien und Studien zeigen, dass eine UAE zumindest das Abortrisiko deutlich erh\u00f6ht; f\u00fcr weitere geburtshilfliche Outcome-Parameter gibt es Hinweise auf pathologisch erh\u00f6hte Werte. Es liegen weiterhin nur wenige prospektive Studien vor, deren Ergebnisse mit der erforderlichen Evidenz eine Aussage \u00fcber den Einfluss der UAE-Therapie auf Fertilit\u00e4tsrate und Schwangerschaftsausgang zulassen.", "term_pairs": [{"src": {"text": "myomas", "char_start": 38, "char_end": 44, "token_start": 6, "token_end": 7}, "tgt": {"text": "Myomen", "char_start": 74, "char_end": 80, "token_start": 9, "token_end": 10}}, {"src": {"text": "minimally invasive surgical myomectomy", "char_start": 91, "char_end": 129, "token_start": 15, "token_end": 19}, "tgt": {"text": "m\u00f6glichst wenig invasive, operative Myomenukleation", "char_start": 89, "char_end": 140, "token_start": 12, "token_end": 18}}, {"src": {"text": "Uterine artery embolisation (UAE)", "char_start": 131, "char_end": 164, "token_start": 20, "token_end": 26}, "tgt": {"text": "Uterusarterienembolisation (UAE)", "char_start": 146, "char_end": 178, "token_start": 20, "token_end": 24}}, {"src": {"text": "fibroid embolisation", "char_start": 314, "char_end": 334, "token_start": 51, "token_end": 53}, "tgt": {"text": "Myomembolisation", "char_start": 350, "char_end": 366, "token_start": 47, "token_end": 48}}, {"src": {"text": "fertility", "char_start": 353, "char_end": 362, "token_start": 57, "token_end": 58}, "tgt": {"text": "Fertilit\u00e4t", "char_start": 382, "char_end": 392, "token_start": 51, "token_end": 52}}, {"src": {"text": "pregnancy", "char_start": 367, "char_end": 376, "token_start": 59, "token_end": 60}, "tgt": {"text": "Schwangerschaft", "char_start": 397, "char_end": 412, "token_start": 53, "token_end": 54}}, {"src": {"text": "ovaries", "char_start": 451, "char_end": 458, "token_start": 72, "token_end": 73}, "tgt": {"text": "Ovarien", "char_start": 501, "char_end": 508, "token_start": 68, "token_end": 69}}, {"src": {"text": "ovarian function", "char_start": 474, "char_end": 490, "token_start": 76, "token_end": 78}, "tgt": {"text": "Ovarialfunktion", "char_start": 533, "char_end": 548, "token_start": 73, "token_end": 74}}, {"src": {"text": "child birth", "char_start": 523, "char_end": 534, "token_start": 84, "token_end": 86}, "tgt": {"text": "Geburt", "char_start": 620, "char_end": 626, "token_start": 84, "token_end": 85}}, {"src": {"text": "spontaneous abortion", "char_start": 926, "char_end": 946, "token_start": 151, "token_end": 153}, "tgt": {"text": "Abortrisiko", "char_start": 1080, "char_end": 1091, "token_start": 147, "token_end": 148}}, {"src": {"text": "obstetric outcome parameters", "char_start": 1016, "char_end": 1044, "token_start": 164, "token_end": 167}, "tgt": {"text": "geburtshilfliche Outcome-Parameter", "char_start": 1121, "char_end": 1155, "token_start": 153, "token_end": 157}}, {"src": {"text": "prospective studies", "char_start": 1071, "char_end": 1090, "token_start": 173, "token_end": 175}, "tgt": {"text": "prospektive Studien", "char_start": 1236, "char_end": 1255, "token_start": 170, "token_end": 172}}, {"src": {"text": "fertility rates", "char_start": 1184, "char_end": 1199, "token_start": 190, "token_end": 192}, "tgt": {"text": "Fertilit\u00e4tsrate", "char_start": 1361, "char_end": 1376, "token_start": 190, "token_end": 191}}, {"src": {"text": "pregnancy outcomes", "char_start": 1204, "char_end": 1222, "token_start": 193, "token_end": 195}, "tgt": {"text": "Schwangerschaftsausgang", "char_start": 1381, "char_end": 1404, "token_start": 192, "token_end": 193}}]}
{"idx": 1061, "pair_id": "29212106", "src": "Pneumocystis jirovecii pneumonia is a common cause of respiratory disease in immunocompromised hosts. We describe a case of an HIV negative, immunocompetent patient and discuss the probable cause.", "tgt": "Beschrieben wird das Auftreten einer Pneumocystis jirovecii-Pneumonie bei einem HIV-negativem, nicht immunkompromittiertem Erwachsenen. Diskutiert werden die m\u00f6glichen Ursachen der Erkrankung.", "term_pairs": [{"src": {"text": "Pneumocystis jirovecii pneumonia", "char_start": 0, "char_end": 32, "token_start": 0, "token_end": 3}, "tgt": {"text": "Pneumocystis jirovecii-Pneumonie", "char_start": 37, "char_end": 69, "token_start": 5, "token_end": 9}}, {"src": {"text": "HIV negative", "char_start": 127, "char_end": 139, "token_start": 20, "token_end": 22}, "tgt": {"text": "HIV-negativem", "char_start": 80, "char_end": 93, "token_start": 11, "token_end": 14}}, {"src": {"text": "immunocompetent", "char_start": 141, "char_end": 156, "token_start": 23, "token_end": 24}, "tgt": {"text": "nicht immunkompromittiertem", "char_start": 95, "char_end": 122, "token_start": 15, "token_end": 17}}]}
{"idx": 1099, "pair_id": "31745941", "src": "Surgical correction of presbyopia can be performed by refractive lens exchange, replacing the lens with a monofocal, a multifocal or an extended-depth-of-focus (EDOF) intraocular lens (IOL). Option 1, a monofocal IOL, must be combined with monovision, otherwise presbyopia cannot be corrected. Monovision in this context means one eye for distance and one eye targeted for -\u20091.5 D. With this concept glasses are still required for near (30\u200a-\u200a40\u2009cm) and for driving, but intermediate distances and everyday life is usually possible without glasses. Option 2, a multifocal IOL, results in spectacle independence. Current multifocal IOL typically use three foci and are therefore called trifocal IOL. Distance vision and near vision are typically good, intermediate vision still acceptable but lower than distance and near, resulting in occasional problems while working on a computer. Option 3, EDOF-IOL, provide good distance and intermediate vision without glasses but near vision typically requires reading glasses.", "tgt": "Die Akkommodationsf\u00e4higkeit der Linse nimmt mit dem Alter ab; eine vollst\u00e4ndige chirurgische Wiederherstellung ist derzeit jedoch noch nicht m\u00f6glich. Durch moderne Intraokularlinsen kann allerdings der weitgehende Verzicht auf eine Brillenkorrektur erreicht werden.", "term_pairs": [{"src": {"text": "Intraocular lens", "char_start": 167, "char_end": 183, "token_start": 33, "token_end": 35}, "tgt": {"text": "Intraokularlinsen", "char_start": 164, "char_end": 181, "token_start": 23, "token_end": 24}}]}
{"idx": 1108, "pair_id": "31746442", "src": "TGF\u03b21 plays an important role in the metabolism of articular cartilage and bone; however, the pathological mechanism and targets of TGF\u03b21 in cartilage degradation and uncoupling of subchondral bone remodeling remain unclear. Therefore, in this study, we investigated the relationship between TGF\u03b21 and major protein-degrading enzymes, and evaluated the role of high levels of active TGF\u03b21 in the thickening of subchondral bone and calcification of articular cartilage. The expression of TGF\u03b21 and protein-degrading enzymes in clinical samples of articular cartilage and subchondral bone obtained from the knee joint of patients with osteoarthritis was detected by immunohistochemistry. The expression levels of TGF\u03b21, MMP-3, MMP-13 and IL-1\u03b2 in cartilage and subchondral bone tissues were detected by absolute real-time quantitative RT-PCR. The expression of TGF\u03b21, nestin and osterix in subchondral bone was detected by Western blot analysis and immunohistochemistry. The degree of subchondral bone thickening was determined by micro-computed tomography (CT) imaging. Expression of TGF\u03b21 and cartilage-degrading enzymes was higher in the cartilage-disrupted group than that in the intact group. Furthermore, expression of TGF\u03b21, nestin and osterix was significantly higher in the OA group than that in the control group. Micro-CT imaging showed that in the OA group, the subchondral bone plate is thickened and the density is increased. The trabecular bone structure is thick plate-like structure, the thickness of the trabecular bone is increased and the gap is small. The data suggest that highly active TGF\u03b21 activates the expression of cartilage-degrading enzymes. Abnormally activated TGF\u03b21 may induce formation of the subchondral bone and expansion of the calcified cartilage area, eventually leading to degradation of the cartilage tissue.", "tgt": "ZIEL: TGF\u03b21 spielt eine wichtige Rolle im Stoffwechsel von Gelenkknorpel und Knochen; jedoch bleiben der pathologische Mechanismus und die Ziele von TGF\u03b21 beim Knorpelabbau und Entkopplung des subchondralen Knochenumbaus unklar. Daher untersuchten wir in dieser Studie die Beziehung zwischen TGF\u03b21 und wichtigen proteinabbauenden Enzymen und der Rolle hoher Konzentrationen an aktivem TGF\u03b21 bei der Verdickung des subchondralen Knochens und Verkalkung des Gelenkknorpels. Die Expression von TGF\u03b21 und der Abbau von Enzymen in klinischen Proben von Gelenkknorpel und subchondralen Knochen aus dem Kniegelenk von Patienten mit Arthrose wurden immunhistochemisch nachgewiesen. Die Expressionsniveaus von TGF\u03b21, MMP-3, MMP-13 und IL-1\u03b2 in Knorpel- und subchondralen Knochengeweben wurden durch absolute quantitative RT-PCR in Echtzeit nachgewiesen. Die Expression von TGF\u03b21, Nestin und Osterix im subchondralen Knochen wurde durch Western-Blot-Analyse und Immunhistochemie nachgewiesen. Der Grad der subchondralen Knochenverdickung wurde durch Mikrocomputertomografie (CT) bestimmt. Die Expression von TGF\u03b21 und knorpelabbauenden Enzymen war in der Gruppe mit Knorpelst\u00f6rungen h\u00f6her als in der intakten Gruppe. Weiterhin war die Expression von TGF\u03b21, Nestin und Osterix in der OA-Gruppe signifikant h\u00f6her als in der Kontrollgruppe. Die Mikro-CT-Bildgebung zeigte, dass in der OA-Gruppe die subchondrale Knochenplatte verdickt und die Dichte erh\u00f6ht ist. Die trabekul\u00e4re Knochenstruktur ist dick pl\u00e4ttchenf\u00f6rmig, die Dicke des Trabekelknochens erh\u00f6ht und die L\u00fccke ist klein. Die Daten legen nahe, dass hochaktives TGF\u03b21 die Expression von knorpelabbauenden Enzymen aktiviert. Ungew\u00f6hnlich aktiviertem TGF\u03b21 kann die Bildung des subchondralen Knochens und Ausdehnung des verkalkten Knorpelbereichs induzieren, was zu einem Abbau des Knorpelgewebes f\u00fchrt.", "term_pairs": [{"src": {"text": "TGF\u03b21", "char_start": 0, "char_end": 5, "token_start": 0, "token_end": 1}, "tgt": {"text": "TGF\u03b21", "char_start": 6, "char_end": 11, "token_start": 2, "token_end": 3}}, {"src": {"text": "articular cartilage", "char_start": 51, "char_end": 70, "token_start": 9, "token_end": 11}, "tgt": {"text": "Gelenkknorpel", "char_start": 59, "char_end": 72, "token_start": 10, "token_end": 11}}, {"src": {"text": "bone", "char_start": 75, "char_end": 79, "token_start": 12, "token_end": 13}, "tgt": {"text": "Knochen", "char_start": 77, "char_end": 84, "token_start": 12, "token_end": 13}}, {"src": {"text": "pathological mechanism", "char_start": 94, "char_end": 116, "token_start": 17, "token_end": 19}, "tgt": {"text": "pathologische Mechanismus", "char_start": 105, "char_end": 130, "token_start": 17, "token_end": 19}}, {"src": {"text": "cartilage degradation", "char_start": 141, "char_end": 162, "token_start": 24, "token_end": 26}, "tgt": {"text": "Knorpelabbau", "char_start": 160, "char_end": 172, "token_start": 25, "token_end": 26}}, {"src": {"text": "subchondral bone", "char_start": 181, "char_end": 197, "token_start": 29, "token_end": 31}, "tgt": {"text": "subchondralen Knochen", "char_start": 193, "char_end": 214, "token_start": 29, "token_end": 31}}, {"src": {"text": "protein-degrading enzymes", "char_start": 308, "char_end": 333, "token_start": 49, "token_end": 53}, "tgt": {"text": "proteinabbauenden Enzymen", "char_start": 312, "char_end": 337, "token_start": 45, "token_end": 47}}, {"src": {"text": "osteoarthritis", "char_start": 633, "char_end": 647, "token_start": 102, "token_end": 103}, "tgt": {"text": "Arthrose", "char_start": 625, "char_end": 633, "token_start": 89, "token_end": 90}}, {"src": {"text": "immunohistochemistry", "char_start": 664, "char_end": 684, "token_start": 106, "token_end": 107}, "tgt": {"text": "Immunhistochemie", "char_start": 952, "char_end": 968, "token_start": 146, "token_end": 147}}, {"src": {"text": "MMP-3", "char_start": 718, "char_end": 723, "token_start": 114, "token_end": 117}, "tgt": {"text": "MMP-3", "char_start": 708, "char_end": 713, "token_start": 99, "token_end": 102}}, {"src": {"text": "MMP-13", "char_start": 725, "char_end": 731, "token_start": 118, "token_end": 121}, "tgt": {"text": "MMP-13", "char_start": 715, "char_end": 721, "token_start": 103, "token_end": 106}}, {"src": {"text": "IL-1\u03b2", "char_start": 736, "char_end": 741, "token_start": 122, "token_end": 125}, "tgt": {"text": "IL-1\u03b2", "char_start": 726, "char_end": 731, "token_start": 107, "token_end": 110}}, {"src": {"text": "real-time quantitative RT-PCR", "char_start": 810, "char_end": 839, "token_start": 135, "token_end": 142}, "tgt": {"text": "quantitative RT-PCR in Echtzeit", "char_start": 799, "char_end": 830, "token_start": 119, "token_end": 125}}, {"src": {"text": "nestin", "char_start": 866, "char_end": 872, "token_start": 148, "token_end": 149}, "tgt": {"text": "Nestin", "char_start": 871, "char_end": 877, "token_start": 132, "token_end": 133}}, {"src": {"text": "osterix", "char_start": 877, "char_end": 884, "token_start": 150, "token_end": 151}, "tgt": {"text": "Osterix", "char_start": 882, "char_end": 889, "token_start": 134, "token_end": 135}}, {"src": {"text": "Western blot analysis", "char_start": 921, "char_end": 942, "token_start": 157, "token_end": 160}, "tgt": {"text": "Western-Blot-Analyse", "char_start": 927, "char_end": 947, "token_start": 140, "token_end": 145}}, {"src": {"text": "micro-computed tomography", "char_start": 1029, "char_end": 1054, "token_start": 172, "token_end": 176}, "tgt": {"text": "Mikrocomputertomografie", "char_start": 1040, "char_end": 1063, "token_start": 156, "token_end": 157}}, {"src": {"text": "CT", "char_start": 377, "char_end": 379, "token_start": 62, "token_end": 63}, "tgt": {"text": "CT", "char_start": 1065, "char_end": 1067, "token_start": 158, "token_end": 159}}, {"src": {"text": "cartilage-degrading enzymes", "char_start": 1093, "char_end": 1120, "token_start": 185, "token_end": 189}, "tgt": {"text": "knorpelabbauenden Enzymen", "char_start": 1108, "char_end": 1133, "token_start": 167, "token_end": 169}}, {"src": {"text": "OA", "char_start": 1281, "char_end": 1283, "token_start": 218, "token_end": 219}, "tgt": {"text": "OA", "char_start": 1273, "char_end": 1275, "token_start": 194, "token_end": 195}}, {"src": {"text": "subchondral bone plate", "char_start": 1372, "char_end": 1394, "token_start": 239, "token_end": 242}, "tgt": {"text": "subchondrale Knochenplatte", "char_start": 1386, "char_end": 1412, "token_start": 219, "token_end": 221}}, {"src": {"text": "trabecular bone", "char_start": 1442, "char_end": 1457, "token_start": 251, "token_end": 253}, "tgt": {"text": "Trabekelknochen", "char_start": 1521, "char_end": 1536, "token_start": 238, "token_end": 239}}]}
{"idx": 1318, "pair_id": "30999326", "src": "Tests of contrast sensitivity (CS) are not routinely performed in the clinic, although CS is reduced in many conditions, such as amblyopia or glaucoma. This may be due to perceived time constraints or unaffordability of equipment. Monocular CS functions obtained with the FACT, CSV 1000E, and Lea Symbols were compared in 19 healthy subjects aged 24\u200a-\u200a78 years and 24 subjects aged 5\u200a-\u200a16 years, 9 of whom had amblyopia. CS functions could be obtained with all three tests. The tests were equally comfortable for young and adult patients, and took less than 5 minutes to perform (one eye). All measured CSs at 3, 6, 12, and 18 cycles per degree (cpd), but the FACT included 1.5 cpd. LINEAR MIXED EFFECT MODELS: were performed. While there was no significant difference at low spatial frequencies, the Lea CS test showed a ceiling effect in that range, while the FACT showed a floor effect at high spatial frequencies. CS in amblyopic children did not differ between the contralateral and the amblyopic eye. Overall, amblyopic eyes had lower CS values than the control eyes and CS did not correlate significantly to visual acuity at distance. All three CS tests could be usefully applied in the clinic in adults as well as children over the age of 4 years. Only the CSV 1000E exhibited neither a ceiling nor a floor effect. This was also the fastest test. In children with amblyopia, CS testing offers additional information on visual function. In contrast to previous reports, we did not find that the CSV and FACT are interchangeable.", "tgt": "Obwohl Kontrastempfindlichkeit bei vielen Augenkrankheiten wie Amblyopie oder Glaukom vermindert ist, werden Kontrastempfindlichkeitstest nicht routinem\u00e4\u00dfig durchgef\u00fchrt. Der Grund daf\u00fcr liegt wom\u00f6glich in der Zeitknappheit oder an mangelnder Ausr\u00fcstung. Kontrastempfindlichkeitsfunktionen wurden mit 3 verschiedenen Tests: FACT, CSV-1000E und Lea Symbolen monokular bei 19 gesunden Erwachsenen (24\u200a\u2013\u200a78\u2009J) und 15 gesunden und 9 amblyopen Kindern (5\u200a\u2013\u200a16\u2009J) gemessen und miteinander verglichen. Mit allen 3 Tests konnten Kontrastempfindlichkeitsfunktionen erhalten werden. Die Tests waren vergleichbar angenehm f\u00fcr Jung und Alt und dauerten alle weniger als 5 Minuten (1 Auge). W\u00e4hrend alle Tests Kontrastempfindlichkeiten bei 3, 6, 12 und 8 Zyklen pro Grad messen, werden mit dem FACT auch Werte bei 1,5 Zyklen pro Grad gemessen. Lineare Mixed-Effect-Modelle wurden erstellt. In tiefen Ortsfrequenzen ergab sich keine signifikante Differenz. Lea zeigte einen Ceiling-Effekt in den tiefen und FACT ein Floor-Effekt in den hohen Ortsfrequenzen. Bei den amblyopen Kindern bestand kein signifikanter Unterschied zwischen dem amblyopen und dem Partnerauge. Insgesamt hatten die amblyopen Augen tiefere Kontrastempfindlichkeiten als die Kontrollen und korrelierten nicht signifikant mit dem Fernvisus. Alle Tests k\u00f6nnen sowohl bei Erwachsenen als auch bei Kindern \u00fcber 4 Jahren sinnvoll in der Praxis eingesetzt werden. F\u00fcr Kinder mit Amblyopie liefert die Kontrastempfindlichkeit zus\u00e4tzliche Informationen \u00fcber die visuelle Funktion. Im Gegensatz zur Literatur waren FACT und CSV nicht austauschbar. Der CSV lie\u00df sich am schnellsten durchf\u00fchren und zeigte als einziger Test weder einen Floor- noch einen Ceiling-Effekt.", "term_pairs": [{"src": {"text": "contrast sensitivity", "char_start": 9, "char_end": 29, "token_start": 2, "token_end": 4}, "tgt": {"text": "Kontrastempfindlichkeit", "char_start": 7, "char_end": 30, "token_start": 1, "token_end": 2}}, {"src": {"text": "CS", "char_start": 31, "char_end": 33, "token_start": 5, "token_end": 6}, "tgt": {"text": "Kontrastempfindlichkeit", "char_start": 109, "char_end": 132, "token_start": 13, "token_end": 14}}, {"src": {"text": "amblyopia", "char_start": 129, "char_end": 138, "token_start": 25, "token_end": 26}, "tgt": {"text": "Amblyopie", "char_start": 63, "char_end": 72, "token_start": 6, "token_end": 7}}, {"src": {"text": "glaucoma", "char_start": 142, "char_end": 150, "token_start": 27, "token_end": 28}, "tgt": {"text": "Glaukom", "char_start": 78, "char_end": 85, "token_start": 8, "token_end": 9}}, {"src": {"text": "FACT", "char_start": 272, "char_end": 276, "token_start": 48, "token_end": 49}, "tgt": {"text": "FACT", "char_start": 324, "char_end": 328, "token_start": 38, "token_end": 39}}, {"src": {"text": "CSV 1000E", "char_start": 278, "char_end": 287, "token_start": 50, "token_end": 52}, "tgt": {"text": "CSV-1000E", "char_start": 330, "char_end": 339, "token_start": 40, "token_end": 43}}, {"src": {"text": "Lea Symbols", "char_start": 293, "char_end": 304, "token_start": 54, "token_end": 56}, "tgt": {"text": "Lea Symbolen", "char_start": 344, "char_end": 356, "token_start": 44, "token_end": 46}}, {"src": {"text": "cycles per degree", "char_start": 627, "char_end": 644, "token_start": 128, "token_end": 131}, "tgt": {"text": "Zyklen pro Grad", "char_start": 742, "char_end": 757, "token_start": 117, "token_end": 120}}, {"src": {"text": "cpd", "char_start": 646, "char_end": 649, "token_start": 132, "token_end": 133}, "tgt": {"text": "Zyklen pro Grad", "char_start": 805, "char_end": 820, "token_start": 132, "token_end": 135}}, {"src": {"text": "LINEAR MIXED EFFECT MODELS", "char_start": 683, "char_end": 709, "token_start": 144, "token_end": 148}, "tgt": {"text": "Lineare Mixed-Effect-Modelle", "char_start": 831, "char_end": 859, "token_start": 137, "token_end": 143}}, {"src": {"text": "ceiling effect", "char_start": 822, "char_end": 836, "token_start": 169, "token_end": 171}, "tgt": {"text": "Ceiling-Effekt", "char_start": 960, "char_end": 974, "token_start": 158, "token_end": 161}}, {"src": {"text": "floor effect", "char_start": 876, "char_end": 888, "token_start": 180, "token_end": 182}, "tgt": {"text": "Floor-Effekt", "char_start": 1002, "char_end": 1014, "token_start": 167, "token_end": 170}}, {"src": {"text": "visual acuity", "char_start": 1115, "char_end": 1128, "token_start": 221, "token_end": 223}, "tgt": {"text": "Fernvisus", "char_start": 1286, "char_end": 1295, "token_start": 206, "token_end": 207}}]}
{"idx": 1367, "pair_id": "30220920", "src": "There has been an\u00a0increase in thrower-specific elbow injuries in recent years. High valgus stresses during the late cocking and acceleration phases of throwing need to be compensated by the flexor pronator muscles as these can exceed the tensile strength of the medial collateral ligament complex. Prevention of injuries is the priority, with a\u00a0focus on strengthening, reducing throwing frequency, decreasing force, and promoting a\u00a0technique. The spectrum of thrower injuries ranges from a\u00a0simple sprain to complete failure of the valgus stabilizing factors. The medial collateral ligament can stretch, leading to posteromedial impingement and radiocapitellar compression forces. This in turn can result in arthrosis and the formation of osteophytes. Ligament failure may eventually occur, making it impossible for the athlete to continue their throwing activities. The outcome of conservative treatment with strengthening, improvement of technique, and relative rest is often disappointing. Direct repair may no longer be possible in these acute-on-chronic injuries and a\u00a0reconstruction with a\u00a0tendon graft may be necessary.", "tgt": "In den letzten Jahren gab es einen Anstieg wurfspezifischer Ellenbogenl\u00e4sionen. Eine hohe Valgusbelastung w\u00e4hrend der sp\u00e4ten Anspannungs- und Beschleunigungsphasen des Werfens muss durch die Flexoren und Pronatoren ausgeglichen werden, da diese die Zugkraft des medialen kollateralen Bandkomplexes \u00fcbersteigen k\u00f6nnen. Der Pr\u00e4vention von Verletzungen wird der Vorzug gegeben, dabei liegt ein Fokus auf der St\u00e4rkung, der Verminderung der Wurfh\u00e4ufigkeit, der Verminderung des Krafteinsatzes und einer ausgefeilten Technik. Werferverletzungen umfassen ein Spektrum von Verletzungen von einer einfachen Zerrung bis zum vollst\u00e4ndigen Ausfall der valgusstabilisierenden Faktoren. Das mediale kollaterale Band kann gedehnt werden, was zu einem posteromedialen Impingement und Kompressionskr\u00e4ften zwischen dem Radius und dem Capitulum humeri f\u00fchrt. Dies kann in einer Arthrose und der Bildung von Osteophyten enden. Das Ligament kann schlie\u00dflich rei\u00dfen, was es f\u00fcr den Sportler unm\u00f6glich macht, seine Wurfsportart weiter auszuf\u00fchren. Das Ergebnis der konservativen Therapie mit St\u00e4rkung, Verbesserung der Technik und relativer Ruhe ist oftmals entt\u00e4uschend. Eine direkte Rekonstruktion ist bei diesen chronischen Verletzungen mit akuter Phase ggf. nicht mehr m\u00f6glich, und u.\u00a0U. bedarf es einer Rekonstruktion mit einem Sehnenimplantat.", "term_pairs": [{"src": {"text": "thrower-specific elbow injuries", "char_start": 30, "char_end": 61, "token_start": 6, "token_end": 11}, "tgt": {"text": "wurfspezifischer Ellenbogenl\u00e4sionen", "char_start": 43, "char_end": 78, "token_start": 8, "token_end": 10}}, {"src": {"text": "High valgus stresses", "char_start": 79, "char_end": 99, "token_start": 15, "token_end": 18}, "tgt": {"text": "hohe Valgusbelastung", "char_start": 85, "char_end": 105, "token_start": 12, "token_end": 14}}, {"src": {"text": "late cocking and acceleration phases", "char_start": 111, "char_end": 147, "token_start": 20, "token_end": 25}, "tgt": {"text": "sp\u00e4ten Anspannungs- und Beschleunigungsphasen", "char_start": 118, "char_end": 163, "token_start": 16, "token_end": 21}}, {"src": {"text": "flexor pronator muscles", "char_start": 190, "char_end": 213, "token_start": 33, "token_end": 36}, "tgt": {"text": "Flexoren und Pronatoren", "char_start": 191, "char_end": 214, "token_start": 26, "token_end": 29}}, {"src": {"text": "medial collateral ligament complex", "char_start": 262, "char_end": 296, "token_start": 45, "token_end": 49}, "tgt": {"text": "medialen kollateralen Bandkomplexes", "char_start": 262, "char_end": 297, "token_start": 37, "token_end": 40}}, {"src": {"text": "Prevention of injuries", "char_start": 298, "char_end": 320, "token_start": 50, "token_end": 53}, "tgt": {"text": "Pr\u00e4vention von Verletzungen", "char_start": 322, "char_end": 349, "token_start": 44, "token_end": 47}}, {"src": {"text": "strengthening", "char_start": 354, "char_end": 367, "token_start": 61, "token_end": 62}, "tgt": {"text": "St\u00e4rkung", "char_start": 405, "char_end": 413, "token_start": 58, "token_end": 59}}, {"src": {"text": "throwing frequency", "char_start": 378, "char_end": 396, "token_start": 64, "token_end": 66}, "tgt": {"text": "Wurfh\u00e4ufigkeit", "char_start": 436, "char_end": 450, "token_start": 63, "token_end": 64}}, {"src": {"text": "force", "char_start": 409, "char_end": 414, "token_start": 68, "token_end": 69}, "tgt": {"text": "Krafteinsatzes", "char_start": 473, "char_end": 487, "token_start": 68, "token_end": 69}}, {"src": {"text": "technique", "char_start": 432, "char_end": 441, "token_start": 73, "token_end": 74}, "tgt": {"text": "Technik", "char_start": 511, "char_end": 518, "token_start": 72, "token_end": 73}}, {"src": {"text": "thrower injuries", "char_start": 459, "char_end": 475, "token_start": 78, "token_end": 80}, "tgt": {"text": "Werferverletzungen", "char_start": 520, "char_end": 538, "token_start": 74, "token_end": 75}}, {"src": {"text": "sprain", "char_start": 497, "char_end": 503, "token_start": 84, "token_end": 85}, "tgt": {"text": "Zerrung", "char_start": 598, "char_end": 605, "token_start": 83, "token_end": 84}}, {"src": {"text": "valgus stabilizing factors", "char_start": 531, "char_end": 557, "token_start": 90, "token_end": 93}, "tgt": {"text": "valgusstabilisierenden Faktoren", "char_start": 640, "char_end": 671, "token_start": 89, "token_end": 91}}, {"src": {"text": "medial collateral ligament", "char_start": 563, "char_end": 589, "token_start": 95, "token_end": 98}, "tgt": {"text": "mediale kollaterale Band", "char_start": 677, "char_end": 701, "token_start": 93, "token_end": 96}}, {"src": {"text": "posteromedial impingement", "char_start": 614, "char_end": 639, "token_start": 103, "token_end": 105}, "tgt": {"text": "posteromedialen Impingement", "char_start": 736, "char_end": 763, "token_start": 103, "token_end": 105}}, {"src": {"text": "radiocapitellar compression forces", "char_start": 644, "char_end": 678, "token_start": 106, "token_end": 109}, "tgt": {"text": "Kompressionskr\u00e4ften zwischen dem Radius und dem Capitulum humeri", "char_start": 768, "char_end": 832, "token_start": 106, "token_end": 114}}, {"src": {"text": "arthrosis", "char_start": 707, "char_end": 716, "token_start": 116, "token_end": 117}, "tgt": {"text": "Arthrose", "char_start": 859, "char_end": 867, "token_start": 120, "token_end": 121}}, {"src": {"text": "osteophytes", "char_start": 738, "char_end": 749, "token_start": 121, "token_end": 122}, "tgt": {"text": "Osteophyten", "char_start": 888, "char_end": 899, "token_start": 125, "token_end": 126}}, {"src": {"text": "Ligament failure", "char_start": 751, "char_end": 767, "token_start": 123, "token_end": 125}, "tgt": {"text": "Ligament kann schlie\u00dflich rei\u00dfen", "char_start": 911, "char_end": 943, "token_start": 129, "token_end": 133}}, {"src": {"text": "conservative treatment", "char_start": 881, "char_end": 903, "token_start": 144, "token_end": 146}, "tgt": {"text": "konservativen Therapie", "char_start": 1042, "char_end": 1064, "token_start": 150, "token_end": 152}}, {"src": {"text": "relative rest", "char_start": 954, "char_end": 967, "token_start": 154, "token_end": 156}, "tgt": {"text": "relativer Ruhe", "char_start": 1108, "char_end": 1122, "token_start": 159, "token_end": 161}}, {"src": {"text": "Direct repair", "char_start": 992, "char_end": 1005, "token_start": 160, "token_end": 162}, "tgt": {"text": "direkte Rekonstruktion", "char_start": 1154, "char_end": 1176, "token_start": 166, "token_end": 168}}, {"src": {"text": "acute-on-chronic injuries", "char_start": 1041, "char_end": 1066, "token_start": 169, "token_end": 175}, "tgt": {"text": "chronischen Verletzungen mit akuter Phase", "char_start": 1192, "char_end": 1233, "token_start": 171, "token_end": 176}}, {"src": {"text": "reconstruction", "char_start": 1073, "char_end": 1087, "token_start": 177, "token_end": 178}, "tgt": {"text": "Rekonstruktion", "char_start": 1285, "char_end": 1299, "token_start": 190, "token_end": 191}}, {"src": {"text": "tendon graft", "char_start": 1095, "char_end": 1107, "token_start": 180, "token_end": 182}, "tgt": {"text": "Sehnenimplantat", "char_start": 1310, "char_end": 1325, "token_start": 193, "token_end": 194}}]}
{"idx": 1382, "pair_id": "32869239", "src": "In Germany, a number of people remain without health insurance, thus unable to access the formal health care sector. Reliable statistics covering the prevalence and description of uninsured patients, especially in the inpatient health care sector, are still lacking. Our study therefore aimed to assess the prevalence of uninsured patients at University Hospital of Essen over a period of five years. Furthermore, we report rates of identification of cost providers and refunded disbursement. Uninsured patients from 2014-2018 were included. We defined the following subgroups for stratification according to the right of access to health insurance: patients with right of access to health insurance in Germany, EU citizens, patients from third countries, patients without residence permit status. Data of 918 uninsured patients (mean age 31.3\u00b120.6 years, 52,1% men) from 2014 to 2018 were evaluated. Over five years, identification of cost provider was successful in 74% and yielded in a total refund of 7.5 million Euros. In most instances, patients were treated in the gynaecological and maternity clinic (20%), paediatric clinic (17%), orthopaedic clinic and trauma surgery (14%) and the clinic for internal medicine (13%). Our study shows that there are still people in Germany who do not have health insurance. Referring to the inpatient health care sector, results show that it is possible to calculate treatment costs, to identify cost providers and to refund medical costs. To apply target group-specific approaches in practice, more research is needed addressing both causes and risk factors. The availability of comprehensive data could improve discussions at a political level on medical compensation not available to patients.", "tgt": "Trotz der seit 2007 grunds\u00e4tzlich geltenden Versicherungspflicht leben in Deutschland Menschen ohne ausreichenden Krankenversicherungsschutz. Daten zur Pr\u00e4valenz oder zur Beschreibung dieser Bev\u00f6lkerungsgruppe gibt es kaum, vor allem f\u00fcr den station\u00e4ren Sektor. Die vorliegende Studie beschreibt deren Pr\u00e4valenz und soziodemographische Verteilung am Beispiel des Universit\u00e4tsklinikums Essen \u00fcber einen Zeitraum von f\u00fcnf Jahren. Dar\u00fcber hinaus berichten wir Ergebnisse der Kostentr\u00e4gerermittlung und deren monet\u00e4re Auswirkungen f\u00fcr den Leistungserbringer. Eingeschlossen wurden Patienten mit fehlendem oder unklarem Versicherungsstatus der Jahre 2014\u20132018. F\u00fcr eine differenzierte Auswertung wurden vier Statusgruppen gebildet Patienten mit Leistungsanspruch in Deutschland, EU-B\u00fcrger, Patienten aus Drittstaaten und Patienten ohne Aufenthaltsstatus. Die Stichprobe umfasst 918 Patienten ohne Krankenversicherungsschutz (mittleres Alter 31,3\u00b120,6 Jahre, 52,1% M\u00e4nner). F\u00fcr den F\u00fcnfjahreszeitraum wurde in 74% der F\u00e4lle ein Kostentr\u00e4ger ermittelt und dadurch eine Kostenerstattung in H\u00f6he von insgesamt 7,5 Million Euro erreicht. Die gr\u00f6\u00dfte Inanspruchnahme zeigt sich in den Fachabteilungen Frauenheilkunde und Geburtshilfe mit 20%, der Kinderheilkunde mit 17%, der Orthop\u00e4die und Unfallchirurgie mit 14% und der Innere Medizin mit 13%. Die Studie belegt, dass Menschen ohne Krankenversicherungsschutz im medizinischen Versorgungssystem nach wie vor existieren. F\u00fcr den station\u00e4ren Sektor zeigen die Ergebnisse, dass eine Kostentr\u00e4gerermittlung und Kostenerstattung m\u00f6glich sind und sich die Kosten beziffern lassen. Um insgesamt zielgruppenspezifischere Ma\u00dfnahmen f\u00fcr die Praxis entwickeln zu k\u00f6nnen, bedarf es intensivere Forschungsans\u00e4tze zu den Ursachen und Einflussfaktoren. Die Verf\u00fcgbarkeit fl\u00e4chendeckender Informationen w\u00fcrde die Thematik der fehlenden Verg\u00fctung f\u00fcr diese Patientengruppe politisch diskutierbar machen.", "term_pairs": [{"src": {"text": "health insurance", "char_start": 46, "char_end": 62, "token_start": 9, "token_end": 11}, "tgt": {"text": "Krankenversicherungsschutz", "char_start": 114, "char_end": 140, "token_start": 13, "token_end": 14}}, {"src": {"text": "uninsured patients", "char_start": 180, "char_end": 198, "token_start": 30, "token_end": 32}, "tgt": {"text": "Patienten ohne Krankenversicherungsschutz", "char_start": 877, "char_end": 918, "token_start": 114, "token_end": 117}}, {"src": {"text": "prevalence", "char_start": 150, "char_end": 160, "token_start": 26, "token_end": 27}, "tgt": {"text": "Pr\u00e4valenz", "char_start": 152, "char_end": 161, "token_start": 17, "token_end": 18}}, {"src": {"text": "inpatient health care sector", "char_start": 218, "char_end": 246, "token_start": 36, "token_end": 40}, "tgt": {"text": "station\u00e4ren Sektor", "char_start": 242, "char_end": 260, "token_start": 31, "token_end": 33}}, {"src": {"text": "University Hospital of Essen", "char_start": 343, "char_end": 371, "token_start": 57, "token_end": 61}, "tgt": {"text": "Universit\u00e4tsklinikums Essen", "char_start": 363, "char_end": 390, "token_start": 46, "token_end": 48}}, {"src": {"text": "cost providers", "char_start": 451, "char_end": 465, "token_start": 76, "token_end": 78}, "tgt": {"text": "Kostentr\u00e4ger", "char_start": 472, "char_end": 484, "token_start": 61, "token_end": 62}}, {"src": {"text": "refunded disbursement", "char_start": 470, "char_end": 491, "token_start": 79, "token_end": 81}, "tgt": {"text": "Kostenerstattung", "char_start": 1062, "char_end": 1078, "token_start": 151, "token_end": 152}}, {"src": {"text": "EU citizens", "char_start": 712, "char_end": 723, "token_start": 119, "token_end": 121}, "tgt": {"text": "EU-B\u00fcrger", "char_start": 774, "char_end": 783, "token_start": 98, "token_end": 101}}, {"src": {"text": "third countries", "char_start": 739, "char_end": 754, "token_start": 124, "token_end": 126}, "tgt": {"text": "Drittstaaten", "char_start": 799, "char_end": 811, "token_start": 104, "token_end": 105}}, {"src": {"text": "residence permit status", "char_start": 773, "char_end": 796, "token_start": 129, "token_end": 132}, "tgt": {"text": "Aufenthaltsstatus", "char_start": 831, "char_end": 848, "token_start": 108, "token_end": 109}}, {"src": {"text": "gynaecological and maternity clinic", "char_start": 1072, "char_end": 1107, "token_start": 198, "token_end": 202}, "tgt": {"text": "Frauenheilkunde und Geburtshilfe", "char_start": 1189, "char_end": 1221, "token_start": 171, "token_end": 174}}, {"src": {"text": "paediatric clinic", "char_start": 1115, "char_end": 1132, "token_start": 207, "token_end": 209}, "tgt": {"text": "Kinderheilkunde", "char_start": 1235, "char_end": 1250, "token_start": 179, "token_end": 180}}, {"src": {"text": "orthopaedic clinic and trauma surgery", "char_start": 1140, "char_end": 1177, "token_start": 214, "token_end": 219}, "tgt": {"text": "Orthop\u00e4die und Unfallchirurgie", "char_start": 1264, "char_end": 1294, "token_start": 185, "token_end": 188}}, {"src": {"text": "clinic for internal medicine", "char_start": 1192, "char_end": 1220, "token_start": 225, "token_end": 229}, "tgt": {"text": "Innere Medizin", "char_start": 1311, "char_end": 1325, "token_start": 193, "token_end": 195}}, {"src": {"text": "medical costs", "char_start": 1468, "char_end": 1481, "token_start": 277, "token_end": 279}, "tgt": {"text": "Kosten", "char_start": 1022, "char_end": 1028, "token_start": 146, "token_end": 147}}, {"src": {"text": "target group-specific approaches", "char_start": 1492, "char_end": 1524, "token_start": 282, "token_end": 287}, "tgt": {"text": "zielgruppenspezifischere Ma\u00dfnahmen", "char_start": 1628, "char_end": 1662, "token_start": 239, "token_end": 241}}, {"src": {"text": "risk factors", "char_start": 1589, "char_end": 1601, "token_start": 298, "token_end": 300}, "tgt": {"text": "Einflussfaktoren", "char_start": 1760, "char_end": 1776, "token_start": 256, "token_end": 257}}, {"src": {"text": "medical compensation", "char_start": 1692, "char_end": 1712, "token_start": 314, "token_end": 316}, "tgt": {"text": "Verg\u00fctung", "char_start": 1860, "char_end": 1869, "token_start": 267, "token_end": 268}}]}
{"idx": 1507, "pair_id": "34212208", "src": "First investigations indicate a\u00a0migration background of residents in Germany as a\u00a0discrete risk factor for poor oral health. A\u00a0lower level of oral health literacy among people with a\u00a0migration background is considered a\u00a0reason worthy of being investigated. This article presents results on oral health literacy and oral health gained from the MuMi study (promoting oral health and oral health literacy of people with a\u00a0migration background). The oral health and oral health literacy as well as the sociodemographics of patients with and without migration background were examined in 40\u00a0dental surgeries in Hamburg, Germany. Associations between migrant status, oral health, and oral health literacy were analyzed with logistic regressions. Potential confounders were gradually integrated into the multivariate analyses. Patients with and without a\u00a0migration background differed significantly in oral health literacy and clinical parameters of oral health (approximal plaque index and degree of caries restoration). The logistic regression analysis revealed highly significant associations between migration background, oral health literacy, and oral hygiene, while also accounting for education and socioeconomic status. Migration background constitutes a\u00a0discrete risk factor for lower oral health and oral health literacy for these relevant population groups. This fact needs stronger reflection in further research and political decision-making in order to promote equality of oral health opportunities.", "tgt": "HINTERGRUND: Erste Studien heben den Migrationshintergrund von Menschen in Deutschland als eigenst\u00e4ndigen Risikofaktor f\u00fcr eine mangelhafte Mundgesundheit hervor. Ein wichtiger Einflussfaktor k\u00f6nnte hierbei eine niedrigere Mundgesundheitskompetenz von Menschen mit Migrationshintergrund sein. ZIEL: In diesem Artikel werden Ergebnisse zur Mundgesundheitskompetenz und Mundgesundheit aus der MuMi-Studie (F\u00f6rderung der Mundgesundheit und Mundgesundheitskompetenz von Menschen mit Migrationshintergrund) vorgestellt. In 40\u00a0Hamburger Zahnarztpraxen wurden von Patient*innen mit und ohne Migrationshintergrund Daten zu Soziodemografie, Mundgesundheit und Mundgesundheitskompetenz erhoben. Der Zusammenhang zwischen Mundgesundheitskompetenz und Mundgesundheit wurde mittels logistischer Regressionen berechnet. Potenzielle Einflussfaktoren wurden schrittweise in die Berechnungsmodelle eingef\u00fcgt. Die Gruppen mit und ohne Migrationshintergrund unterschieden sich signifikant hinsichtlich ihrer Mundgesundheitskompetenz und ausgew\u00e4hlter klinischer Parameter ihrer Mundgesundheit (Approximalraum-Plaqueindex und Kariessanierungsgrad). Die logistischen Regressionsanalysen zeigen einen deutlichen Zusammenhang zwischen Migrationshintergrund, Mundgesundheitskompetenz und Mundhygiene auch unter Ber\u00fccksichtigung von Bildung und sozio\u00f6konomischem Status. Der Migrationshintergrund stellt einen eigenst\u00e4ndigen Indikator f\u00fcr eine niedrige Mundgesundheitskompetenz und schlechtere Mundgesundheit dar. Dieser Umstand sollte st\u00e4rker in den Fokus von Forschung und politischen Entscheidungen r\u00fccken, um die mundgesundheitliche Chancengleichheit in Deutschland zu erh\u00f6hen.", "term_pairs": [{"src": {"text": "migration background", "char_start": 32, "char_end": 52, "token_start": 4, "token_end": 6}, "tgt": {"text": "Migrationshintergrund", "char_start": 37, "char_end": 58, "token_start": 6, "token_end": 7}}, {"src": {"text": "risk factor", "char_start": 91, "char_end": 102, "token_start": 13, "token_end": 15}, "tgt": {"text": "Risikofaktor", "char_start": 106, "char_end": 118, "token_start": 13, "token_end": 14}}, {"src": {"text": "oral health", "char_start": 112, "char_end": 123, "token_start": 17, "token_end": 19}, "tgt": {"text": "Mundgesundheit", "char_start": 140, "char_end": 154, "token_start": 17, "token_end": 18}}, {"src": {"text": "oral health literacy", "char_start": 142, "char_end": 162, "token_start": 24, "token_end": 27}, "tgt": {"text": "Mundgesundheitskompetenz", "char_start": 223, "char_end": 247, "token_start": 27, "token_end": 28}}, {"src": {"text": "MuMi study", "char_start": 343, "char_end": 353, "token_start": 56, "token_end": 58}, "tgt": {"text": "MuMi-Studie", "char_start": 391, "char_end": 402, "token_start": 47, "token_end": 50}}, {"src": {"text": "dental surgeries", "char_start": 586, "char_end": 602, "token_start": 97, "token_end": 99}, "tgt": {"text": "Zahnarztpraxen", "char_start": 531, "char_end": 545, "token_start": 66, "token_end": 67}}, {"src": {"text": "logistic regressions", "char_start": 718, "char_end": 738, "token_start": 119, "token_end": 121}, "tgt": {"text": "logistischer Regressionen", "char_start": 769, "char_end": 794, "token_start": 93, "token_end": 95}}, {"src": {"text": "multivariate analyses", "char_start": 797, "char_end": 818, "token_start": 129, "token_end": 131}, "tgt": {"text": "Berechnungsmodelle", "char_start": 862, "char_end": 880, "token_start": 103, "token_end": 104}}, {"src": {"text": "approximal plaque index", "char_start": 956, "char_end": 979, "token_start": 152, "token_end": 155}, "tgt": {"text": "Approximalraum-Plaqueindex", "char_start": 1074, "char_end": 1100, "token_start": 125, "token_end": 128}}, {"src": {"text": "degree of caries restoration", "char_start": 984, "char_end": 1012, "token_start": 156, "token_end": 160}, "tgt": {"text": "Kariessanierungsgrad", "char_start": 1105, "char_end": 1125, "token_start": 129, "token_end": 130}}, {"src": {"text": "socioeconomic status", "char_start": 1199, "char_end": 1219, "token_start": 188, "token_end": 190}, "tgt": {"text": "sozio\u00f6konomischem Status", "char_start": 1319, "char_end": 1343, "token_start": 151, "token_end": 153}}, {"src": {"text": "education", "char_start": 1185, "char_end": 1194, "token_start": 186, "token_end": 187}, "tgt": {"text": "Bildung", "char_start": 1307, "char_end": 1314, "token_start": 149, "token_end": 150}}, {"src": {"text": "oral hygiene", "char_start": 1145, "char_end": 1157, "token_start": 179, "token_end": 181}, "tgt": {"text": "Mundhygiene", "char_start": 1263, "char_end": 1274, "token_start": 144, "token_end": 145}}]}
{"idx": 1572, "pair_id": "34231896", "src": "COVID-19, Black Lives Matter, and financial and political turmoil have uprooted our sense of personal and collective safety and predictability. Analysts are faced with professional and personal challenges, as well as a charge to help make sense of this new normal. This reflective piece focuses on the author's thoughts on a wounded and bleeding temenos. She grapples with the new reality of analysis carried out via technology (e.g. Zoom or telehealth). The article interweaves personal experiences with theoretical and professional reflections on two Jewish myths that relate to creating temenos or sacred space in the face of ancient disasters. Specifically, she discusses Choni HaMagel, a first-century BCE Jewish scholar and miracle-maker who prays for relief from a drought from inside a sacred circle. She also tells the tale of four Chassidic Rebbes who face crisis from a sacred space in the forest. The author frames this piece with two personal and numinous dreams dreamt during the pandemic; one offering scenes of destruction and one offering hope for a future transformation.", "tgt": "COVID-19, Black Lives Matter sowie finanzielle und politische Turbulenzen haben unser Gef\u00fchl f\u00fcr pers\u00f6nliche und kollektive Sicherheit und Vorhersehbarkeit entwurzelt. Analytiker stehen vor beruflichen und pers\u00f6nlichen Herausforderungen wie auch vor der Aufgabe, diese neue Normalit\u00e4t zu verstehen. Dieser dieses reflektierende Beitrag konzentriert sich auf die Gedanken der Autorin zu einem verwundeten und blutenden Temenos. Sie setzt sich mit der neuen Realit\u00e4t der Analyse auseinander, die mit Hilfe von Technologien (z. B. Zoom oder Telemedizin) bewerkstelligt wird. Der Artikel verwebt pers\u00f6nliche Erfahrungen mit theoretischen und professionellen \u00dcberlegungen zu zwei j\u00fcdischen Mythen, die sich angesichts antiker Katastrophen auf die Schaffung von Temenos oder heiligen Raumes beziehen. Insbesondere spricht sie \u00fcber Choni HaMagel, einen j\u00fcdischen Gelehrten und Wundert\u00e4ter des ersten Jahrhunderts vor Christus, der innerhalb eines heiligen Kreises um Hilfe gegen die D\u00fcrre betet. Sie erz\u00e4hlt auch die Geschichte von vier chassidischen Rabbinern, die aus einem heiligen Raum im Wald heraus einer Krise begegnen. Die Autorin umrahmt dieses St\u00fcck mit zwei pers\u00f6nlichen und numinosen Tr\u00e4umen, die w\u00e4hrend der Pandemie getr\u00e4umt wurden, eine mit Szenen der Zerst\u00f6rung und eine mit der Aussicht auf Hoffnung auf einen zuk\u00fcnftigen Wandel.", "term_pairs": [{"src": {"text": "COVID-19", "char_start": 0, "char_end": 8, "token_start": 0, "token_end": 3}, "tgt": {"text": "COVID-19", "char_start": 0, "char_end": 8, "token_start": 0, "token_end": 3}}, {"src": {"text": "Black Lives Matter", "char_start": 10, "char_end": 28, "token_start": 4, "token_end": 7}, "tgt": {"text": "Black Lives Matter", "char_start": 10, "char_end": 28, "token_start": 4, "token_end": 7}}, {"src": {"text": "Zoom", "char_start": 434, "char_end": 438, "token_start": 82, "token_end": 83}, "tgt": {"text": "Zoom", "char_start": 528, "char_end": 532, "token_start": 82, "token_end": 83}}, {"src": {"text": "telehealth", "char_start": 442, "char_end": 452, "token_start": 84, "token_end": 85}, "tgt": {"text": "Telemedizin", "char_start": 538, "char_end": 549, "token_start": 84, "token_end": 85}}, {"src": {"text": "temenos", "char_start": 346, "char_end": 353, "token_start": 63, "token_end": 64}, "tgt": {"text": "Temenos", "char_start": 418, "char_end": 425, "token_start": 59, "token_end": 60}}, {"src": {"text": "Choni HaMagel", "char_start": 676, "char_end": 689, "token_start": 120, "token_end": 122}, "tgt": {"text": "Choni HaMagel", "char_start": 825, "char_end": 838, "token_start": 123, "token_end": 125}}, {"src": {"text": "first-century BCE", "char_start": 693, "char_end": 710, "token_start": 124, "token_end": 128}, "tgt": {"text": "ersten Jahrhunderts vor Christus", "char_start": 886, "char_end": 918, "token_start": 132, "token_end": 136}}, {"src": {"text": "Chassidic Rebbes", "char_start": 841, "char_end": 857, "token_start": 154, "token_end": 156}, "tgt": {"text": "chassidischen Rabbinern", "char_start": 1030, "char_end": 1053, "token_start": 156, "token_end": 158}}]}
{"idx": 1736, "pair_id": "24938160", "src": "A lumbar disc herniation is a frequent pathology. The incidence of a postoperative recurrence is between 1-18%. According to the current literature, a large anular defect and a limited perioperative microdiscectomy leads to an increased risk of recurrence. In contrast, a generous perioperative microdiscectomy comes along with an accelerated postoperative disc height loss and a progressive degenerative disc disease. The present work discusses the position of an anular-closure-device in respect of the problem risk of recurrence versus postoperative degenerative disc disease.", "tgt": "Die lumbale Diskushernie (LDH) ist ein Krankheitsbild mit hoher Pr\u00e4valenz. Das gr\u00f6sste Risiko w\u00e4hrend des postoperativen Verlaufes ist das Risiko eines Diskushernienrezidivs mit einer Inzidenz, je nach Literaturangabe, von 1\u201318%. Aus der aktuellen Literatur geht hervor, dass ein grosser Anulus-Defekt und eine limitierte perioperative Bandscheibenfachausr\u00e4umung zu einem erh\u00f6hten Risiko eines Diskushernienrezidivs f\u00fchren. Im Gegensatz dazu ist eine grossz\u00fcgige perioperative Ausr\u00e4umung des Bandscheibenfachs mit einem beschleunigten postoperativen Verlust der Bandscheibenh\u00f6he und damit mit einer zunehmenden Bandscheibendegeneration vergesellschaftet. Der Wirbels\u00e4ulenchirurg ist perioperativ bei jeder LDH-Operation mit dieser Problematik konfrontiert. Seit einiger Zeit wurden sogenannte Anulus-Verschluss-Produkte (engl. anular closure devices) mit dem Ziel entwickelt, das postoperative Rezidivrisiko zu senken. Die vorliegende Arbeit diskutiert anhand einer aktuellen Patientengeschichte die Position einer Anulus-Verschluss-Prothese in Bezug auf die Problematik Rezidivrisiko vs. postoperative Bandscheibendegeneration.", "term_pairs": [{"src": {"text": "lumbar disc herniation", "char_start": 2, "char_end": 24, "token_start": 1, "token_end": 4}, "tgt": {"text": "lumbale Diskushernie", "char_start": 4, "char_end": 24, "token_start": 1, "token_end": 3}}, {"src": {"text": "incidence", "char_start": 54, "char_end": 63, "token_start": 10, "token_end": 11}, "tgt": {"text": "Inzidenz", "char_start": 184, "char_end": 192, "token_start": 27, "token_end": 28}}, {"src": {"text": "anular defect", "char_start": 157, "char_end": 170, "token_start": 30, "token_end": 32}, "tgt": {"text": "Anulus-Defekt", "char_start": 288, "char_end": 301, "token_start": 49, "token_end": 52}}, {"src": {"text": "perioperative microdiscectomy", "char_start": 185, "char_end": 214, "token_start": 35, "token_end": 37}, "tgt": {"text": "perioperative Bandscheibenfachausr\u00e4umung", "char_start": 322, "char_end": 362, "token_start": 55, "token_end": 57}}, {"src": {"text": "risk of recurrence", "char_start": 237, "char_end": 255, "token_start": 41, "token_end": 44}, "tgt": {"text": "Rezidivrisiko", "char_start": 894, "char_end": 907, "token_start": 128, "token_end": 129}}, {"src": {"text": "postoperative disc height loss", "char_start": 343, "char_end": 373, "token_start": 57, "token_end": 61}, "tgt": {"text": "postoperativen Verlust der Bandscheibenh\u00f6he", "char_start": 535, "char_end": 578, "token_start": 78, "token_end": 82}}, {"src": {"text": "degenerative disc disease", "char_start": 392, "char_end": 417, "token_start": 64, "token_end": 67}, "tgt": {"text": "Bandscheibendegeneration", "char_start": 611, "char_end": 635, "token_start": 87, "token_end": 88}}, {"src": {"text": "anular-closure-device", "char_start": 465, "char_end": 486, "token_start": 76, "token_end": 81}, "tgt": {"text": "Anulus-Verschluss-Prothese", "char_start": 1015, "char_end": 1041, "token_start": 143, "token_end": 148}}]}
{"idx": 1790, "pair_id": "32189055", "src": "The implementation of an electronic patient health record (EHR) system in the field of ophthalmology can be a\u00a0challenging project for many hospitals. Although all hospitals have a hospital information systems (HIS), these systems are often not capable of managing the complexity of ophthalmological patient records. This article reports the implementation of an ophthalmological EHR into the pre-existing HIS (Agfa-ORBIS; Agfa HealthCare GmbH, Bonn, Germany). The digital record management and the connections to the peripheral examination devices are presented. The EHR developed by us has been in clinical use since 2009 and is subject to continuous further development. Through close cooperation with the IT department, all examination devices could be digitally connected, enabling paperless work and avoiding the drawbacks of paper files. The advantages of an EHR implemented into the existing HIS are manifold. Through such a\u00a0system a\u00a0complete, interdisciplinary and ubiquitous documentation can take place. The alternative is the acquisition of a\u00a0third system, which must be connected by an interface with the main system and has significantly higher acquisition and maintenance costs.", "tgt": "HINTERGRUND: Die Einf\u00fchrung einer elektronischen Patientenakte (EPA) im Bereich der Ophthalmologie stellt f\u00fcr viele Kliniken eine Herausforderung dar. Obwohl alle Kliniken ein Krankenhausinformationssystem (KIS) besitzen, sind die wenigsten dieser Systeme f\u00fcr die komplexe ophthalmologische Patientenakte ger\u00fcstet. Wir berichten \u00fcber die Implementierung einer ophthalmologischen EPA innerhalb des vorherrschenden KIS (Agfa-ORBIS; Agfa HealthCare GmbH, Bonn). Dabei werden sowohl die digitale Aktenf\u00fchrung als auch die Anbindung der vorhandenen Untersuchungsger\u00e4te dargestellt. Die von uns entwickelte EPA wird im klinischen Alltag seit 2009 genutzt und seitdem kontinuierlich weiterentwickelt. Durch eine enge Zusammenarbeit mit der IT-Abteilung konnten alle Untersuchungsger\u00e4te digital angebunden werden und ein papierloses Arbeiten erm\u00f6glichen und die Nachteile der Papierakte vermeiden. Die Nutzungsm\u00f6glichkeiten einer in das vorhandene KIS implementierten EPA sind vielf\u00e4ltig. Durch solch ein System kann eine l\u00fcckenlose, f\u00e4cher\u00fcbergreifende und ubiquit\u00e4re Dokumentation erfolgen. Die Alternative stellt die Anschaffung eines Drittsystems dar, welches sowohl durch eine Schnittstelle mit dem Hauptsystem verbunden werden muss als auch deutliche h\u00f6here Anschaffungs- und Erhaltungskosten aufweist.", "term_pairs": [{"src": {"text": "electronic patient health record (EHR)", "char_start": 25, "char_end": 63, "token_start": 4, "token_end": 11}, "tgt": {"text": "elektronischen Patientenakte (EPA)", "char_start": 34, "char_end": 68, "token_start": 5, "token_end": 10}}, {"src": {"text": "EHR", "char_start": 379, "char_end": 382, "token_start": 61, "token_end": 62}, "tgt": {"text": "EPA", "char_start": 379, "char_end": 382, "token_start": 51, "token_end": 52}}, {"src": {"text": "hospital information systems (HIS)", "char_start": 180, "char_end": 214, "token_start": 31, "token_end": 37}, "tgt": {"text": "Krankenhausinformationssystem (KIS)", "char_start": 176, "char_end": 211, "token_start": 26, "token_end": 30}}, {"src": {"text": "HIS", "char_start": 317, "char_end": 320, "token_start": 53, "token_end": 54}, "tgt": {"text": "KIS", "char_start": 413, "char_end": 416, "token_start": 55, "token_end": 56}}, {"src": {"text": "ophthalmology", "char_start": 87, "char_end": 100, "token_start": 16, "token_end": 17}, "tgt": {"text": "Ophthalmologie", "char_start": 84, "char_end": 98, "token_start": 13, "token_end": 14}}, {"src": {"text": "ophthalmological", "char_start": 282, "char_end": 298, "token_start": 49, "token_end": 50}, "tgt": {"text": "ophthalmologische", "char_start": 273, "char_end": 290, "token_start": 40, "token_end": 41}}, {"src": {"text": "Agfa-ORBIS", "char_start": 410, "char_end": 420, "token_start": 69, "token_end": 72}, "tgt": {"text": "Agfa-ORBIS", "char_start": 418, "char_end": 428, "token_start": 57, "token_end": 60}}, {"src": {"text": "Agfa HealthCare GmbH", "char_start": 422, "char_end": 442, "token_start": 73, "token_end": 76}, "tgt": {"text": "Agfa HealthCare GmbH", "char_start": 430, "char_end": 450, "token_start": 61, "token_end": 64}}, {"src": {"text": "Bonn, Germany", "char_start": 444, "char_end": 457, "token_start": 77, "token_end": 80}, "tgt": {"text": "Bonn", "char_start": 452, "char_end": 456, "token_start": 65, "token_end": 66}}, {"src": {"text": "digital record management", "char_start": 464, "char_end": 489, "token_start": 83, "token_end": 86}, "tgt": {"text": "digitale Aktenf\u00fchrung", "char_start": 483, "char_end": 504, "token_start": 72, "token_end": 74}}, {"src": {"text": "peripheral examination devices", "char_start": 517, "char_end": 547, "token_start": 91, "token_end": 94}, "tgt": {"text": "Untersuchungsger\u00e4te", "char_start": 544, "char_end": 563, "token_start": 80, "token_end": 81}}, {"src": {"text": "examination devices", "char_start": 727, "char_end": 746, "token_start": 126, "token_end": 128}, "tgt": {"text": "Untersuchungsger\u00e4te", "char_start": 759, "char_end": 778, "token_start": 111, "token_end": 112}}, {"src": {"text": "IT department", "char_start": 708, "char_end": 721, "token_start": 122, "token_end": 124}, "tgt": {"text": "IT-Abteilung", "char_start": 733, "char_end": 745, "token_start": 106, "token_end": 109}}, {"src": {"text": "paperless work", "char_start": 786, "char_end": 800, "token_start": 134, "token_end": 136}, "tgt": {"text": "papierloses Arbeiten", "char_start": 813, "char_end": 833, "token_start": 117, "token_end": 119}}, {"src": {"text": "paper files", "char_start": 831, "char_end": 842, "token_start": 141, "token_end": 143}, "tgt": {"text": "Papierakte", "char_start": 868, "char_end": 878, "token_start": 124, "token_end": 125}}, {"src": {"text": "interdisciplinary", "char_start": 951, "char_end": 968, "token_start": 164, "token_end": 165}, "tgt": {"text": "f\u00e4cher\u00fcbergreifende", "char_start": 1026, "char_end": 1045, "token_start": 147, "token_end": 148}}, {"src": {"text": "ubiquitous documentation", "char_start": 973, "char_end": 997, "token_start": 166, "token_end": 168}, "tgt": {"text": "ubiquit\u00e4re Dokumentation", "char_start": 1050, "char_end": 1074, "token_start": 149, "token_end": 151}}, {"src": {"text": "third system", "char_start": 1054, "char_end": 1066, "token_start": 179, "token_end": 181}, "tgt": {"text": "Drittsystems", "char_start": 1130, "char_end": 1142, "token_start": 159, "token_end": 160}}, {"src": {"text": "interface", "char_start": 1098, "char_end": 1107, "token_start": 188, "token_end": 189}, "tgt": {"text": "Schnittstelle", "char_start": 1174, "char_end": 1187, "token_start": 166, "token_end": 167}}, {"src": {"text": "main system", "char_start": 1117, "char_end": 1128, "token_start": 191, "token_end": 193}, "tgt": {"text": "Hauptsystem", "char_start": 1196, "char_end": 1207, "token_start": 169, "token_end": 170}}, {"src": {"text": "maintenance costs", "char_start": 1174, "char_end": 1191, "token_start": 199, "token_end": 201}, "tgt": {"text": "Erhaltungskosten", "char_start": 1274, "char_end": 1290, "token_start": 180, "token_end": 181}}]}
{"idx": 1820, "pair_id": "34100984", "src": "The superior mesenteric artery (SMA) is exposed and dissected during pancreatic resections (PR) and mesenteric vascular surgery (MVS). The resulting damage of the surrounding extrinsic and intrinsic vegetative nerve plexus can lead to a temporary or treatment refractory diarrhea. This study aimed to provide an overview of the current status of SMA revascularization and dissection-associated diarrhea (SMARD syndrome) in Germany. After a\u00a0selective literature search (SLS) on the frequency of newly developed postoperative diarrhea after PR and MVS, an online survey was initiated. The SLS (n\u202f=\u20094) confirmed that newly developed postoperative diarrhea is a\u00a0frequent complication after preparation for revascularization (RV) or dissection (DIS) of the SMA (incidence approximately 62%). Treatment refractive courses were relatively uncommon with 14%. Out of 159 centers 54 took part in the survey and 63% stated that they carried out an SMA RV/DIS during PR or MVS. The average PR per center was\u00a047 in 2018 and\u00a049 in 2019. The average MVS was 5 per center in both years and on average 3 patients suffered from SMARD syndrome. This survey recorded the current status of the SMARD syndrome in Germany for the first time. So far there are no recommendations for the treatment of such a diarrhea. The results show that initially a symptomatic treatment should be carried out. Due to the complexity of the pathophysiology, causal treatment approaches have not yet been developed.", "tgt": "HINTERGRUND: Die A.\u00a0mesenterica superior (AMS) wird im Rahmen von Pankreasresektionen (PR) und mesenterialen Gef\u00e4\u00dfeingriffen (MG) freigelegt und disseziert. Eine dadurch entstandene Sch\u00e4digung des umliegenden ex- und intrinsischen vegetativen Nervenplexus kann zu einer passageren oder therapierefrakt\u00e4ren Diarrh\u00f6 f\u00fchren. Die vorliegende Studie soll einen \u00dcberblick \u00fcber den derzeitigen Stellenwert der AMS-Revaskularisations- und -Dissektions-assoziierten Diarrh\u00f6 (\u201esuperior mesenteric artery revascularisation and dissection-associated diarrhea\u201c[SMARD]-Syndrom) in Deutschland geben. Nach selektiver Literaturrecherche (SLR) mit der Fragestellung, ob und wie h\u00e4ufig eine postoperativ neu aufgetretene Diarrh\u00f6 nach PR und MG vorkommt, wurde eine Onlineumfrage versendet. Die SLR (n\u202f=\u20094) best\u00e4tigte, dass eine postoperativ neu aufgetretene Diarrh\u00f6 eine h\u00e4ufige Komplikation nach Pr\u00e4paration zur Revaskularisation (RV) bzw. Dissektion (DIS) der AMS ist (Inzidenz ca.\u00a062\u202f%). Therapierefrakt\u00e4re Verl\u00e4ufe sind selten 14\u202f%. 54\u00a0von 159\u00a0Zentren beteiligten sich an der Umfrage. 63\u202f% gaben an, eine AMS-RV/-DIS im Rahmen von PR oder MG durchzuf\u00fchren. Der Durchschnitt an PR pro Zentrum lag 2018 bei\u00a047 und bei\u00a049 im Jahr 2019. F\u00fcnf MG erfolgten durchschnittlich in beiden Jahren pro Zentrum. Drei Patienten litten durchschnittlich am SMARD-Syndrom. Diese Umfrage erfasst erstmals den derzeitigen Stellenwert des SMARD-Syndroms in Deutschland. Bisher fehlen Empfehlungen zur Therapie einer solchen Diarrh\u00f6. Die Ergebnisse zeigen, dass zun\u00e4chst eine symptomatische Therapie erfolgen sollte. Aufgrund der Komplexit\u00e4t der Pathophysiologie sind kausale Therapieans\u00e4tze bislang nicht entwickelt.", "term_pairs": [{"src": {"text": "superior mesenteric artery", "char_start": 4, "char_end": 30, "token_start": 1, "token_end": 4}, "tgt": {"text": "A. mesenterica superior", "char_start": 17, "char_end": 40, "token_start": 3, "token_end": 7}}, {"src": {"text": "SMA", "char_start": 32, "char_end": 35, "token_start": 5, "token_end": 6}, "tgt": {"text": "AMS", "char_start": 42, "char_end": 45, "token_start": 8, "token_end": 9}}, {"src": {"text": "pancreatic resections", "char_start": 69, "char_end": 90, "token_start": 12, "token_end": 14}, "tgt": {"text": "Pankreasresektionen", "char_start": 66, "char_end": 85, "token_start": 14, "token_end": 15}}, {"src": {"text": "PR", "char_start": 92, "char_end": 94, "token_start": 15, "token_end": 16}, "tgt": {"text": "PR", "char_start": 87, "char_end": 89, "token_start": 16, "token_end": 17}}, {"src": {"text": "mesenteric vascular surgery", "char_start": 100, "char_end": 127, "token_start": 18, "token_end": 21}, "tgt": {"text": "mesenterialen Gef\u00e4\u00dfeingriffen", "char_start": 95, "char_end": 124, "token_start": 19, "token_end": 21}}, {"src": {"text": "MVS", "char_start": 129, "char_end": 132, "token_start": 22, "token_end": 23}, "tgt": {"text": "MG", "char_start": 126, "char_end": 128, "token_start": 22, "token_end": 23}}, {"src": {"text": "extrinsic and intrinsic vegetative nerve plexus", "char_start": 175, "char_end": 222, "token_start": 31, "token_end": 37}, "tgt": {"text": "ex- und intrinsischen vegetativen Nervenplexus", "char_start": 209, "char_end": 255, "token_start": 34, "token_end": 40}}, {"src": {"text": "diarrhea", "char_start": 271, "char_end": 279, "token_start": 45, "token_end": 46}, "tgt": {"text": "Diarrh\u00f6", "char_start": 306, "char_end": 313, "token_start": 46, "token_end": 47}}, {"src": {"text": "SMARD syndrome", "char_start": 404, "char_end": 418, "token_start": 67, "token_end": 69}, "tgt": {"text": "SMARD-Syndrom", "char_start": 1326, "char_end": 1339, "token_start": 233, "token_end": 236}}, {"src": {"text": "selective literature search", "char_start": 440, "char_end": 467, "token_start": 75, "token_end": 78}, "tgt": {"text": "selektiver Literaturrecherche", "char_start": 591, "char_end": 620, "token_start": 93, "token_end": 95}}, {"src": {"text": "SLS", "char_start": 469, "char_end": 472, "token_start": 79, "token_end": 80}, "tgt": {"text": "SLR", "char_start": 622, "char_end": 625, "token_start": 96, "token_end": 97}}, {"src": {"text": "postoperative diarrhea", "char_start": 510, "char_end": 532, "token_start": 87, "token_end": 89}, "tgt": {"text": "postoperativ neu aufgetretene Diarrh\u00f6", "char_start": 673, "char_end": 710, "token_start": 107, "token_end": 111}}, {"src": {"text": "revascularization", "char_start": 350, "char_end": 367, "token_start": 60, "token_end": 61}, "tgt": {"text": "Revaskularisation", "char_start": 407, "char_end": 424, "token_start": 62, "token_end": 63}}, {"src": {"text": "RV", "char_start": 315, "char_end": 317, "token_start": 53, "token_end": 54}, "tgt": {"text": "RV", "char_start": 914, "char_end": 916, "token_start": 145, "token_end": 146}}, {"src": {"text": "dissection", "char_start": 372, "char_end": 382, "token_start": 62, "token_end": 63}, "tgt": {"text": "Dissektion", "char_start": 432, "char_end": 442, "token_start": 66, "token_end": 67}}, {"src": {"text": "DIS", "char_start": 52, "char_end": 55, "token_start": 10, "token_end": 11}, "tgt": {"text": "DIS", "char_start": 145, "char_end": 148, "token_start": 26, "token_end": 27}}, {"src": {"text": "incidence", "char_start": 757, "char_end": 766, "token_start": 133, "token_end": 134}, "tgt": {"text": "Inzidenz", "char_start": 953, "char_end": 961, "token_start": 157, "token_end": 158}}, {"src": {"text": "treatment refractive", "char_start": 787, "char_end": 807, "token_start": 139, "token_end": 141}, "tgt": {"text": "Therapierefrakt\u00e4re", "char_start": 286, "char_end": 304, "token_start": 45, "token_end": 46}}, {"src": {"text": "pathophysiology", "char_start": 1401, "char_end": 1416, "token_start": 261, "token_end": 262}, "tgt": {"text": "Pathophysiologie", "char_start": 1610, "char_end": 1626, "token_start": 276, "token_end": 277}}]}
{"idx": 1994, "pair_id": "24627317", "src": "Autoantibodies (Abs) against angiotensin-II type 1 (AT(1)R) and endothelin-1 type A receptors (ETAR) are investigated in the present study as B-cell originated humoral factors that may activate the respective receptors on endothelial cells. The prevalence of the Abs was determined in patients with peripheral arterial occlusive disease (PAD). In a prospective observational study 200 patients undergoing angiography and proven advanced PAD were enrolled. Serum samples, clinical data and laboratory values for classical cardiovascular risk factors were collected. Autoantibody titers for AT(1)R and ETAR were determined by solid-phase ELISA and correlative analyses with laboratory parameters and clinical data for common cardiovascular risk factors were performed. Anti-ETAR antibody titers were detected in 57 % of the patients, elevated anti-AT(1)R titers in 61.5 %. About 50 % were positive for both Abs. A strong intercorrelation between ETAR and AT(1)R titers was present (r2 0.79). In patients with positive titers for both Abs females presented significantly higher titers for ETAR (p = 0.045) and AT(1)R (p = 0.02). Autoantibody titers directed against surface receptors ETA and AT(1) are highly correlated in PAD. Titers were independent from classical risk factors in any patient subgroup. This study opens a new perspective on the involvement of the immune system, hereby represented by functional autoantibodies, in the atherosclerotic pathophysiology, leaving behind the common background of classical risk factors.", "tgt": "Hintergrund: Immunologischen Faktoren wird eine Rolle bei der Entstehung der Athero- und Arteriosklerose zugeschrieben. B-Zell-vermittelte humorale Faktoren wie Autoantik\u00f6rper gegen Angiotensin-II Typ1 (AT1R) und Endothelin-1 Typ-A Rezeptoren (ETAR) werden in der vorliegenden Studie hinsichtlich ihrer Pr\u00e4valenz bei pAVK untersucht. Patienten und Methoden: In einer prospektiv angelegten Beobachtungsstudie wurden von 200 Patienten mit fortgeschrittener angiographisch gesicherter pAVK Serumproben und klinische Daten sowie Laborwerte f\u00fcr klassische kardiovaskul\u00e4re Risikofaktoren gesammelt. Autoantik\u00f6rpertiter f\u00fcr AT1R und ETAR wurden mittels solid phase ELISA analysiert. Ergebnisse: Autoantik\u00f6rpertiter wurden gegen ETAR in 57 %, gegen AT1R in 61,5 % der Patienten gefunden. Etwa 50% der Patienten waren positiv f\u00fcr beide Autoantik\u00f6rper. Es bestand eine starke positive Korrelation beider Autoantik\u00f6rper untereinander (r2 0.79). Es konnten geschlechtsspezifische Unterschiede nachgewiesen werden. Frauen waren h\u00e4ufiger positiv f\u00fcr beide Autoantik\u00f6rper getestet und wiesen in der Subgruppenanalyse gegen\u00fcber M\u00e4nnern h\u00f6here Titer auf: ETAR (p = 0.045), AT1R (p = 0.02). Autoantik\u00f6rper gegen ETA- und AT1-Oberfl\u00e4chenrezeptoren treten in etwa 60% aller untersuchten pAVK Patienten auf, wobei oft beide vorliegen. Das Vorkommen und die H\u00f6he der Antik\u00f6rper werden nicht durch klassische Risikofaktoren beeinflusst. Schlussfolgerungen: Diese Studie er\u00f6ffnet eine neue Sichtweise auf die Pathophysiologie immunologisch vermittelter Prozesse bei pAVK, hierbei repr\u00e4sentiert durch Autoantik\u00f6rper gegen funktionelle Oberfl\u00e4chenrezeptoren, deren Vorkommen und Titerh\u00f6he nicht durch klassische Risikofaktoren beeinflusst zu sein scheint.", "term_pairs": [{"src": {"text": "Autoantibodies", "char_start": 0, "char_end": 14, "token_start": 0, "token_end": 1}, "tgt": {"text": "Autoantik\u00f6rper", "char_start": 161, "char_end": 175, "token_start": 25, "token_end": 26}}, {"src": {"text": "angiotensin-II type 1 (AT(1)R)", "char_start": 29, "char_end": 59, "token_start": 5, "token_end": 17}, "tgt": {"text": "Angiotensin-II Typ1 (AT1R)", "char_start": 182, "char_end": 208, "token_start": 27, "token_end": 34}}, {"src": {"text": "endothelin-1 type A receptors (ETAR)", "char_start": 64, "char_end": 100, "token_start": 18, "token_end": 27}, "tgt": {"text": "Endothelin-1 Typ-A Rezeptoren (ETAR)", "char_start": 213, "char_end": 249, "token_start": 35, "token_end": 45}}, {"src": {"text": "B-cell", "char_start": 142, "char_end": 148, "token_start": 34, "token_end": 37}, "tgt": {"text": "B-Zell", "char_start": 120, "char_end": 126, "token_start": 17, "token_end": 20}}, {"src": {"text": "humoral factors", "char_start": 160, "char_end": 175, "token_start": 38, "token_end": 40}, "tgt": {"text": "humorale Faktoren", "char_start": 139, "char_end": 156, "token_start": 22, "token_end": 24}}, {"src": {"text": "endothelial cells", "char_start": 222, "char_end": 239, "token_start": 47, "token_end": 49}, "tgt": {"text": "Oberfl\u00e4chenrezeptoren", "char_start": 1207, "char_end": 1228, "token_start": 198, "token_end": 199}}, {"src": {"text": "peripheral arterial occlusive disease (PAD)", "char_start": 299, "char_end": 342, "token_start": 60, "token_end": 67}, "tgt": {"text": "pAVK", "char_start": 317, "char_end": 321, "token_start": 54, "token_end": 55}}, {"src": {"text": "prospective observational study", "char_start": 349, "char_end": 380, "token_start": 70, "token_end": 73}, "tgt": {"text": "prospektiv angelegten Beobachtungsstudie", "char_start": 367, "char_end": 407, "token_start": 63, "token_end": 66}}, {"src": {"text": "angiography", "char_start": 405, "char_end": 416, "token_start": 76, "token_end": 77}, "tgt": {"text": "angiographisch", "char_start": 455, "char_end": 469, "token_start": 72, "token_end": 73}}, {"src": {"text": "PAD", "char_start": 437, "char_end": 440, "token_start": 80, "token_end": 81}, "tgt": {"text": "pAVK", "char_start": 482, "char_end": 486, "token_start": 74, "token_end": 75}}, {"src": {"text": "Serum samples", "char_start": 456, "char_end": 469, "token_start": 84, "token_end": 86}, "tgt": {"text": "Serumproben", "char_start": 487, "char_end": 498, "token_start": 75, "token_end": 76}}, {"src": {"text": "clinical data", "char_start": 471, "char_end": 484, "token_start": 87, "token_end": 89}, "tgt": {"text": "klinische Daten", "char_start": 503, "char_end": 518, "token_start": 77, "token_end": 79}}, {"src": {"text": "laboratory values", "char_start": 489, "char_end": 506, "token_start": 90, "token_end": 92}, "tgt": {"text": "Laborwerte", "char_start": 525, "char_end": 535, "token_start": 80, "token_end": 81}}, {"src": {"text": "cardiovascular risk factors", "char_start": 521, "char_end": 548, "token_start": 94, "token_end": 97}, "tgt": {"text": "kardiovaskul\u00e4re Risikofaktoren", "char_start": 551, "char_end": 581, "token_start": 83, "token_end": 85}}, {"src": {"text": "Autoantibody titers", "char_start": 565, "char_end": 584, "token_start": 100, "token_end": 102}, "tgt": {"text": "Autoantik\u00f6rpertiter", "char_start": 593, "char_end": 612, "token_start": 87, "token_end": 88}}, {"src": {"text": "AT(1)R", "char_start": 589, "char_end": 595, "token_start": 103, "token_end": 108}, "tgt": {"text": "AT1R", "char_start": 617, "char_end": 621, "token_start": 89, "token_end": 90}}, {"src": {"text": "ETAR", "char_start": 600, "char_end": 604, "token_start": 109, "token_end": 110}, "tgt": {"text": "ETAR", "char_start": 626, "char_end": 630, "token_start": 91, "token_end": 92}}, {"src": {"text": "solid-phase ELISA", "char_start": 624, "char_end": 641, "token_start": 113, "token_end": 117}, "tgt": {"text": "solid phase ELISA", "char_start": 646, "char_end": 663, "token_start": 94, "token_end": 97}}, {"src": {"text": "correlative analyses", "char_start": 646, "char_end": 666, "token_start": 118, "token_end": 120}, "tgt": {"text": "Korrelation", "char_start": 875, "char_end": 886, "token_start": 136, "token_end": 137}}, {"src": {"text": "females", "char_start": 1036, "char_end": 1043, "token_start": 201, "token_end": 202}, "tgt": {"text": "Frauen", "char_start": 1002, "char_end": 1008, "token_start": 154, "token_end": 155}}, {"src": {"text": "surface receptors", "char_start": 1163, "char_end": 1180, "token_start": 233, "token_end": 235}, "tgt": {"text": "Oberfl\u00e4chenrezeptoren", "char_start": 1610, "char_end": 1631, "token_start": 252, "token_end": 253}}, {"src": {"text": "ETA", "char_start": 772, "char_end": 775, "token_start": 136, "token_end": 137}, "tgt": {"text": "ETA", "char_start": 721, "char_end": 724, "token_start": 104, "token_end": 105}}, {"src": {"text": "AT(1)", "char_start": 846, "char_end": 851, "token_start": 151, "token_end": 155}, "tgt": {"text": "AT1", "char_start": 741, "char_end": 744, "token_start": 110, "token_end": 111}}, {"src": {"text": "autoantibodies", "char_start": 1411, "char_end": 1425, "token_start": 277, "token_end": 278}, "tgt": {"text": "Autoantik\u00f6rper", "char_start": 688, "char_end": 702, "token_start": 101, "token_end": 102}}, {"src": {"text": "atherosclerotic pathophysiology", "char_start": 1434, "char_end": 1465, "token_start": 281, "token_end": 283}, "tgt": {"text": "Pathophysiologie", "char_start": 1485, "char_end": 1501, "token_start": 239, "token_end": 240}}, {"src": {"text": "classical risk factors", "char_start": 1254, "char_end": 1276, "token_start": 251, "token_end": 254}, "tgt": {"text": "klassische Risikofaktoren", "char_start": 1375, "char_end": 1400, "token_start": 225, "token_end": 227}}]}
{"idx": 2002, "pair_id": "24647778", "src": "In this multicenter study, we aimed to compare concurrent (18)F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) and bone scan results of breast cancer patient. 162 patients with breast cancer (158 female, 4 male; mean age 50.6 years) were included in the study. FDG PET/CT examination was performed in all patients, and concurrent bone scintigraphy in 68 patients. The results of FDG PET/CT and bone scan were compared. 132 of the 162 patients were operated on because of breast cancer. 89 patients had metastasis, and 4 had recurrent disease according to FDG PET/CT results. Metastatic sites in order of frequency were lymph nodes, bone, lung, liver, adrenal gland, local skin or muscle, brain, and peritoneum (peritonitis carcinomatosa). The sensitivity, specificity, accuracy, and negative and positive predictive value of bone scintigraphy versus FDG PET/CT were 96 vs. 100%, 100 vs. 98%, 100 vs. 83%, 100 vs. 100%, and 90 vs. 100%, respectively. Although the 2 modalities were in concordance with each other, in 5 (21%) cases, FDG PET/CT could not show bone metastasis which were detected on bone scintigraphy. Hence, bone scintigraphy was superior to FDG PET/CT in the determination of bone metastasis derived from breast cancer. However, FDG PET/CT should be considered for soft tissue metastasis.", "tgt": "Ziel dieser multizentrischen Studie war es, die Ergebnisse gleichzeitig erstellter <sup>18</sup>F-Fluordesoxyglucose-Positronen-Emissions-Tomographie/Computer-tomographie (FDG PET/CT)-Studien und knochenszin-tigraphischer Untersuchungen von Mammakarzinompatienten zu vergleichen. 162 Mammakarzinompatienten (158 weiblich, 4 m\u00e4nnlich; mittleres Alter 50,6 Jahre) wurden in die Studie aufgenommen. FDG PET/CT-Studien wurden bei allen Patienten durchgef\u00fchrt, und 68 wurden gleichzeitig knochenszintigraphisch untersucht. Die Ergebnisse beider Modalit\u00e4ten wurden verglichen. 132 der 162 Patienten wurden auf Grund eines Mammakarzinoms operiert. 89 Patienten hatten Metastasen, und 4 Patienten hatten laut FDG PET/CT ein Rezidiv. Metastasen wurden entsprechend der H\u00e4ufigkeit des Auftretens in folgenden Organsystemen gefunden: Lymphknoten, Knochen, Lunge, Leber, Nebenniere, lokale Haut oder Muskel, Gehirn und Peritoneum (Peritonealkarzinose). Die Sensitivit\u00e4t, Spezifizit\u00e4t und Genauigkeit sowie der negative und positive Vorhersagewert der Knochenszintigraphie versus FDG PET/CT waren 96 vs. 100%, 100 vs. 98%, 100 vs. 83% sowie 100 vs. 100% und 90 vs.100%. Obgleich beide Modalit\u00e4ten weitestgehend miteinander \u00fcbereinstimmten, konnte das FDG PET/CT bei 5 (21%) Patienten Metastasen, die in der Knochenszintigraphie sichtbar waren, nicht darstellen. Die Knochenszintigraphie war demnach dem FDG PET/CT bei der Detektion von Knochenmetastasen eines Mammakarzinoms \u00fcberlegen. FDG PET/CT sollte dennoch bei Weichteilmetastasen in Erw\u00e4gung gezogen werden.", "term_pairs": [{"src": {"text": "multicenter study", "char_start": 8, "char_end": 25, "token_start": 2, "token_end": 4}, "tgt": {"text": "multizentrischen Studie", "char_start": 12, "char_end": 35, "token_start": 2, "token_end": 4}}, {"src": {"text": "(18)F-fluorodeoxyglucose positron emission tomography/computed tomography", "char_start": 58, "char_end": 131, "token_start": 10, "token_end": 22}, "tgt": {"text": "<sup>18</sup>F-Fluordesoxyglucose-Positronen-Emissions-Tomographie/Computer-tomographie", "char_start": 83, "char_end": 170, "token_start": 11, "token_end": 32}}, {"src": {"text": "FDG PET/CT", "char_start": 133, "char_end": 143, "token_start": 23, "token_end": 27}, "tgt": {"text": "FDG PET/CT", "char_start": 172, "char_end": 182, "token_start": 33, "token_end": 37}}, {"src": {"text": "bone scan", "char_start": 149, "char_end": 158, "token_start": 29, "token_end": 31}, "tgt": {"text": "knochenszin-tigraphischer Untersuchungen", "char_start": 196, "char_end": 236, "token_start": 41, "token_end": 45}}, {"src": {"text": "breast cancer", "char_start": 170, "char_end": 183, "token_start": 33, "token_end": 35}, "tgt": {"text": "Mammakarzinom", "char_start": 241, "char_end": 254, "token_start": 46, "token_end": 47}}, {"src": {"text": "patients", "char_start": 197, "char_end": 205, "token_start": 38, "token_end": 39}, "tgt": {"text": "Patienten", "char_start": 254, "char_end": 263, "token_start": 46, "token_end": 47}}, {"src": {"text": "FDG PET/CT examination", "char_start": 295, "char_end": 317, "token_start": 62, "token_end": 67}, "tgt": {"text": "FDG PET/CT-Studien", "char_start": 396, "char_end": 414, "token_start": 72, "token_end": 78}}, {"src": {"text": "bone scintigraphy", "char_start": 364, "char_end": 381, "token_start": 75, "token_end": 77}, "tgt": {"text": "Knochenszintigraphie", "char_start": 1039, "char_end": 1059, "token_start": 173, "token_end": 174}}, {"src": {"text": "metastasis", "char_start": 536, "char_end": 546, "token_start": 110, "token_end": 111}, "tgt": {"text": "Metastasen", "char_start": 661, "char_end": 671, "token_start": 112, "token_end": 113}}, {"src": {"text": "recurrent disease", "char_start": 558, "char_end": 575, "token_start": 115, "token_end": 117}, "tgt": {"text": "Rezidiv", "char_start": 716, "char_end": 723, "token_start": 124, "token_end": 125}}, {"src": {"text": "lymph nodes", "char_start": 653, "char_end": 664, "token_start": 132, "token_end": 134}, "tgt": {"text": "Lymphknoten", "char_start": 823, "char_end": 834, "token_start": 138, "token_end": 139}}, {"src": {"text": "bone", "char_start": 428, "char_end": 432, "token_start": 89, "token_end": 90}, "tgt": {"text": "Knochen", "char_start": 483, "char_end": 490, "token_start": 88, "token_end": 89}}, {"src": {"text": "lung", "char_start": 672, "char_end": 676, "token_start": 137, "token_end": 138}, "tgt": {"text": "Lunge", "char_start": 845, "char_end": 850, "token_start": 142, "token_end": 143}}, {"src": {"text": "liver", "char_start": 678, "char_end": 683, "token_start": 139, "token_end": 140}, "tgt": {"text": "Leber", "char_start": 852, "char_end": 857, "token_start": 144, "token_end": 145}}, {"src": {"text": "adrenal gland", "char_start": 685, "char_end": 698, "token_start": 141, "token_end": 143}, "tgt": {"text": "Nebenniere", "char_start": 859, "char_end": 869, "token_start": 146, "token_end": 147}}, {"src": {"text": "local skin or muscle", "char_start": 700, "char_end": 720, "token_start": 144, "token_end": 148}, "tgt": {"text": "lokale Haut oder Muskel", "char_start": 871, "char_end": 894, "token_start": 148, "token_end": 152}}, {"src": {"text": "brain", "char_start": 722, "char_end": 727, "token_start": 149, "token_end": 150}, "tgt": {"text": "Gehirn", "char_start": 896, "char_end": 902, "token_start": 153, "token_end": 154}}, {"src": {"text": "peritoneum", "char_start": 733, "char_end": 743, "token_start": 152, "token_end": 153}, "tgt": {"text": "Peritoneum", "char_start": 907, "char_end": 917, "token_start": 155, "token_end": 156}}, {"src": {"text": "peritonitis carcinomatosa", "char_start": 745, "char_end": 770, "token_start": 154, "token_end": 156}, "tgt": {"text": "Peritonealkarzinose", "char_start": 919, "char_end": 938, "token_start": 157, "token_end": 158}}, {"src": {"text": "sensitivity", "char_start": 777, "char_end": 788, "token_start": 159, "token_end": 160}, "tgt": {"text": "Sensitivit\u00e4t", "char_start": 945, "char_end": 957, "token_start": 161, "token_end": 162}}, {"src": {"text": "specificity", "char_start": 790, "char_end": 801, "token_start": 161, "token_end": 162}, "tgt": {"text": "Spezifizit\u00e4t", "char_start": 959, "char_end": 971, "token_start": 163, "token_end": 164}}, {"src": {"text": "accuracy", "char_start": 803, "char_end": 811, "token_start": 163, "token_end": 164}, "tgt": {"text": "Genauigkeit", "char_start": 976, "char_end": 987, "token_start": 165, "token_end": 166}}, {"src": {"text": "positive predictive value", "char_start": 830, "char_end": 855, "token_start": 168, "token_end": 171}, "tgt": {"text": "positive Vorhersagewert", "char_start": 1011, "char_end": 1034, "token_start": 170, "token_end": 172}}, {"src": {"text": "bone metastasis", "char_start": 1091, "char_end": 1106, "token_start": 239, "token_end": 241}, "tgt": {"text": "Knochenmetastasen", "char_start": 1423, "char_end": 1440, "token_start": 255, "token_end": 256}}, {"src": {"text": "soft tissue metastasis", "char_start": 1314, "char_end": 1336, "token_start": 280, "token_end": 283}, "tgt": {"text": "Weichteilmetastasen", "char_start": 1503, "char_end": 1522, "token_start": 267, "token_end": 268}}]}
{"idx": 2054, "pair_id": "33201295", "src": "In recent years there have been substantial changes in the therapeutic landscape for systemic treatment of advanced prostate cancer (PCa), which resulted in a multitude of novel treatment options for different stages of the disease. In the current narrative review currently available treatment options for metastatic hormone-sensitive PCa as well as nonmetastatic castration-resistant PCa are presented. In addition, current treatment sequence options and targeted treatment in the stage of metastatic castration-resistant PCa are highlighted.", "tgt": "Die systemische Therapie des fortgeschrittenen Prostatakarzinoms (PCa) erlebte in den vergangenen Jahren tiefgreifende Ver\u00e4nderungen, die eine Vielzahl an neuartigen Therapieoptionen f\u00fcr verschiedene Krankheitsstadien induzierten. In der aktuellen \u00dcbersichtsarbeit werden zugelassene Therapieoptionen f\u00fcr das metastasierte hormonsensitive PCa sowie das nichtmetastasierte, kastrationsrefrakt\u00e4re PCa vorgestellt. Zus\u00e4tzlich werden aktuelle Therapiesequenzoptionen und die zielgerichtete Therapie im Stadium des metastasierten kastrationsrefrakt\u00e4ren PCa beleuchtet.", "term_pairs": [{"src": {"text": "systemic treatment", "char_start": 85, "char_end": 103, "token_start": 13, "token_end": 15}, "tgt": {"text": "systemische Therapie", "char_start": 4, "char_end": 24, "token_start": 1, "token_end": 3}}, {"src": {"text": "advanced prostate cancer", "char_start": 107, "char_end": 131, "token_start": 16, "token_end": 19}, "tgt": {"text": "fortgeschrittenen Prostatakarzinoms", "char_start": 29, "char_end": 64, "token_start": 4, "token_end": 6}}, {"src": {"text": "PCa", "char_start": 133, "char_end": 136, "token_start": 20, "token_end": 21}, "tgt": {"text": "PCa", "char_start": 66, "char_end": 69, "token_start": 7, "token_end": 8}}, {"src": {"text": "treatment options", "char_start": 178, "char_end": 195, "token_start": 30, "token_end": 32}, "tgt": {"text": "Therapieoptionen", "char_start": 166, "char_end": 182, "token_start": 22, "token_end": 23}}, {"src": {"text": "metastatic hormone-sensitive PCa", "char_start": 307, "char_end": 339, "token_start": 49, "token_end": 54}, "tgt": {"text": "metastasierte hormonsensitive PCa", "char_start": 309, "char_end": 342, "token_start": 37, "token_end": 40}}, {"src": {"text": "nonmetastatic castration-resistant PCa", "char_start": 351, "char_end": 389, "token_start": 57, "token_end": 62}, "tgt": {"text": "nichtmetastasierte, kastrationsrefrakt\u00e4re PCa", "char_start": 353, "char_end": 398, "token_start": 42, "token_end": 46}}, {"src": {"text": "treatment sequence options", "char_start": 426, "char_end": 452, "token_start": 69, "token_end": 72}, "tgt": {"text": "Therapiesequenzoptionen", "char_start": 439, "char_end": 462, "token_start": 51, "token_end": 52}}, {"src": {"text": "targeted treatment", "char_start": 457, "char_end": 475, "token_start": 73, "token_end": 75}, "tgt": {"text": "zielgerichtete Therapie", "char_start": 471, "char_end": 494, "token_start": 54, "token_end": 56}}, {"src": {"text": "metastatic castration-resistant PCa", "char_start": 492, "char_end": 527, "token_start": 79, "token_end": 84}, "tgt": {"text": "metastasierten kastrationsrefrakt\u00e4ren PCa", "char_start": 510, "char_end": 551, "token_start": 59, "token_end": 62}}]}
{"idx": 2058, "pair_id": "33201298", "src": "The question of what came first-in this case the diagnosis of prostate cancer or its therapy-seems absurd at first glance and is reminiscent of the classic metaphor-like problem that preoccupied the Greek writer Plutarch (45-125). Today it is a\u00a0matter of course that a\u00a0reliable diagnosis is made before treating a\u00a0disease, but this must be viewed as inconsistent in medical history. The beginnings of radical prostatectomy for the treatment of prostate cancer, like the first surgical therapies for kidney and bladder tumors, can be located in the pioneering period of organ surgery in the German Empire (1871-1918). The establishment of this procedure in its current form with larger numbers of cases is in turn thanks to the Nestor of American urology, Hugh Hampton Young, who carried out the first perineal prostatovesiculectomy, which from today's perspective can be described as complete. Although the indication has remained largely unchanged since then, this intervention has undergone extensive changes in recent decades. But how has the diagnosis of prostate cancer developed in this period? Of course, much more dynamic. While the procedure prostatovesiculectomy was already established, development of prostate cancer diagnosis began first slowly in the course of the 20th century, then more dynamically. The following article uses medical (historical) original sources to present not only the basics and further developments of the established and, at the same time, subject to constant intervention in urology, but also the essential developments in the environment of neighboring medical disciplines, for example, think of laboratory medicine, radiology, nuclear medicine or rehabilitation medicine, but especially pathology. Incidentally, it was only these developments that created the basis for the correct setting of indications and the identification of alternatives to radical prostatovesiculectomy.", "tgt": "Die Frage, was zuerst war \u2013 in diesem Falle die Diagnostik des Prostatakarzinoms oder seine Therapie \u2013 erscheint auf den ersten Blick widersinnig und erinnert an die klassische metapherartige Problemstellung, die schon den griechischen Schriftsteller Plutarch (45\u2013125) besch\u00e4ftigte. Ist es heute selbstverst\u00e4ndlich, dass vor der Behandlung einer Erkrankung die sichere Diagnosestellung steht, so muss dies medizinhistorisch jedoch als nicht konsistent erachtet werden. Die Anf\u00e4nge der radikalen Prostatektomie zur Behandlung des Prostatakarzinoms lassen sich, \u00e4hnlich wie die ersten operativen Therapien von Nieren- und Harnblasentumoren, in der Pionierzeit der Organchirurgie im Deutschen Kaiserreich (1871\u20131918) verorten. Die Etablierung dieses Eingriffs in seiner heutigen Form mit gr\u00f6\u00dferen Fallzahlen ist wiederum dem Nestor der US-amerikanischen Urologie, Hugh Hampton Young (1870\u20131945), zu verdanken, der 1904 die erste aus heutiger Sicht als vollumf\u00e4nglich zu bezeichnende perineale Prostatovesikulektomie durchf\u00fchrte. Wenngleich die Indikation seither weitgehend unver\u00e4ndert geblieben ist, war dieser Eingriff in den letzten Jahrzehnten doch umfangreichen Ver\u00e4nderungen unterworfen. Wie aber hat sich die Diagnostik des Prostatakarzinoms in dieser Zeitspanne entwickelt? Naturgem\u00e4\u00df sehr viel dynamischer! Denn als der Leiteingriff Prostatovesikulektomie bereits etabliert war, begann im Laufe des 20.\u00a0Jahrhunderts erst langsam, dann dynamischer deren Entwicklung. Wir stellen anhand medizin(histor)ischer Originalquellen daher nicht nur die Grundlagen und Weiterentwicklungen des etablierten und zugleich immer wieder Innovationen unterworfenen Leiteingriffs der Urologie vor, sondern gehen vielmehr auch auf wesentliche Umfeldentwicklungen benachbarter medizinischer Disziplinen ein. Erst diese Entwicklungen schafften \u00fcbrigens auch die Grundlage f\u00fcr die korrekte Indikationsstellung und das Aufzeigen von Alternativen zur radikalen Prostatovesikulektomie.", "term_pairs": [{"src": {"text": "prostate cancer", "char_start": 62, "char_end": 77, "token_start": 13, "token_end": 15}, "tgt": {"text": "Prostatakarzinoms", "char_start": 63, "char_end": 80, "token_start": 13, "token_end": 14}}, {"src": {"text": "radical prostatectomy", "char_start": 401, "char_end": 422, "token_start": 78, "token_end": 80}, "tgt": {"text": "radikalen Prostatektomie", "char_start": 485, "char_end": 509, "token_start": 75, "token_end": 77}}, {"src": {"text": "prostatovesiculectomy", "char_start": 810, "char_end": 831, "token_start": 153, "token_end": 154}, "tgt": {"text": "Prostatovesikulektomie", "char_start": 990, "char_end": 1012, "token_start": 156, "token_end": 157}}, {"src": {"text": "radical prostatovesiculectomy", "char_start": 1889, "char_end": 1918, "token_start": 327, "token_end": 329}, "tgt": {"text": "radikalen Prostatovesikulektomie", "char_start": 1932, "char_end": 1964, "token_start": 281, "token_end": 283}}, {"src": {"text": "urology", "char_start": 746, "char_end": 753, "token_start": 141, "token_end": 142}, "tgt": {"text": "Urologie", "char_start": 851, "char_end": 859, "token_start": 130, "token_end": 131}}]}
{"idx": 2060, "pair_id": "29359282", "src": "Alcohol dependence is one of the most serious diseases of addiction in Germany. The new S3-guideline 'Screening, Diagnostics and Treatment of Alcohol-Related Disorders' has been presented in 2015 and summarizes the present state of knowledge pertaining to the diagnosis and treatment of alcohol abuse and alcohol dependence. This guideline was developed over four years within the framework of the Association of the Scientific Medical Societies in Germany (AWMF). The German Association for Psychiatry, Psychotherapy and Psychosomatics (<i>DGPPN</i>) and the German Society for Research and Therapy in Addiction (DG-Sucht) took the lead in the organization. More than 50 professional societies and associations and health organizations as well as more than 60 acknowledged experts were involved, including networks of self-help groups and relatives. The working group on 'health care organization', whose results are presented here, was one out of thirteen working groups, focusing on the task how to implement the guideline under the basic conditions of the German health care system with its sectors and interfaces. For the chapter on 'health care organization' 27 recommendations have been consented. Many of these have been prepared by the respective working groups. These recommendations cover areas such as screening, diagnostics and short interventions, detoxification and withdrawal as well as pharmacotherapy, physical complications and psychic comorbidity, medical rehabilitation and other forms of post-acute treatment, primary care by general practitioners, as well as specific target groups such as children and adolescents, (pregnant) women and the elderly, and, in addition, self-help approaches. For needs-based diagnostics and treatment of alcohol-related disorders, guideline-based recommendations for health care organization offer a framework for the cooperation and coordination of all health sectors and occupational groups, especially with respect to their interfaces. This includes the cooperation between the medical and the psychosocial system and stretches from harm reduction to social inclusion of people concerned. Particularly the field of rehabilitation with its explicit aims for participation relies heavily on such a cooperation.", "tgt": "Alkoholabh\u00e4ngigkeit geh\u00f6rt in Deutschland zu den schwerwiegendsten Suchterkrankungen. Die neue S3-Leitlinie 'Screening, Diagnose und Behandlung alkoholbezogener St\u00f6rungen\u201c wurde im Jahre 2015 vorgestellt und fasst den aktuellen Kenntnisstand zur Diagnose und Behandlung von sch\u00e4dlichem und abh\u00e4ngigem Alkoholkonsum zusammen. Die Entwicklung der Leitlinie basiert auf einem vierj\u00e4hrigen Entwicklungsprozess im Rahmen der Arbeitsgemeinschaft Wissenschaftlich Medizinischer Fachgesellschaften (AWMF). Die Federf\u00fchrung lag bei der Deutschen Gesellschaft f\u00fcr Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde (DGPPN) und der Deutschen Gesellschaft f\u00fcr Suchtforschung und Suchttherapie (DG-Sucht). In die Entwicklung waren insgesamt mehr als 50 Fachgesellschaften, Berufsverb\u00e4nde und Gesundheitsorganisationen sowie \u00fcber 60 ausgewiesene Suchtexperten involviert, unter Beteiligung von Selbsthilfe- und Angeh\u00f6rigenverb\u00e4nden. Die Arbeitsgruppe \u201eVersorgungsorganisation\u201c, deren Ergebnisse hier dargestellt werden, war eine von dreizehn Autorengruppen und widmete sich der Aufgabe, wie die Leitlinie unter den Rahmenbedingungen des deutschen Gesundheitssystems mit seinen Versorgungssektoren und Schnittstellen umgesetzt werden kann. F\u00fcr das Kapitel \u201eVersorgungsorganisation\u201c wurden 27 Empfehlungen konsentiert, von denen viele speziell f\u00fcr dieses Kapitel von den entsprechenden Arbeitsgruppen erarbeitet wurden. Die Empfehlungen beziehen sich auf Screening und Diagnostik sowie Kurzinterventionen, Entgiftung und Entzug sowie Pharmakotherapie, k\u00f6rperliche Komplikationen und psychische Komorbidit\u00e4t, Entw\u00f6hnung und andere Formen der Postakutbehandlung, die haus\u00e4rztliche Versorgung, sowie besondere Zielgruppen wie Kinder und Jugendliche, Frauen/Schwangere sowie \u00c4ltere. Zus\u00e4tzlich wurde der Bereich \u201eSelbsthilfe\u201c aufgenommen. F\u00fcr die bedarfsgerechte Diagnostik und Behandlung alkoholbezogener St\u00f6rungen bieten leitliniengest\u00fctzte Empfehlungen zur Versorgungsorganisation einen Orientierungsrahmen f\u00fcr die Zusammenarbeit und Koordinierung aller Sektoren und Berufsgruppen, besonders an den Schnittstellen der Versorgung. Dies schlie\u00dft die Zusammenarbeit zwischen dem medizinischen und psychosozialen Hilfesystem mit ein und reicht von der Schadensbegrenzung bis hin zur sozialen Inklusion der Betroffenen. Insbesondere die Rehabilitation mit ihren Teilhabezielen ist auf diese Zusammenarbeit angewiesen.", "term_pairs": []}
{"idx": 2136, "pair_id": "32987440", "src": "Successful treatment of foot and ankle diseases requires an accurate diagnosis. In addition to differentiated history taking, clinical examination is the most important component in the diagnosis of foot and ankle diseases. The present video explains the common provocation tests and functional tests that are used in the basic clinical examination of the foot and ankle complex. In addition to general inspection and palpation, the focus is on different diagnostic tests and clinical signs that improve diagnostic accuracy. The present basic clinical examination methods allow a structured approach to clinical issues and can be a good basis, if supplemented by further specific and individual tests.", "tgt": "Eine fundierte, klinische Basisuntersuchung ist neben einer zielgerichteten Anamneseerhebung und Bilddiagnostik die Grundvoraussetzung, um die verschiedenen Beschwerde- und Erkrankungsbilder am Fu\u00df und am Sprunggelenk sicher zu diagnostizieren und erfolgreich zu therapieren. Nur wenn vom Untersucher entsprechende klinische Untersuchungstechniken sicher erlernt und beherrscht werden, erlauben diese auch reproduzierbare Befunderhebungen und damit differenzialdiagnostische R\u00fcckschl\u00fcsse auf vorliegende Pathologien. Eine standardisierte und strukturierte Herangehensweise ist im Rahmen der k\u00f6rperlichen Untersuchung unerl\u00e4sslich und stellt f\u00fcr den \u00e4rztlichen Behandler das wichtigste Diagnostikum f\u00fcr eine zielgerichtete Diagnosestellung und die Grundlage f\u00fcr einen richtigen Behandlungsansatz dar. Das vorliegende Video demonstriert neben Instruktionen zur systematischen Inspektion und Palpation, vor allem die wichtigsten Untersuchungstechniken in der Funktions- und Beweglichkeitspr\u00fcfung sowie Durchf\u00fchrung von Provokationstests des Fu\u00dfes und des Sprunggelenkes, die im Rahmen einer klinischen Basisuntersuchung zur Anwendung kommen sollten. Die demonstrierte Untersuchungsabfolge stellt eine solide und systematische Anleitung f\u00fcr eine standardisierte und strukturierte k\u00f6rperliche Untersuchung des Fu\u00dfes und des Sprunggelenkes dar. Diese bildet die Grundlage f\u00fcr eine klinische Basisdiagnostik in der Erkennung und Behandlung von Erkrankungsbildern des Fu\u00dfes und Sprunggelenkes.", "term_pairs": [{"src": {"text": "foot and ankle diseases", "char_start": 24, "char_end": 47, "token_start": 3, "token_end": 7}, "tgt": {"text": "Erkrankungsbilder am Fu\u00df und am Sprunggelenk", "char_start": 173, "char_end": 217, "token_start": 21, "token_end": 27}}, {"src": {"text": "clinical examination", "char_start": 126, "char_end": 146, "token_start": 19, "token_end": 21}, "tgt": {"text": "klinische Basisuntersuchung", "char_start": 16, "char_end": 43, "token_start": 3, "token_end": 5}}, {"src": {"text": "diagnosis", "char_start": 69, "char_end": 78, "token_start": 10, "token_end": 11}, "tgt": {"text": "Diagnostikum", "char_start": 685, "char_end": 697, "token_start": 81, "token_end": 82}}, {"src": {"text": "provocation tests", "char_start": 262, "char_end": 279, "token_start": 41, "token_end": 43}, "tgt": {"text": "Provokationstests", "char_start": 1016, "char_end": 1033, "token_start": 121, "token_end": 122}}, {"src": {"text": "functional tests", "char_start": 284, "char_end": 300, "token_start": 44, "token_end": 46}, "tgt": {"text": "Funktions- und Beweglichkeitspr\u00fcfung", "char_start": 956, "char_end": 992, "token_start": 114, "token_end": 118}}, {"src": {"text": "foot and ankle complex", "char_start": 356, "char_end": 378, "token_start": 56, "token_end": 60}, "tgt": {"text": "Fu\u00dfes und des Sprunggelenkes", "char_start": 1038, "char_end": 1066, "token_start": 123, "token_end": 127}}, {"src": {"text": "inspection", "char_start": 403, "char_end": 413, "token_start": 65, "token_end": 66}, "tgt": {"text": "Inspektion", "char_start": 874, "char_end": 884, "token_start": 103, "token_end": 104}}, {"src": {"text": "palpation", "char_start": 418, "char_end": 427, "token_start": 67, "token_end": 68}, "tgt": {"text": "Palpation", "char_start": 889, "char_end": 898, "token_start": 105, "token_end": 106}}, {"src": {"text": "diagnostic tests", "char_start": 455, "char_end": 471, "token_start": 74, "token_end": 76}, "tgt": {"text": "Untersuchungstechniken", "char_start": 325, "char_end": 347, "token_start": 41, "token_end": 42}}, {"src": {"text": "diagnostic accuracy", "char_start": 504, "char_end": 523, "token_start": 81, "token_end": 83}, "tgt": {"text": "Diagnosestellung", "char_start": 722, "char_end": 738, "token_start": 85, "token_end": 86}}, {"src": {"text": "clinical issues", "char_start": 603, "char_end": 618, "token_start": 95, "token_end": 97}, "tgt": {"text": "k\u00f6rperlichen Untersuchung", "char_start": 591, "char_end": 616, "token_start": 70, "token_end": 72}}, {"src": {"text": "treatment", "char_start": 11, "char_end": 20, "token_start": 1, "token_end": 2}, "tgt": {"text": "Behandlungsansatz", "char_start": 777, "char_end": 794, "token_start": 92, "token_end": 93}}]}
{"idx": 2164, "pair_id": "28614865", "src": "We report on a patient who developed a space-occupying cerebellar infarction with occlusive hydrocephalus after a poisoning with carbon monoxide with the intention to commit suicide. A neurosurgical and intensive care therapy were needed. The patient's survival without severe neurological deficits could be secured due to the early detection of the intracerebral lesions.", "tgt": "Es wird von einem Patienten berichtet, der nach einem Suizidversuch mittels Kohlenmonoxidintoxikation einen raumfordernden Kleinhirninfarkt und konsekutiven okklusiven Hydrozephalus entwickelte. Durch das rechtzeitige Detektieren der intrazerebralen L\u00e4sion konnte ein \u00dcberleben des Patienten ohne schwerwiegendes neurologisches Defizit erm\u00f6glicht werden.", "term_pairs": [{"src": {"text": "space-occupying cerebellar infarction", "char_start": 39, "char_end": 76, "token_start": 8, "token_end": 13}, "tgt": {"text": "raumfordernden Kleinhirninfarkt", "char_start": 108, "char_end": 139, "token_start": 14, "token_end": 16}}, {"src": {"text": "occlusive hydrocephalus", "char_start": 82, "char_end": 105, "token_start": 14, "token_end": 16}, "tgt": {"text": "okklusiven Hydrozephalus", "char_start": 157, "char_end": 181, "token_start": 18, "token_end": 20}}, {"src": {"text": "poisoning with carbon monoxide", "char_start": 114, "char_end": 144, "token_start": 18, "token_end": 22}, "tgt": {"text": "Kohlenmonoxidintoxikation", "char_start": 76, "char_end": 101, "token_start": 12, "token_end": 13}}, {"src": {"text": "intention to commit suicide", "char_start": 154, "char_end": 181, "token_start": 24, "token_end": 28}, "tgt": {"text": "Suizidversuch", "char_start": 54, "char_end": 67, "token_start": 10, "token_end": 11}}, {"src": {"text": "neurological deficits", "char_start": 277, "char_end": 298, "token_start": 45, "token_end": 47}, "tgt": {"text": "neurologisches Defizit", "char_start": 313, "char_end": 335, "token_start": 36, "token_end": 38}}, {"src": {"text": "intracerebral lesions", "char_start": 350, "char_end": 371, "token_start": 57, "token_end": 59}, "tgt": {"text": "intrazerebralen L\u00e4sion", "char_start": 234, "char_end": 256, "token_start": 27, "token_end": 29}}]}
{"idx": 2223, "pair_id": "29742784", "src": "As strategy for postoperative pain therapy, epidural analgesia (EDA) is superior to systemic opiate analgesia after abdominal and thoracic surgery. In addition, EDA may significantly reduce the incidence of complications in some large operations, such as, e.g. cardiac (myocardial infarction, atrial fibrillation) and pulmonary complications (pneumonia, atelectasis), and even reduce mortality. Intestinal motility can also be improved. However, these positive effects do not appear in all interventions and not to the same degree. Therefore, for benefit-risk assessment, it is important to know both the operation-specific benefits and disadvantages of EDA. In the meantime, the distinctly different complication rates of epidural bleeding and abscesses after EDA are also known for different surgical interventions. In large open abdominal interventions, open thorax operations, and especially open abdominal aortic surgeries, EDA reduces pain and complications. It should be noted that the positive effects of EDA have so far hardly been directly compared with those of intraoperative lidocaine administration.", "tgt": "Die Epiduralanalgesie (EDA) kann nicht f\u00fcr alle Eingriffe mit mittelstarkem bis starkem Schmerzniveau der Goldstandard der Therapie sein. Die EDA ist der PCA (patientenkontrollierte Analgesie) und den oralen Analgetika in Bezug auf Reduktion der postoperativen Schmerzintensit\u00e4t \u00fcberlegen [1]. M\u00f6gliche schwerwiegende Komplikationen sowie die h\u00f6heren Kosten der EDA erfordern aber eine sorgf\u00e4ltige, evidenzbasierte operationsspezifische Abw\u00e4gung.", "term_pairs": [{"src": {"text": "EDA", "char_start": 64, "char_end": 67, "token_start": 10, "token_end": 11}, "tgt": {"text": "EDA", "char_start": 23, "char_end": 26, "token_start": 3, "token_end": 4}}, {"src": {"text": "postoperative", "char_start": 16, "char_end": 29, "token_start": 3, "token_end": 4}, "tgt": {"text": "postoperativen", "char_start": 246, "char_end": 260, "token_start": 39, "token_end": 40}}, {"src": {"text": "analgesia", "char_start": 53, "char_end": 62, "token_start": 8, "token_end": 9}, "tgt": {"text": "Analgesie", "char_start": 12, "char_end": 21, "token_start": 1, "token_end": 2}}, {"src": {"text": "complications", "char_start": 207, "char_end": 220, "token_start": 34, "token_end": 35}, "tgt": {"text": "Komplikationen", "char_start": 318, "char_end": 332, "token_start": 48, "token_end": 49}}]}
{"idx": 2318, "pair_id": "34889991", "src": "Paediatric acute liver failure (PALF; also fulminant hepatic failure, fulminant hepatitis) is a\u00a0critical clinical syndrome that is characterised by a\u00a0sudden, rapid deterioration and disease progression in a\u00a0usually previously healthy child. The pathogenesis is an advanced degree of hepatocellular necrosis that exceeds the rate of hepatocyte regeneration. The diagnostic criteria of PALF (modelled on adult criteria) were developed by the 'Pediatric Acute Liver Failure (PALF) Study Group' (NIH). The rule of the liver biopsy in PALF is controversial and in some cases contraindicated (coagulopathic state). In addition, extensive necrosis is a\u00a0common finding in PALFs but may not be predictive of the overall outcome (transplantation versus continuous treatment) due to sampling issues. There are, however, some histological patterns that offer a\u00a0degree of specificity that can be carefully considered in the overall clinical picture. The histopathologists will be part of a\u00a0multidisciplinary team and can contribute to the diagnostic and prognostic pathway.The aetiologies of PALF are numerous and depend on age and geographical region. For all age groups the main causes can be divided into infectious, immunological, metabolic and toxin drug related. Rarer causes include circulatory disorders and malignancies. In the paediatric group, up to 30-50% of causes leading to PALF remain unknown.", "tgt": "Das p\u00e4diatrische akute Leberversagen (pALV) repr\u00e4sentiert die Endstufe verschiedenster pathologischer \u00c4tiologien, die innerhalb von Tagen bis Wochen zu einer lebensbedrohlichen Multisystemerkrankung mit oder ohne hepatischer Enzephalopathie f\u00fchren k\u00f6nnen.Die \u00c4tiologie des pALV ist weit gef\u00e4chert und nicht nur abh\u00e4ngig vom Alter des Kindes, sondern auch der geografischen Herkunft. Generell sind die Non-A\u2013E-Hepatitiden/seronegativen Hepatitiden am h\u00e4ufigsten vertreten. Ein Gro\u00dfteil des neonatalen ALV beruht auf einer fetalen alloimmunen Lebernekrose (GALD), gefolgt von metabolischen und infekti\u00f6sen Ursachen bei S\u00e4uglingen. Bei \u00e4lteren Kindern sind Virushepatitiden und medikament\u00f6se/toxische Ursachen h\u00e4ufig. Im Teenageralter sind vor allem der Morbus Wilson und autoimmune \u00c4tiologien zu finden. Andere Ursachen sind Infektionen, Isch\u00e4mien und maligne (onkoh\u00e4matologische) Erkrankungen.Bei der Pathogenese spielt die hepatozellul\u00e4re Nekrose, die die Rate der Hepatozytenregeneration \u00fcbersteigt, eine zentrale Rolle. Differenzialdiagnostisch sollte eine bereits bestehende chronische Lebererkrankung immer vorweg ausgeschlossen werden. Die \u201ePediatric Acute Liver Failure (PALF) Study Group\u201c (NIH) entwickelte diesbez\u00fcglich einen klinische Kriterienkatalog f\u00fcr den angloamerikanischen Raum.Bei der pathomorphologischen Diagnose ist die M\u00f6glichkeit, dass die Biopsie nicht repr\u00e4sentativ ist, immer mit zu ber\u00fccksichtigen. Durch die nichtspezifische Nekrose kann die Aussagekraft der Leberbiopsie im pALV begrenzt sein. Die histologische Diagnose stellt in jedem Fall nur einen Baustein bei der Diagnosefindung dar. In den meisten F\u00e4llen (mit bestehender Koagulopathie) ist eine Leberbiopsie sogar kontraindiziert.", "term_pairs": [{"src": {"text": "Paediatric acute liver failure", "char_start": 0, "char_end": 30, "token_start": 0, "token_end": 4}, "tgt": {"text": "p\u00e4diatrische akute Leberversagen", "char_start": 4, "char_end": 36, "token_start": 1, "token_end": 4}}, {"src": {"text": "PALF", "char_start": 32, "char_end": 36, "token_start": 5, "token_end": 6}, "tgt": {"text": "pALV", "char_start": 38, "char_end": 42, "token_start": 5, "token_end": 6}}, {"src": {"text": "fulminant hepatitis", "char_start": 70, "char_end": 89, "token_start": 12, "token_end": 14}, "tgt": {"text": "Hepatitiden", "char_start": 409, "char_end": 420, "token_start": 63, "token_end": 64}}, {"src": {"text": "hepatocellular necrosis", "char_start": 283, "char_end": 306, "token_start": 46, "token_end": 48}, "tgt": {"text": "hepatozellul\u00e4re Nekrose", "char_start": 923, "char_end": 946, "token_start": 139, "token_end": 141}}, {"src": {"text": "hepatocyte regeneration", "char_start": 332, "char_end": 355, "token_start": 53, "token_end": 55}, "tgt": {"text": "Hepatozytenregeneration", "char_start": 965, "char_end": 988, "token_start": 146, "token_end": 147}}, {"src": {"text": "Pediatric Acute Liver Failure (PALF) Study Group", "char_start": 441, "char_end": 489, "token_start": 72, "token_end": 81}, "tgt": {"text": "Pediatric Acute Liver Failure (PALF) Study Group", "char_start": 1146, "char_end": 1194, "token_start": 167, "token_end": 176}}, {"src": {"text": "liver biopsy", "char_start": 514, "char_end": 526, "token_start": 90, "token_end": 92}, "tgt": {"text": "Leberbiopsie", "char_start": 1486, "char_end": 1498, "token_start": 218, "token_end": 219}}, {"src": {"text": "coagulopathic state", "char_start": 587, "char_end": 606, "token_start": 102, "token_end": 104}, "tgt": {"text": "Koagulopathie", "char_start": 1657, "char_end": 1670, "token_start": 246, "token_end": 247}}, {"src": {"text": "necrosis", "char_start": 632, "char_end": 640, "token_start": 110, "token_end": 111}, "tgt": {"text": "Nekrose", "char_start": 546, "char_end": 553, "token_start": 81, "token_end": 82}}, {"src": {"text": "histological", "char_start": 814, "char_end": 826, "token_start": 143, "token_end": 144}, "tgt": {"text": "histologische", "char_start": 1526, "char_end": 1539, "token_start": 225, "token_end": 226}}, {"src": {"text": "aetiologies", "char_start": 1064, "char_end": 1075, "token_start": 182, "token_end": 183}, "tgt": {"text": "\u00c4tiologie", "char_start": 102, "char_end": 111, "token_start": 12, "token_end": 13}}, {"src": {"text": "infectious", "char_start": 1195, "char_end": 1205, "token_start": 206, "token_end": 207}, "tgt": {"text": "infekti\u00f6sen", "char_start": 592, "char_end": 603, "token_start": 90, "token_end": 91}}, {"src": {"text": "metabolic", "char_start": 1222, "char_end": 1231, "token_start": 210, "token_end": 211}, "tgt": {"text": "metabolischen", "char_start": 574, "char_end": 587, "token_start": 88, "token_end": 89}}, {"src": {"text": "toxin drug related", "char_start": 1236, "char_end": 1254, "token_start": 212, "token_end": 215}, "tgt": {"text": "medikament\u00f6se/toxische", "char_start": 675, "char_end": 697, "token_start": 101, "token_end": 104}}, {"src": {"text": "circulatory disorders", "char_start": 1277, "char_end": 1298, "token_start": 219, "token_end": 221}, "tgt": {"text": "Isch\u00e4mien", "char_start": 836, "char_end": 845, "token_start": 126, "token_end": 127}}, {"src": {"text": "malignancies", "char_start": 1303, "char_end": 1315, "token_start": 222, "token_end": 223}, "tgt": {"text": "maligne", "char_start": 850, "char_end": 857, "token_start": 128, "token_end": 129}}]}
{"idx": 2348, "pair_id": "31711244", "src": "To investigate the value of I-124 positron emission tomography (PET) / ultrasound (US) fusion imaging in comparison to conventional diagnostics (CD) of Thyroid nodules (TN) by multiple observers. \u2002Digital patient case files (PCF) of patients that received CD and I-124-PET/US in clinical routine were prepared containing cine-loops of the examinations. All physicians with nuclear medicine specialty from Germany, Austria, and Switzerland were invited to participate. 106 acquired observers completed 7.2\u200a\u00b1\u200a1.8 (median: 8, range: 4-14) randomly assigned PCF (CD only or CD+PET/US). They assessed the TN function, stated their confidence in functional assessment, and suggested a treatment course for each TN. \u200268 PCF of 34 patients comprising 66 TN \u2265\u200a1\u200acm (=\u200a1.94 TN/patient) were created. A total of 748 (11.2/TN), and 751 ratings (11.4/TN) were recorded for CD only, and CD+PET/US, respectively. The functional assessment revealed more hyper- or hypofunctioning (524 vs. 320, p\u200a<\u200a0.0001) and less indifferent or not rateable (209 vs. 428, p\u200a<\u200a0.0001) TN in CD+PET/US vs. CD only. The observers' confidence in\u00a0functional assessment was superior in CD+PET/US (p\u200a<\u200a0.0001). Furthermore, the ratings were carried out more homogeneous in CD+PET/US (p\u200a<\u200a0.0001). Fewer suggestion of follow up (p\u200a<\u200a0.0001), and more (p\u200a<\u200a0.0001) suggestion of invasive treatments (fine-needle aspiration & surgery) was observed in CD+PET/US.\u200aRadioiodine therapy was more often (p\u200a=\u200a0.0036), and thyroid medication less often (p\u200a=\u200a0.0167) advised in CD+PET/US. \u2002Functional assessment of equivocal TN shows frequent failures in CD, underestimating the incidence of hyper- and hypofunctioning lesions. Confidence in functional assessment significantly increases with additional PET/US.\u200aThis influences the proposed treatment course.", "tgt": "ZIEL: \u2002Multi-Observer-Untersuchung des diagnostischen Mehrwerts der I-124-Positronenemissionstomografie (PET)/Ultraschall (US) -Fusionsbildgebung im Vergleich zur konventionellen Diagnostik (CD) bei der Funktionsbeurteilung von Schilddr\u00fcsenknoten. \u2002Es erfolgte die Erstellung digitaler Patientenakten inklusive Filmsequenzen von Probanden, die im Rahmen der klinischen Routine sowohl mittels CD als auch I-124-PET/US untersucht wurden. Alle nuklearmedizinischen \u00c4rzte aus Deutschland, \u00d6sterreich und der Schweiz waren zur Teilnahme eingeladen. 106 Untersucher absolvierten jeweils 7,2\u200a\u00b1\u200a1,8 (Median: 8, Bandbreite: 4\u201314) randomisiert zugewiesene digitale Patientenakten (CD oder CD+PET/US). Sie beurteilten die Funktion der Schilddr\u00fcsenknoten, ihre subjektive Sicherheit bei der Funktionsbeurteilung und schlugen einen Behandlungsverlauf vor. \u200268 digitale Patientenakten von 34 Patienten mit 66 Schilddr\u00fcsenknoten \u2265\u200a1\u200acm (=\u200a1,94 Knoten pro Patient) wurden erstellt. Insgesamt wurden 748 Bewertungen (11,2\u00a0pro Knoten) f\u00fcr CD und 751 Bewertungen (11,4 pro Knoten) f\u00fcr CD+PET/US dokumentiert. Bei CD+PET/US wurde die Funktion der Knoten im Vergleich zu CD h\u00e4ufiger als hyper- oder hypofunktionell (524 vs. 320; p\u200a<\u200a0,0001) und seltener als indifferent oder nicht bewertbar (209 vs. 428; p\u200a<\u200a0,0001) beurteilt. Die subjektive Sicherheit der Untersucher war bei CD+PET/US h\u00f6her (p\u200a<\u200a0,0001) und die Funktionsbeurteilungen wurden mit gr\u00f6\u00dferer Homogenit\u00e4t abgegeben (p\u200a<\u200a0,0001). Bei CD+PET/US wurden im Vergleich zu CD weniger Verlaufskontrollen (p\u200a<\u200a0,0001), mehr invasive Behandlungen (Feinnadelaspiration & Operation) (p\u200a<\u200a0,0001), h\u00e4ufiger Radioiodtherapien (p\u200a=\u200a0,0036) und seltener medikament\u00f6se Therapien (p\u200a=\u200a0,0167) empfohlen. \u2002Die Funktion von Schilddr\u00fcsenknoten wird in der konventionellen Diagnostik h\u00e4ufig falsch beurteilt. Der Anteil hyper- oder hypofunktioneller L\u00e4sionen wird untersch\u00e4tzt. Die subjektive Sicherheit bei der Funktionsbeurteilung steigt durch den Einsatz der I-124-PET/US.\u200aDiese Ergebnisse beeinflussen die vorgeschlagenen Behandlungsverl\u00e4ufe.", "term_pairs": [{"src": {"text": "I-124 positron emission tomography (PET)", "char_start": 28, "char_end": 68, "token_start": 5, "token_end": 14}, "tgt": {"text": "I-124-Positronenemissionstomografie (PET)", "char_start": 68, "char_end": 109, "token_start": 11, "token_end": 19}}, {"src": {"text": "ultrasound (US)", "char_start": 71, "char_end": 86, "token_start": 15, "token_end": 19}, "tgt": {"text": "Ultraschall (US)", "char_start": 110, "char_end": 126, "token_start": 20, "token_end": 24}}, {"src": {"text": "fusion imaging", "char_start": 87, "char_end": 101, "token_start": 19, "token_end": 21}, "tgt": {"text": "Fusionsbildgebung", "char_start": 128, "char_end": 145, "token_start": 25, "token_end": 26}}, {"src": {"text": "conventional diagnostics (CD)", "char_start": 119, "char_end": 148, "token_start": 24, "token_end": 29}, "tgt": {"text": "konventionellen Diagnostik (CD)", "char_start": 163, "char_end": 194, "token_start": 29, "token_end": 34}}, {"src": {"text": "Thyroid nodules (TN)", "char_start": 152, "char_end": 172, "token_start": 30, "token_end": 35}, "tgt": {"text": "Schilddr\u00fcsenknoten", "char_start": 228, "char_end": 246, "token_start": 38, "token_end": 39}}, {"src": {"text": "patient case files (PCF)", "char_start": 205, "char_end": 229, "token_start": 40, "token_end": 46}, "tgt": {"text": "Patientenakten", "char_start": 286, "char_end": 300, "token_start": 45, "token_end": 46}}, {"src": {"text": "nuclear medicine", "char_start": 373, "char_end": 389, "token_start": 75, "token_end": 77}, "tgt": {"text": "nuklearmedizinischen", "char_start": 441, "char_end": 461, "token_start": 73, "token_end": 74}}, {"src": {"text": "Germany", "char_start": 405, "char_end": 412, "token_start": 79, "token_end": 80}, "tgt": {"text": "Deutschland", "char_start": 472, "char_end": 483, "token_start": 76, "token_end": 77}}, {"src": {"text": "Austria", "char_start": 414, "char_end": 421, "token_start": 81, "token_end": 82}, "tgt": {"text": "\u00d6sterreich", "char_start": 485, "char_end": 495, "token_start": 78, "token_end": 79}}, {"src": {"text": "Switzerland", "char_start": 427, "char_end": 438, "token_start": 84, "token_end": 85}, "tgt": {"text": "Schweiz", "char_start": 504, "char_end": 511, "token_start": 81, "token_end": 82}}, {"src": {"text": "functional assessment", "char_start": 640, "char_end": 661, "token_start": 136, "token_end": 138}, "tgt": {"text": "Funktionsbeurteilung", "char_start": 203, "char_end": 223, "token_start": 36, "token_end": 37}}, {"src": {"text": "treatment course", "char_start": 679, "char_end": 695, "token_start": 142, "token_end": 144}, "tgt": {"text": "Behandlungsverlauf", "char_start": 819, "char_end": 837, "token_start": 139, "token_end": 140}}, {"src": {"text": "hyper- or hypofunctioning", "char_start": 938, "char_end": 963, "token_start": 213, "token_end": 217}, "tgt": {"text": "hyper- oder hypofunktionell", "char_start": 1166, "char_end": 1193, "token_start": 214, "token_end": 218}}, {"src": {"text": "fine-needle aspiration", "char_start": 1360, "char_end": 1382, "token_start": 332, "token_end": 336}, "tgt": {"text": "Feinnadelaspiration", "char_start": 1582, "char_end": 1601, "token_start": 312, "token_end": 313}}, {"src": {"text": "surgery", "char_start": 1385, "char_end": 1392, "token_start": 337, "token_end": 338}, "tgt": {"text": "Operation", "char_start": 1604, "char_end": 1613, "token_start": 314, "token_end": 315}}, {"src": {"text": "Radioiodine therapy", "char_start": 1421, "char_end": 1440, "token_start": 348, "token_end": 350}, "tgt": {"text": "Radioiodtherapien", "char_start": 1638, "char_end": 1655, "token_start": 325, "token_end": 326}}, {"src": {"text": "thyroid medication", "char_start": 1474, "char_end": 1492, "token_start": 362, "token_end": 364}, "tgt": {"text": "medikament\u00f6se Therapien", "char_start": 1682, "char_end": 1705, "token_start": 335, "token_end": 337}}]}
{"idx": 2384, "pair_id": "29514385", "src": "Purpose of this paper to present results of a group of 21 consecutive patients who underwent uterine artery embolization (UAE) immediately before myomectomy. Surgical myomectomy can lead to a substantial blood loss in case of large or multiple tumors due to the hypervascularization of the tumors. This may lead to multiple blood transfusion or hysterectomy. In cases were the preservation of the uterus is demanded, pre-operative embolization could reduce the risk of substantial bleeding. Between January 2011 and March 2016, 21 patients underwent UAE 24 hours before myomectomy. All patients were asked by questionnaire about post-surgical follow-up, complications, the length of the scar, satisfaction and improvement of symptoms. Data of the operation and embolization were retrospectively assessed. UAE could be performed in all patients without complications. Mean diameter of the largest myoma was 12.7\u200a\u00b1\u200a3.2\u200acm, primary preservation of the uterus succeeded in all cases. In none of the cases a perioperative blood transfusion was necessary. One patient underwent hysterectomy in another hospital after primary successful resection, one patient received transfusion of 2 bags of red blood cell concentrate during her stay in hospital.11 of 21 patients responded to the questionnaire. 10 of 11\u00a0had subjective symptom improvement. Mean inability to work was 31 days, the mean self-measured length was 12\u200acm. 9 of 11 patients would recommend the procedure, one patient was in the second trimester of pregnancy. Preoperative uterine artery embolization facilitates a safe and uterus-preserving myomectomy in patients with very large or multiple fibroids. \u00b7 Uterus-preserving myomectomy can be used in cases of large uteri or with multiple fibroids with low amount of blood loss.. \u00b7 The combination of preoperative embolization and subsequent myomectomy may be a therapeutic option in cases of infertility due to a fibroid-induced uterine deformation.. \u00b7 Good interdisciplinary cooperation is essential for sustainable results in this complex group of patients.. \u00b7 Schnapauff D, Russ M, Kr\u00f6ncke T et\u200aal. Analysis of presurgical uterine artery embolization (PUAE) for very large uterus myomatosus; patient's desire to preserve the uterus; case series and literature review. Fortschr R\u00f6ntgenstr 2018; 190: 616\u200a-\u200a622.", "tgt": "ZIEL: \u2002Die operative Myomresektion kann durch die Hypervaskularisation der Tumoren bei gro\u00dfen und/ oder zahlreichen Myomen mit einem erheblichen Blutverlust und daraus folgendem Transfusions- und Hysterektomierisiko verbunden sein. Falls ein Erhalt der Geb\u00e4rmutter erw\u00fcnscht ist, k\u00f6nnte die pr\u00e4operative Embolisation das Blutungs- und Hysterektomierisiko reduzieren. Ziel der vorliegenden Arbeit ist es, die Ergebnisse eines Kollektivs von 21 konsekutiven Patientinnen vorzustellen, die unmittelbar vor operativer Myomresektion eine Uterus-Arterien-Embolisation (UAE) erhielten. Zwischen Januar 2011 und M\u00e4rz 2016 erhielten insgesamt 21 Patientinnen eine Uterus-Arterien-Embolisation ca. 24 Stunden vor geplanter Myomresektion. Alle Patientinnen wurden per Fragebogen zu sp\u00e4tpostoperativem Verlauf, Komplikationen, Narbenl\u00e4nge, Zufriedenheit und Beschwerdebesserung nachbefragt. Daten der OP und Embolisation wurden ebenfalls retrospektiv ausgewertet. Die UAE konnte bei allen Patientinnen komplikationslos durchgef\u00fchrt werden. Der mittlere Durchmesser des gr\u00f6\u00dften resezierten Myoms betrug 12,7\u200a\u00b1\u200a3,2\u200acm, der Uteruserhalt gelang prim\u00e4r in allen F\u00e4llen. In keinem Fall war eine Bluttransfusion perioperativ erforderlich. Eine Patientin erhielt extern 14 Tage nach prim\u00e4rer Resektion eine Hysterektomie aufgrund von vaginalen Blutungen, bei einer Patientin war w\u00e4hrend des station\u00e4ren Aufenthaltes eine Transfusion von 2 Erythrozytenkonzentraten erforderlich.11 von 21 Patientinnen beantworteten den Fragebogen. 10\u00a0von 11 Patientinnen gaben eine subjektive Beschwerdebesserung an. Die mittlere Krankschreibungsdauer betrug 31 Tage, die mittlere selbst gemessene Narbenl\u00e4nge 12\u200acm. 9\u00a0von 11 w\u00fcrden den Eingriff weiterempfehlen, eine Patientin war im II. Trimenon schwanger. Die pr\u00e4operative Uterusarterienembolisation erm\u00f6glicht eine sichere, uteruserhaltende Myomentfernung bei Patientinnen mit sehr gro\u00dfen oder zahlreichen Myomen. \u00b7 Uteruserhaltende Myomresektionen bei gro\u00dfem Uterus myomatosus sind nach vorheriger Embolisation mit geringem Blutverlust m\u00f6glich.. \u00b7 Die Kombination aus Embolisation und Resektion kann eine Therapieoption sein bei Infertilit\u00e4t aufgrund eines myomat\u00f6s durchsetzten Uterus.. \u00b7 Gut abgestimmte interdisziplin\u00e4re Strukturen sind notwendig um diesen komplexen F\u00e4llen gerecht zu werden.. \u00b7 Schnapauff D, Russ M, Kr\u00f6ncke T et\u200aal. Analysis of Presurgical Uterine artery Embolization (PUAE) in very large Uterus myomatosus and patients wish to preserve the uterus- case series and literature review. Fortschr R\u00f6ntgenstr 2018; 190: 616\u200a\u2013\u200a622.", "term_pairs": [{"src": {"text": "uterine artery embolization", "char_start": 93, "char_end": 120, "token_start": 16, "token_end": 19}, "tgt": {"text": "Uterus-Arterien-Embolisation", "char_start": 533, "char_end": 561, "token_start": 74, "token_end": 79}}, {"src": {"text": "UAE", "char_start": 122, "char_end": 125, "token_start": 20, "token_end": 21}, "tgt": {"text": "UAE", "char_start": 563, "char_end": 566, "token_start": 80, "token_end": 81}}, {"src": {"text": "myomectomy", "char_start": 146, "char_end": 156, "token_start": 24, "token_end": 25}, "tgt": {"text": "Myomresektion", "char_start": 21, "char_end": 34, "token_start": 4, "token_end": 5}}, {"src": {"text": "hypervascularization", "char_start": 262, "char_end": 282, "token_start": 45, "token_end": 46}, "tgt": {"text": "Hypervaskularisation", "char_start": 50, "char_end": 70, "token_start": 8, "token_end": 9}}, {"src": {"text": "blood loss", "char_start": 204, "char_end": 214, "token_start": 33, "token_end": 35}, "tgt": {"text": "Blutverlust", "char_start": 145, "char_end": 156, "token_start": 21, "token_end": 22}}, {"src": {"text": "blood transfusion", "char_start": 324, "char_end": 341, "token_start": 55, "token_end": 57}, "tgt": {"text": "Bluttransfusion", "char_start": 1177, "char_end": 1192, "token_start": 176, "token_end": 177}}, {"src": {"text": "hysterectomy", "char_start": 345, "char_end": 357, "token_start": 58, "token_end": 59}, "tgt": {"text": "Hysterektomie", "char_start": 196, "char_end": 209, "token_start": 28, "token_end": 29}}, {"src": {"text": "uterus", "char_start": 397, "char_end": 403, "token_start": 67, "token_end": 68}, "tgt": {"text": "Uterus", "char_start": 655, "char_end": 661, "token_start": 95, "token_end": 96}}, {"src": {"text": "embolization", "char_start": 431, "char_end": 443, "token_start": 74, "token_end": 75}, "tgt": {"text": "Embolisation", "char_start": 304, "char_end": 316, "token_start": 43, "token_end": 44}}, {"src": {"text": "myoma", "char_start": 896, "char_end": 901, "token_start": 152, "token_end": 153}, "tgt": {"text": "Myom", "char_start": 116, "char_end": 120, "token_start": 17, "token_end": 18}}, {"src": {"text": "perioperative", "char_start": 1003, "char_end": 1016, "token_start": 179, "token_end": 180}, "tgt": {"text": "perioperativ", "char_start": 1193, "char_end": 1205, "token_start": 177, "token_end": 178}}, {"src": {"text": "red blood cell concentrate", "char_start": 1187, "char_end": 1213, "token_start": 205, "token_end": 209}, "tgt": {"text": "Erythrozytenkonzentrat", "char_start": 1419, "char_end": 1441, "token_start": 208, "token_end": 209}}, {"src": {"text": "symptom improvement", "char_start": 1316, "char_end": 1335, "token_start": 229, "token_end": 231}, "tgt": {"text": "Beschwerdebesserung", "char_start": 846, "char_end": 865, "token_start": 123, "token_end": 124}}, {"src": {"text": "trimester", "char_start": 1492, "char_end": 1501, "token_start": 265, "token_end": 266}, "tgt": {"text": "Trimenon", "char_start": 1751, "char_end": 1759, "token_start": 258, "token_end": 259}}, {"src": {"text": "fibroids", "char_start": 1649, "char_end": 1657, "token_start": 288, "token_end": 289}, "tgt": {"text": "Myomen", "char_start": 1857, "char_end": 1863, "token_start": 269, "token_end": 270}}, {"src": {"text": "infertility", "char_start": 1897, "char_end": 1908, "token_start": 332, "token_end": 333}, "tgt": {"text": "Infertilit\u00e4t", "char_start": 2146, "char_end": 2158, "token_start": 308, "token_end": 309}}, {"src": {"text": "interdisciplinary cooperation", "char_start": 1963, "char_end": 1992, "token_start": 345, "token_end": 347}, "tgt": {"text": "interdisziplin\u00e4re Strukturen", "char_start": 2223, "char_end": 2251, "token_start": 319, "token_end": 321}}]}
{"idx": 2698, "pair_id": "34652477", "src": "Follow-up for non-muscle invasive bladder cancer (NMIBC) is a\u00a0challenge for urologists that has not been finally resolved. The intensity of follow-up is based on the recurrence and progression behavior of the tumor as well as the patient's individual situation. The following article focuses on the current data situation, the valid German S3\u00a0guideline and the available instruments for the detection of relapses and progression, taking into account tumor stages and degree of malignancy. Urethrocystoscopy, imaging and urine cytology are generally recommended, but the recommendations appear to be too extensive in the case of so-called intermediate risk profiles. Depending on the situation, urine markers could optimize follow-up, although results from prospective randomized studies are still pending. The current follow-up of NMIBC is invasive, carries the risk of side effects and increases costs. In the absence of scientific evidence, recommendations for follow-up for NMIBC are naturally based on expert opinion. In the opinion of the authors, overdiagnosis is currently taking place particularly in patients with an intermediate risk profile. The first prospective, marker-based studies are ongoing and will be helpful in the near future to improve the data situation relevant to urological practice.", "tgt": "HINTERGRUND: Die Nachsorge des nicht-muskelinvasiven Harnblasenkarzinoms (NMIBC) stellt eine nicht abschlie\u00dfend gel\u00f6ste Herausforderung an den Urologen dar. Dabei muss sich die Intensit\u00e4t der Nachsorge am Rezidiv- bzw. Progressionsverhalten des Tumors einerseits und der individuellen Situation des Patienten andererseits orientieren. Der nachfolgende Artikel besch\u00e4ftigt sich mit der aktuellen Datenlage, der g\u00fcltigen S3-Leitlinie und den verf\u00fcgbaren Instrumenten zur Detektion von Rezidiven und Progression unter Ber\u00fccksichtigung von Tumorstadien und Malignit\u00e4tsgrad. Grunds\u00e4tzlich werden Urethrozystoskopie, Bildgebung und die Urinzytologie empfohlen, allerdings erscheinen die Empfehlungen bei sog. intermedi\u00e4rem Risikoprofil zu weitgehend. Situationsbedingt k\u00f6nnten Urinmarker die Nachsorge optimieren, wobei Ergebnisse aus prospektiv-randomisierten Studien bislang ausstehen. Die aktuelle Nachsorge des NMIBC ist invasiv, mit dem Risiko von Nebenwirkungen behaftet und kostentreibend. Angesichts fehlender wissenschaftlicher Evidenz beruhen Empfehlungen zur Nachsorge des NMIBC naturgem\u00e4\u00df auf Expertenmeinung. Insbesondere bei Patienten mit intermedi\u00e4rem Risikoprofil erfolgt nach Ansicht der Autoren derzeit eine \u00dcberdiagnostik. Erste prospektive, markerbasierte Studien laufen und werden zeitnah hilfreich sein, die Datenlage in diesem f\u00fcr die urologische Praxis relevanten Sektor zu verbessern.", "term_pairs": [{"src": {"text": "non-muscle invasive bladder cancer", "char_start": 14, "char_end": 48, "token_start": 4, "token_end": 10}, "tgt": {"text": "nicht-muskelinvasiven Harnblasenkarzinoms", "char_start": 31, "char_end": 72, "token_start": 5, "token_end": 9}}, {"src": {"text": "NMIBC", "char_start": 50, "char_end": 55, "token_start": 11, "token_end": 12}, "tgt": {"text": "NMIBC", "char_start": 74, "char_end": 79, "token_start": 10, "token_end": 11}}, {"src": {"text": "follow-up", "char_start": 0, "char_end": 9, "token_start": 0, "token_end": 3}, "tgt": {"text": "Nachsorge", "char_start": 17, "char_end": 26, "token_start": 3, "token_end": 4}}, {"src": {"text": "urologists", "char_start": 76, "char_end": 86, "token_start": 17, "token_end": 18}, "tgt": {"text": "Urologen", "char_start": 143, "char_end": 151, "token_start": 20, "token_end": 21}}, {"src": {"text": "recurrence", "char_start": 166, "char_end": 176, "token_start": 35, "token_end": 36}, "tgt": {"text": "Rezidiv", "char_start": 205, "char_end": 212, "token_start": 31, "token_end": 32}}, {"src": {"text": "progression", "char_start": 181, "char_end": 192, "token_start": 37, "token_end": 38}, "tgt": {"text": "Progression", "char_start": 219, "char_end": 230, "token_start": 35, "token_end": 36}}, {"src": {"text": "tumor", "char_start": 209, "char_end": 214, "token_start": 41, "token_end": 42}, "tgt": {"text": "Tumors", "char_start": 245, "char_end": 251, "token_start": 37, "token_end": 38}}, {"src": {"text": "S3 guideline", "char_start": 340, "char_end": 352, "token_start": 65, "token_end": 67}, "tgt": {"text": "S3-Leitlinie", "char_start": 419, "char_end": 431, "token_start": 60, "token_end": 63}}, {"src": {"text": "tumor stages", "char_start": 450, "char_end": 462, "token_start": 82, "token_end": 84}, "tgt": {"text": "Tumorstadien", "char_start": 536, "char_end": 548, "token_start": 76, "token_end": 77}}, {"src": {"text": "degree of malignancy", "char_start": 467, "char_end": 487, "token_start": 85, "token_end": 88}, "tgt": {"text": "Malignit\u00e4tsgrad", "char_start": 553, "char_end": 568, "token_start": 78, "token_end": 79}}, {"src": {"text": "Urethrocystoscopy", "char_start": 489, "char_end": 506, "token_start": 89, "token_end": 90}, "tgt": {"text": "Urethrozystoskopie", "char_start": 591, "char_end": 609, "token_start": 82, "token_end": 83}}, {"src": {"text": "imaging", "char_start": 508, "char_end": 515, "token_start": 91, "token_end": 92}, "tgt": {"text": "Bildgebung", "char_start": 611, "char_end": 621, "token_start": 84, "token_end": 85}}, {"src": {"text": "urine cytology", "char_start": 520, "char_end": 534, "token_start": 93, "token_end": 95}, "tgt": {"text": "Urinzytologie", "char_start": 630, "char_end": 643, "token_start": 87, "token_end": 88}}, {"src": {"text": "intermediate risk profiles", "char_start": 638, "char_end": 664, "token_start": 114, "token_end": 117}, "tgt": {"text": "intermedi\u00e4rem Risikoprofil", "char_start": 703, "char_end": 729, "token_start": 97, "token_end": 99}}, {"src": {"text": "urine markers", "char_start": 694, "char_end": 707, "token_start": 123, "token_end": 125}, "tgt": {"text": "Urinmarker", "char_start": 771, "char_end": 781, "token_start": 104, "token_end": 105}}, {"src": {"text": "prospective randomized studies", "char_start": 756, "char_end": 786, "token_start": 134, "token_end": 137}, "tgt": {"text": "prospektiv-randomisierten Studien", "char_start": 829, "char_end": 862, "token_start": 112, "token_end": 116}}, {"src": {"text": "side effects", "char_start": 870, "char_end": 882, "token_start": 155, "token_end": 157}, "tgt": {"text": "Nebenwirkungen", "char_start": 947, "char_end": 961, "token_start": 131, "token_end": 132}}, {"src": {"text": "expert opinion", "char_start": 1006, "char_end": 1020, "token_start": 179, "token_end": 181}, "tgt": {"text": "Expertenmeinung", "char_start": 1099, "char_end": 1114, "token_start": 148, "token_end": 149}}, {"src": {"text": "overdiagnosis", "char_start": 1053, "char_end": 1066, "token_start": 189, "token_end": 190}, "tgt": {"text": "\u00dcberdiagnostik", "char_start": 1220, "char_end": 1234, "token_start": 163, "token_end": 164}}, {"src": {"text": "prospective, marker-based studies", "char_start": 1163, "char_end": 1196, "token_start": 205, "token_end": 211}, "tgt": {"text": "prospektive, markerbasierte Studien", "char_start": 1242, "char_end": 1277, "token_start": 166, "token_end": 170}}]}
{"idx": 2731, "pair_id": "34665282", "src": "Early i.v. fluid administration is a cornerstone in modern therapy of shock, especially in septic shock. However, there is much uncertainty concerning the amount and rate of fluid and which goals and measures could guide fluid management. Administering the optimal fluid volume is important because fluid overload can lead to severe negative consequences like organ failure and worsening of patient's outcome. This review aims to describe the importance of fluid therapy and discuss possible strategies in fluid management as well as possible measurements and goals to guide such therapy. There is no single measurement to guide fluid management alone. It is important to assess fluid responsiveness, which together with multiple other parameters can be used to repeatedly assess optimal fluid management. However, it has also not been shown that assessing fluid responsiveness can improve outcome. After the initial resuscitation, further fluid administration should be determined by individual patient factors and measures of fluid responsiveness. A\u00a0more restrictive fluid management with early vasopressor administration seems to be increasingly used in modern fluid management. However many questions regarding optimal fluid management remain to be solved.", "tgt": "HINTERGRUND: Die rasche Gabe von Volumen ist einer der Eckpfeiler einer initialen Schocktherapie, speziell auch des septischen Schocks. Allerdings gibt es erhebliche Unsicherheiten, wann wie viel Volumen sinnvoll ist und an welchen Zielen oder Messgr\u00f6\u00dfen das Volumenmanagement ausgerichtet werden kann. Dabei ist es wichtig nur die \u201eoptimale\u201c Fl\u00fcssigkeitsmenge zu geben, da eine Volumen\u00fcberladung erhebliche negative Konsequenzen, wie Organversagen und Verschlechterung des Outcomes, nach sich ziehen kann ZIEL: Dieser Review soll die Bedeutung der Volumentherapie, m\u00f6gliche Strategien des Volumenmanagements sowie m\u00f6gliche Ziele und Steuerungsparameter darstellen und kritisch diskutieren. Es gibt keinen einzelnen Zielparameter, an dem das Volumenmanagement allein ausgerichtet werden kann. Ein wichtiger Parameter ist die Volumenreagibilit\u00e4t des Patienten, die zusammen mit vielen anderen Parametern zu einer wiederholten Einsch\u00e4tzung des optimalen Volumenmanagements herangezogen werden sollte. Eine Verbesserung des Outcomes ist aber auch f\u00fcr die Messung der Volumenreagibilit\u00e4t nicht gezeigt. Nach einer initialen Volumenreanimation muss die weitere Volumentherapie m\u00f6glichst individuell anhand multipler Patientenfaktoren und wiederholter Messung der Volumenreagibilit\u00e4t fortgef\u00fchrt werden. Eine eher restriktive Volumengabe mit auch fr\u00fcherem Einsatz von Vasopressoren scheint zunehmend in den Fokus eines modernen Volumenmanagements zu r\u00fccken. Allerdings sind viel Fragen bez\u00fcglich eines optimalen Volumenmanagements noch ungel\u00f6st.", "term_pairs": [{"src": {"text": "shock", "char_start": 70, "char_end": 75, "token_start": 14, "token_end": 15}, "tgt": {"text": "Schock", "char_start": 82, "char_end": 88, "token_start": 13, "token_end": 14}}, {"src": {"text": "septic shock", "char_start": 91, "char_end": 103, "token_start": 18, "token_end": 20}, "tgt": {"text": "septischen Schocks", "char_start": 116, "char_end": 134, "token_start": 18, "token_end": 20}}, {"src": {"text": "fluid administration", "char_start": 11, "char_end": 31, "token_start": 5, "token_end": 7}, "tgt": {"text": "Gabe von Volumen", "char_start": 24, "char_end": 40, "token_start": 4, "token_end": 7}}, {"src": {"text": "fluid management", "char_start": 221, "char_end": 237, "token_start": 41, "token_end": 43}, "tgt": {"text": "Volumenmanagement", "char_start": 259, "char_end": 276, "token_start": 40, "token_end": 41}}, {"src": {"text": "fluid therapy", "char_start": 457, "char_end": 470, "token_start": 79, "token_end": 81}, "tgt": {"text": "Volumentherapie", "char_start": 549, "char_end": 564, "token_start": 84, "token_end": 85}}, {"src": {"text": "fluid overload", "char_start": 299, "char_end": 313, "token_start": 52, "token_end": 54}, "tgt": {"text": "Volumen\u00fcberladung", "char_start": 379, "char_end": 396, "token_start": 60, "token_end": 61}}, {"src": {"text": "organ failure", "char_start": 360, "char_end": 373, "token_start": 61, "token_end": 63}, "tgt": {"text": "Organversagen", "char_start": 435, "char_end": 448, "token_start": 66, "token_end": 67}}, {"src": {"text": "outcome", "char_start": 401, "char_end": 408, "token_start": 69, "token_end": 70}, "tgt": {"text": "Outcome", "char_start": 474, "char_end": 481, "token_start": 70, "token_end": 71}}, {"src": {"text": "fluid responsiveness", "char_start": 679, "char_end": 699, "token_start": 116, "token_end": 118}, "tgt": {"text": "Volumenreagibilit\u00e4t", "char_start": 825, "char_end": 844, "token_start": 120, "token_end": 121}}, {"src": {"text": "resuscitation", "char_start": 917, "char_end": 930, "token_start": 154, "token_end": 155}, "tgt": {"text": "Volumenreanimation", "char_start": 1120, "char_end": 1138, "token_start": 159, "token_end": 160}}, {"src": {"text": "vasopressor", "char_start": 1097, "char_end": 1108, "token_start": 179, "token_end": 180}, "tgt": {"text": "Vasopressoren", "char_start": 1362, "char_end": 1375, "token_start": 186, "token_end": 187}}]}
{"idx": 2810, "pair_id": "29898479", "src": "Irritable bowel syndrome (IBS) in humans is described as the recurrent presence of gastrointestinal signs, without gross histopathologic evidence of inflammation and of other morphologic lesions; however, it is a syndrome not unanimously defined in veterinary medicine. There is some evidence that dysmotility could be related to stressors in some dogs that present with clinical signs (e.g. chronic idiopathic large-bowel diarrhea) that share overlapping aspects with human IBS. The authors hypothesize that an IBS-like condition, similar to that described in humans, might also be present in dogs. Nevertheless, the diagnostic path for canine IBS needs to be further elucidated and its pathogenesis better defined for a more rational therapeutic approach.", "tgt": "In der Humanmedizin beschreibt der Begriff Reizdarmsyndrom das Auftreten wiederkehrender gastrointestinaler Symptome ohne ausgepr\u00e4gte entz\u00fcndliche oder andere morphologische Ver\u00e4nderungen in Darmbioptaten. In der Veterin\u00e4rmedizin ist dieses Syndrom nicht einheitlich definiert. Es gibt jedoch Hinweise, dass bei Hunden Motilit\u00e4tsst\u00f6rungen des Magen-Darm-Trakts aufgrund verschiedener Stressfaktoren zu klinischen Symptomen (z. B. chronische idiopathische Dickdarmdiarrh\u00f6) f\u00fchren, die in einigen Aspekten dem Reizdarmsyndrom des Menschen entsprechen. Die Autoren vermuten, dass beim Hund ein klinisches \u00c4quivalent des Reizdarmsyndroms des Menschen vorliegt. Die Pathogenese dieses Syndroms und Kriterien zur Diagnosestellung m\u00fcssen jedoch besser definiert werden.", "term_pairs": [{"src": {"text": "Irritable bowel syndrome", "char_start": 0, "char_end": 24, "token_start": 0, "token_end": 3}, "tgt": {"text": "Reizdarmsyndrom", "char_start": 43, "char_end": 58, "token_start": 6, "token_end": 7}}, {"src": {"text": "IBS", "char_start": 26, "char_end": 29, "token_start": 4, "token_end": 5}, "tgt": {"text": "Reizdarmsyndrom", "char_start": 508, "char_end": 523, "token_start": 69, "token_end": 70}}, {"src": {"text": "gastrointestinal signs", "char_start": 83, "char_end": 105, "token_start": 15, "token_end": 17}, "tgt": {"text": "gastrointestinaler Symptome", "char_start": 89, "char_end": 116, "token_start": 10, "token_end": 12}}, {"src": {"text": "histopathologic evidence", "char_start": 121, "char_end": 145, "token_start": 20, "token_end": 22}, "tgt": {"text": "morphologische Ver\u00e4nderungen", "char_start": 159, "char_end": 187, "token_start": 17, "token_end": 19}}, {"src": {"text": "veterinary medicine", "char_start": 249, "char_end": 268, "token_start": 40, "token_end": 42}, "tgt": {"text": "Veterin\u00e4rmedizin", "char_start": 213, "char_end": 229, "token_start": 24, "token_end": 25}}, {"src": {"text": "dysmotility", "char_start": 298, "char_end": 309, "token_start": 48, "token_end": 49}, "tgt": {"text": "Motilit\u00e4tsst\u00f6rungen", "char_start": 319, "char_end": 338, "token_start": 40, "token_end": 41}}, {"src": {"text": "stressors", "char_start": 330, "char_end": 339, "token_start": 53, "token_end": 54}, "tgt": {"text": "Stressfaktoren", "char_start": 384, "char_end": 398, "token_start": 49, "token_end": 50}}, {"src": {"text": "clinical signs", "char_start": 371, "char_end": 385, "token_start": 60, "token_end": 62}, "tgt": {"text": "klinischen Symptomen", "char_start": 402, "char_end": 422, "token_start": 51, "token_end": 53}}, {"src": {"text": "chronic idiopathic large-bowel diarrhea", "char_start": 392, "char_end": 431, "token_start": 67, "token_end": 73}, "tgt": {"text": "chronische idiopathische Dickdarmdiarrh\u00f6", "char_start": 430, "char_end": 470, "token_start": 58, "token_end": 61}}, {"src": {"text": "IBS-like condition", "char_start": 512, "char_end": 530, "token_start": 87, "token_end": 91}, "tgt": {"text": "klinisches \u00c4quivalent des Reizdarmsyndroms", "char_start": 591, "char_end": 633, "token_start": 82, "token_end": 86}}, {"src": {"text": "diagnostic path", "char_start": 618, "char_end": 633, "token_start": 109, "token_end": 111}, "tgt": {"text": "Diagnosestellung", "char_start": 707, "char_end": 723, "token_start": 97, "token_end": 98}}, {"src": {"text": "pathogenesis", "char_start": 688, "char_end": 700, "token_start": 121, "token_end": 122}, "tgt": {"text": "Pathogenese", "char_start": 661, "char_end": 672, "token_start": 91, "token_end": 92}}]}
{"idx": 2852, "pair_id": "29913524", "src": "In forensic odontology the comparison between antemortem and postmortem panoramic radiographs (PRs) is a reliable method for person identification. The purpose of this study was to improve and automate identification of unknown people by comparison between antemortem and postmortem PR using computer vision. \u2002The study includes 43\u200a467 PRs from 24\u200a545 patients (46\u200a% females/54\u200a% males). All PRs were filtered and evaluated with Matlab R2014b including the toolboxes image processing and computer vision system. The matching process used the SURF feature to find the corresponding points between two PRs (unknown person and database entry) out of the whole database. \u2002From 40 randomly selected persons, 34 persons (85\u200a%) could be reliably identified by corresponding PR matching points between an already existing scan in the database and the most recent PR. The systematic matching yielded a maximum of 259 points for a successful identification between two different PRs of the same person and a maximum of 12 corresponding matching points for other non-identical persons in the database. Hence 12 matching points are the threshold for reliable assignment. \u2002Operating with an automatic PR system and computer vision could be a successful and reliable tool for identification purposes. The applied method distinguishes itself by virtue of its fast and reliable identification of persons by PR. This Identification method is suitable even if dental characteristics were removed or added in the past. The system seems to be robust for large amounts of data. \u2002 \u00b7 Computer vision allows an automated antemortem and postmortem comparison of panoramic radiographs (PRs) for person identification.. \u00b7 The present method is able to find identical matching partners among huge datasets (big data) in a short computing time.. \u00b7 The identification method is suitable even if dental characteristics were removed or added.. \u00b7 Heinrich A, G\u00fcttler F, Wendt S et\u200aal. Forensic Odontology: Automatic Identification of Persons Comparing Antemortem and Postmortem Panoramic Radiographs Using Computer Vision. Fortschr R\u00f6ntgenstr 2018; 190: 1152\u200a-\u200a1158.", "tgt": "ZIEL: \u2002In der forensischen Odontologie ist der Vergleich von\u00a0Ante-mortem und Post-mortem Panorama-R\u00f6ntgenaufnahmen (PR) eine zuverl\u00e4ssige Methode zur Personenidentifizierung. Das Ziel ist die automatische Identifizierung von unbekannten Personen mithilfe eines Vergleichs von Ante-mortem und Post-mortem PR unter Anwendung der Computer Vision. \u2002Die Studie umfasste 43\u200a467 PR von 24\u200a545 Personen (46\u200a% Frauen/ 54\u200a% M\u00e4nner). Alle PR wurden mit Matlab R2014b, einschlie\u00dflich der Toolboxen image processing und computer vision system, gefiltert und ausgewertet. Der Identifizierungsprozess verwendet die SURF-Funktion, um \u00dcbereinstimmungspunkte zwischen zwei PR (unbekannte Person und Datenbankeintrag) zu finden. \u2002Insgesamt konnten 34 von 40 Personen (85\u200a%) aufgrund einer hohen Zahl von \u00dcbereinstimmungspunkten zwischen dem aktuellsten PR und einem Datenbankeintrag eindeutig identifiziert werden. Die maximale Zahl an \u00dcbereinstimmungen zwischen zwei PR betrug 259 Punkte f\u00fcr dieselbe Person und nur 12 Punkte f\u00fcr zwei verschiedene Individuen. Daher waren 12 \u00dcbereinstimmungspunkte die Schwelle f\u00fcr eine eindeutige Identifizierung. \u2002Die Anwendung eines automatischen, Computer-Vision-gest\u00fctzten PR-Systems kann ein erfolgreiches und zuverl\u00e4ssiges Werkzeug zur Identifikation sein. Die angewandte Methode zeichnet sich durch eine schnelle und zuverl\u00e4ssige Identifizierung von Personen anhand von PR aus. Diese Identifikationsmethode ist f\u00fcr gro\u00dfe Datenmengen robust und auch dann erfolgreich, wenn in der Vergangenheit Zahnmerkmale entfernt oder hinzugekommen sind. \u2002 \u00b7 Zur Personenidentifizierung ist die Computer Vision f\u00fcr einen automatisierten Vergleich zwischen Ante-mortem und Post-mortem Panorama-R\u00f6ntgenaufnahmen (PR) geeignet.. \u00b7 Die beschriebene Methode erm\u00f6glicht die Identifizierung einer unbekannten Person durch Abgleich mit gro\u00dfen Datens\u00e4tzen (Big Data) in kurzer Rechenzeit.. \u00b7 Die Identifizierungsmethode ist auch dann geeignet, wenn Zahnmerkmale entfernt oder hinzugef\u00fcgt wurden..", "term_pairs": [{"src": {"text": "forensic odontology", "char_start": 3, "char_end": 22, "token_start": 1, "token_end": 3}, "tgt": {"text": "forensischen Odontologie", "char_start": 14, "char_end": 38, "token_start": 4, "token_end": 6}}, {"src": {"text": "antemortem", "char_start": 46, "char_end": 56, "token_start": 6, "token_end": 7}, "tgt": {"text": "Ante-mortem", "char_start": 61, "char_end": 72, "token_start": 10, "token_end": 13}}, {"src": {"text": "postmortem", "char_start": 61, "char_end": 71, "token_start": 8, "token_end": 9}, "tgt": {"text": "Post-mortem", "char_start": 77, "char_end": 88, "token_start": 14, "token_end": 17}}, {"src": {"text": "panoramic radiographs", "char_start": 72, "char_end": 93, "token_start": 9, "token_end": 11}, "tgt": {"text": "Panorama-R\u00f6ntgenaufnahmen", "char_start": 89, "char_end": 114, "token_start": 17, "token_end": 20}}, {"src": {"text": "PRs", "char_start": 95, "char_end": 98, "token_start": 12, "token_end": 13}, "tgt": {"text": "PR", "char_start": 116, "char_end": 118, "token_start": 21, "token_end": 22}}, {"src": {"text": "person identification", "char_start": 125, "char_end": 146, "token_start": 19, "token_end": 21}, "tgt": {"text": "Personenidentifizierung", "char_start": 150, "char_end": 173, "token_start": 27, "token_end": 28}}, {"src": {"text": "computer vision", "char_start": 292, "char_end": 307, "token_start": 44, "token_end": 46}, "tgt": {"text": "Computer Vision", "char_start": 327, "char_end": 342, "token_start": 53, "token_end": 55}}, {"src": {"text": "Matlab R2014b", "char_start": 429, "char_end": 442, "token_start": 74, "token_end": 76}, "tgt": {"text": "Matlab R2014b", "char_start": 442, "char_end": 455, "token_start": 80, "token_end": 82}}, {"src": {"text": "image processing", "char_start": 467, "char_end": 483, "token_start": 79, "token_end": 81}, "tgt": {"text": "image processing", "char_start": 486, "char_end": 502, "token_start": 86, "token_end": 88}}, {"src": {"text": "computer vision system", "char_start": 488, "char_end": 510, "token_start": 82, "token_end": 85}, "tgt": {"text": "computer vision system", "char_start": 507, "char_end": 529, "token_start": 89, "token_end": 92}}, {"src": {"text": "SURF feature", "char_start": 542, "char_end": 554, "token_start": 91, "token_end": 93}, "tgt": {"text": "SURF-Funktion", "char_start": 600, "char_end": 613, "token_start": 101, "token_end": 104}}, {"src": {"text": "database", "char_start": 624, "char_end": 632, "token_start": 105, "token_end": 106}, "tgt": {"text": "Datenbank", "char_start": 681, "char_end": 690, "token_start": 114, "token_end": 115}}, {"src": {"text": "matching points", "char_start": 770, "char_end": 785, "token_start": 133, "token_end": 135}, "tgt": {"text": "\u00dcbereinstimmungspunkte", "char_start": 618, "char_end": 640, "token_start": 106, "token_end": 107}}, {"src": {"text": "identification", "char_start": 202, "char_end": 216, "token_start": 32, "token_end": 33}, "tgt": {"text": "Identifizierung", "char_start": 205, "char_end": 220, "token_start": 34, "token_end": 35}}, {"src": {"text": "dental characteristics", "char_start": 1442, "char_end": 1464, "token_start": 244, "token_end": 246}, "tgt": {"text": "Zahnmerkmale", "char_start": 1516, "char_end": 1528, "token_start": 237, "token_end": 238}}, {"src": {"text": "big data", "char_start": 1779, "char_end": 1787, "token_start": 302, "token_end": 304}, "tgt": {"text": "Big Data", "char_start": 1856, "char_end": 1864, "token_start": 287, "token_end": 289}}]}
{"idx": 2887, "pair_id": "24425548", "src": "Patients with spinal cord injuries suffer not only from sensory and motor deficits, but from failure of the autonomic nerve system which in consequence involves many organs and metabolic pathways. These deficits lead to a different approach to these patients and their medical, psychological and social problems. Three examples will illustrate the different approaches to typical medical problems of these patients. Regularly ambulatory long term follow up visits in specialized centres in close collaboration with general practitioners help to diminish complications and rehospitalisations. Facing the now ageing population with a spinal cord injury we need evidence based guidelines in follow up and preventive strategies for these patients. We updated these recommendations recently. The brochure is available on the webside oft he swiss society of paraplegia www.ssop.ch.", "tgt": "Eine R\u00fcckenmarkssch\u00e4digung verursacht eine Querschnittsl\u00e4hmung mit Motorik- und Sensibilit\u00e4tsst\u00f6rung, betrifft aber auch die inneren Organe und Stoffwechselvorg\u00e4nge. Fallbeispiele zeigen auf, dass die nur teilweise vorhandene oder fehlende Sensibilit\u00e4t und Schmerzwahrnehmung die Interpretation von Symptomen erschwert. Das Wissen um die spezifischen Probleme im Langzeitverlauf und die Komplikationen nach einer Querschnittsl\u00e4hmung f\u00fchrte zur Entwicklung von umfassenden paraplegiologischen Standortbestimmungen, die alle Aspekte der Gesundheit erfassen: die K\u00f6rperfunktionen, die psychosoziale Situation, die Kontextfaktoren und den Rehabilitationszustand. Auf Basis der Untersuchungsbefunde werden gemeinsam mit den Betroffenen die rehabilitativen Ziele zur Erhaltung der Selbst\u00e4ndigkeit vereinbart und die Vorschl\u00e4ge zur Erhaltung und Verbesserung des Gesundheitszustandes diskutiert. Das aktualisierte Konzept der Vorsorge und Nachsorge f\u00fcr Querschnittgel\u00e4hmte, ber\u00fccksichtigt die spezifischen Probleme dieser Patienten.", "term_pairs": [{"src": {"text": "spinal cord injuries", "char_start": 14, "char_end": 34, "token_start": 2, "token_end": 5}, "tgt": {"text": "R\u00fcckenmarkssch\u00e4digung", "char_start": 5, "char_end": 26, "token_start": 1, "token_end": 2}}, {"src": {"text": "sensory and motor deficits", "char_start": 56, "char_end": 82, "token_start": 9, "token_end": 13}, "tgt": {"text": "Motorik- und Sensibilit\u00e4tsst\u00f6rung", "char_start": 67, "char_end": 100, "token_start": 6, "token_end": 10}}, {"src": {"text": "autonomic nerve system", "char_start": 108, "char_end": 130, "token_start": 19, "token_end": 22}, "tgt": {"text": "inneren Organe", "char_start": 125, "char_end": 139, "token_start": 15, "token_end": 17}}, {"src": {"text": "metabolic pathways", "char_start": 177, "char_end": 195, "token_start": 29, "token_end": 31}, "tgt": {"text": "Stoffwechselvorg\u00e4nge", "char_start": 144, "char_end": 164, "token_start": 18, "token_end": 19}}, {"src": {"text": "complications", "char_start": 554, "char_end": 567, "token_start": 85, "token_end": 86}, "tgt": {"text": "Komplikationen", "char_start": 387, "char_end": 401, "token_start": 50, "token_end": 51}}, {"src": {"text": "spinal cord injury", "char_start": 632, "char_end": 650, "token_start": 96, "token_end": 99}, "tgt": {"text": "Querschnittsl\u00e4hmung", "char_start": 43, "char_end": 62, "token_start": 4, "token_end": 5}}, {"src": {"text": "follow up", "char_start": 447, "char_end": 456, "token_start": 70, "token_end": 72}, "tgt": {"text": "Nachsorge", "char_start": 932, "char_end": 941, "token_start": 116, "token_end": 117}}, {"src": {"text": "preventive strategies", "char_start": 702, "char_end": 723, "token_start": 108, "token_end": 110}, "tgt": {"text": "Vorsorge", "char_start": 919, "char_end": 927, "token_start": 114, "token_end": 115}}, {"src": {"text": "paraplegia", "char_start": 852, "char_end": 862, "token_start": 132, "token_end": 133}, "tgt": {"text": "Querschnittgel\u00e4hmte", "char_start": 946, "char_end": 965, "token_start": 118, "token_end": 119}}]}
{"idx": 3039, "pair_id": "28697517", "src": "About 4000 patients receive a cochlear implant in Germany every year. Adults have become the main group for cochlear implantation candidacy.Elderly people with progressive and profound hearing loss experienced high communication restraints due to the limits of conventional hearing aids in the past. Nowadays cochlear implants can be offered as a well-established extension to the supply chain of hearing systems. The option of cochlear implantation for children with profound hearing impairment has led to a paradigm shift in hearing rehabilitation. However, there is still great variability in spoken language outcomes in CI children. These range from communicative and linguistic competencies similar to normal hearing children to clearly limited receptive and productive language skills. Besides age of implantation and the quality of previous auditory stimulation, there are additional factors that likely influence the outcome after cochlea implantation. Among them are the quality of caregivers' linguistic input and an intensive post-operative rehabilitation and intervention program. Ideally, children with CI are included into mainstream educational settings. Considering the high incidence of additional disabilities in children with hearing loss, it seems obvious that this goal cannot be achieved by all implanted children. Therefore, highly complex and individualized rehabilitation concepts are needed, which, in addition to oral language intervention programs, include total communication approaches as well.", "tgt": "In Deutschland werden j\u00e4hrlich etwa 4000 Patienten mit einem Kochleaimplantat versorgt. W\u00e4hrend noch vor Jahren schwerh\u00f6rige \u00e4ltere Menschen mit konventionellen H\u00f6rger\u00e4ten und progredientem H\u00f6rverlust bei unzureichendem Sprachverst\u00e4ndnis mit dem Risiko der sozialen Isolation leben mussten, k\u00f6nnen heute Cochleaimplantate als Folgeglied in der H\u00f6rsystemversorgung mit hoffnungsvollen Ergebnissen auch bei im fortgeschrittenen Alter angesehen werden. Auch bei Kindern ergeben sich neue Indikationen, mit besonderen Anforderungen in der Rehabilitation.", "term_pairs": [{"src": {"text": "cochlear implant", "char_start": 30, "char_end": 46, "token_start": 5, "token_end": 7}, "tgt": {"text": "Kochleaimplantat", "char_start": 61, "char_end": 77, "token_start": 9, "token_end": 10}}, {"src": {"text": "cochlear implantation", "char_start": 108, "char_end": 129, "token_start": 19, "token_end": 21}, "tgt": {"text": "Cochleaimplantate", "char_start": 304, "char_end": 321, "token_start": 39, "token_end": 40}}, {"src": {"text": "profound hearing loss", "char_start": 176, "char_end": 197, "token_start": 28, "token_end": 31}, "tgt": {"text": "H\u00f6rverlust", "char_start": 190, "char_end": 200, "token_start": 24, "token_end": 25}}, {"src": {"text": "hearing aids", "char_start": 274, "char_end": 286, "token_start": 41, "token_end": 43}, "tgt": {"text": "H\u00f6rger\u00e4ten", "char_start": 161, "char_end": 171, "token_start": 21, "token_end": 22}}, {"src": {"text": "hearing systems", "char_start": 397, "char_end": 412, "token_start": 64, "token_end": 66}, "tgt": {"text": "H\u00f6rsystemversorgung", "char_start": 344, "char_end": 363, "token_start": 44, "token_end": 45}}, {"src": {"text": "hearing rehabilitation", "char_start": 527, "char_end": 549, "token_start": 85, "token_end": 87}, "tgt": {"text": "Rehabilitation", "char_start": 535, "char_end": 549, "token_start": 69, "token_end": 70}}]}
{"idx": 3053, "pair_id": "28704875", "src": "Children are particularly at risk for stroke in the neonatal period. 1/3 of all strokes in children occur during the perinatal period. The incidence of perinatal stroke is 1:4000. A differentiation is made between ischemic stroke and hemorrhagic stroke. Ischemic strokes are caused by arterial occlusion due to thrombosis or embolism. As a result of the nonspecific clinical symptoms in this age group, diagnosis is usually made too late. The only relatively specific symptom is focal cerebral seizure during the first week of life. Therefore, stroke should be ruled out by diagnostic imaging in the case of any seizure in the first days of life. Although the diagnostic method of choice is MRI, it is not always available. Most neonatal ischemic strokes can be detected with high-resolution duplex ultrasound. On ultrasound, ischemic stroke appears as a wedge-shaped focal increase in echogenicity in the supply region of an artery, typically the middle cerebral artery. The corresponding arterial inflow can be visualized with duplex ultrasound and measured with spectral Doppler. Doppler ultrasound can be used to differentiate between complete occlusion and severe stenosis. The success of therapeutic measures can be determined in the further course with Doppler ultrasound on the basis of the recanalization of vessels and the morphological consequences of stroke (cyst formation due to liquefactive necrosis).", "tgt": "In der Neonatalperiode ist das Kind durch das Auftreten von\u00a0Schlaganf\u00e4llen besonders gef\u00e4hrdet. 1/3 aller kindlichen Schlaganf\u00e4lle treten perinatal auf. Die Inzidenz des perinatalen Schlaganfalls liegt bei 1:4000. Man unterscheidet isch\u00e4mische Schlaganf\u00e4lle von h\u00e4morrhagischen Schlaganf\u00e4llen. Isch\u00e4mische Schlaganf\u00e4lle sind durch einen arteriellen Verschluss, hervorgerufen durch eine Thrombose oder Embolie, bedingt. Aufgrund der unspezifischen klinischen Symptome in dieser Altersgruppe wird die Diagnose meist zu sp\u00e4t gestellt. Das einzige relativ spezifische Symptom ist ein fokaler zerebraler Krampfanfall innerhalb der ersten Lebenswoche. Bei allen Krampfanf\u00e4llen in den ersten Lebenstagen sollte deswegen ein Schlaganfall durch bildgebende Diagnostik ausgeschlossen werden. Das Diagnostikum der Wahl ist zwar die MRT, die jedoch nicht \u00fcberall und zu jedem Zeitpunkt verf\u00fcgbar ist. Mit der hochaufl\u00f6senden Duplexsonografie k\u00f6nnen die meisten neonatalen isch\u00e4mischen Schlaganf\u00e4lle erfasst werden. Sonografisch imponieren isch\u00e4mische Schlaganf\u00e4lle als keilf\u00f6rmige fokale Echogenit\u00e4tsvermehrung im Versorgungsgebiet einer Arterie, meist der A. cerebri media. Mit der Duplexsonografie gilt es den entsprechenden arteriellen Zufluss darzustellen und mit dem Spektraldoppler zu erfassen. Dopplersonografisch kann dabei zwischen komplettem Verschluss oder hochgradiger Einengung unterschieden werden. Im weiteren Verlauf kann der Erfolg therapeutischer Bem\u00fchungen mit der Dopplersonografie anhand der Rekanalisierung von Gef\u00e4\u00dfen und den morphologischen Folgen des Schlaganfalls (Zystenbildung durch Kolliquationsnekrose) dargestellt werden.", "term_pairs": []}
{"idx": 3097, "pair_id": "25146945", "src": "Neurological symptoms in cancer patients have a great impact on quality of life and need an interdisciplinary approach. They lead to significant impairment in activities of daily living (gait disorders, dizziness), a loss of patients independency (vegetative disturbances, wheel-chair dependency) and interfere with social activities (ban of driving in case of epilepsy). In this article we describe three main and serious neurological problems in the context of oncological patients. These are chemotherapy-induced polyneuropathy, malignant spinal cord compression and epileptic seizures. Our aim is to increase the awareness of neurological complications in cancer patients to improve patients care.", "tgt": "Neurologische Symptome und Komplikationen bei Patienten mit einer onkologischen Erkrankung sind in vielerlei Hinsicht f\u00fcr die interdisziplin\u00e4re Betreuung von Bedeutung. Nicht selten f\u00fchren sie zu einer erheblichen Behinderung in den Alltagsf\u00e4higkeiten (Gangst\u00f6rungen, Schwindel), zu einem Verlust der Patientenautonomie (Blasen-Mastdarmst\u00f6rungen, Rollstuhlpflichtigkeit) und zu einer St\u00f6rung des Sozial- und Arbeitslebens (Verlust der Fahreignung bei Epilepsie). In diesem Artikel stellen wir drei klinisch relevante neurologische Komplikationen im Kontext onkologischer Erkrankungen vor. Dieses sind die Chemotherapie-induzierte Polyneuropathie, spinale Kompressionen und epileptische Anf\u00e4lle. Der vorliegende \u00dcbersichtsartikel zielt darauf ab, das Wissen um neurologische Komplikationen bei Krebspatienten zu vertiefen, Komplikationen vorzubeugen, um die Patientenversorgung weiter zu verbessern.", "term_pairs": [{"src": {"text": "Neurological symptoms", "char_start": 0, "char_end": 21, "token_start": 0, "token_end": 2}, "tgt": {"text": "Neurologische Symptome", "char_start": 0, "char_end": 22, "token_start": 0, "token_end": 2}}, {"src": {"text": "cancer patients", "char_start": 25, "char_end": 40, "token_start": 3, "token_end": 5}, "tgt": {"text": "Krebspatienten", "char_start": 793, "char_end": 807, "token_start": 110, "token_end": 111}}, {"src": {"text": "interdisciplinary approach", "char_start": 92, "char_end": 118, "token_start": 16, "token_end": 18}, "tgt": {"text": "interdisziplin\u00e4re Betreuung", "char_start": 126, "char_end": 153, "token_start": 16, "token_end": 18}}, {"src": {"text": "gait disorders", "char_start": 187, "char_end": 201, "token_start": 30, "token_end": 32}, "tgt": {"text": "Gangst\u00f6rungen", "char_start": 253, "char_end": 266, "token_start": 33, "token_end": 34}}, {"src": {"text": "dizziness", "char_start": 203, "char_end": 212, "token_start": 33, "token_end": 34}, "tgt": {"text": "Schwindel", "char_start": 268, "char_end": 277, "token_start": 35, "token_end": 36}}, {"src": {"text": "wheel-chair dependency", "char_start": 273, "char_end": 295, "token_start": 45, "token_end": 49}, "tgt": {"text": "Rollstuhlpflichtigkeit", "char_start": 347, "char_end": 369, "token_start": 48, "token_end": 49}}, {"src": {"text": "epilepsy", "char_start": 361, "char_end": 369, "token_start": 62, "token_end": 63}, "tgt": {"text": "Epilepsie", "char_start": 451, "char_end": 460, "token_start": 64, "token_end": 65}}, {"src": {"text": "chemotherapy-induced polyneuropathy", "char_start": 495, "char_end": 530, "token_start": 85, "token_end": 89}, "tgt": {"text": "Chemotherapie-induzierte Polyneuropathie", "char_start": 605, "char_end": 645, "token_start": 86, "token_end": 90}}, {"src": {"text": "malignant spinal cord compression", "char_start": 532, "char_end": 565, "token_start": 90, "token_end": 94}, "tgt": {"text": "spinale Kompressionen", "char_start": 647, "char_end": 668, "token_start": 91, "token_end": 93}}, {"src": {"text": "epileptic seizures", "char_start": 570, "char_end": 588, "token_start": 95, "token_end": 97}, "tgt": {"text": "epileptische Anf\u00e4lle", "char_start": 673, "char_end": 693, "token_start": 94, "token_end": 96}}, {"src": {"text": "neurological complications", "char_start": 630, "char_end": 656, "token_start": 106, "token_end": 108}, "tgt": {"text": "neurologische Komplikationen", "char_start": 517, "char_end": 545, "token_start": 75, "token_end": 77}}, {"src": {"text": "patients care", "char_start": 687, "char_end": 700, "token_start": 113, "token_end": 115}, "tgt": {"text": "Patientenversorgung", "char_start": 857, "char_end": 876, "token_start": 119, "token_end": 120}}]}
{"idx": 3124, "pair_id": "33970339", "src": "This article describes a\u00a0first use of an electronic case-based assessment tool in undergraduate palliative care education. It describes the development of the tool presenting strengths and shortcomings in order to contribute to an innovative design of assessment tools in medical education. An electronic (virtual) case-based assessment tool (the virtual palliative patient, vPp) was developed. Palliative care levels of knowledge, skills and attitude of students were tested at a\u00a0computer workplace as a\u00a0voluntary and non-performance-relevant pilot project at four faculties. On average the students achieved 80% of the points using the vPp tool, which is below the average score of 91% achieved in the regular examination. In particular, the free text task on reflection of dealing with the patient's death wish caused uncertainty, while multiple choice questions and an interactive conversation sequence were perceived as relatively easy. Technical problems were also identified in the evaluation but overall the concept was evaluated positively and establishment as a\u00a0regular examination or e\u2011learning tool was desired. The implementation of an innovative assessment tool in medical education is technically challenging. A\u00a0coordination with contents of the individual faculties is necessary in order that students do not have a feeling of a lack of preparation. The development of the vPp describes an innovative assessment format. In the long term, all interested faculties could receive a\u00a0form of toolbox containing the technical framework of the assessment tool, which can then be fed with new contents.", "tgt": "HINTERGRUND: Die Pilotversion eines elektronischen, fallbasierten Pr\u00fcfungstools in der palliativmedizinischen Lehre sollte angewendet und auf St\u00e4rken und Schw\u00e4chen untersucht werden. Es wurde ein elektronisches (virtuelles) Pr\u00fcfungstool (Die virtuelle Palliativpatientin [vPp]) zur Pr\u00fcfung von Wissen, Fertigkeiten und Haltung in Palliativmedizin entwickelt. Die Pr\u00fcfung an einem Computerarbeitsplatz wurde als freiwilliges Pilotprojekt nicht leistungsrelevant an vier Fakult\u00e4ten von Studierenden durchgef\u00fchrt und evaluiert. Im Mittel haben die Studierenden im vPp-Tool knapp 80\u202f% der Punkte erreicht. Dies liegt unter der durchschnittlich erreichten Punktzahl in der Regelpr\u00fcfung mit rund 91\u202f%. Insbesondere die Reflexion des eigenen Umgangs mit dem Todeswunsch der Patientin hat zu gro\u00dfer Unsicherheit gef\u00fchrt, w\u00e4hrend die eingebetteten Multiple-Choice-Fragen und eine interaktive Gespr\u00e4chssequenz eher als leicht empfunden wurden. Bei der Evaluation wurden auch technische Probleme identifiziert. Insgesamt wurde das Konzept aber positiv evaluiert und eine Etablierung als regul\u00e4re Pr\u00fcfung oder E\u2011Learning-Tool gew\u00fcnscht. Die Implementierung eines innovativen Pr\u00fcfungstools im Medizinstudium stellt insbesondere eine technische Herausforderung dar. Eine Abstimmung mit den Lehrinhalten der einzelnen Fakult\u00e4ten ist erforderlich, um Studierenden nicht das Gef\u00fchl der mangelnden Vorbereitung zu geben. Die Entwicklung von vPp beschreibt ein innovatives Pr\u00fcfungsformat. Langfristig k\u00f6nnte von interessierten Fakult\u00e4ten eine Art Toolbox gepflegt werden, die das technische Ger\u00fcst der Pr\u00fcfung enth\u00e4lt und mit neuen Inhalten best\u00fcckt werden kann.", "term_pairs": [{"src": {"text": "electronic case-based assessment tool", "char_start": 41, "char_end": 78, "token_start": 8, "token_end": 14}, "tgt": {"text": "elektronischen, fallbasierten Pr\u00fcfungstools", "char_start": 36, "char_end": 79, "token_start": 5, "token_end": 9}}, {"src": {"text": "palliative care education", "char_start": 96, "char_end": 121, "token_start": 16, "token_end": 19}, "tgt": {"text": "palliativmedizinischen Lehre", "char_start": 87, "char_end": 115, "token_start": 11, "token_end": 13}}, {"src": {"text": "virtual palliative patient", "char_start": 347, "char_end": 373, "token_start": 58, "token_end": 61}, "tgt": {"text": "virtuelle Palliativpatientin", "char_start": 242, "char_end": 270, "token_start": 33, "token_end": 35}}, {"src": {"text": "vPp", "char_start": 375, "char_end": 378, "token_start": 62, "token_end": 63}, "tgt": {"text": "vPp", "char_start": 272, "char_end": 275, "token_start": 36, "token_end": 37}}, {"src": {"text": "knowledge, skills and attitude", "char_start": 421, "char_end": 451, "token_start": 71, "token_end": 76}, "tgt": {"text": "Wissen, Fertigkeiten und Haltung", "char_start": 294, "char_end": 326, "token_start": 42, "token_end": 47}}, {"src": {"text": "pilot project", "char_start": 544, "char_end": 557, "token_start": 93, "token_end": 95}, "tgt": {"text": "Pilotprojekt", "char_start": 424, "char_end": 436, "token_start": 59, "token_end": 60}}, {"src": {"text": "multiple choice questions", "char_start": 840, "char_end": 865, "token_start": 151, "token_end": 154}, "tgt": {"text": "Multiple-Choice-Fragen", "char_start": 839, "char_end": 861, "token_start": 122, "token_end": 127}}, {"src": {"text": "interactive conversation sequence", "char_start": 873, "char_end": 906, "token_start": 156, "token_end": 159}, "tgt": {"text": "interaktive Gespr\u00e4chssequenz", "char_start": 871, "char_end": 899, "token_start": 129, "token_end": 131}}, {"src": {"text": "technical problems", "char_start": 942, "char_end": 960, "token_start": 165, "token_end": 167}, "tgt": {"text": "technische Probleme", "char_start": 965, "char_end": 984, "token_start": 142, "token_end": 144}}, {"src": {"text": "e\u2011learning tool", "char_start": 1095, "char_end": 1110, "token_start": 187, "token_end": 191}, "tgt": {"text": "E\u2011Learning-Tool", "char_start": 1098, "char_end": 1113, "token_start": 160, "token_end": 165}}, {"src": {"text": "medical education", "char_start": 272, "char_end": 289, "token_start": 43, "token_end": 45}, "tgt": {"text": "Medizinstudium", "char_start": 1180, "char_end": 1194, "token_start": 173, "token_end": 174}}, {"src": {"text": "assessment tool", "char_start": 252, "char_end": 267, "token_start": 40, "token_end": 42}, "tgt": {"text": "Pr\u00fcfungstool", "char_start": 224, "char_end": 236, "token_start": 30, "token_end": 31}}, {"src": {"text": "toolbox", "char_start": 1503, "char_end": 1510, "token_start": 257, "token_end": 258}, "tgt": {"text": "Toolbox", "char_start": 1528, "char_end": 1535, "token_start": 219, "token_end": 220}}]}
{"idx": 3305, "pair_id": "32020285", "src": "The prevalence of insomnia is particularly high in old age. Sleep disturbances and impaired daytime functioning reflected in mood swings and concentration difficulties are often accompanied by other mental disorders such as depression. The objective of this article is to shed light on the role of insomnia in the context of frequent comorbidities in middle and old age. The focus is on the identification of linkage points between insomnia and associated diseases on a\u00a0neurobiological level; however, possible distinguishing features are also named and deliberations on cognitive behavioral aspects and integrative theories, such as the hyperarousal theory are discussed. In order to provide an outlook for future research opportunities, the UK Biobank is presented as a\u00a0promising resource of long-term data. Finally, the contents of the preceding deliberations are critically reflected and practical implications for the treatment of older patients with insomnia are derived.", "tgt": "Die Pr\u00e4valenz von Insomnien ist im Alter besonders hoch. Oft treten Ein- und Durchschlafst\u00f6rungen sowie hieraus resultierende Beeintr\u00e4chtigungen wie Stimmungsschwankungen oder Konzentrationsschwierigkeiten im Zusammenspiel mit anderen Erkrankungen wie beispielsweise Depressionen auf. Dieser Beitrag zielt darauf ab, die Rolle der Insomnie im Kontext h\u00e4ufiger Komorbidit\u00e4ten im Alter zu beleuchten. Der Schwerpunkt liegt auf der Identifizierung von Verkn\u00fcpfungspunkten zwischen Insomnien und damit assoziierten Erkrankungen auf neurobiologischer Ebene. Es werden jedoch auch m\u00f6gliche Abgrenzungsmerkmale benannt und Ausf\u00fchrungen zu kognitiv-behavioralen Aspekten und integrativen Theorien wie der \u201eHyperarousal\u201c-Theorie eingeflochten. Um einen Ausblick auf zuk\u00fcnftige Forschungsans\u00e4tze zu erm\u00f6glichen, wird in einem weiteren Abschnitt die sog. UK Biobank als vielversprechende Ressource portraitiert. Abschlie\u00dfend finden eine kritische Einordung der vorangegangenen Ausf\u00fchrungen sowie die Ableitung praktischer Implikationen f\u00fcr die Behandlung von \u00e4lteren Patienten mit Insomnie statt.", "term_pairs": [{"src": {"text": "insomnia", "char_start": 18, "char_end": 26, "token_start": 3, "token_end": 4}, "tgt": {"text": "Insomnien", "char_start": 18, "char_end": 27, "token_start": 3, "token_end": 4}}, {"src": {"text": "sleep disturbances", "char_start": 60, "char_end": 78, "token_start": 11, "token_end": 13}, "tgt": {"text": "Ein- und Durchschlafst\u00f6rungen", "char_start": 68, "char_end": 97, "token_start": 12, "token_end": 16}}, {"src": {"text": "mood swings", "char_start": 125, "char_end": 136, "token_start": 19, "token_end": 21}, "tgt": {"text": "Stimmungsschwankungen", "char_start": 149, "char_end": 170, "token_start": 21, "token_end": 22}}, {"src": {"text": "concentration difficulties", "char_start": 141, "char_end": 167, "token_start": 22, "token_end": 24}, "tgt": {"text": "Konzentrationsschwierigkeiten", "char_start": 176, "char_end": 205, "token_start": 23, "token_end": 24}}, {"src": {"text": "depression", "char_start": 224, "char_end": 234, "token_start": 33, "token_end": 34}, "tgt": {"text": "Depressionen", "char_start": 267, "char_end": 279, "token_start": 31, "token_end": 32}}, {"src": {"text": "comorbidities", "char_start": 334, "char_end": 347, "token_start": 54, "token_end": 55}, "tgt": {"text": "Komorbidit\u00e4ten", "char_start": 360, "char_end": 374, "token_start": 47, "token_end": 48}}, {"src": {"text": "neurobiological", "char_start": 470, "char_end": 485, "token_start": 77, "token_end": 78}, "tgt": {"text": "neurobiologischer", "char_start": 528, "char_end": 545, "token_start": 68, "token_end": 69}}, {"src": {"text": "cognitive behavioral", "char_start": 571, "char_end": 591, "token_start": 91, "token_end": 93}, "tgt": {"text": "kognitiv-behavioralen", "char_start": 632, "char_end": 653, "token_start": 81, "token_end": 84}}, {"src": {"text": "UK Biobank", "char_start": 743, "char_end": 753, "token_start": 118, "token_end": 120}, "tgt": {"text": "UK Biobank", "char_start": 844, "char_end": 854, "token_start": 114, "token_end": 116}}]}
{"idx": 3309, "pair_id": "32023647", "src": "Physical activity shows preventive and positive treatment effects on burnout syndromes. A systematic literature research was performed to prove possible effects on burnout. Positive effects were found and the Standard Index of Convergence (SIC) showed a moderately strong evidence for both, longitudinal studies SIC (3)\u200a=\u200a-1 and interventional studies SCI (6)\u200a= -0.50,\u00a0that physical activity is suited for threatening burnout syndromes.Because of widespread heterogeneity and difficulties in study comparability, further research is needed. Independent of the positive and preventive effects of physical activity, a good life balance in private and work environment as well as self-care is of fundamental importance. Therefore, a combination of multiple settings, like cognitive training, relaxation exercise, stress management and physical activity seems to be optimal for preventing burnout.", "tgt": "Das vorliegende Review legt dar, dass regelm\u00e4\u00dfige k\u00f6rperliche Aktivit\u00e4t einen positiven Einfluss auf die Burn-out-Symptomatik hat. Mittels einer systematischen Literaturrecherche wurden die m\u00f6glichen Effekte untersucht und die Evidenz mithilfe des Standard-Index of Convergence (SIC) bewertet. Der SIC lag in den L\u00e4ngsschnittstudien bei SIC (3)\u200a=\u200a\u20131, w\u00e4hrend er in den Interventionsstudien bei SIC (6)\u200a= \u20130,50\u00a0lag. Daher ist jeweils von einer moderat starken Evidenz auszugehen, dass k\u00f6rperliche Aktivit\u00e4t einen positiven gesundheitlichen Effekt auf das Burn-out-Syndrom hat. Aufgrund der Heterogenit\u00e4t der Erhebungstools und der Studienlage ist es notwendig, weitere qualitativ hochwertige Studien zur Burn-out-Thematik durchzuf\u00fchren, um repr\u00e4sentative Aussagen zu gew\u00e4hrleisten. Unabh\u00e4ngig von den positiven pr\u00e4ventiven und therapeutischen Effekten ist die regelm\u00e4\u00dfige k\u00f6rperliche Aktivit\u00e4t ein grundlegender, jedoch kein alleiniger Ansatzpunkt, um der Ersch\u00f6pfungssymptomatik vorzubeugen und entgegenzuwirken. Eine ausgewogene Life-Balance (privates Umfeld, berufliches Umfeld und Hygiene der Grundbed\u00fcrfnisse) ist daher unerl\u00e4sslich.", "term_pairs": [{"src": {"text": "physical activity", "char_start": 0, "char_end": 17, "token_start": 0, "token_end": 2}, "tgt": {"text": "k\u00f6rperliche Aktivit\u00e4t", "char_start": 50, "char_end": 71, "token_start": 8, "token_end": 10}}, {"src": {"text": "burnout syndromes", "char_start": 69, "char_end": 86, "token_start": 9, "token_end": 11}, "tgt": {"text": "Burn-out-Syndrom", "char_start": 554, "char_end": 570, "token_start": 97, "token_end": 102}}, {"src": {"text": "systematic literature research", "char_start": 90, "char_end": 120, "token_start": 13, "token_end": 16}, "tgt": {"text": "systematischen Literaturrecherche", "char_start": 145, "char_end": 178, "token_start": 24, "token_end": 26}}, {"src": {"text": "Standard Index of Convergence (SIC)", "char_start": 209, "char_end": 244, "token_start": 31, "token_end": 38}, "tgt": {"text": "Standard-Index of Convergence (SIC)", "char_start": 248, "char_end": 283, "token_start": 36, "token_end": 44}}, {"src": {"text": "longitudinal studies", "char_start": 291, "char_end": 311, "token_start": 46, "token_end": 48}, "tgt": {"text": "L\u00e4ngsschnittstudien", "char_start": 313, "char_end": 332, "token_start": 51, "token_end": 52}}, {"src": {"text": "interventional studies", "char_start": 329, "char_end": 351, "token_start": 56, "token_end": 58}, "tgt": {"text": "Interventionsstudien", "char_start": 369, "char_end": 389, "token_start": 65, "token_end": 66}}, {"src": {"text": "burnout", "char_start": 164, "char_end": 171, "token_start": 23, "token_end": 24}, "tgt": {"text": "Burn-out", "char_start": 105, "char_end": 113, "token_start": 15, "token_end": 18}}]}
{"idx": 3387, "pair_id": "30630194", "src": "To prospectively assess liver fibrosis with two-dimensional shear wave elastography (2D-SWE) in patients with chronic hepatitis B (CHB) and to compare the performance of this modality with that of serum indices using Scheuer scoring from liver biopsies as the reference standard. \u2002123 patients with CHB underwent 2D-SWE measurements and serological tests between April 2016 and February 2018. The 2D-SWE and serum indices in the diagnosis of liver fibrosis were assessed using receiver operating characteristic (ROC) analyses. \u2002The areas under ROC (AUCs) for 2D-SWE, aspartate transaminase-to-platelet ratio index, fibrosis index based on the four factors, Forns score, King's score, FibroIndex, red cell distribution width-to-platelet ratio, Hepascore, type IV collagen, and hyaluronic acid were 0.851, 0.738, 0.701, 0.739, 0.734, 0.711, 0.692, 0.601, 0.640, and 0.522, respectively, in the diagnosis of substantial fibrosis, 0.975, 0.819, 0.792, 0.829, 0.818, 0.807, 0.732, 0.572, 0.676, and 0.544, respectively, in the diagnosis of severe fibrosis, and 0.972, 0.883, 0.862, 0.908, 0.889, 0.918, 0.808, 0.601, 0.807, and 0.775, respectively, in the diagnosis of cirrhosis. The AUCs of 2D-SWE in the diagnosis of substantial fibrosis, severe fibrosis, and cirrhosis were significantly higher than those of the serum indices (p\u200a<\u200a0.05). \u20022D-SWE is a reliable noninvasive method for the\u00a0assessment of liver fibrosis in patients with CHB with better diagnostic performance than that of nine serum fibrosis indices.", "tgt": "ZIEL: \u2002Prospektive Beurteilung der Leber-Fibrose mit 2-dimensionaler Scherwellen-Elastografie (2D-SWE) bei Patienten mit chronischer Hepatitis B (CHB) und Vergleich der Treffsicherheit dieser Methode mit den Serumindizes unter Verwendung des Scheuer-Scores aus Leberbiopsien als Referenzstandard. \u2002123 Patienten mit CHB wurden zwischen April 2016 und Februar 2018\u200aden 2D-SWE-Messungen und serologischen Tests unterzogen. Die 2D-SWE und Serumindizes f\u00fcr die Diagnose von Leber-Fibrose wurden anhand von Receiver-Operating-Characteristic (ROC) -Analysen bewertet. \u2002Die \u201eareas under ROC\u201c (AUCs) betrugen f\u00fcr die Diagnose einer a) erheblichen Fibrose und einer b) schweren Fibrose bzw. f\u00fcr die Diagnose einer c) Zirrhose f\u00fcr 2D-SWE: a)\u00a00,851, b) 0,975c) 0,972; f\u00fcr die Aspartat-Transaminase/Thrombozyten-Ratio: a) 0,738, b) 0,819, c) 0,883; f\u00fcr den Fibrose-Index a) 0,701, b) 0,792, c) 0,862, basierend auf den 4 Faktoren, Forns-Score: a) 0,739, b) 0,829, c) 0,908; King-Score: a) 0,734, b) 0,818, c) 0,889; FibroIndex: a) 0,711, b)\u00a00,807, c) 0,918; Erythrozyten-Verteilungsbreite/Thrombozyten-Ratio: a) 0,692, b) 0,732, c) 0,808; f\u00fcr den Hepa-Score a) 0,601, b) 0,572, c) 0,601; f\u00fcr Typ-IV-Kollagen a) 0,640, b)\u00a00,676, c) 0,807 und f\u00fcr Hyalurons\u00e4ure a) 0,522, b) 0,544, c) 0,775. Die AUCs der 2D-SWE bei der Diagnose von erheblicher Fibrose (a), schwerer Fibrose (b) und Zirrhose (c) waren signifikant h\u00f6her als die der Serumindizes (p\u200a<\u200a0,05). \u20022D-SWE ist eine zuverl\u00e4ssige nichtinvasive Methode zur Beurteilung der Leber-Fibrose bei Patienten mit CHB und weist eine bessere diagnostische Leistung als die 9 Serum-Fibrose-Indizes auf.", "term_pairs": []}
{"idx": 3421, "pair_id": "24794237", "src": "Computed tomographic (CT) findings of the urinary tract and adrenal glands of five healthy male calves in the first 105 days of life were compared with corresponding cadaver slices. The structures seen on CT images were identified using the corresponding cadaver slices. CT produced exact images of the kidneys, urinary bladder, urethra and adrenal glands, but reliable images of the ureters were only obtained near the renal hilus. There was excellent agreement between the structures on the CT images and the tissue slices. The structure and vessels of the kidneys, the origin of the ureters, the location, size and content of the urinary bladder and the course of the urethra in the pelvis and penis were evident on images. The size and volume of the kidneys and the length and width of the adrenal glands increased significantly during the study, but the ureteral and urethral diameters changed little.", "tgt": "In der vorliegenden Arbeit werden die computertomographischen (CT) Befunde an Harnapparat und Nebennieren von 5 gesunden m\u00e4nnlichen K\u00e4lbern von der Geburt bis zum Alter von 105 Tagen beschrieben und mit denjenigen der postmortalen Untersuchung verglichen. Nieren, Harnblase, Urethra und Nebennieren konnten computertomographisch exakt dargestellt werden, w\u00e4hrend die Ureteren nur im Bereich des Hilus renalis zuverl\u00e4ssig identifiziert werden konnten. Die Topographie der Organe bzw. der Strukturen und der anatomischen Schnittpr\u00e4parate stimmten sehr gut \u00fcberein. An den Nieren waren die Struktur und die Blutgef\u00e4sse, an den Ureteren deren Anfangsteil, an der Harnblase Lage, Gr\u00f6sse und Inhalt und an der Urethra der Verlauf im Becken und Penis zu sehen. Die Ausdehnung und das Volumen der Nieren nahmen von der ersten bis zur sechsten Untersuchung signifikant zu. Das Gleiche gilt f\u00fcr die L\u00e4nge und Breite der Nebennieren, w\u00e4hrend sich die Durchmesser von Ureteren und Urethra kaum ver\u00e4nderten.", "term_pairs": [{"src": {"text": "Computed tomographic (CT)", "char_start": 0, "char_end": 25, "token_start": 0, "token_end": 5}, "tgt": {"text": "computertomographischen (CT)", "char_start": 38, "char_end": 66, "token_start": 6, "token_end": 10}}, {"src": {"text": "urinary tract", "char_start": 42, "char_end": 55, "token_start": 8, "token_end": 10}, "tgt": {"text": "Harnapparat", "char_start": 78, "char_end": 89, "token_start": 12, "token_end": 13}}, {"src": {"text": "adrenal glands", "char_start": 60, "char_end": 74, "token_start": 11, "token_end": 13}, "tgt": {"text": "Nebennieren", "char_start": 94, "char_end": 105, "token_start": 14, "token_end": 15}}, {"src": {"text": "calves", "char_start": 96, "char_end": 102, "token_start": 17, "token_end": 18}, "tgt": {"text": "K\u00e4lbern", "char_start": 132, "char_end": 139, "token_start": 19, "token_end": 20}}, {"src": {"text": "cadaver slices", "char_start": 166, "char_end": 180, "token_start": 29, "token_end": 31}, "tgt": {"text": "anatomischen Schnittpr\u00e4parate", "char_start": 506, "char_end": 535, "token_start": 75, "token_end": 77}}, {"src": {"text": "CT images", "char_start": 205, "char_end": 214, "token_start": 36, "token_end": 38}, "tgt": {"text": "computertomographisch", "char_start": 307, "char_end": 328, "token_start": 46, "token_end": 47}}, {"src": {"text": "kidneys", "char_start": 303, "char_end": 310, "token_start": 52, "token_end": 53}, "tgt": {"text": "Nieren", "char_start": 256, "char_end": 262, "token_start": 38, "token_end": 39}}, {"src": {"text": "urinary bladder", "char_start": 312, "char_end": 327, "token_start": 54, "token_end": 56}, "tgt": {"text": "Harnblase", "char_start": 264, "char_end": 273, "token_start": 40, "token_end": 41}}, {"src": {"text": "urethra", "char_start": 329, "char_end": 336, "token_start": 57, "token_end": 58}, "tgt": {"text": "Urethra", "char_start": 275, "char_end": 282, "token_start": 42, "token_end": 43}}, {"src": {"text": "ureters", "char_start": 384, "char_end": 391, "token_start": 67, "token_end": 68}, "tgt": {"text": "Ureteren", "char_start": 367, "char_end": 375, "token_start": 53, "token_end": 54}}, {"src": {"text": "renal hilus", "char_start": 420, "char_end": 431, "token_start": 73, "token_end": 75}, "tgt": {"text": "Hilus renalis", "char_start": 395, "char_end": 408, "token_start": 58, "token_end": 60}}, {"src": {"text": "vessels", "char_start": 544, "char_end": 551, "token_start": 95, "token_end": 96}, "tgt": {"text": "Blutgef\u00e4sse", "char_start": 604, "char_end": 615, "token_start": 90, "token_end": 91}}, {"src": {"text": "pelvis", "char_start": 686, "char_end": 692, "token_start": 124, "token_end": 125}, "tgt": {"text": "Becken", "char_start": 727, "char_end": 733, "token_start": 113, "token_end": 114}}, {"src": {"text": "penis", "char_start": 697, "char_end": 702, "token_start": 126, "token_end": 127}, "tgt": {"text": "Penis", "char_start": 738, "char_end": 743, "token_start": 115, "token_end": 116}}, {"src": {"text": "volume", "char_start": 740, "char_end": 746, "token_start": 135, "token_end": 136}, "tgt": {"text": "Volumen", "char_start": 777, "char_end": 784, "token_start": 123, "token_end": 124}}, {"src": {"text": "length", "char_start": 770, "char_end": 776, "token_start": 141, "token_end": 142}, "tgt": {"text": "L\u00e4nge", "char_start": 889, "char_end": 894, "token_start": 142, "token_end": 143}}, {"src": {"text": "width", "char_start": 781, "char_end": 786, "token_start": 143, "token_end": 144}, "tgt": {"text": "Breite", "char_start": 899, "char_end": 905, "token_start": 144, "token_end": 145}}, {"src": {"text": "diameters", "char_start": 881, "char_end": 890, "token_start": 159, "token_end": 160}, "tgt": {"text": "Durchmesser", "char_start": 940, "char_end": 951, "token_start": 151, "token_end": 152}}]}
{"idx": 3429, "pair_id": "24794341", "src": "Sleep disturbances (SD) are a frequent finding in patients with asthma and chronic obstructive pulmonary disease (COPD) and have a negative impact on quality of life and the clinical course of the disease. The causes of SD are multiple and include for example respiratory symptoms and comorbidities. On the other hand sleep goes along with multiple physiological changes in respiration, so that sleep itself interacts with asthma and COPD. This interaction favors respiratory symptoms and may lead to hypoxemia and hypercapnia. A further complication of the respiratory situation and the clinical course can be found in asthma and COPD patients with coexisting obstructive sleep apnea syndrome (OSAS). Due to the heterogeneity of SD in asthma and COPD, a detailed patient survey is the most important diagnostical tool. Based on the survey further technical examinations should be considered. Treatment strategies for the reduction of SD in asthma and COPD include an optimized medication and treatment of comorbidities. If indicated oxygen therapy, positive pressure breathing and pulmonary rehabilitation can contribute.", "tgt": "Schlafst\u00f6rungen stellen bei Patienten mit Asthma bronchiale und chronisch obstruktiver Lungenerkrankung (COPD) ein h\u00e4ufiges Problem dar, das sich negativ auf Lebensqualit\u00e4t und Krankheitsverlauf auswirken kann. Als Ursache der Schlafst\u00f6rungen kommen multiple Faktoren wie beispielweise respiratorische Symptome und Komorbidit\u00e4ten in Betracht. Gleichzeitig l\u00e4sst auch Schlaf selber eine Interaktion mit beiden obstruktiven Atemwegserkrankungen erkennen. Sie beg\u00fcnstigt respiratorische Symptome und kann bei fortgeschrittener Erkrankung in schlafbezogenen Hypox\u00e4mien und Hyperkapnien resultieren. Das obstruktive Schlafapnoe-Syndrom ist eine h\u00e4ufige und wichtige Begleiterkrankung bei Asthma und COPD. Es f\u00fchrt zu vermehrten respiratorischen Symptomen bei beiden Erkrankungen und ging in Studien bei der COPD mit einer gesteigerten Mortalit\u00e4t einher. Aufgrund der Heterogenit\u00e4t von Schlafst\u00f6rungen bei Asthma und COPD stellt die Anamnese das wichtigste Instrument zur Abkl\u00e4rung dar und ist gleichzeitig Weichensteller f\u00fcr eine weitere apparative Diagnostik. Therapeutische Ziele zur Reduktion von Schlafst\u00f6rungen sind die optimale medikament\u00f6se Einstellung und die Behandlung relevanter Komorbidit\u00e4ten. Weitere Therapies\u00e4ulen sind bei entsprechender Indikation die Verfahren der Positivdruckatmung, die Sauerstofftherapie und die pneumologische Rehabilitation.", "term_pairs": [{"src": {"text": "Sleep disturbances", "char_start": 0, "char_end": 18, "token_start": 0, "token_end": 2}, "tgt": {"text": "Schlafst\u00f6rungen", "char_start": 0, "char_end": 15, "token_start": 0, "token_end": 1}}, {"src": {"text": "asthma", "char_start": 64, "char_end": 70, "token_start": 12, "token_end": 13}, "tgt": {"text": "Asthma", "char_start": 42, "char_end": 48, "token_start": 5, "token_end": 6}}, {"src": {"text": "chronic obstructive pulmonary disease", "char_start": 75, "char_end": 112, "token_start": 14, "token_end": 18}, "tgt": {"text": "chronisch obstruktiver Lungenerkrankung", "char_start": 64, "char_end": 103, "token_start": 8, "token_end": 11}}, {"src": {"text": "COPD", "char_start": 114, "char_end": 118, "token_start": 19, "token_end": 20}, "tgt": {"text": "COPD", "char_start": 105, "char_end": 109, "token_start": 12, "token_end": 13}}, {"src": {"text": "respiratory symptoms", "char_start": 260, "char_end": 280, "token_start": 48, "token_end": 50}, "tgt": {"text": "respiratorische Symptome", "char_start": 286, "char_end": 310, "token_start": 38, "token_end": 40}}, {"src": {"text": "comorbidities", "char_start": 285, "char_end": 298, "token_start": 51, "token_end": 52}, "tgt": {"text": "Komorbidit\u00e4ten", "char_start": 315, "char_end": 329, "token_start": 41, "token_end": 42}}, {"src": {"text": "hypoxemia", "char_start": 501, "char_end": 510, "token_start": 86, "token_end": 87}, "tgt": {"text": "Hypox\u00e4mien", "char_start": 554, "char_end": 564, "token_start": 69, "token_end": 70}}, {"src": {"text": "hypercapnia", "char_start": 515, "char_end": 526, "token_start": 88, "token_end": 89}, "tgt": {"text": "Hyperkapnien", "char_start": 569, "char_end": 581, "token_start": 71, "token_end": 72}}, {"src": {"text": "obstructive sleep apnea syndrome", "char_start": 661, "char_end": 693, "token_start": 111, "token_end": 115}, "tgt": {"text": "obstruktive Schlafapnoe-Syndrom", "char_start": 599, "char_end": 630, "token_start": 75, "token_end": 79}}, {"src": {"text": "oxygen therapy", "char_start": 1034, "char_end": 1048, "token_start": 174, "token_end": 176}, "tgt": {"text": "Sauerstofftherapie", "char_start": 1301, "char_end": 1319, "token_start": 169, "token_end": 170}}, {"src": {"text": "positive pressure breathing", "char_start": 1050, "char_end": 1077, "token_start": 177, "token_end": 180}, "tgt": {"text": "Positivdruckatmung", "char_start": 1277, "char_end": 1295, "token_start": 166, "token_end": 167}}, {"src": {"text": "pulmonary rehabilitation", "char_start": 1082, "char_end": 1106, "token_start": 181, "token_end": 183}, "tgt": {"text": "pneumologische Rehabilitation", "char_start": 1328, "char_end": 1357, "token_start": 172, "token_end": 174}}]}
{"idx": 3565, "pair_id": "33837442", "src": "Osteoarthritis (OA)-the progressive degeneration of synovial joints-is a\u00a0worldwide problem that affects society, is associated with age and is the dominant reason for pain and immobility of the locomotor system. In the population, 70% of people over the age of 70\u00a0show some signs of OA. Overall, up to 25% of the total population is affected, due to the general aging of the population itself, and this is an increasing tendency. However, in people over the age of 40\u00a0the incidence of OA is already rising due to posttraumatic or secondary forms, like dysplasia, malalignment and other background factors. There is a\u00a0high need for mobility and sports in all generations, so the demands on the joints are high, especially if early degenerative changes are already present. Orthopaedic physicians are challenged with the limited load capacity, pain and the progressive joint problems, on the one hand to get the patient back to full mobility, and, on the other, to prevent early joint replacement. Early diagnosis and preventive measurements, as well as conservative treatments-from medication to braces-are necessary to achieve symptom-free movement and joint preservation to avoid joint replacement.", "tgt": "HINTERGRUND: Arthrose \u2013\u00a0die Degeneration von Gelenken\u00a0\u2013 ist ein weit verbreitetes Problem durch alle Bev\u00f6lkerungsschichten, das im zunehmenden Alter vermehrt auftritt und die h\u00e4ufigste Ursache f\u00fcr mobilit\u00e4tseinschr\u00e4nkende Schmerzen am Bewegungsapparat ist. Etwa 70\u201380\u202f% der \u00fcber 70-J\u00e4hrigen zeigen Zeichen einer Gelenksdegeneration. Insgesamt sind bis zu 25\u202f% der Gesamtbev\u00f6lkerung davon betroffen, aufgrund der generellen Alterung der Bev\u00f6lkerung mit steigender Tendenz. Die Inzidenz der Arthrose steigt aber schon ab dem 40\u00a0Lebensjahr, wobei besonders posttraumatische und sekund\u00e4re Arthroseformen zum Tragen kommen. Der Wunsch nach hoher Mobilit\u00e4t und Sport zieht sich als Ph\u00e4nomen ebenfalls durch alle Altersgruppe. Dies ist mit hohen Gelenkbelastungen verbunden und stellt damit eine gro\u00dfe Herausforderung an vor allem fr\u00fch degenerativ ver\u00e4nderte Gelenksstrukturen dar. In diesem Zusammenhang ist der orthop\u00e4disch t\u00e4tige Arzt gefordert, die Belastbarkeit von gesch\u00e4digten Gelenken abzusch\u00e4tzen und so fr\u00fch wie m\u00f6glich pr\u00e4ventive Schritte sowie gegebenenfalls konservative Therapien einzuleiten, um die Progression der Arthrose zu verhindern und damit den eventuell notwendigen Gelenkersatz m\u00f6glichst weit nach hinten zu schieben.", "term_pairs": [{"src": {"text": "Osteoarthritis (OA)", "char_start": 0, "char_end": 19, "token_start": 0, "token_end": 4}, "tgt": {"text": "Arthrose", "char_start": 13, "char_end": 21, "token_start": 2, "token_end": 3}}, {"src": {"text": "synovial joints", "char_start": 52, "char_end": 67, "token_start": 9, "token_end": 11}, "tgt": {"text": "Gelenken", "char_start": 45, "char_end": 53, "token_start": 7, "token_end": 8}}, {"src": {"text": "locomotor system", "char_start": 194, "char_end": 210, "token_start": 35, "token_end": 37}, "tgt": {"text": "Bewegungsapparat", "char_start": 235, "char_end": 251, "token_start": 32, "token_end": 33}}, {"src": {"text": "posttraumatic", "char_start": 513, "char_end": 526, "token_start": 105, "token_end": 106}, "tgt": {"text": "posttraumatische", "char_start": 554, "char_end": 570, "token_start": 85, "token_end": 86}}, {"src": {"text": "secondary forms", "char_start": 530, "char_end": 545, "token_start": 107, "token_end": 109}, "tgt": {"text": "sekund\u00e4re Arthroseformen", "char_start": 575, "char_end": 599, "token_start": 87, "token_end": 89}}, {"src": {"text": "Orthopaedic physicians", "char_start": 772, "char_end": 794, "token_start": 150, "token_end": 152}, "tgt": {"text": "orthop\u00e4disch t\u00e4tige Arzt", "char_start": 906, "char_end": 930, "token_start": 135, "token_end": 138}}, {"src": {"text": "joint replacement", "char_start": 977, "char_end": 994, "token_start": 189, "token_end": 191}, "tgt": {"text": "Gelenkersatz", "char_start": 1182, "char_end": 1194, "token_start": 171, "token_end": 172}}, {"src": {"text": "Early diagnosis", "char_start": 996, "char_end": 1011, "token_start": 192, "token_end": 194}, "tgt": {"text": "fr\u00fch", "char_start": 824, "char_end": 828, "token_start": 124, "token_end": 125}}, {"src": {"text": "preventive measurements", "char_start": 1016, "char_end": 1039, "token_start": 195, "token_end": 197}, "tgt": {"text": "pr\u00e4ventive Schritte", "char_start": 1023, "char_end": 1042, "token_start": 151, "token_end": 153}}, {"src": {"text": "conservative treatments", "char_start": 1052, "char_end": 1075, "token_start": 201, "token_end": 203}, "tgt": {"text": "konservative Therapien", "char_start": 1064, "char_end": 1086, "token_start": 155, "token_end": 157}}]}
{"idx": 3577, "pair_id": "28718869", "src": "Aim of the study was to examine how discourses of refugees in the media influence the perspective of independent psychotherapists working with refugees. 20 problem-centered interviews were carried out across Germany with independent psychotherapists, and were analyzed using the principles of Grounded Theory. 4 portrayals of refugees were identified: 'The problematic Other' (1), 'No Other' (2), 'The advantageous Other' (3) and 'The excluded subject' (4). The impact of discourses about refugees in the media can contribute to understand the findings in this study. Further explanations for the findings could be the differing access to knowledge about the situation of refugees, difficult living conditions of refugees in Germany and a psychotherapeutic approach focusing mainly on mental disorders.", "tgt": "In den Medien finden sich verschiedene Diskurse von Gefl\u00fcchteten. Bisher ist allerdings kaum bekannt, ob und wie mediale Diskurse die Perspektive von Psychotherapeuten, die mit Gefl\u00fcchteten arbeiten, beeinflussen. In einer Untersuchung zu den Schwierigkeiten in der psychotherapeutischen Arbeit mit Gefl\u00fcchteten wurden bundesweit 20 niedergelassene Psychotherapeuten befragt. F\u00fcr die Datenerhebung wurde das Problemzentrierte Interview gew\u00e4hlt, die Daten wurden entsprechend den Prinzipien der Grounded Theory ausgewertet. Es zeigten sich in den Daten unterschiedliche Bilder von Gefl\u00fcchteten seitens der befragten Psychotherapeuten. Aus den Interviews konnten 4 Bilder von Gefl\u00fcchteten herausgearbeitet werden: \u201aDer problematische Andere\u2018 (1), \u201aKein Anderer\u2018 (2), \u201aDer gewinnbringende Andere\u2018 (3) und \u201aDas ausgeschlossene Subjekt\u2018 (4). Dar\u00fcber hinaus zeigten sich Zusammenh\u00e4nge zwischen den gefundenen Bildern und der Erfahrung sowie dem Therapieverst\u00e4ndnis der jeweiligen Psychotherapeuten. Der Einfluss (medialer) Diskurse \u00fcber Gefl\u00fcchtete kann dazu beitragen, die in den Interviews von niedergelassenen Psychotherapeuten gefundenen Bilder von Gefl\u00fcchteten verst\u00e4ndlich zu machen. Als weitere Erkl\u00e4rungen f\u00fcr die Bilder von Gefl\u00fcchteten werden ein unterschiedlicher Zugang zu Wissen \u00fcber die Lebenssituation von Gefl\u00fcchteten, problematische Lebensbedingungen von Asylsuchenden in Deutschland und ein haupts\u00e4chlich an psychischen St\u00f6rungen ausgerichteter psychotherapeutischer Behandlungsauftrag diskutiert.", "term_pairs": [{"src": {"text": "problem-centered interviews", "char_start": 156, "char_end": 183, "token_start": 25, "token_end": 29}, "tgt": {"text": "Problemzentrierte Interview", "char_start": 408, "char_end": 435, "token_start": 57, "token_end": 59}}, {"src": {"text": "Grounded Theory", "char_start": 293, "char_end": 308, "token_start": 45, "token_end": 47}, "tgt": {"text": "Grounded Theory", "char_start": 494, "char_end": 509, "token_start": 68, "token_end": 70}}, {"src": {"text": "The problematic Other", "char_start": 353, "char_end": 374, "token_start": 56, "token_end": 59}, "tgt": {"text": "Der problematische Andere", "char_start": 713, "char_end": 738, "token_start": 99, "token_end": 102}}, {"src": {"text": "No Other", "char_start": 382, "char_end": 390, "token_start": 65, "token_end": 67}, "tgt": {"text": "Kein Anderer", "char_start": 746, "char_end": 758, "token_start": 108, "token_end": 110}}, {"src": {"text": "The advantageous Other", "char_start": 398, "char_end": 420, "token_start": 73, "token_end": 76}, "tgt": {"text": "Der gewinnbringende Andere", "char_start": 766, "char_end": 792, "token_start": 116, "token_end": 119}}, {"src": {"text": "The excluded subject", "char_start": 431, "char_end": 451, "token_start": 82, "token_end": 85}, "tgt": {"text": "Das ausgeschlossene Subjekt", "char_start": 803, "char_end": 830, "token_start": 125, "token_end": 128}}, {"src": {"text": "mental disorders", "char_start": 785, "char_end": 801, "token_start": 141, "token_end": 143}, "tgt": {"text": "psychischen St\u00f6rungen", "char_start": 1420, "char_end": 1441, "token_start": 209, "token_end": 211}}]}
{"idx": 3609, "pair_id": "32990790", "src": "In spite of the introduction of numerous new antiseizure drugs (ASD) over the last decades, the percentage of drug-resistant epilepsies has remained almost stable. To achieve seizure freedom in such patients with any modified ASD regimen is an exception. Cenobamate (CNB) is a\u00a0new ASD that showed unusually high efficacy in the pivotal placebo controlled, randomized trials. In both studies (C013 and C017), the rate of seizure-free patients was sometimes more than 20% and thus in a\u00a0range never reached over the last decades in comparable trials with other new ASDs. This suggests that CNB which is already approved in the USA might actually offer a\u00a0new and encouraging perspective for epilepsy treatment concerning efficacy. In this review the pharmacological profile, the currently known mode of action, and the results of the clinical trials are summarized.", "tgt": "Trotz der Einf\u00fchrung zahlreicher neuer Antikonvulsiva hat sich der Anteil pharmakoresistenter Epilepsiepatienten in den letzten Jahrzehnten kaum ge\u00e4ndert. Dass solche Patienten durch medikament\u00f6se Schritte gar noch anfallsfrei werden, ist nach wie vor eine Rarit\u00e4t. Cenobamat (CNB) ist ein neues Antikonvulsivum, das in den Zulassungsstudien eine au\u00dfergew\u00f6hnlich hohe Wirksamkeit zeigte. In beiden placebokontrollierten Studien betrug der Anteil anfallsfreier Patienten dosisabh\u00e4ngig teilweise \u00fcber 20\u202f% und lag damit in einem Bereich, der in vergleichbaren Studien in den letzten 20\u00a0Jahren von keinem der dann zugelassenen Antikonvulsiva erreicht wurde. Dies l\u00e4sst hoffen, dass das in den Vereinigten Staaten bereits zugelassene CNB hinsichtlich der Wirksamkeit tats\u00e4chlich eine echte neue Perspektive f\u00fcr die Epilepsiebehandlung bedeuten k\u00f6nnte. In dieser \u00dcbersichtsarbeit werden das pharmakologische Profil, der wahrscheinliche Wirkmechanismus und die wesentlichen Ergebnisse der klinischen Studien vorgestellt.", "term_pairs": [{"src": {"text": "antiseizure drugs (ASD)", "char_start": 45, "char_end": 68, "token_start": 8, "token_end": 13}, "tgt": {"text": "Antikonvulsiva", "char_start": 39, "char_end": 53, "token_start": 5, "token_end": 6}}, {"src": {"text": "drug-resistant epilepsies", "char_start": 110, "char_end": 135, "token_start": 21, "token_end": 25}, "tgt": {"text": "pharmakoresistenter Epilepsiepatienten", "char_start": 74, "char_end": 112, "token_start": 10, "token_end": 12}}, {"src": {"text": "seizure freedom", "char_start": 175, "char_end": 190, "token_start": 32, "token_end": 34}, "tgt": {"text": "anfallsfrei", "char_start": 215, "char_end": 226, "token_start": 27, "token_end": 28}}, {"src": {"text": "Cenobamate (CNB)", "char_start": 255, "char_end": 271, "token_start": 46, "token_end": 50}, "tgt": {"text": "Cenobamat (CNB)", "char_start": 266, "char_end": 281, "token_start": 37, "token_end": 41}}, {"src": {"text": "placebo controlled, randomized trials", "char_start": 336, "char_end": 373, "token_start": 62, "token_end": 67}, "tgt": {"text": "placebokontrollierten Studien", "char_start": 398, "char_end": 427, "token_start": 58, "token_end": 60}}, {"src": {"text": "seizure-free patients", "char_start": 420, "char_end": 441, "token_start": 80, "token_end": 84}, "tgt": {"text": "anfallsfreier Patienten", "char_start": 446, "char_end": 469, "token_start": 63, "token_end": 65}}, {"src": {"text": "epilepsy treatment", "char_start": 687, "char_end": 705, "token_start": 129, "token_end": 131}, "tgt": {"text": "Epilepsiebehandlung", "char_start": 811, "char_end": 830, "token_start": 118, "token_end": 119}}, {"src": {"text": "pharmacological profile", "char_start": 746, "char_end": 769, "token_start": 138, "token_end": 140}, "tgt": {"text": "pharmakologische Profil", "char_start": 886, "char_end": 909, "token_start": 127, "token_end": 129}}, {"src": {"text": "mode of action", "char_start": 791, "char_end": 805, "token_start": 144, "token_end": 147}, "tgt": {"text": "Wirkmechanismus", "char_start": 931, "char_end": 946, "token_start": 132, "token_end": 133}}, {"src": {"text": "clinical trials", "char_start": 830, "char_end": 845, "token_start": 153, "token_end": 155}, "tgt": {"text": "klinischen Studien", "char_start": 983, "char_end": 1001, "token_start": 138, "token_end": 140}}]}
{"idx": 3673, "pair_id": "33011722", "src": "Although acupuncture is effective in the treatment of lumbar disc herniation (LDH), based on comprehensive literature review, reports of the resorption of large herniated discs in LDH patients treated merely by acupuncture are very rare. A 49-year-old patient presented with distending pain in the left lower limb and numbness on the dorsum of the left foot. Physical examination revealed positive signs associated with mechanical compression by herniated lumbar discs. Magnetic resonance imaging (MRI) at symptom onset confirmed the diagnosis of LDH at L4-L5 and L5-S1. Electroacupuncture was administered on local acupoints combined with distal acupoints. His clinical symptoms gradually improved with time throughout acupuncture treatment, verified by increased Japanese Orthopaedic Association scores. The patient was discharged after a total of 20 acupuncture sessions within 1 month. Follow-up indicated that his symptoms had disappeared completely at 1.5 months after discharge and had not recurred since then. At the 10-month follow-up, MRI re-examination confirmed that the herniated discs had been resorbed significantly. Electroacupuncture could significantly improve clinical symptoms and might promote the spontaneous resorption of herniated discs in LDH patients. Thus, for LDH patients suitable for conservative treatment, electroacupuncture could be a favourable option recommended to patients.", "tgt": "Hintergrund: Zwar hat sich die Akupunktur bei der Behandlung der lumbalen Diskushernie (LDH) als wirksam erwiesen, doch gibt es nur sehr wenige Berichte \u00fcber die Resorption von gro\u00dfen Diskushernien bei LDH-Patienten, die allein mit Akupunktur behandelt wurden. Fallbericht:Ein 49-j\u00e4hriger Patient stellte sich mit ausstrahlenden Schmerzen im linken Unterschenkel und Taubheitsgef\u00fchl am linken Fu\u00dfr\u00fccken vor. Die k\u00f6rperliche Untersuchung ergab positive Zeichen im Zusammenhang mit mechanischer Kompression aufgrund lumbaler Diskushernien. Die zu Beginn der Symptome durchgef\u00fchrte Magnetresonanztomographie (MRT) best\u00e4tigte die Diagnose einer LDH auf H\u00f6he L4-L5 sowie L5-S1. Es erfolgte eine Elektroakupunktur an den lokalen Akupunkturpunkten in Kombination mit distalen Akupunkturpunkten. Unter der Akupunkturbehandlung besserten sich die klinischen Symptome, was durch h\u00f6here Werte des Japanese Orthopaedic Association Scores best\u00e4tigt wurde. Nach insgesamt 20 Akupunktursitzungen innerhalb eines Monats wurde der Patient entlassen. Die Nachuntersuchungen zeigten, dass seine Symptome eineinhalb Monate nach der Entlassung vollst\u00e4ndig verschwunden und danach nicht wieder aufgetreten waren. Bei der Follow-Up-Untersuchung nach 10 Monaten wurde ein erneutes MRT durchgef\u00fchrt, welches best\u00e4tigte, dass es zu einer deutlichen Resorption der Diskushernien gekommen war. Schlussfolgerung:Die Elektroakupunktur kann die klinischen Symptome von LDH-Patienten signifikant verbessern und die Spontanresorption von Diskushernien f\u00f6rdern. F\u00fcr LDH-Patienten, die sich f\u00fcr eine konservative Therapie eignen, kann die Elektroakupunktur daher eine g\u00fcnstige therapeutische Option sein, die den Patienten empfohlen wird.", "term_pairs": [{"src": {"text": "acupuncture", "char_start": 9, "char_end": 20, "token_start": 1, "token_end": 2}, "tgt": {"text": "Akupunktur", "char_start": 31, "char_end": 41, "token_start": 6, "token_end": 7}}, {"src": {"text": "lumbar disc herniation", "char_start": 54, "char_end": 76, "token_start": 8, "token_end": 11}, "tgt": {"text": "lumbalen Diskushernie", "char_start": 65, "char_end": 86, "token_start": 11, "token_end": 13}}, {"src": {"text": "LDH", "char_start": 78, "char_end": 81, "token_start": 12, "token_end": 13}, "tgt": {"text": "LDH", "char_start": 88, "char_end": 91, "token_start": 14, "token_end": 15}}, {"src": {"text": "resorption", "char_start": 141, "char_end": 151, "token_start": 24, "token_end": 25}, "tgt": {"text": "Resorption", "char_start": 162, "char_end": 172, "token_start": 29, "token_end": 30}}, {"src": {"text": "herniated discs", "char_start": 161, "char_end": 176, "token_start": 27, "token_end": 29}, "tgt": {"text": "Diskushernien", "char_start": 184, "char_end": 197, "token_start": 32, "token_end": 33}}, {"src": {"text": "Magnetic resonance imaging", "char_start": 470, "char_end": 496, "token_start": 80, "token_end": 83}, "tgt": {"text": "Magnetresonanztomographie", "char_start": 579, "char_end": 604, "token_start": 88, "token_end": 89}}, {"src": {"text": "MRI", "char_start": 498, "char_end": 501, "token_start": 84, "token_end": 85}, "tgt": {"text": "MRT", "char_start": 606, "char_end": 609, "token_start": 90, "token_end": 91}}, {"src": {"text": "L4-L5", "char_start": 554, "char_end": 559, "token_start": 95, "token_end": 98}, "tgt": {"text": "L4-L5", "char_start": 654, "char_end": 659, "token_start": 99, "token_end": 102}}, {"src": {"text": "L5-S1", "char_start": 564, "char_end": 569, "token_start": 99, "token_end": 102}, "tgt": {"text": "L5-S1", "char_start": 666, "char_end": 671, "token_start": 103, "token_end": 106}}, {"src": {"text": "Electroacupuncture", "char_start": 571, "char_end": 589, "token_start": 103, "token_end": 104}, "tgt": {"text": "Elektroakupunktur", "char_start": 690, "char_end": 707, "token_start": 110, "token_end": 111}}, {"src": {"text": "acupoints", "char_start": 616, "char_end": 625, "token_start": 108, "token_end": 109}, "tgt": {"text": "Akupunkturpunkten", "char_start": 723, "char_end": 740, "token_start": 114, "token_end": 115}}, {"src": {"text": "Japanese Orthopaedic Association scores", "char_start": 765, "char_end": 804, "token_start": 128, "token_end": 132}, "tgt": {"text": "Japanese Orthopaedic Association Scores", "char_start": 886, "char_end": 925, "token_start": 135, "token_end": 139}}, {"src": {"text": "conservative treatment", "char_start": 1314, "char_end": 1336, "token_start": 221, "token_end": 223}, "tgt": {"text": "konservative Therapie", "char_start": 1565, "char_end": 1586, "token_start": 235, "token_end": 237}}]}
{"idx": 3888, "pair_id": "34414467", "src": "The objective of kinematic alignment in total knee arthroplasty is to implant the prosthesis according to the individual joint line, leg axis and ligament tension. Knee osteoarthritis with failure of nonsurgical treatment according to current guidelines. Severe deformity or instability requiring a\u00a0constrained knee prosthesis. Necessity of intramedullary stems. Medial parapatellar approach to the knee. Resection of the cruciate ligaments, the meniscus and the osteophytes. Femur-first technique with distal resection of the femur, the intramedullary guide is only used for the extension/flexion positioning of the femoral component. The positioning in varus-valgus is orientated according to the native joint line after correction of chondral wear. The distal resection should be equal to the thickness of the prosthesis considering the chondral wear (up to 2\u202fmm) and the thickness of the saw blade (1\u202fmm). The rotation of the femoral component is set according to the posterior condylar axis under consideration of chondral wear. The amount of resected dorsal bone should correspond to the thickness of the dorsal condyles of the prosthesis. The alignment of the tibia is parallel to the individual joint line. This enables reconstruction of the individual physiological slope, rotation and the varus-valgus axis. Extension and flexion gap are controlled. Asymmetries between the lateral and medial joint space are corrected through a\u00a0varus or valgus recut of the tibia as long as the surgical planning has not been achieved. The hip-knee angle is controlled; however, the aim in kinematic alignment is to reconstruct the individual axes and ligament tensions and not a\u00a0straight leg axis. Persisting asymmetries in ligament tension are adjusted by classical soft tissue balancing techniques. Differences between the extension and flexion spaces are corrected by adapting the tibial slope. Release of the ligaments is usually not necessary; sometimes a\u00a0stripping of the dorsal capsule is performed. After the trial implantation, the original prosthesis is implanted. Functional rehabilitation with weight bearing as tolerated. Randomized studies showed a\u00a0better function in the Knee Society Score and a\u00a0better range of motion with kinematically aligned prostheses compared to mechanical alignment. Available meta-analyses also showed better results for kinematically aligned knees. The first mid-term results of this new technique with a\u00a0follow-up of 10\u00a0years show a\u00a0survival rate of 97.5% of the prosthesis.", "tgt": "OPERATIONSZIEL: Ziel des kinematischen Alignment in der Knietotalendoprothetik ist es, die Prothese entsprechend der individuellen Gelenklinie, Beinachse und Bandspannung zu implantieren. Fortgeschrittene Pangonarthrose nach Versagen der konservativen Ma\u00dfnahmen entsprechend der geltenden Leitlinie. Schwere Achsabweichungen bzw. Instabilit\u00e4t, welche die Versorgung mit einer (teil)gekoppelten Knietotalendoprothese erforderlich machen. Notwendigkeit f\u00fcr eine intramedull\u00e4re Schaftverankerung. Medialer parapatellarer Zugang zum Kniegelenk. Entfernung der Kreuzb\u00e4nder, der Menisken und s\u00e4mtlicher Osteophyten. Femur-first-Vorgehen mit distaler Femurresektion, die intramedull\u00e4re Ausrichtung dient nur zur Festlegung des Extension-Flexion-Winkels der Femurkomponente. Die Ausrichtung des Varus-Valgus-Winkels orientiert sich an der urspr\u00fcnglichen Gelenklinie mit Korrektur des Knorpelabriebs. Die distale Resektion sollte der Dicke der Prothese unter Ber\u00fccksichtigung des Knorpelabriebs (bis zu 2\u00a0mm) und der Dicke des S\u00e4geblatts (1\u00a0mm) entsprechen. Die Rotation der Femurkomponente wird entsprechend der posterioren Kondylenachse unter Ber\u00fccksichtigung eines m\u00f6glichen Knorpelabriebs eingestellt. Das Ma\u00df des resezierten dorsalen Knochens sollte ebenfalls der Dicke der dorsalen Prothesenkondylen entsprechen. Die Ausrichtung der Tibia erfolgt parallel zur individuellen Gelenklinie, unter Rekonstruktion des individuellen physiologischen Slope, der Rotation und der Varus-Valgus-Achse. Anschlie\u00dfend werden der Streck- und der Beugespalt kontrolliert. Asymmetrien zwischen dem lateralen und medialen Gelenkspalt werden durch einen Varus- oder Valgusr\u00fcckschnitt der Tibia korrigiert, sofern die Gelenklinie nicht exakt der pr\u00e4operativen Planung entspricht. Der H\u00fcft-Knie-Winkel wird kontrolliert, allerdings ist das Ziel bei der kinematischen Ausrichtung die Rekonstruktion der einzelnen Achsen und Bandspannungen und nicht eine gerade Beinachse. Fortbestehende Asymmetrien in der Bandspannung werden durch klassische Weichteilausgleichstechniken korrigiert, Differenzen zwischen Streck- und Beugespalt durch eine Anpassung des tibialen Slope. Ein Release der Ligamente ist in der Regel nicht erforderlich, gelegentlich muss die dorsale Kapsel etwas gel\u00f6st werden. Im Anschluss an die Probeeinsetzung erfolgt die Prothesenimplantation. Mobilisation ab dem Operationstag unter Vollbelastung und unter freier Beweglichkeit. Randomisierte Studien haben f\u00fcr die kinematische im Vergleich zur mechanischen Ausrichtung g\u00fcnstigere Ergebnisse im funktionellen Bereich des Knee-Society-Scores und einen h\u00f6heren Bewegungsumfang nachgewiesen. Verf\u00fcgbare Metaanalysen haben bessere Ergebnisse nach kinematischer Ausrichtung ergeben. Erste Zwischenergebnisse zu dieser neuen Technik mit einem Follow-up von 10 Jahren zeigen eine Prothesen\u00fcberlebensrate von 97,5\u202f%.", "term_pairs": []}
{"idx": 4026, "pair_id": "32851632", "src": "Patient safety is a major challenge and has high priority in the inpatient care. Notably, drug therapy is considered critical after surgery. The medication process is particularly difficult and problematic in newborns and children. \u2002In a retrospective analysis, hospital-internal spontaneous reports on Drug-related Problems (DRP) from a children's hospital were analysed, which were reported between 2000 and 2014. 229 spontaneous reports on DRP were considered for analysis. 72.5% of these were due to a Medication Error. Nearly half of the DRP occurred during drug dispensing (44.5%), followed by problems during administration (38.0%) and prescribing (11.4%). 61.4% of Medication Errors were dispensing errors (esp. confusion of patients, wrong dose). Almost all Other Incidents happened during drug administration (mainly extravasations). 40.6% of DRP reports were associated with clinically relevant patient harm and occurred particularly during drug administration. These results show that drug therapy in paediatrics is a complex and hazardous process. The system of hospital-internal spontaneous reports has led to regular training and raising awareness of the employees for critical situations. In addition, it fosters a safety culture to report mistakes. Spontaneous reporting is suitable for increasing the safety of drug therapy in paediatrics.", "tgt": "Die Patientensicherheit ist eine gro\u00dfe Herausforderung und hat hohe Priorit\u00e4t in der station\u00e4ren Behandlung von Patienten. Neben chirurgischen Eingriffen gilt v.\u2009a. die Arzneimitteltherapie als kritisch. Dabei ist der Medikationsprozess bei Neugeborenen und Kindern besonders diffizil und problematisch. In einer retrospektiven Analyse wurden klinikinterne Spontanberichte zu Arzneimitteltherapiebezogenen Problemen (ATBP) einer Kinder- und Jugendklinik analysiert, die in den Jahren 2000\u20132014 gemeldet wurden. 229 Spontanmeldungen zu ATBP wurden f\u00fcr die Analyse ber\u00fccksichtigt. 72,5% dieser erfolgten aufgrund eines Medikationsfehlers. Knapp die H\u00e4lfte der ATBP ereignete sich w\u00e4hrend der Abgabe von Arzneimitteln (44,5%), gefolgt von Problemen bei der Anwendung (38,0%) und der Verordnung (11,4%). Medikationsfehler waren zu 61,4% Abgabefehler (v.\u2009a. Verwechslung von Patienten, fehlerhafte Dosis), sonstige Ereignisse wurden nahezu vollst\u00e4ndig der Arzneimittelanwendung zugeordnet (v.\u2009a. Paravasate). 40,6% der ATBP waren mit einem klinisch relevanten Patientenschaden verbunden und traten prim\u00e4r w\u00e4hrend der Arzneimittelanwendung auf. Die Ergebnisse zeigen, dass die Arzneimitteltherapie in der P\u00e4diatrie ein komplexer und riskanter Prozess ist. Das System der klinikinternen Spontanmeldungen f\u00fchrte zu regelm\u00e4\u00dfigen Schulungen und zur Sensibilisierung der Mitarbeiter f\u00fcr kritische Situationen. Zudem f\u00f6rdert es eine Kultur der Sicherheit, Fehler offen zu berichten. Spontanmeldungen sind geeignet die Arzneimitteltherapie in der P\u00e4diatrie sicherer zu machen.", "term_pairs": []}
{"idx": 4130, "pair_id": "34529128", "src": "Emergency departments and emergency services are increasingly burdened by non-emergency patients. A\u00a0substantial proportion of these is represented by older people. The project 'community emergency paramedic' ('Gemeindenotfallsanit\u00e4ter' [G-NFS]) was initiated to prevent unnecessary use of emergency services. To identify specific utilizations of the G\u2011NFS services by older people at home and in nursing homes. Retrospective analysis of the assignment protocols from July 2019 through June 2020. Only data from patients aged \u2265\u202f65\u00a0years were included. Data were grouped into whether patients lived on their own or in nursing homes. A\u00a0total of 2358 protocols of older patients (mean age 80.8\u00a0years; 52.9% female) were evaluated and 55% of patients were treated on-site. The most frequently used measures by G\u2011NFS were counselling (79.4%), aid in self-medication (16.7%) and administration of medication (23.2%). Of the G\u2011NFS assignments 329 (14.0%) were carried out for nursing home residents. Measures related to urine catheter complications were more frequently performed in nursing home residents than in patients who lived at home (32.2% vs. 5.7%). Compared to other emergency cases, patients with catheter-related complications were most often treated at the scene (84.3% vs. 52.2%). The G\u2011NFS enabled the majority of patients to be treated on-site, thus saving resources of emergency services and hospitals; however, the G\u2011NFS also performed measures that were normally the responsibility of general practitioners. This possibly highlights structural deficits in the medical and nursing care of older people.", "tgt": "HINTERGRUND: Notaufnahmen und Rettungsdienste werden zunehmend durch nicht vital bedrohlich erkrankte Patienten belastet. Ein gro\u00dfer Anteil der Rettungsdiensteins\u00e4tze entf\u00e4llt auf \u00e4ltere Menschen. Um eine unn\u00f6tige Disponierung h\u00f6herwertiger Rettungsmittel zu reduzieren, wurde das Modellprojekt Gemeindenotfallsanit\u00e4ter (G-NFS) entwickelt. Ziel dieser Arbeit war es herauszufinden, ob sich spezifische Einsatzschwerpunkte des G\u2011NFS in der Versorgung \u00e4lterer Menschen in h\u00e4uslicher Umgebung und im Pflegeheim zeigen. Es handelt sich um eine retrospektive Beobachtungsstudie auf Basis der Einsatzdokumentation vom 01.07.2019 bis zum 30.06.2020. Es wurden G\u2011NFS Eins\u00e4tze bei \u00e4lteren Menschen (\u2265\u202f65\u00a0Jahre) analysiert, unterteilt nach den Einsatzorten Pflegeheim oder H\u00e4uslichkeit. Es wurden 2358\u00a0Protokolle ausgewertet (Durchschnittsalter: 80,8\u00a0Jahre; 52,9\u202f% weiblich). Vor Ort wurden 55\u202f% der Patienten versorgt. Die durchgef\u00fchrten Ma\u00dfnahmen umfassten Beratungsgespr\u00e4che (79,4\u202f%), Hilfe bei Selbstmedikation (16,7\u202f%) und Medikamentengabe (23,2\u202f%). Auf Pflegeheimbewohner entfielen 329 (14,0\u202f%) Eins\u00e4tze. Ma\u00dfnahmen in Bezug auf Urindauerkatheter wurden h\u00e4ufiger bei Pflegeheimbewohnern als in der H\u00e4uslichkeit durchgef\u00fchrt (32,2\u202f% bzw. 5,7\u202f% aller Eins\u00e4tze). Bei Patienten mit Katheterproblemen erfolgte im Vergleich zu anderen Eins\u00e4tzen nahezu immer eine Versorgung vor Ort (84,3\u202f% bzw. 52,2\u202f%). Durch G\u2011NFS k\u00f6nnen die Mehrzahl der \u00e4lteren Patienten ambulant versorgt und andere Ressourcen entlastet werden. Allerdings f\u00fchren G\u2011NFS auch Ma\u00dfnahmen durch, die im Verantwortungsbereich der haus\u00e4rztlichen Versorgung liegen, und gleichen somit strukturelle Defizite in der medizinisch-pflegerischen Versorgung aus.", "term_pairs": [{"src": {"text": "Emergency departments", "char_start": 0, "char_end": 21, "token_start": 0, "token_end": 2}, "tgt": {"text": "Notaufnahmen", "char_start": 13, "char_end": 25, "token_start": 2, "token_end": 3}}, {"src": {"text": "emergency services", "char_start": 26, "char_end": 44, "token_start": 3, "token_end": 5}, "tgt": {"text": "Rettungsdienste", "char_start": 30, "char_end": 45, "token_start": 4, "token_end": 5}}, {"src": {"text": "non-emergency patients", "char_start": 74, "char_end": 96, "token_start": 9, "token_end": 13}, "tgt": {"text": "nicht vital bedrohlich erkrankte Patienten", "char_start": 69, "char_end": 111, "token_start": 8, "token_end": 13}}, {"src": {"text": "older people", "char_start": 150, "char_end": 162, "token_start": 22, "token_end": 24}, "tgt": {"text": "\u00e4ltere Menschen", "char_start": 180, "char_end": 195, "token_start": 22, "token_end": 24}}, {"src": {"text": "community emergency paramedic", "char_start": 177, "char_end": 206, "token_start": 28, "token_end": 31}, "tgt": {"text": "Gemeindenotfallsanit\u00e4ter", "char_start": 295, "char_end": 319, "token_start": 37, "token_end": 38}}, {"src": {"text": "G-NFS", "char_start": 237, "char_end": 242, "token_start": 37, "token_end": 40}, "tgt": {"text": "G-NFS", "char_start": 321, "char_end": 326, "token_start": 39, "token_end": 42}}, {"src": {"text": "nursing homes", "char_start": 396, "char_end": 409, "token_start": 69, "token_end": 71}, "tgt": {"text": "Pflegeheim", "char_start": 497, "char_end": 507, "token_start": 70, "token_end": 71}}, {"src": {"text": "Retrospective analysis", "char_start": 411, "char_end": 433, "token_start": 72, "token_end": 74}, "tgt": {"text": "retrospektive Beobachtungsstudie", "char_start": 540, "char_end": 572, "token_start": 78, "token_end": 80}}, {"src": {"text": "patients aged \u2265 65 years", "char_start": 511, "char_end": 535, "token_start": 88, "token_end": 93}, "tgt": {"text": "\u00e4lteren Menschen (\u2265 65 Jahre)", "char_start": 672, "char_end": 701, "token_start": 105, "token_end": 112}}, {"src": {"text": "counselling", "char_start": 816, "char_end": 827, "token_start": 156, "token_end": 157}, "tgt": {"text": "Beratungsgespr\u00e4che", "char_start": 949, "char_end": 967, "token_start": 155, "token_end": 156}}, {"src": {"text": "self-medication", "char_start": 844, "char_end": 859, "token_start": 166, "token_end": 169}, "tgt": {"text": "Selbstmedikation", "char_start": 988, "char_end": 1004, "token_start": 165, "token_end": 166}}, {"src": {"text": "administration of medication", "char_start": 872, "char_end": 900, "token_start": 176, "token_end": 179}, "tgt": {"text": "Medikamentengabe", "char_start": 1018, "char_end": 1034, "token_start": 173, "token_end": 174}}, {"src": {"text": "nursing home residents", "char_start": 968, "char_end": 990, "token_start": 203, "token_end": 206}, "tgt": {"text": "Pflegeheimbewohner", "char_start": 1049, "char_end": 1067, "token_start": 182, "token_end": 183}}, {"src": {"text": "urine catheter complications", "char_start": 1012, "char_end": 1040, "token_start": 210, "token_end": 213}, "tgt": {"text": "Urindauerkatheter", "char_start": 1124, "char_end": 1141, "token_start": 197, "token_end": 198}}, {"src": {"text": "catheter-related complications", "char_start": 1200, "char_end": 1230, "token_start": 249, "token_end": 253}, "tgt": {"text": "Katheterproblemen", "char_start": 1273, "char_end": 1290, "token_start": 225, "token_end": 226}}, {"src": {"text": "general practitioners", "char_start": 1496, "char_end": 1517, "token_start": 313, "token_end": 315}, "tgt": {"text": "haus\u00e4rztlichen Versorgung", "char_start": 1584, "char_end": 1609, "token_start": 282, "token_end": 284}}]}
{"idx": 4236, "pair_id": "31995816", "src": "Congenital corrected transposition of the great arteries (ccTGA) is a rare congenital cardiac anomaly which remains difficult to diagnose prenatally. We aim to investigate the natural history, associated anomalies and the outcome of patients in prenatally diagnosed ccTGA. \u2002This was an international multicenter retrospective analysis of fetuses with a diagnosis of ccTGA from 2002 to 2017. We reviewed clinical and echocardiographic databases of seven centers. Anatomic survey and fetal echocardiography were performed according to international guidelines of ISUOG. \u2002We considered 69 fetuses with prenatally suspected ccTGA. There was an overall survival rate of 91\u200a% among 54\u00a0patients with a confirmed diagnosis. Survival to live birth was 96\u200a% (52/54) and survival on an intention-to-treat basis was 94\u200a% (49/52). The mean gestational age at the time of diagnosis was 25.6\u200a\u00b1\u200a5.9 weeks of gestation. In 7 out of 54\u00a0fetuses (13\u200a%), ccTGA was an isolated finding. Dextro/mesocardia was present in 15 cases (27.8\u200a%). Intracardiac anomalies were present in 46/54 cases (85.2\u200a%) with the most frequent anomaly being a ventricular septal defect present in 41 fetuses (75.9\u200a%). Complete heart block was diagnosed in 10 cases (18.5\u200a%). Extracardiac anomalies were observed in 9 out of 54 cases (16.7\u200a%). Prenatal karyotyping of the fetus was available in 30/54 (55.6\u200a%) cases with chromosomal anomalies in 4/30 (13.3\u200a%). \u2002ccTGA is a rare cardiac anomaly often accompanied by a variable spectrum of further intracardiac abnormalities. Accurate diagnosis of ccTGA, which can be integrated into parental counselling, is feasible with a favorable short-term outcome for affected neonates.", "tgt": "ZIEL: \u2002Die kongenitale korrigierte Transposition der gro\u00dfen Arterien (cc-TGA) ist ein seltener angeborener Herzfehler, der pr\u00e4natal immer noch schwer zu diagnostizieren ist. Unser Ziel ist die Untersuchung des Krankheitsverlaufs, die damit verbundenen Anomalien und das Outcome von Patienten mit pr\u00e4natal diagnostizierter cc-TGA. \u2002Internationale multizentrische retrospektive Analyse von F\u00f6ten mit Diagnose einer cc-TGA von 2002 bis 2017. Wir haben klinische und echokardiografische Datenbanken von 7 Zentren \u00fcberpr\u00fcft. Die anatomische Untersuchung und die fetale Echokardiografie wurden nach den internationalen Richtlinien der ISUOG durchgef\u00fchrt. \u2002Wir untersuchten 69 F\u00f6ten mit pr\u00e4natalem Verdacht auf cc-TGA. Die Gesamt\u00fcberlebensrate von 54 Patienten mit best\u00e4tigter Diagnose betrug 91\u200a%. Das \u00dcberleben bis zur Lebendgeburt betrug 96\u200a% (52/54) und das \u00dcberleben auf Intention-to-treat-Basis 94\u200a% (49/52). Das mittlere Gestationsalter zum Zeitpunkt der Diagnose betrug 25,6\u200a\u00b1\u200a5,9 Wochen. Bei 7 von 54 F\u00f6ten (13\u200a%) war die cc-TGA ein isolierter Befund. Dextro-/Mesokardie trat in 15 F\u00e4llen auf (27,8\u200a%). Intrakardiale Anomalien waren in 46/54 F\u00e4llen (85,2\u200a%) vorhanden, wobei die h\u00e4ufigste Anomalie ein ventrikul\u00e4rer Septumdefekt bei 41 F\u00f6ten (75,9\u200a%) war. In 10 F\u00e4llen wurde ein kompletter Herzblock diagnostiziert (18,5\u200a%). Extrakardiale Anomalien wurden in 9 von 54 F\u00e4llen (16,7\u200a%) beobachtet. Bei 30/54 (55,6\u200a%) F\u00f6ten wurde eine pr\u00e4natale Karyotypisierung durchgef\u00fchrt und ergab chromosomale Anomalien bei 4/30 (13,3\u200a%). \u2002cc-TGA ist ein seltener Herzfehler, der oft von einem variablen Spektrum weiterer intrakardialer Anomalien begleitet wird. In Hinblick auf cc-TGA ist eine treffsichere Diagnose, die in die Aufkl\u00e4rung der Eltern aufgenommen werden kann, mit einem g\u00fcnstigen Kurzzeit-Outcome f\u00fcr die betroffenen Neugeborenen m\u00f6glich.", "term_pairs": []}
{"idx": 4242, "pair_id": "26157194", "src": "In this guideline, recommendations and standards for optimum diagnosis and treatment of endometriosis are presented. They are based on the analysis of the available scientific evidence as published in prospective randomized and retrospective studies as well as in systematic reviews. The guideline working group consisted of experts from Austria, Germany, Switzerland, and the Czech Republic.", "tgt": "Mit dieser Leitlinie werden Empfehlungen und Standards f\u00fcr eine optimale Diagnostik und Therapie der Endometriose vorgestellt. Sie basieren auf einer Analyse prospektiv-randomisierter und retrospektiver Studien sowie systematischer \u00dcbersichten. Die Arbeitsgruppe bestand aus Experten aus Deutschland, \u00d6sterreich, der Schweiz und Tschechien.", "term_pairs": [{"src": {"text": "endometriosis", "char_start": 88, "char_end": 101, "token_start": 13, "token_end": 14}, "tgt": {"text": "Endometriose", "char_start": 101, "char_end": 113, "token_start": 14, "token_end": 15}}, {"src": {"text": "diagnosis", "char_start": 61, "char_end": 70, "token_start": 9, "token_end": 10}, "tgt": {"text": "Diagnostik", "char_start": 73, "char_end": 83, "token_start": 10, "token_end": 11}}, {"src": {"text": "treatment", "char_start": 75, "char_end": 84, "token_start": 11, "token_end": 12}, "tgt": {"text": "Therapie", "char_start": 88, "char_end": 96, "token_start": 12, "token_end": 13}}, {"src": {"text": "prospective randomized", "char_start": 201, "char_end": 223, "token_start": 31, "token_end": 33}, "tgt": {"text": "prospektiv-randomisierter", "char_start": 158, "char_end": 183, "token_start": 22, "token_end": 25}}, {"src": {"text": "retrospective studies", "char_start": 228, "char_end": 249, "token_start": 34, "token_end": 36}, "tgt": {"text": "retrospektiver Studien", "char_start": 188, "char_end": 210, "token_start": 26, "token_end": 28}}, {"src": {"text": "systematic reviews", "char_start": 264, "char_end": 282, "token_start": 40, "token_end": 42}, "tgt": {"text": "systematischer \u00dcbersichten", "char_start": 217, "char_end": 243, "token_start": 29, "token_end": 31}}, {"src": {"text": "Austria", "char_start": 338, "char_end": 345, "token_start": 51, "token_end": 52}, "tgt": {"text": "\u00d6sterreich", "char_start": 301, "char_end": 311, "token_start": 40, "token_end": 41}}, {"src": {"text": "Germany", "char_start": 347, "char_end": 354, "token_start": 53, "token_end": 54}, "tgt": {"text": "Deutschland", "char_start": 288, "char_end": 299, "token_start": 38, "token_end": 39}}, {"src": {"text": "Switzerland", "char_start": 356, "char_end": 367, "token_start": 55, "token_end": 56}, "tgt": {"text": "Schweiz", "char_start": 317, "char_end": 324, "token_start": 43, "token_end": 44}}, {"src": {"text": "Czech Republic", "char_start": 377, "char_end": 391, "token_start": 59, "token_end": 61}, "tgt": {"text": "Tschechien", "char_start": 329, "char_end": 339, "token_start": 45, "token_end": 46}}]}
{"idx": 4315, "pair_id": "32514605", "src": "Since emergence of the new coronavirus in China in December 2019, many countries have been struggling to control skyrocketing numbers of infections, including among healthcare personnel. It has now been clearly demonstrated that SARS-CoV\u20112 resides in the upper airways and transmits easily via aerosols and droplets, which significantly increases the risk of infection when performing upper airway procedures. Ventilated COVID-19 patients in a\u00a0critical condition in the intensive care unit may require tracheotomy for long-term ventilation and to improve weaning. However, the risk of secondary infection of medical personnel performing subsequent tracheostomy care remains unclear. This study aimed to evaluate the risk of droplet dispersion during tracheostomy tube change and overview tracheostomy tube change in COVID-19 patients. The current literature was reviewed, quantitative and qualitative analyses of droplet formation during tracheostomy tube change in n\u202f=\u20098\u00a0patients were performed, and an overview of and checklist for tracheostomy tube change were compiled. This study demonstrates that tracheostomy tube change, in particular insertion of the new tube, may cause significant droplet formation. The aerosolization of particles smaller than 5\u202f\u00b5m was not analyzed. Our data, together with the current literature, clearly emphasize that tracheostomy care is associated with a\u00a0high infection risk and should only be performed by a\u00a0small group of well-trained, maximally protected healthcare personnel.", "tgt": "HINTERGRUND: Seit dem Auftreten des neuen Coronavirus im Dezember 2019 in China haben viele L\u00e4nder Schwierigkeiten, die ansteigende Zahl der Infektionen, auch innerhalb des medizinischen Personals, zu kontrollieren. Es hat sich mittlerweile deutlich gezeigt, dass das neue SARS-CoV-2-Virus insbesondere \u00fcber Aerosole und Tr\u00f6pfchen der oberen Atemwege \u00fcbertragen wird und die Infektionsgefahr bei oberen Atemwegsprozeduren deutlich erh\u00f6ht ist. Ein Anteil der schwererkrankten beatmungspflichtigen Patienten ben\u00f6tigt ab einem gewissen Zeitpunkt eine Tracheotomie zur langfristigen Beatmung und einfacheren Entw\u00f6hnung von der Beatmungsmaschine. Diese Patienten erfordern jedoch im Anschluss eine nicht unerhebliche Betreuung durch medizinisches Pflegepersonal, und es ist bislang unklar, inwieweit die Tracheostomapflege ein Risiko f\u00fcr sekund\u00e4re Infektionen darstellt. Evaluierung der Gefahr der Tr\u00f6pfchenbildung bei Trachealkan\u00fclenwechsel, \u00dcberblick zum Kan\u00fclenwechsel bei COVID-19-Patienten. Literaturrecherche, quantitative und qualitative Analyse der Tr\u00f6pfchenfreisetzung bei Kan\u00fclenwechsel an n\u202f=\u20098\u00a0Patienten, \u00dcbersicht und Checkliste f\u00fcr Kan\u00fclenwechsel. Diese Studie demonstriert, dass beim Kan\u00fclenwechsel, insbesondere bei Einf\u00fchren der neuen Kan\u00fcle, eine nicht unbetr\u00e4chtliche Menge an Tr\u00f6pfchen entstehen kann. Eine Aerosolbildung von Partikeln kleiner als 5\u202f\u00b5m wurde nicht untersucht. Unsere Ergebnisse im Zusammenhang mit der aktuellen Literatur verdeutlichen, dass die Pflege nach Tracheotomie eine hoch risikoreiche Prozedur darstellt und nur von einer kleinen Gruppe von geschultem und gut gesch\u00fctztem Personal durchgef\u00fchrt werden sollte.", "term_pairs": [{"src": {"text": "coronavirus", "char_start": 27, "char_end": 38, "token_start": 5, "token_end": 6}, "tgt": {"text": "Coronavirus", "char_start": 42, "char_end": 53, "token_start": 7, "token_end": 8}}, {"src": {"text": "SARS-CoV\u20112", "char_start": 229, "char_end": 239, "token_start": 36, "token_end": 41}, "tgt": {"text": "SARS-CoV-2-Virus", "char_start": 273, "char_end": 289, "token_start": 43, "token_end": 50}}, {"src": {"text": "upper airways", "char_start": 255, "char_end": 268, "token_start": 44, "token_end": 46}, "tgt": {"text": "oberen Atemwege", "char_start": 335, "char_end": 350, "token_start": 56, "token_end": 58}}, {"src": {"text": "aerosols", "char_start": 294, "char_end": 302, "token_start": 50, "token_end": 51}, "tgt": {"text": "Aerosole", "char_start": 308, "char_end": 316, "token_start": 52, "token_end": 53}}, {"src": {"text": "droplets", "char_start": 307, "char_end": 315, "token_start": 52, "token_end": 53}, "tgt": {"text": "Tr\u00f6pfchen", "char_start": 321, "char_end": 330, "token_start": 54, "token_end": 55}}, {"src": {"text": "upper airway procedures", "char_start": 385, "char_end": 408, "token_start": 63, "token_end": 66}, "tgt": {"text": "oberen Atemwegsprozeduren", "char_start": 396, "char_end": 421, "token_start": 64, "token_end": 66}}, {"src": {"text": "COVID-19", "char_start": 421, "char_end": 429, "token_start": 68, "token_end": 71}, "tgt": {"text": "COVID-19", "char_start": 971, "char_end": 979, "token_start": 135, "token_end": 138}}, {"src": {"text": "tracheotomy", "char_start": 502, "char_end": 513, "token_start": 83, "token_end": 84}, "tgt": {"text": "Tracheotomie", "char_start": 548, "char_end": 560, "token_start": 82, "token_end": 83}}, {"src": {"text": "ventilation", "char_start": 528, "char_end": 539, "token_start": 88, "token_end": 89}, "tgt": {"text": "Beatmung", "char_start": 475, "char_end": 483, "token_start": 74, "token_end": 75}}, {"src": {"text": "weaning", "char_start": 555, "char_end": 562, "token_start": 92, "token_end": 93}, "tgt": {"text": "Entw\u00f6hnung", "char_start": 604, "char_end": 614, "token_start": 88, "token_end": 89}}, {"src": {"text": "secondary infection", "char_start": 585, "char_end": 604, "token_start": 99, "token_end": 101}, "tgt": {"text": "sekund\u00e4re Infektionen", "char_start": 833, "char_end": 854, "token_start": 119, "token_end": 121}}, {"src": {"text": "tracheostomy", "char_start": 648, "char_end": 660, "token_start": 106, "token_end": 107}, "tgt": {"text": "Tracheostomapflege", "char_start": 799, "char_end": 817, "token_start": 115, "token_end": 116}}, {"src": {"text": "droplet dispersion", "char_start": 724, "char_end": 742, "token_start": 119, "token_end": 121}, "tgt": {"text": "Tr\u00f6pfchenbildung", "char_start": 893, "char_end": 909, "token_start": 127, "token_end": 128}}, {"src": {"text": "tracheostomy tube change", "char_start": 750, "char_end": 774, "token_start": 122, "token_end": 125}, "tgt": {"text": "Kan\u00fclenwechsel", "char_start": 922, "char_end": 936, "token_start": 129, "token_end": 130}}, {"src": {"text": "quantitative", "char_start": 872, "char_end": 884, "token_start": 142, "token_end": 143}, "tgt": {"text": "quantitative", "char_start": 1011, "char_end": 1023, "token_start": 143, "token_end": 144}}, {"src": {"text": "qualitative", "char_start": 889, "char_end": 900, "token_start": 144, "token_end": 145}, "tgt": {"text": "qualitative", "char_start": 1028, "char_end": 1039, "token_start": 145, "token_end": 146}}, {"src": {"text": "droplet formation", "char_start": 913, "char_end": 930, "token_start": 147, "token_end": 149}, "tgt": {"text": "Tr\u00f6pfchenfreisetzung", "char_start": 1052, "char_end": 1072, "token_start": 148, "token_end": 149}}, {"src": {"text": "checklist", "char_start": 1020, "char_end": 1029, "token_start": 166, "token_end": 167}, "tgt": {"text": "Checkliste", "char_start": 1126, "char_end": 1136, "token_start": 159, "token_end": 160}}, {"src": {"text": "aerosolization", "char_start": 1215, "char_end": 1229, "token_start": 197, "token_end": 198}, "tgt": {"text": "Aerosolbildung", "char_start": 1322, "char_end": 1336, "token_start": 188, "token_end": 189}}, {"src": {"text": "particles", "char_start": 1233, "char_end": 1242, "token_start": 199, "token_end": 200}, "tgt": {"text": "Partikeln", "char_start": 1341, "char_end": 1350, "token_start": 190, "token_end": 191}}, {"src": {"text": "infection risk", "char_start": 1394, "char_end": 1408, "token_start": 227, "token_end": 229}, "tgt": {"text": "Infektionsgefahr", "char_start": 375, "char_end": 391, "token_start": 62, "token_end": 63}}, {"src": {"text": "healthcare personnel", "char_start": 165, "char_end": 185, "token_start": 26, "token_end": 28}, "tgt": {"text": "Pflegepersonal", "char_start": 742, "char_end": 756, "token_start": 105, "token_end": 106}}]}
{"idx": 4345, "pair_id": "24973323", "src": "A 22-year old mare from Switzerland was admitted to an equine clinic in May 2011. She presented with fever, lethargy, icteric mucous membranes, reduced alertness, an unsteady gait and ataxia. An Anaplasma phagocytophilum infection was confirmed by blood smear and PCR. The mare was treated with oxytetracylin and recovered rapidly, but she still suffered from a slight atactic gait disturbance at 3 weeks post infection.", "tgt": "Eine 22 Jahre alte Stute aus der Schweiz wurde im Mai 2011 in eine Pferdeklinik aufgenommen. Die klinischen Symptome bestanden in Fieber, Abgeschlagenheit, ikterischen Schleimh\u00e4uten, reduzierter Aufmerksamkeit, einem unsicherem Gang und einer Ataxie. Eine Infektion mit Anaplasma phagocytophilum wurde durch den Erregernachweis im Blutausstrich und in der PCR best\u00e4tigt. Die Stute wurde mit Oxytetrazyklin behandelt, worunter eine rasche Besserung eintrat. Trotzdem war drei Wochen nach der Infektion noch eine geringgradige ataktische Gangst\u00f6rung nachweisbar.", "term_pairs": [{"src": {"text": "fever", "char_start": 101, "char_end": 106, "token_start": 21, "token_end": 22}, "tgt": {"text": "Fieber", "char_start": 130, "char_end": 136, "token_start": 22, "token_end": 23}}, {"src": {"text": "lethargy", "char_start": 108, "char_end": 116, "token_start": 23, "token_end": 24}, "tgt": {"text": "Abgeschlagenheit", "char_start": 138, "char_end": 154, "token_start": 24, "token_end": 25}}, {"src": {"text": "icteric mucous membranes", "char_start": 118, "char_end": 142, "token_start": 25, "token_end": 28}, "tgt": {"text": "ikterischen Schleimh\u00e4uten", "char_start": 156, "char_end": 181, "token_start": 26, "token_end": 28}}, {"src": {"text": "reduced alertness", "char_start": 144, "char_end": 161, "token_start": 29, "token_end": 31}, "tgt": {"text": "reduzierter Aufmerksamkeit", "char_start": 183, "char_end": 209, "token_start": 29, "token_end": 31}}, {"src": {"text": "unsteady gait", "char_start": 166, "char_end": 179, "token_start": 33, "token_end": 35}, "tgt": {"text": "unsicherem Gang", "char_start": 217, "char_end": 232, "token_start": 33, "token_end": 35}}, {"src": {"text": "ataxia", "char_start": 184, "char_end": 190, "token_start": 36, "token_end": 37}, "tgt": {"text": "Ataxie", "char_start": 243, "char_end": 249, "token_start": 37, "token_end": 38}}, {"src": {"text": "Anaplasma phagocytophilum infection", "char_start": 195, "char_end": 230, "token_start": 39, "token_end": 42}, "tgt": {"text": "Infektion mit Anaplasma phagocytophilum", "char_start": 256, "char_end": 295, "token_start": 40, "token_end": 44}}, {"src": {"text": "blood smear", "char_start": 248, "char_end": 259, "token_start": 45, "token_end": 47}, "tgt": {"text": "Blutausstrich", "char_start": 331, "char_end": 344, "token_start": 49, "token_end": 50}}, {"src": {"text": "PCR", "char_start": 264, "char_end": 267, "token_start": 48, "token_end": 49}, "tgt": {"text": "PCR", "char_start": 356, "char_end": 359, "token_start": 53, "token_end": 54}}, {"src": {"text": "oxytetracylin", "char_start": 295, "char_end": 308, "token_start": 55, "token_end": 56}, "tgt": {"text": "Oxytetrazyklin", "char_start": 391, "char_end": 405, "token_start": 60, "token_end": 61}}, {"src": {"text": "atactic gait disturbance", "char_start": 369, "char_end": 393, "token_start": 67, "token_end": 70}, "tgt": {"text": "ataktische Gangst\u00f6rung", "char_start": 525, "char_end": 547, "token_start": 79, "token_end": 81}}]}
{"idx": 4372, "pair_id": "32610330", "src": "This study aimed to determine the effect of cold therapy (CT) on pain and physiological parameters after spine surgery. This study was a prospective, randomized controlled trial. Study participants were randomly assigned to either a control group or a CT group. The outcome measured was pain intensity rated by a numeric rating scale. Psychological outcome measures were considered secondary. Thirty-eight patients in each group completed the study. No statistically significant difference was found between the pain scores of patients in the CT and those in the control group during the 24-h period following surgery (group: F = 0.01, p = 0.922). However, it was found that the pain scores of patients in the CT group were significantly lower than those in the control group during the 48-h period (group: F = 10.59, p = 0.002). CT reduced pain scores during the 48-h period following spine surgery. Our findings support the use of CT as an adjuvant therapy in pain management.", "tgt": "Hintergrund: Ziel dieser Studie war die Beurteilung der Effekte von K\u00e4ltetherapie (KT) auf Schmerzen und physiologische Parameter nach einer Wirbels\u00e4ulenoperation. Material und Methoden: Es handelt sich um eine prospektive, randomisierte kontrollierte Studie. Die Studienteilnehmer wurden per Randomisierung einer Kontrollgruppe oder einer KT-Gruppe zugeteilt. Der gemessene Endpunkt war die Schmerzst\u00e4rke auf einer nummerischen Rating-Skala. Verschiedene physiologische Parameter wurden als sekund\u00e4re Endpunkte betrachtet. Ergebnisse: 38 Patienten pro Gruppe schlossen die Studie ab. Dabei wurde kein statistisch signifikanter Unterschied zwischen den Schmerz\u00adscores der Patienten in der KT- und in der Kontrollgruppe in den ersten 24 h nach der Operation festgestellt (Gruppe: F = 0,01; p = 0,922). Jedoch wurde f\u00fcr den 48-h-Zeitraum festgestellt, dass die Schmerzscores der Patienten in der KT-Gruppe signifikant niedriger waren als in der Kontrollgruppe (Gruppe: F = 10,59, p = 0,002). Schlussfolgerung: Die KT bewirkte eine Reduktion der Schmerzscores 48 h nach einer Wirbels\u00e4ulenoperation. Unsere Ergebnisse sprechen f\u00fcr die Anwendung der KT als adjuvante Ma\u00dfnahme im Rahmen des Schmerzmanagements.", "term_pairs": [{"src": {"text": "cold therapy (CT)", "char_start": 44, "char_end": 61, "token_start": 8, "token_end": 13}, "tgt": {"text": "K\u00e4ltetherapie (KT)", "char_start": 68, "char_end": 86, "token_start": 11, "token_end": 15}}, {"src": {"text": "spine surgery", "char_start": 105, "char_end": 118, "token_start": 19, "token_end": 21}, "tgt": {"text": "Wirbels\u00e4ulenoperation", "char_start": 141, "char_end": 162, "token_start": 22, "token_end": 23}}, {"src": {"text": "prospective, randomized controlled trial", "char_start": 137, "char_end": 177, "token_start": 26, "token_end": 31}, "tgt": {"text": "prospektive, randomisierte kontrollierte Studie", "char_start": 211, "char_end": 258, "token_start": 33, "token_end": 38}}, {"src": {"text": "control group", "char_start": 233, "char_end": 246, "token_start": 40, "token_end": 42}, "tgt": {"text": "Kontrollgruppe", "char_start": 314, "char_end": 328, "token_start": 45, "token_end": 46}}, {"src": {"text": "CT group", "char_start": 252, "char_end": 260, "token_start": 44, "token_end": 46}, "tgt": {"text": "KT-Gruppe", "char_start": 340, "char_end": 349, "token_start": 48, "token_end": 51}}, {"src": {"text": "pain intensity", "char_start": 287, "char_end": 301, "token_start": 51, "token_end": 53}, "tgt": {"text": "Schmerzst\u00e4rke", "char_start": 392, "char_end": 405, "token_start": 58, "token_end": 59}}, {"src": {"text": "numeric rating scale", "char_start": 313, "char_end": 333, "token_start": 56, "token_end": 59}, "tgt": {"text": "nummerischen Rating-Skala", "char_start": 416, "char_end": 441, "token_start": 61, "token_end": 65}}, {"src": {"text": "pain scores", "char_start": 512, "char_end": 523, "token_start": 86, "token_end": 88}, "tgt": {"text": "Schmerzscores", "char_start": 859, "char_end": 872, "token_start": 145, "token_end": 146}}, {"src": {"text": "adjuvant therapy", "char_start": 942, "char_end": 958, "token_start": 192, "token_end": 194}, "tgt": {"text": "adjuvante Ma\u00dfnahme", "char_start": 1152, "char_end": 1170, "token_start": 200, "token_end": 202}}, {"src": {"text": "pain management", "char_start": 962, "char_end": 977, "token_start": 195, "token_end": 197}, "tgt": {"text": "Schmerzmanagements", "char_start": 1185, "char_end": 1203, "token_start": 205, "token_end": 206}}]}
{"idx": 4380, "pair_id": "32613274", "src": "Machine perfusion will become established as the standard of care for solid organ transplantation in the near future. Ongoing studies are investigating the appropriate perfusion algorithms for each specific organ. Although it is neither proven which perfusion principle nor type of device is superior, it has already been sufficiently shown that the increasing number of marginal organs that are currently transplanted in Germany would benefit from machine perfusion for conditioning before transplantation. The addition of hypothermic and normothermic perfusion sequences opens up the possibility of conditioning of previously damaged organs as well as viability testing. Overall, machine perfusion increases the safety for the recipient and can counteract the increasingly more difficult scenario of working hour restrictions because solid organ transplantations in the future will be\u00a0plannable and carried out during the day.", "tgt": "Die Maschinenperfusion wird sich in den n\u00e4chsten Jahren als Standard in der Transplantation solider Organe etablieren. Aktuelle Studien untersuchen noch die ad\u00e4quaten Perfusionsalgorithmen der entsprechenden Organe. Trotz der noch nicht gekl\u00e4rten \u00dcberlegenheit eines Systems ist bereits jetzt hinreichend gezeigt worden, dass die zunehmende Anzahl marginaler Organe, die aktuell in Deutschland transplantiert werden, von einer Maschinenperfusion zur Konditionierung vor Transplantation profitieren. Dabei er\u00f6ffnet die Erg\u00e4nzung von hypothermen und normothermen Perfusionssequenzen die M\u00f6glichkeit der Konditionierung vorgesch\u00e4digter Organe sowie der Viabilit\u00e4tstestung. Insgesamt erh\u00f6ht die Maschinenperfusion die Sicherheit f\u00fcr den Empf\u00e4nger und kann den zunehmenden arbeitsrechtlichen Reglementierungen entgegenwirken, da Organtransplantation in Zukunft planbar und tags\u00fcber durchf\u00fchrbar wird.", "term_pairs": [{"src": {"text": "Machine perfusion", "char_start": 0, "char_end": 17, "token_start": 0, "token_end": 2}, "tgt": {"text": "Maschinenperfusion", "char_start": 4, "char_end": 22, "token_start": 1, "token_end": 2}}, {"src": {"text": "solid organ transplantation", "char_start": 70, "char_end": 97, "token_start": 11, "token_end": 14}, "tgt": {"text": "Transplantation solider Organe", "char_start": 76, "char_end": 106, "token_start": 12, "token_end": 15}}, {"src": {"text": "perfusion algorithms", "char_start": 168, "char_end": 188, "token_start": 25, "token_end": 27}, "tgt": {"text": "Perfusionsalgorithmen", "char_start": 167, "char_end": 188, "token_start": 23, "token_end": 24}}, {"src": {"text": "marginal organs", "char_start": 371, "char_end": 386, "token_start": 58, "token_end": 60}, "tgt": {"text": "marginaler Organe", "char_start": 348, "char_end": 365, "token_start": 47, "token_end": 49}}, {"src": {"text": "hypothermic", "char_start": 524, "char_end": 535, "token_start": 79, "token_end": 80}, "tgt": {"text": "hypothermen", "char_start": 532, "char_end": 543, "token_start": 71, "token_end": 72}}, {"src": {"text": "normothermic", "char_start": 540, "char_end": 552, "token_start": 81, "token_end": 82}, "tgt": {"text": "normothermen", "char_start": 548, "char_end": 560, "token_start": 73, "token_end": 74}}, {"src": {"text": "viability testing", "char_start": 654, "char_end": 671, "token_start": 97, "token_end": 99}, "tgt": {"text": "Viabilit\u00e4tstestung", "char_start": 650, "char_end": 668, "token_start": 83, "token_end": 84}}]}
{"idx": 4561, "pair_id": "31298216", "src": "We describe patient-specific surgical guide prototyping and surgical treatment of a complex antebrachial deformity in two skeletally mature dogs presented with chronic lameness. Computer-assisted surgery was elected to increase accuracy in the correction of the complex deformity. Radiographs and computed tomography (CT) scans revealed a biplane deformity with valgus, procurvatum and external torsion of the right radius in both cases. The pre-surgical planning started from the quantification of the angular deformity, followed by computer simulated correction and to end up with a rehearsal surgery on 3D printed bone models. During the surgery, the custom-made osteotomy guides closely fitted the bone, allowing for a precise corrective osteotomy, that was stabilized with two locking plates. Postoperative radiographs showed the successful correction of the deformity. Eight and 12 weeks postoperative follow up examinations showed improved lameness, weight-bearing and progression of bone healing in both dogs. Patient-specific surgical guides allowed for a satisfactory correction of the antebrachial deformity. Additional benefits of using customized surgical devices include standardization and reduced surgical time.", "tgt": "Der vorliegende Fallbericht beschreibt eine Korrekturosteotomie mit Hilfe einer patientenspezifischen chirurgischen Schablone bei zwei ausgewachsenen Hunden mit chronischer Lahmheit. Aufgrund der Komplexit\u00e4t der Unterarmdeformit\u00e4t wurde eine computerassistierte Chirurgie gew\u00e4hlt. Sowohl die R\u00f6ntgenbilder als auch die Computertomographie zeigten biplanare Deformit\u00e4ten mit einer Valgus, Prokurvatum und Aussenrotation Fehlstellung des rechten Radius. Die pr\u00e4operative Planung beinhaltete die Quantifizierung der Deformit\u00e4t, die Computersimulation der Korrekturosteotomie und die Durchf\u00fchrung der Operation an 3D gedruckten Knochenmo\u00addellen. Die spezialangefertigten Osteotomie-Schablonen wiesen intraoperativ eine akkurate Knochenanpassung auf, welche pr\u00e4zise Korrekturosteotomien mittels jeweils zwei winkelstabilen Platten erlaubten. Die postoperativen R\u00f6ntgenbilder zeigten in beiden F\u00e4llen eine gelungene Korrektur der vorangegangenen Deformit\u00e4ten. Die klinischen und r\u00f6ntgenologischen Kontrollen nach 8 und 12\u00a0Wochen wiesen eine abnehmende Lahmheit, bessere Gewichtsbelastung und progressive Knochenheilung bei beiden Hunden nach. Die Patientenspezifischen chirurgischen Schablonen erlaubten akkurate Osteotomien und Korrekturen der Unterarmdeformit\u00e4ten. Ein zus\u00e4tzlicher Nutzen dieser Methode ist eine m\u00f6gliche Standardi\u00adsierung und eine Verk\u00fcrzung der Operationszeit.", "term_pairs": []}
{"idx": 4621, "pair_id": "34009728", "src": "MicroRNAs (miRNA) are short, single-stranded RNA molecules that regulate gene expression in a post-transcriptional manner. Their expression is proposed to be tissue-specific and alterations in miRNA expression have been detected in many diseases. To compare miRNA expression in the skin of healthy Labrador and golden retrievers, and those with allergic and nonallergic dermatitis. Formalin-fixed and paraffin-embedded (FFPE) skin specimens from seven healthy Labrador and golden retrievers, and seven dogs with allergic skin disease were collected. A further mixed nonallergic inflammation group consisted of samples from five dogs with fungal infection, demodicosis and mast cell tumours. Total RNA was extracted and miRNA primer assays for 18 target miRNAs (miR-142, miR-363, miR-18b, miR-451, miR-146a, miR-124, miR-409, miR-193b, miR-223, miR-215, miR-155, miR-423a, miR-143, miR-1839, miR-21, miR-34b, miR-146b and miR-202) were performed, with RNU6-2 and SNORD95 as miRNAs for normalisation. The selection of miRNAs for investigation was based on reported data and a pilot study evaluating miRNA extraction from FFPE tissue specimens. In the two dogs with mast cell tumours, miRNA expression was undetermined for most miRNAs, so both were excluded from analysis. Although there were differences in the miRNA expression between healthy and inflamed skin, allergic and nonallergic inflammation showed similar expression patterns. Although the number of included dogs was small, based on this study, none of the evaluated miRNAs allowed differentiation of allergic dermatitis from other inflammatory skin diseases in retriever dogs.", "tgt": "MicroRNAs (miRNAs) sind kurze, einzelstr\u00e4ngige RNA Molek\u00fcle, die die Genexprimierung post-transkriptional regulieren. Es wird vermutet, dass ihre Exprimierung Gewebe-spezifisch ist. Ver\u00e4nderungen der miRNA Exprimierung wurden bei verschiedenen Krankheiten beobachtet. ZIEL: Ein Vergleich der miRNA Exprimierung in der Haut gesunder Labrador und Golden Retriever, sowie jener mit allergischer und nicht allergischer Dermatitis. Formalin-fixierte und in Paraffin eingebettete (FFPE) Hautproben von sieben gesunden Labrador und Golden Retrievern sowie sieben Hunden mit allergischer Hauterkrankung wurden entnommen. Eine weitere gemischte Gruppe mit nicht allergischer Entz\u00fcndung bestand aus Proben von f\u00fcnf Hunden mit einer Pilzinfektion, Demodikose und Mastzelltumoren. Totale RNA wurde extrahiert und miRNA Primer Assays f\u00fcr 18 Target miRNAs (miR-142, miR-363, mi-R-18b, mi-R451, miR-146a, miR-124, miR-409, miR-193b, miR-223, miR-215, miR-155, miR-423a, miR-143, miR-1839, miR-21, miR-34b, miR-146b und miR-202) durchgef\u00fchrt, wobei RNU6-2 und SNORAD95 als miRNAs zur Normalisierung verwendet wurden. Die Auswahl der miRNAs f\u00fcr die Untersuchung basierte auf den beschriebenen Daten und einer Pilotstudie, welche die miRNA Extraktion von FFPE Geweben evaluiert hatte. Bei den beiden Hunden mit Mastzelltumoren war die miRNA f\u00fcr die meisten miRNAs unbestimmt, daher wurden beide von der Analyse ausgeschlossen. Obwohl Unterschiede bei der miRNA Exprimierung zwischen der gesunden und der entz\u00fcndeten Haut bestanden, zeigte die allergische und die nicht allergische Entz\u00fcndung ein \u00e4hnliches Exprimierungsmuster. Obwohl die Anzahl der Hunde in der Studie klein war, erlaubte - basierend auf dieser Studie - keine der evaluierten miRNAs eine Differenzierung zwischen einer allergischen Dermatitis anderer entz\u00fcndlicher Hauterkrankungen von Retrieverhunden.", "term_pairs": []}
{"idx": 4720, "pair_id": "31896107", "src": "Osteoarthritis is one of the most common rheumatic disease in the world and one of the leading causes of disability in the elderly. There is still no curative management for the disease, so the search for new therapeutic alternatives continues. -Apitherapy is a therapeutic tool based on the use of beehive products used since ancient times and, at present, their mechanism of action begins to be known. Many of the mechanisms of action of the beehive products are useful for chronic articular pathophysiological processes such as those described in osteoarthritis. This article presents a review of the current state of understanding of the mechanisms through which bee venom, propolis, honey, pollen, and royal jelly may act on osteoarthritis.", "tgt": "Osteoarthritis ist eine der weltweit h\u00e4ufigsten rheumatischen Erkrankungen und eine der f\u00fchrenden Ursachen f\u00fcr k\u00f6rperliche Beeintr\u00e4chtigung im Alter. Eine kurative Behandlungsoption steht bis heute nicht zur Verf\u00fcgung, daher wird weiter nach therapeutischen Alternativen gesucht. Die Apitherapie ist ein therapeutisches Instrument, das auf der Anwendung von Bienenprodukten beruht, die seit dem Altertum verwendet werden und deren Wirkmechanismen wir gerade beginnen zu verstehen. Viele dieser Mechanismen, \u00fcber die die Bienenprodukte ihre Wirkung entfalten, spielen eine n\u00fctzliche Rolle in pathophysiologischen Prozessen von chronischen Gelenkerkrankungen wie zum Beispiel der Osteoarthritis. Dieser Artikel gibt einen \u00dcberblick \u00fcber den aktuellen Kenntnisstand der Mechanismen, \u00fcber die Bienengift, Propolis, Honig, Pollen und Gel\u00e9e royale bei Osteoarthritis wirken k\u00f6nnten.", "term_pairs": [{"src": {"text": "Osteoarthritis", "char_start": 0, "char_end": 14, "token_start": 0, "token_end": 1}, "tgt": {"text": "Osteoarthritis", "char_start": 0, "char_end": 14, "token_start": 0, "token_end": 1}}, {"src": {"text": "rheumatic disease", "char_start": 41, "char_end": 58, "token_start": 7, "token_end": 9}, "tgt": {"text": "rheumatischen Erkrankungen", "char_start": 48, "char_end": 74, "token_start": 6, "token_end": 8}}, {"src": {"text": "disability", "char_start": 105, "char_end": 115, "token_start": 19, "token_end": 20}, "tgt": {"text": "k\u00f6rperliche Beeintr\u00e4chtigung", "char_start": 111, "char_end": 139, "token_start": 14, "token_end": 16}}, {"src": {"text": "curative management", "char_start": 150, "char_end": 169, "token_start": 28, "token_end": 30}, "tgt": {"text": "kurative Behandlungsoption", "char_start": 155, "char_end": 181, "token_start": 20, "token_end": 22}}, {"src": {"text": "therapeutic alternatives", "char_start": 209, "char_end": 233, "token_start": 39, "token_end": 41}, "tgt": {"text": "therapeutischen Alternativen", "char_start": 242, "char_end": 270, "token_start": 33, "token_end": 35}}, {"src": {"text": "Apitherapy", "char_start": 246, "char_end": 256, "token_start": 44, "token_end": 45}, "tgt": {"text": "Apitherapie", "char_start": 284, "char_end": 295, "token_start": 38, "token_end": 39}}, {"src": {"text": "beehive products", "char_start": 299, "char_end": 315, "token_start": 54, "token_end": 56}, "tgt": {"text": "Bienenprodukte", "char_start": 358, "char_end": 372, "token_start": 49, "token_end": 50}}, {"src": {"text": "mechanism of action", "char_start": 364, "char_end": 383, "token_start": 66, "token_end": 69}, "tgt": {"text": "Wirkmechanismen", "char_start": 431, "char_end": 446, "token_start": 60, "token_end": 61}}, {"src": {"text": "chronic articular pathophysiological processes", "char_start": 476, "char_end": 522, "token_start": 87, "token_end": 91}, "tgt": {"text": "pathophysiologischen Prozessen von chronischen Gelenkerkrankungen", "char_start": 591, "char_end": 656, "token_start": 84, "token_end": 89}}, {"src": {"text": "osteoarthritis", "char_start": 550, "char_end": 564, "token_start": 96, "token_end": 97}, "tgt": {"text": "Osteoarthritis", "char_start": 678, "char_end": 692, "token_start": 93, "token_end": 94}}, {"src": {"text": "bee venom", "char_start": 667, "char_end": 676, "token_start": 114, "token_end": 116}, "tgt": {"text": "Bienengift", "char_start": 789, "char_end": 799, "token_start": 109, "token_end": 110}}, {"src": {"text": "propolis", "char_start": 678, "char_end": 686, "token_start": 117, "token_end": 118}, "tgt": {"text": "Propolis", "char_start": 801, "char_end": 809, "token_start": 111, "token_end": 112}}, {"src": {"text": "honey", "char_start": 688, "char_end": 693, "token_start": 119, "token_end": 120}, "tgt": {"text": "Honig", "char_start": 811, "char_end": 816, "token_start": 113, "token_end": 114}}, {"src": {"text": "pollen", "char_start": 695, "char_end": 701, "token_start": 121, "token_end": 122}, "tgt": {"text": "Pollen", "char_start": 818, "char_end": 824, "token_start": 115, "token_end": 116}}, {"src": {"text": "royal jelly", "char_start": 707, "char_end": 718, "token_start": 124, "token_end": 126}, "tgt": {"text": "Gel\u00e9e royale", "char_start": 829, "char_end": 841, "token_start": 117, "token_end": 119}}]}
{"idx": 4797, "pair_id": "28505699", "src": "The study investigates the impact of organizational structures in hospitals on nursing staff's psychological stress. The stress level that is caused by the specific working conditions of a major hospital is presented in a cross-sectional analysis differentiated by organizational categories with regard to effects of structure and status. Data were collected via Impuls-Test and by a context-specific supplementary questionnaire among the registered nursing staff of a major maximum care hospital. For analysis of the data, we used the effort-reward-imbalance and the job-demand-control model as well as an average calculation of 13 different dimensions of working conditions, differentiated by organizational categories. The results show that the nursing staff's level of psychological stress can only be understood against the background of their organizational involvement and position in the hospital. The effects clearly vary in terms of organizational unit, working hour model and status and position occupied.", "tgt": "Die Studie untersucht Effekte von Krankenhausarbeit auf die psychische Gesundheit von Pflegekr\u00e4ften. Mittels Querschnittsanalyse werden psychische Belastungen des Pflegepersonals durch dessen Arbeitsbedingungen an einem Gro\u00dfkrankenhaus differenziert nach organisationalen durch die Organisation bedingten Kategorien hinsichtlich Status- und Struktureffekten dargestellt. Die Daten wurden standardisiert als Vollerhebung aller examinierten Pflegekr\u00e4fte eines Gro\u00dfkrankenhauses der Maximalversorgung mithilfe des Impuls-Tests und eines kontextspezifischen Zusatzfragebogens erhoben. Die Analyse der Daten erfolgte anhand des Gratifikationskrisen- und Job-Demand-Control-Modells sowie einer Mittelwertberechnung der erhobenen 13 Dimensionen der Arbeitsbedingungen, die nach nominalen organisationalen Kategorien der Arbeitsorganisation unterscheidet. Die Ergebnisse zeigen, dass psychische Belastungen von Pflegekr\u00e4ften nur unter Ber\u00fccksichtigung von deren arbeitsorganisatorischen Einbindung und Verortung in der Organisation Krankenhaus sinnvoll verstanden werden k\u00f6nnen. Es lassen sich eindeutige Effekte daraufhin feststellen, welchem Arbeitszeitmodell Pflegekr\u00e4fte unterworfen sind, welcher Organisationseinheit und Klinik sie angeh\u00f6ren und insbesondere, ob sie eine F\u00fchrungsposition innehaben oder nicht.", "term_pairs": [{"src": {"text": "organizational structures", "char_start": 37, "char_end": 62, "token_start": 6, "token_end": 8}, "tgt": {"text": "Organisation", "char_start": 255, "char_end": 267, "token_start": 28, "token_end": 29}}, {"src": {"text": "hospitals", "char_start": 66, "char_end": 75, "token_start": 9, "token_end": 10}, "tgt": {"text": "Krankenhaus", "char_start": 34, "char_end": 45, "token_start": 5, "token_end": 6}}, {"src": {"text": "nursing staff", "char_start": 79, "char_end": 92, "token_start": 11, "token_end": 13}, "tgt": {"text": "Pflegekr\u00e4fte", "char_start": 86, "char_end": 98, "token_start": 11, "token_end": 12}}, {"src": {"text": "psychological stress", "char_start": 95, "char_end": 115, "token_start": 15, "token_end": 17}, "tgt": {"text": "psychische Belastungen", "char_start": 136, "char_end": 158, "token_start": 16, "token_end": 18}}, {"src": {"text": "cross-sectional analysis", "char_start": 222, "char_end": 246, "token_start": 37, "token_end": 41}, "tgt": {"text": "Querschnittsanalyse", "char_start": 109, "char_end": 128, "token_start": 14, "token_end": 15}}, {"src": {"text": "organizational categories", "char_start": 265, "char_end": 290, "token_start": 43, "token_end": 45}, "tgt": {"text": "organisationalen Kategorien", "char_start": 781, "char_end": 808, "token_start": 95, "token_end": 97}}, {"src": {"text": "Impuls-Test", "char_start": 363, "char_end": 374, "token_start": 58, "token_end": 61}, "tgt": {"text": "Impuls-Tests", "char_start": 511, "char_end": 523, "token_start": 56, "token_end": 59}}, {"src": {"text": "questionnaire", "char_start": 415, "char_end": 428, "token_start": 68, "token_end": 69}, "tgt": {"text": "Zusatzfragebogens", "char_start": 554, "char_end": 571, "token_start": 62, "token_end": 63}}, {"src": {"text": "effort-reward-imbalance", "char_start": 536, "char_end": 559, "token_start": 90, "token_end": 95}, "tgt": {"text": "Gratifikationskrisen", "char_start": 623, "char_end": 643, "token_start": 72, "token_end": 73}}, {"src": {"text": "job-demand-control model", "char_start": 568, "char_end": 592, "token_start": 97, "token_end": 103}, "tgt": {"text": "Job-Demand-Control-Modells", "char_start": 649, "char_end": 675, "token_start": 75, "token_end": 82}}, {"src": {"text": "working conditions", "char_start": 165, "char_end": 183, "token_start": 27, "token_end": 29}, "tgt": {"text": "Arbeitsbedingungen", "char_start": 192, "char_end": 210, "token_start": 22, "token_end": 23}}, {"src": {"text": "organizational unit", "char_start": 943, "char_end": 962, "token_start": 159, "token_end": 161}, "tgt": {"text": "Organisationseinheit", "char_start": 1193, "char_end": 1213, "token_start": 143, "token_end": 144}}, {"src": {"text": "working hour model", "char_start": 964, "char_end": 982, "token_start": 162, "token_end": 165}, "tgt": {"text": "Arbeitszeitmodell", "char_start": 1136, "char_end": 1153, "token_start": 137, "token_end": 138}}, {"src": {"text": "status", "char_start": 331, "char_end": 337, "token_start": 52, "token_end": 53}, "tgt": {"text": "Status", "char_start": 329, "char_end": 335, "token_start": 35, "token_end": 36}}, {"src": {"text": "position", "char_start": 880, "char_end": 888, "token_start": 147, "token_end": 148}, "tgt": {"text": "Position", "char_start": 1277, "char_end": 1285, "token_start": 154, "token_end": 155}}]}
{"idx": 4830, "pair_id": "29316575", "src": "The frequency of autochthonous hepatitis E virus (HEV) infections in Western countries has increased since the millennium, probably due to a higher awareness for HEV. The aim of this study was to analyze the epidemiological situation and regional distribution of HEV in comparison to hepatitis A\u200a-\u200aD in Germany. Data of the reported cases, patients' travel histories, and the regional distribution of hepatitis A\u200a-\u200aE virus infections from 2001 to 2017 were extracted from databases of the Robert Koch Institute. The number of publications per year on each hepatitis virus was used as a surrogate parameter for scientific awareness. The incidence of HEV infections increased from 31 reported cases in 2001 to 1991 cases in 2016 with a rate of autochthonous HEV infections of 44.4\u200a% in 2001 and 83.9\u200a% in 2016. In 2016, the HEV incidence was 4.4/100\u200a000 in Eastern Germany and 2.0/100\u200a000 in Western Germany. From 2001 to 2016, the numbers of hepatitis A and C virus infections decreased, while the number of hepatitis B virus infections initially decreased followed by an increase since 2014. The incidence of hepatitis D virus infections remained low. The incidence rates of hepatitis A\u200a-\u200aD virus infections were comparable between Eastern and Western Germany in 2016. There was a strong correlation between publications on HEV and reported HEV cases (Pearson r\u200a=\u200a0.9803, p\u200a<\u200a0.01). Especially in Eastern Germany, but also in Western Germany, the rate of reported HEV cases and the scientific awareness for this disease increased strongly since 2001.", "tgt": "Die H\u00e4ufigkeit autochthoner Hepatitis E Virus (HEV) Infektionen in der Westlichen Welt hat seit der Jahrtausendwende zugenommen, m\u00f6glicherweise durch eine gesteigerte Aufmerksamkeit f\u00fcr HEV. Diese Studie sollte die epidemiologische Situation und die regionale Verteilung von HEV im Vergleich zu Hepatitis A-D in Deutschland untersuchen. Daten der gemeldeten F\u00e4lle, Reiseanamnese und regionale Verteilung von Hepatitis A-E F\u00e4llen (2001\u200a\u2013\u200a2017) wurden vom Robert-Koch-Institut bezogen. Die j\u00e4hrliche Anzahl an Publikationen \u00fcber eines der Hepatitisviren wurde als Surrogatparameter f\u00fcr wissenschaftliches Interesse bewertet. Die Anzahl an HEV Infektionen stieg von 31 gemeldeten F\u00e4llen (2001) auf 1991 F\u00e4lle (2016) an. Die Rate autochthoner HEV Infektionen betrug 44,4\u200a% 2001 und 83,9\u200a% 2016. 2016 betrug die HEV Inzidenz 4,4/100\u200a000 in Ost- und 2,0/100\u200a000 in Westdeutschland. Zwischen 2001 und 2016 nahm die Zahl an HAV und HCV Virus Infektionen ab, w\u00e4hrend die Anzahl an Hepatitis B Virus Infektionen initial abfiehl und seit 2014 anstieg. Die Inzidenz an Hepatitis D Virus Infektionen blieb niedrig. Die Inzidenz an Hepatitis A\u200a-\u200aD Virus Infektionen war 2016 vergleichbar zwischen Ost- und Westdeutschland. Es gab eine starke Korrelation zwischen Publikationen \u00fcber HEV und gemeldeten HEV F\u00e4llen (Pearson r\u200a=\u200a0.9803; P <\u200a0.01). SCHLU\u00dfFOLGERUNG: \u2002Insbesondere in Ost- aber auch in Westdeutschland stiegen die Rate an gemeldeten HEV F\u00e4llen und die Aufmerksamkeit f\u00fcr diese Infektion seit 2001 an.", "term_pairs": [{"src": {"text": "autochthonous hepatitis E virus (HEV) infections", "char_start": 17, "char_end": 65, "token_start": 3, "token_end": 11}, "tgt": {"text": "autochthoner Hepatitis E Virus (HEV) Infektionen", "char_start": 15, "char_end": 63, "token_start": 2, "token_end": 10}}, {"src": {"text": "HEV", "char_start": 162, "char_end": 165, "token_start": 27, "token_end": 28}, "tgt": {"text": "HEV", "char_start": 186, "char_end": 189, "token_start": 26, "token_end": 27}}, {"src": {"text": "hepatitis A", "char_start": 284, "char_end": 295, "token_start": 48, "token_end": 50}, "tgt": {"text": "Hepatitis A", "char_start": 295, "char_end": 306, "token_start": 43, "token_end": 45}}, {"src": {"text": "hepatitis B", "char_start": 1007, "char_end": 1018, "token_start": 197, "token_end": 199}, "tgt": {"text": "Hepatitis B", "char_start": 972, "char_end": 983, "token_start": 179, "token_end": 181}}, {"src": {"text": "hepatitis D", "char_start": 1109, "char_end": 1120, "token_start": 213, "token_end": 215}, "tgt": {"text": "Hepatitis D", "char_start": 1057, "char_end": 1068, "token_start": 193, "token_end": 195}}, {"src": {"text": "Robert Koch Institute", "char_start": 489, "char_end": 510, "token_start": 87, "token_end": 90}, "tgt": {"text": "Robert-Koch-Institut", "char_start": 454, "char_end": 474, "token_start": 73, "token_end": 78}}, {"src": {"text": "incidence", "char_start": 636, "char_end": 645, "token_start": 112, "token_end": 113}, "tgt": {"text": "Inzidenz", "char_start": 811, "char_end": 819, "token_start": 140, "token_end": 141}}, {"src": {"text": "Western Germany", "char_start": 890, "char_end": 905, "token_start": 174, "token_end": 176}, "tgt": {"text": "Westdeutschland", "char_start": 859, "char_end": 874, "token_start": 158, "token_end": 159}}, {"src": {"text": "Pearson r", "char_start": 1352, "char_end": 1361, "token_start": 254, "token_end": 256}, "tgt": {"text": "Pearson r", "char_start": 1299, "char_end": 1308, "token_start": 232, "token_end": 234}}]}
{"idx": 4910, "pair_id": "34779052", "src": "The efficacy of lotilaner was evaluated in three tick-infested cane toads. A single oral administration of lotilaner eliminated all ticks from all three toads from Day (D)1. Environmental samples collected from toad enclosures were negative for ticks until D30.", "tgt": "Die Wirksamkeit von Lotilaner wurde an drei mit Zecken befallenen Kr\u00f6ten untersucht. Eine einzige Verabreichung per os eliminierte alle Zecke von allen drei Kr\u00f6ten mit dem ersten Tag (D1). Proben aus den Kr\u00f6tengehegen war bis zum D30 frei von Zecken.", "term_pairs": [{"src": {"text": "lotilaner", "char_start": 16, "char_end": 25, "token_start": 3, "token_end": 4}, "tgt": {"text": "Lotilaner", "char_start": 20, "char_end": 29, "token_start": 3, "token_end": 4}}, {"src": {"text": "tick-infested", "char_start": 49, "char_end": 62, "token_start": 8, "token_end": 11}, "tgt": {"text": "mit Zecken befallenen", "char_start": 44, "char_end": 65, "token_start": 7, "token_end": 10}}, {"src": {"text": "cane toads", "char_start": 63, "char_end": 73, "token_start": 11, "token_end": 13}, "tgt": {"text": "Kr\u00f6ten", "char_start": 66, "char_end": 72, "token_start": 10, "token_end": 11}}, {"src": {"text": "ticks", "char_start": 132, "char_end": 137, "token_start": 22, "token_end": 23}, "tgt": {"text": "Zecken", "char_start": 243, "char_end": 249, "token_start": 43, "token_end": 44}}, {"src": {"text": "oral administration", "char_start": 84, "char_end": 103, "token_start": 16, "token_end": 18}, "tgt": {"text": "Verabreichung per os", "char_start": 98, "char_end": 118, "token_start": 15, "token_end": 18}}, {"src": {"text": "Day (D)1", "char_start": 164, "char_end": 172, "token_start": 28, "token_end": 33}, "tgt": {"text": "ersten Tag (D1)", "char_start": 172, "char_end": 187, "token_start": 27, "token_end": 32}}, {"src": {"text": "D30", "char_start": 257, "char_end": 260, "token_start": 45, "token_end": 46}, "tgt": {"text": "D30", "char_start": 230, "char_end": 233, "token_start": 40, "token_end": 41}}]}
{"idx": 5016, "pair_id": "33063307", "src": "Gender Dysphoria (GD, formerly known as transsexualism) describes distress and impairment in an individual caused by the incongruence between the experienced gender and the sex assigned at birth (Gender Incongruence: GI). Transgender health care focusses on gender-affirmative treatments (e.\u2009g., hormone therapy) and associated needs (e.\u2009g., psychotherapy). Moreover, genital surgery is considered an effective treatment to reduce GI/GD and improve mental health and quality of life. Interdisciplinary cooperation between the associated medical facilities is regarded as evidence-based health care. To date, THC is delivered in zwei different health care settings: interdisciplinary and centralized from one medical institution vs. decentralized, spread over several medical institutions. In Germany, individuals with GI/GD access health care mostly in decentralized structures. The consequences of feminizing genital surgery carried out in centralized and decentralized health care structures in terms of quality and effectiveness have not been investigated so far. The goal of the TransCare study is to prospectively examine individuals with GI/GD seeking feminizing genital surgery regarding demographics and clinical characteristics as well as to analyze the influence of centralized and decentralized health care settings on the psychosocial and clinical outcome. To recruit a valid and comprehensive sample, participants were questioned prospectively. The results of the study should help gain new insights into the influence of centralized and decentralized health care settings carrying out feminizing genital surgery on psychosocial and clinical outcomes for the patients. Based on the TransCare study, we suggest that health care should be improved according to individual patient needs.", "tgt": "Geschlechtsdysphorie (GD, ehemals Transsexualit\u00e4t) bezeichnet einen Leidensdruck, der sich aus der Inkongruenz zwischen den k\u00f6rperlichen Geschlechtsmerkmalen und dem Erleben des eigenen Geschlechts ergeben kann (Geschlechtsinkongruenz: GIK). Die Gesundheitsversorgung von Personen mit GIK/GD bezieht sich v.\u2009a. auf geschlechtsangleichende Ma\u00dfnahmen (z.\u2009B. Hormonbehandlung) und Unterst\u00fctzung bei assoziierten Bed\u00fcrfnissen (z.\u2009B. durch Psychotherapie). Zudem gelten genitalchirurgische Eingriffe als effektive Verfahren zur Reduktion von GIK/GD und zur Verbesserung der psychischen Gesundheit und Lebensqualit\u00e4t. Als evidenzbasiert gilt eine integrative Gesundheitsversorgung, bei der die beteiligten Bereiche interdisziplin\u00e4r kooperieren. Bei der medizinischen Versorgung von Patient_innen mit GIK/GD lassen sich grunds\u00e4tzlich zwei Settings unterscheiden: interdisziplin\u00e4r integriert an einem Standort vs. dezentral verteilt \u00fcber mehrere Standorte. Die Trans-Gesundheitsversorgung in Deutschland ist bisher weitgehend dezentral organisiert. Wie sich das Versorgungssetting auf die Wirksamkeit und Qualit\u00e4t genitalangleichender Operationen auswirkt, wurde bisher nicht untersucht. Ziel der TransCare-Studie ist es daher, prospektiv katamnestisch das psychosoziale und klinische Outcome von Patient_innen mit GIK/GD zu untersuchen, die eine feminisierende Genitaloperation in Anspruch nehmen, und auf die m\u00f6glichen Auswirkungen des Versorgungssettings (interdisziplin\u00e4r integriert vs. dezentral verteilt) hin zu vergleichen. Im Zuge eines naturalistischen L\u00e4ngsschnittdesigns soll eine m\u00f6glichst praxisnahe Stichprobe rekrutiert und die teilnehmenden Patient_innen prospektiv befragt werden. Die Studienergebnisse sollen Erkenntnisse \u00fcber die Rolle des Versorgungssettings im Rahmen der genitalchirurgischen Behandlung von Patient_innen mit GIK/GD hervorbringen. Auf Basis der TransCare-Studie soll die Versorgungsqualit\u00e4t empirisch fundiert verbessert werden.", "term_pairs": []}
{"idx": 5054, "pair_id": "33851384", "src": "Digital media have found their way into almost all areas of daily life. The aim of this study was to analyse the extent to which injured athletes use online media to gather information on sports injuries or on how to prevent them. \u2002Between 07-2017 and 12-2019, both recreational and competitive climbing athletes were surveyed on their use of various media with regard to sports medicine and prevention. \u2002488 athletes were included in the study (70.9\u200a% male, 29.1\u200a% female, 33.2\u200a\u00b1\u200a10.3 (13-71) years of age). 69.9\u200a% of the athletes use web-based medical content, with the video platform YouTube being most frequently used for specific searches (24.4\u200a%). Younger athletes (<\u200a30y) use video platforms significantly more often than older athletes (p\u200a=\u200a0.011). Sports-specific literature is most frequently used by the age group 30-50 years (37.4\u200a%). The age group\u200a>\u200a50 uses this medium significantly less frequently (18.8\u200a%; p\u200a=\u200a0.013). Competitive athletes use web-based medical content significantly more often than recreational athletes (p\u200a=\u200a0.005). The general interest in injury prevention is high, with competitive athletes using relevant content more often. Almost 9\u200a% of all patients interviewed visited a sports-orthopaedic facility because of their online research work. \u2002Internet-based medical information is used by 69.9\u200a% of athletes, with the video platform YouTube being most frequently used. Video platforms and sports-specific literature are used significantly more often by younger athletes than by older athletes. Web-based medical content is accessed significantly more often by professional athletes than by recreational athletes. The general interest in injury prophylaxis is high, with competitive athletes using or browsing medical content more often.", "tgt": "Die Nutzung digitaler Medien ist in nahezu allen Bereich des t\u00e4glichen Lebens zur Normalit\u00e4t geworden. Ziel dieser Arbeit war es zu analysieren, inwieweit verletzte Sportler Online-Medien nutzen, um Informationen \u00fcber Sportverletzungen oder deren Pr\u00e4vention zu erhalten. \u2002Zwischen 07/2017 und 12/2019 wurden im Klettersport sowohl Freizeit- als auch Wettkampfsportler nach ihrer Nutzung verschiedener Medien mit Hinblick auf die Bereiche Sportmedizin und Pr\u00e4vention befragt. \u2002488 Athleten wurden in die Studie eingeschlossen (70,9\u200a% m\u00e4nnlich, 29,1\u200a% weiblich, 33,2\u200a\u00b1\u200a10,3 (13\u201371) Jahre). 69,9\u200a% der Athleten nutzen online verf\u00fcgbare medizinische Inhalte, wobei die Videoplattform YouTube am h\u00e4ufigsten zur spezifischen Suche verwendet wird (24,4\u200a%). J\u00fcngere Athleten (<\u200a30 Jahre) nutzen Videoplattformen deutlich h\u00e4ufiger als \u00e4ltere Athleten (p\u200a=\u200a0,011). Sportspezifische Literatur wird von der Altersgruppe 30.\u201350. Lebensjahr am h\u00e4ufigsten verwendet (37,4\u200a%). Die Altersgruppe >\u200a50 Jahre nutzt dieses Medium signifikant seltener (18,8\u200a%; p\u200a=\u200a0,013). Wettkampfathleten nutzen signifikant h\u00e4ufiger webbasierte medizinische Inhalte als Freizeitathleten (p\u200a=\u200a0,005). Das generelle Interesse an Verletzungsprophylaxe ist gro\u00df, wobei Wettkampfathleten h\u00e4ufiger entsprechende Inhalte nutzen. Fast 9\u200a% aller befragten Patienten begaben sich aufgrund ihrer Online-Recherchearbeit in eine entsprechende sportorthop\u00e4dische Einrichtung. \u2002Internetbasierte medizinische Informationen werden von 69,9\u200a% der Athleten genutzt, die Videoplattform YouTube wird am h\u00e4ufigsten verwendet. Videoplattformen und sportspezifische Literatur werden von j\u00fcngeren Athleten deutlich h\u00e4ufiger als von \u00e4lteren Athleten genutzt. Webbasierte medizinische Inhalte werden von Wettkampfathleten signifikant h\u00e4ufiger aufgerufen als von Freizeitathleten. Das generelle Interesse an Verletzungsprophylaxe ist gro\u00df, wobei Wettkampfathleten h\u00e4ufiger entsprechende Inhalte nutzen bzw. suchen.", "term_pairs": [{"src": {"text": "sports injuries", "char_start": 188, "char_end": 203, "token_start": 35, "token_end": 37}, "tgt": {"text": "Sportverletzungen", "char_start": 218, "char_end": 235, "token_start": 35, "token_end": 36}}, {"src": {"text": "sports medicine", "char_start": 372, "char_end": 387, "token_start": 70, "token_end": 72}, "tgt": {"text": "Sportmedizin", "char_start": 438, "char_end": 450, "token_start": 69, "token_end": 70}}, {"src": {"text": "injury prevention", "char_start": 1074, "char_end": 1091, "token_start": 241, "token_end": 243}, "tgt": {"text": "Verletzungsprophylaxe", "char_start": 1191, "char_end": 1212, "token_start": 227, "token_end": 228}}, {"src": {"text": "sports-orthopaedic facility", "char_start": 1211, "char_end": 1238, "token_start": 264, "token_end": 268}, "tgt": {"text": "sportorthop\u00e4dische Einrichtung", "char_start": 1394, "char_end": 1424, "token_start": 254, "token_end": 256}}, {"src": {"text": "injury prophylaxis", "char_start": 1673, "char_end": 1691, "token_start": 342, "token_end": 344}, "tgt": {"text": "Verletzungsprophylaxe", "char_start": 1844, "char_end": 1865, "token_start": 311, "token_end": 312}}]}
{"idx": 5106, "pair_id": "33858023", "src": "Cancer is a life-threatening disease often with curative therapy approaches, high risk of relapse and distressing symptoms, which require immediate, quality-assured care throughout the entire therapy process including rehabilitation, even in a pandemie. We started to develop a pandemic plan to maintain oncological rehabilitation in February 2020. With the involvement of the whole clinic staff we developed protection scenarios with the aim of achieving Covid-19-free clinics. Schedules were developed and implemented based on the epidemiological bulletins of the RKI (Robert Koch Institute, Germany) of 2017 (influenza infection) and 2020 (Covid-19). The effects of these measures were evaluated by means of a patient and employee survey. The challenges of the pandemic have been successfully implemented. Both the patient and employee surveys showed a high level of acceptance of the measures. For example, 98.5% of patients stated that the continuation of rehabilitation was important for their health, even in the pandemic situation. At the same time, 87% felt safe. 88% of all employees (MA) and 93% of MA in the risk group stated that the protective measures were introduced at the right time. At the same time, 76% of all employees and 84% of the employees in the risk group agreed with the additional burden. In spite of the high risk potential in the clinics (immunocompromised patients, patients from different districts with different levels of exposure), an outbreak of SARS-CoV-2 could be avoided in the clinics. The timely roll-out of adapted pandemic rules in rehabilitation clinics enables the continuation of high-quality oncological rehabilitation even in pandemic times and thus contributes to a stabilisation of the supply chain for cancer diseases. A high level of acceptance of the measures among patients and hospital staff was evaluated.", "tgt": "EINF\u00fcHRUNG: Krebserkrankungen sind lebensbedrohliche Erkrankungen, h\u00e4ufig mit kurativen Therapieans\u00e4tzen, hohem Rezidivrisiko und belastenden Symptomen, die einer unmittelbaren, qualit\u00e4tsgesicherten Versorgung bei gleichzeitiger Patientenzufriedenheit und hoher Mitarbeitermotivation \u00fcber die gesamte Versorgungskette hinweg einschlie\u00dflich Rehabilitation, auch in Zeiten einer Pandemie, bed\u00fcrfen. Bevor Empfehlungen und Vorschriften \u00fcbergeordneter Beh\u00f6rden erlassen wurden, begannen wir bereits im Februar 2020 einen Pandemieplan zur Aufrechterhaltung der onkologischen Rehabilitation zu entwickeln. Unter Einbeziehung der Mitarbeiter wurden Schutzpl\u00e4ne f\u00fcr Rehabilitanden und Mitarbeiter entwickelt mit dem Ziel einer Covid-19-freien Rehabilitation. Ablaufpl\u00e4ne wurden auf Grundlage der Epidemiologischen Bulletins des RKI (Robert Koch Institut, Deutschland) von 2017 (Influenza-Infektion) und 2020 (Covid-19) erarbeitet und eingesetzt. Die Effekte dieser Ma\u00dfnahmen wurden mittels einer Patienten- und Mitarbeiterbefragung evaluiert. Die Herausforderungen des pandemischen Geschehens wurden erfolgreich umgesetzt. Sowohl die Patienten-, als auch die Mitarbeiterbefragung zeigten eine hohe Akzeptanz der Ma\u00dfnahmen bei gleichzeitig hoher Zufriedenheit, trotz der Mehrbelastungen bzw. Einschr\u00e4nkungen. So gaben 98,5% der Patienten an, dass die Fortsetzung der Rehabilitation wichtig f\u00fcr ihre Gesundheit sei. Gleichzeitig f\u00fchlten sich 87% sicher in den Kliniken aufgehoben. 88% aller Mitarbeiter (MA) und 93% der MA der Risikogruppe gaben an, dass die Schutzma\u00dfnahmen zum richtigen Zeitpunkt eingef\u00fchrt wurden. Gleichzeitig waren 76% aller und 84% der Mitarbeiter der Risikogruppe mit der Mehrbelastung einverstanden. Trotz des hohen Risikopotentials in den Kliniken (immungeschw\u00e4chte Patienten, Patienten aus verschiedenen z.T. sehr unterschiedlich belasteten Landkreisen) konnte bis dato ein SARS-CoV-2 Ausbruch in den Kliniken vermieden werden. Das rechtzeitige Ausrollen adaptierter Pandemieregeln in Rehabilitationskliniken, erm\u00f6glicht auch in Pandemiezeiten die Fortf\u00fchrung einer qualitativ hochwertigen onkologischen Rehabilitation und tr\u00e4gt damit zu einer Stabilisierung der Versorgungskette bei Krebserkrankungen bei. Gleichzeitig konnte eine hohe Akzeptanz der Ma\u00dfnahmen bei Patienten und Mitarbeitern der Kliniken evaluiert werden.", "term_pairs": [{"src": {"text": "Cancer", "char_start": 0, "char_end": 6, "token_start": 0, "token_end": 1}, "tgt": {"text": "Krebserkrankungen", "char_start": 12, "char_end": 29, "token_start": 2, "token_end": 3}}, {"src": {"text": "curative therapy approaches", "char_start": 48, "char_end": 75, "token_start": 9, "token_end": 12}, "tgt": {"text": "kurativen Therapieans\u00e4tzen", "char_start": 78, "char_end": 104, "token_start": 9, "token_end": 11}}, {"src": {"text": "relapse", "char_start": 90, "char_end": 97, "token_start": 16, "token_end": 17}, "tgt": {"text": "Rezidivrisiko", "char_start": 112, "char_end": 125, "token_start": 13, "token_end": 14}}, {"src": {"text": "rehabilitation", "char_start": 218, "char_end": 232, "token_start": 35, "token_end": 36}, "tgt": {"text": "Rehabilitation", "char_start": 340, "char_end": 354, "token_start": 36, "token_end": 37}}, {"src": {"text": "pandemic", "char_start": 278, "char_end": 286, "token_start": 47, "token_end": 48}, "tgt": {"text": "Pandemie", "char_start": 377, "char_end": 385, "token_start": 42, "token_end": 43}}, {"src": {"text": "oncological rehabilitation", "char_start": 304, "char_end": 330, "token_start": 51, "token_end": 53}, "tgt": {"text": "onkologischen Rehabilitation", "char_start": 556, "char_end": 584, "token_start": 66, "token_end": 68}}, {"src": {"text": "Covid-19-free clinics", "char_start": 456, "char_end": 477, "token_start": 74, "token_end": 80}, "tgt": {"text": "Covid-19-freien Rehabilitation", "char_start": 719, "char_end": 749, "token_start": 86, "token_end": 92}}, {"src": {"text": "epidemiological bulletins", "char_start": 533, "char_end": 558, "token_start": 89, "token_end": 91}, "tgt": {"text": "Epidemiologischen Bulletins", "char_start": 788, "char_end": 815, "token_start": 98, "token_end": 100}}, {"src": {"text": "RKI", "char_start": 566, "char_end": 569, "token_start": 93, "token_end": 94}, "tgt": {"text": "RKI", "char_start": 820, "char_end": 823, "token_start": 101, "token_end": 102}}, {"src": {"text": "Robert Koch Institute", "char_start": 571, "char_end": 592, "token_start": 95, "token_end": 98}, "tgt": {"text": "Robert Koch Institut", "char_start": 825, "char_end": 845, "token_start": 103, "token_end": 106}}, {"src": {"text": "influenza infection", "char_start": 612, "char_end": 631, "token_start": 104, "token_end": 106}, "tgt": {"text": "Influenza-Infektion", "char_start": 870, "char_end": 889, "token_start": 112, "token_end": 115}}, {"src": {"text": "Covid-19", "char_start": 643, "char_end": 651, "token_start": 110, "token_end": 113}, "tgt": {"text": "Covid-19", "char_start": 901, "char_end": 909, "token_start": 119, "token_end": 122}}, {"src": {"text": "patient and employee survey", "char_start": 713, "char_end": 740, "token_start": 126, "token_end": 130}, "tgt": {"text": "Patienten- und Mitarbeiterbefragung", "char_start": 988, "char_end": 1023, "token_start": 134, "token_end": 138}}, {"src": {"text": "SARS-CoV-2", "char_start": 1484, "char_end": 1494, "token_start": 277, "token_end": 282}, "tgt": {"text": "SARS-CoV-2", "char_start": 1891, "char_end": 1901, "token_start": 278, "token_end": 283}}, {"src": {"text": "oncological rehabilitation", "char_start": 1641, "char_end": 1667, "token_start": 308, "token_end": 310}, "tgt": {"text": "onkologischen Rehabilitation", "char_start": 2107, "char_end": 2135, "token_start": 307, "token_end": 309}}, {"src": {"text": "cancer diseases", "char_start": 1755, "char_end": 1770, "token_start": 325, "token_end": 327}, "tgt": {"text": "Krebserkrankungen", "char_start": 2201, "char_end": 2218, "token_start": 318, "token_end": 319}}]}
{"idx": 5162, "pair_id": "28002851", "src": "To report and review our experience with antenatal evaluation for fetuses diagnosed with congenital cataract. \u2002We retrospectively identified pregnancies diagnosed with fetal cataract during antenatal ultrasound. Evaluation of fetal eyes included intraocular anatomy and biometry. Data on fetal malformations, serology and fetal karyotype were collected. \u20028 cases, identified over the course of 10 years, were reviewed. Week 15 was the mean time for diagnosis (range 11\u200a-\u200a34). Extraocular anomalies were demonstrated in 6 cases (central nervous system, cardiac and renal systems). Additional intraocular abnormalities were detected in two cases: one fetus had persistent hyperplastic primary vitreous and another had bilateral retinal detachment. All cases but one involved cataracts in both eyes. The unilateral case was associated with microphthalmic aphakia. All cases had negative serology for TORCHs. 7 out of the 8 fetuses were terminated. The only one who survived developed in utero cataracts secondary to maternal steroid therapy. He underwent bilateral cataract extraction during the first weeks of life and ophthalmologic evaluation at 2 years of age was unremarkable, without any visual impairment. \u2002In most cases, fetal cataract was associated with additional abnormalities, both intra- and extra-ocular. In instances when cataracts are isolated, we suggest conducting a detailed and thorough in utero ophthalmic examination in order to improve antenatal parental counselling.", "tgt": "ZIEL: \u2002Bericht und \u00dcberpr\u00fcfung unserer Erfahrungen bei der antenatalen Einsch\u00e4tzung von Feten mit kongenitaler Kataraktdiagnose. \u2002Retrospektiv w\u00e4hlten wir Schwangerschaften mit Diagnose der fetalen Katarakt mittels pr\u00e4natalen Ultraschalls aus. In die Bewertung der fetalen Augen wurde die intraokul\u00e4re Anatomie und Biometrie eingeschlossen. Alle Daten \u00fcber fetale Anomalien, Serologie und fetaler Karyotyp wurden erhoben. \u2002Wir werteten 8 F\u00e4lle aus, die \u00fcber einen Zeitraum von 10 Jahren identifiziert wurden. Das Gestationsalter zum Zeitpunkt der Diagnose betrug im Mittel 15 Wochen (Bereich 11\u200a\u2013\u200a34). Extraokul\u00e4re Anomalien wurden in 6\u00a0F\u00e4llen gezeigt (zentrales Nervensystem und Nierensystem). Weitere intraokul\u00e4re Anomalien wurden in zwei F\u00e4llen nachgewiesen: Ein Fetus hatte einen persistierenden hyperplastischen prim\u00e4ren Glask\u00f6rper, ein weiterer hatte eine bilaterale Netzhautabl\u00f6sung. Bis auf einen Fall bestand bei allen \u00fcbrigen eine Katarakt beider Augen. Der unilaterale Fall stand in Zusammenhang mit einer mikrophtalmischen Aphakie. Alle F\u00e4lle hatten eine negative TORCH-Serologie. Schwangerschaftsabbr\u00fcche wurden bei 7 von 8 Feten durchgef\u00fchrt. Der einzig \u00fcberlebende Fetus entwickelte intrauterin sekund\u00e4r Katarakte aufgrund einer maternalen Steroidtherapie. In den ersten Lebenswochen wurde bei ihm eine bilaterale Kataraktextraktion durchgef\u00fchrt und die augen\u00e4rztliche Untersuchung im Alter von 2 Jahren war unauff\u00e4llig, ohne jegliche visuelle Beeintr\u00e4chtigung. \u2002In den meisten F\u00e4llen war die fetale Katarakt sowohl mit weiteren intra- als auch extraokularen Auff\u00e4lligkeiten assoziiert. In F\u00e4llen mit isolierter Katarakt empfehlen wir eine detaillierte und eingehende intrauterine ophthalmologische Untersuchung, um die Beratung der Eltern in der Schwangerschaft zu verbessern.", "term_pairs": []}
{"idx": 5178, "pair_id": "29490391", "src": "Infectious inflammation of the cornea (microbial keratitis) represents a potentially vision threatening disease. Depending on the infectious agent and the course of the disease it can result in a complete loss of the involved eye. Early diagnosis and accurate treatment are mandatory to maintain a sufficient visual acuity. The purpose of this review is to highlight and discuss characteristic clinical features, diagnostic procedures, and therapeutic aspects of three major forms of microbial keratitis (bacteria, fungi, and acanthamoeba; the latter two in the 2nd part of this article).", "tgt": "Infekti\u00f6se Entz\u00fcndungen der Hornhaut (mikrobielle Keratitiden) stellen potenziell visusbedrohende Erkrankungen dar. Je nach Schweregrad und Verlauf k\u00f6nnen sie bis zum Verlust des Auges f\u00fchren. Entscheidend f\u00fcr das Sehverm\u00f6gen ist, dass die Erreger schnell erkannt und zielgerichtet therapiert werden. Dieser Beitrag behandelt zun\u00e4chst generelle klinische, diagnostische und therapeutische Aspekte mikrobieller Keratitiden und geht anschlie\u00dfend auf die Besonderheiten bakterieller Keratitiden ein. In einem zweiten Teil werden klinische, methodische und therapeutische Besonderheiten von Keratomykosen und Akantham\u00f6benkeratitiden besprochen [1].", "term_pairs": [{"src": {"text": "Infectious inflammation of the cornea", "char_start": 0, "char_end": 37, "token_start": 0, "token_end": 5}, "tgt": {"text": "Infekti\u00f6se Entz\u00fcndungen der Hornhaut", "char_start": 0, "char_end": 36, "token_start": 0, "token_end": 4}}, {"src": {"text": "microbial keratitis", "char_start": 39, "char_end": 58, "token_start": 6, "token_end": 8}, "tgt": {"text": "mikrobielle Keratitiden", "char_start": 38, "char_end": 61, "token_start": 5, "token_end": 7}}, {"src": {"text": "vision threatening disease", "char_start": 85, "char_end": 111, "token_start": 12, "token_end": 15}, "tgt": {"text": "visusbedrohende Erkrankungen", "char_start": 82, "char_end": 110, "token_start": 10, "token_end": 12}}, {"src": {"text": "loss of the involved eye", "char_start": 205, "char_end": 229, "token_start": 33, "token_end": 38}, "tgt": {"text": "Verlust des Auges", "char_start": 167, "char_end": 184, "token_start": 23, "token_end": 26}}, {"src": {"text": "diagnostic procedures", "char_start": 413, "char_end": 434, "token_start": 67, "token_end": 69}, "tgt": {"text": "diagnostische", "char_start": 356, "char_end": 369, "token_start": 51, "token_end": 52}}, {"src": {"text": "therapeutic aspects", "char_start": 440, "char_end": 459, "token_start": 71, "token_end": 73}, "tgt": {"text": "therapeutische Aspekte", "char_start": 374, "char_end": 396, "token_start": 53, "token_end": 55}}, {"src": {"text": "bacteria", "char_start": 505, "char_end": 513, "token_start": 81, "token_end": 82}, "tgt": {"text": "bakterieller Keratitiden", "char_start": 467, "char_end": 491, "token_start": 63, "token_end": 65}}, {"src": {"text": "fungi", "char_start": 515, "char_end": 520, "token_start": 83, "token_end": 84}, "tgt": {"text": "Keratomykosen", "char_start": 587, "char_end": 600, "token_start": 79, "token_end": 80}}, {"src": {"text": "acanthamoeba", "char_start": 526, "char_end": 538, "token_start": 86, "token_end": 87}, "tgt": {"text": "Akantham\u00f6benkeratitiden", "char_start": 605, "char_end": 628, "token_start": 81, "token_end": 82}}]}
{"idx": 5191, "pair_id": "29499580", "src": "Our body is both, the object experiencing the world and the subject of our self- experience. As an object, the body provides sensory information via the bodily surface, which is processed and integrated into a coherent representation of the body, the body schema. This representation is considered to form a crucial structure underlying bodily self-identification. The process of integrating multimodal information into a coherent body representation has received extensive research interest with the aim to further clarify its neuronal correlates and functioning in health and disease. However, little is known about the ontogenetic functioning of body schema or multisensory integration processing and their role in the development of socio-emotional in children. This narrative overview discusses implication of a dysfunctional body schematic functioning for socio-emotional competencies. A general introduction on body schematic processes is followed by a narrative review of current findings on the maturation of the body schema and multisensory integration. We finally outline implications for the self- and socio-emotional development in children and discuss possible implications for a role of disrupted body schema functions in developmental disorders.", "tgt": "Diese \u00dcbersichtsarbeit diskutiert m\u00f6gliche Zusammenh\u00e4nge zwischen der \u00fcbergeordneten neuronalen Repr\u00e4sentation des K\u00f6rpers, dem \u201eK\u00f6rperschema\u201c, und St\u00f6rungen der sensorischen Wahrnehmung, motorischen Funktionen und sozio-emotionalen Entwicklung. Die Erforschung der neurophysiologischen Grundlagen und Funktionen des K\u00f6rperschemas konzentrierte sich bisher vorwiegend auf das Erwachsenenalter. Es ist wenig bekannt dar\u00fcber, wie sich bestimmte K\u00f6rperschemafunktionen im Kindesalter entwickeln, wie r\u00e4umliche Aspekte der taktilen Verarbeitung mit der Bewegungsplanung interagieren und in Wechselwirkung mit Meilensteinen der emotionalen und sozial-emotionalen Entwicklung stehen. In diesem Beitrag werden die existierenden Befunde zur Entwicklung des K\u00f6rperschemas mit Fokus auf multisensorische Verarbeitungs- und Integrationsprozesse und Wechselwirkungen f\u00fcr St\u00f6rungen der sozio-emotionalen Entwicklung diskutiert.", "term_pairs": [{"src": {"text": "body schema", "char_start": 251, "char_end": 262, "token_start": 47, "token_end": 49}, "tgt": {"text": "K\u00f6rperschema", "char_start": 129, "char_end": 141, "token_start": 15, "token_end": 16}}, {"src": {"text": "multisensory integration", "char_start": 664, "char_end": 688, "token_start": 110, "token_end": 112}, "tgt": {"text": "multisensorische Verarbeitungs- und Integrationsprozesse", "char_start": 777, "char_end": 833, "token_start": 101, "token_end": 106}}, {"src": {"text": "socio-emotional", "char_start": 737, "char_end": 752, "token_start": 120, "token_end": 123}, "tgt": {"text": "sozio-emotionalen", "char_start": 215, "char_end": 232, "token_start": 27, "token_end": 30}}, {"src": {"text": "developmental disorders", "char_start": 1237, "char_end": 1260, "token_start": 198, "token_end": 200}, "tgt": {"text": "St\u00f6rungen der sozio-emotionalen Entwicklung", "char_start": 859, "char_end": 902, "token_start": 109, "token_end": 115}}]}
{"idx": 5197, "pair_id": "29506301", "src": "We report a 79-year-old patient with post-polio syndrome (PPS). In the course of this disease, recurrent upper abdominal pain and a therapy-resistant nausea developed without vomiting. In addition, the patient was limited by the combination of muscular weakness, obesity, dietary-treated diabetes and a degenerative spinal cord injury significantly in its mobility and physical capacity. \u2002Despite extensive diagnostics, no somatic cause could be found neither for the nausea nor for the upper abdominal pain. Due to the psychological stress within the scope of the PPS, the development of a somatoform autonomic function disorder of the upper gastrointestinal tract may have occurred. \u2002Even under combination therapy of antiemetic and pain-modulating drugs, no adequate symptom control could be achieved. In the absence of therapy alternatives and increasing psychological strain the patient was prescribed medical cannabis. Under the therapy there was a relief of the nausea symptoms and decreased pain. \u2002Cannabis is a treatment option for treatment-resistant symptoms as part of a PPS.", "tgt": "Wir berichten \u00fcber einen 79 Jahre alten Patienten mit einem Post-Polio-Syndrom (PPS). Im Verlauf dieser Erkrankung entwickelten sich rezidivierende Oberbauchschmerzen und eine therapieresistente \u00dcbelkeit ohne Erbrechen. Zudem war der Patient durch die Kombination von muskul\u00e4rer Schw\u00e4che, Adipositas, di\u00e4tetisch behandelter Diabetes und einer degenerativen Wirbels\u00e4ulensch\u00e4digung deutlich in seiner Beweglichkeit und Belastbarkeit eingeschr\u00e4nkt. \u2002Trotz einer umfangreichen Diagnostik konnte keine somatische Ursache weder f\u00fcr die \u00dcbelkeit, noch f\u00fcr die Oberbauchschmerzen gefunden werden. Durch die psychische Belastung im Rahmen des PPS kam es m\u00f6glicherweise zu der Entwicklung einer somatoformen autonomen Funktionsst\u00f6rung des oberen Gastrointestinaltrakts. \u2002Auch unter einer Kombinationstherapie von Antiemetika und schmerzmodulierenden Medikamenten konnte keine ausreichende Symptomkontrolle erreicht werden. Bei Fehlen von Therapiealternativen und einem zunehmenden Leidensdruck wurde dem Patienten medizinischer Cannabis verordnet. Darunter kam es zu einer Erleichterung der \u00dcbelkeit-Symptomatik und R\u00fcckgang der Schmerzen. \u2002Cannabis stellt eine Behandlungsoption bei therapieresistenten Beschwerden im Rahmen eines PPS dar.", "term_pairs": [{"src": {"text": "post-polio syndrome (PPS)", "char_start": 37, "char_end": 62, "token_start": 10, "token_end": 17}, "tgt": {"text": "Post-Polio-Syndrom (PPS)", "char_start": 60, "char_end": 84, "token_start": 10, "token_end": 18}}, {"src": {"text": "upper abdominal pain", "char_start": 105, "char_end": 125, "token_start": 26, "token_end": 29}, "tgt": {"text": "Oberbauchschmerzen", "char_start": 148, "char_end": 166, "token_start": 26, "token_end": 27}}, {"src": {"text": "therapy-resistant nausea", "char_start": 132, "char_end": 156, "token_start": 31, "token_end": 35}, "tgt": {"text": "therapieresistente \u00dcbelkeit", "char_start": 176, "char_end": 203, "token_start": 29, "token_end": 31}}, {"src": {"text": "muscular weakness", "char_start": 244, "char_end": 261, "token_start": 50, "token_end": 52}, "tgt": {"text": "muskul\u00e4rer Schw\u00e4che", "char_start": 268, "char_end": 287, "token_start": 42, "token_end": 44}}, {"src": {"text": "obesity", "char_start": 263, "char_end": 270, "token_start": 53, "token_end": 54}, "tgt": {"text": "Adipositas", "char_start": 289, "char_end": 299, "token_start": 45, "token_end": 46}}, {"src": {"text": "dietary-treated diabetes", "char_start": 272, "char_end": 296, "token_start": 55, "token_end": 59}, "tgt": {"text": "di\u00e4tetisch behandelter Diabetes", "char_start": 301, "char_end": 332, "token_start": 47, "token_end": 50}}, {"src": {"text": "degenerative spinal cord injury", "char_start": 303, "char_end": 334, "token_start": 61, "token_end": 65}, "tgt": {"text": "degenerativen Wirbels\u00e4ulensch\u00e4digung", "char_start": 343, "char_end": 379, "token_start": 52, "token_end": 54}}, {"src": {"text": "somatic cause", "char_start": 423, "char_end": 436, "token_start": 78, "token_end": 80}, "tgt": {"text": "somatische Ursache", "char_start": 497, "char_end": 515, "token_start": 68, "token_end": 70}}, {"src": {"text": "somatoform autonomic function disorder", "char_start": 591, "char_end": 629, "token_start": 110, "token_end": 114}, "tgt": {"text": "somatoformen autonomen Funktionsst\u00f6rung", "char_start": 685, "char_end": 724, "token_start": 97, "token_end": 100}}, {"src": {"text": "upper gastrointestinal tract", "char_start": 637, "char_end": 665, "token_start": 116, "token_end": 119}, "tgt": {"text": "oberen Gastrointestinaltrakts", "char_start": 729, "char_end": 758, "token_start": 101, "token_end": 103}}, {"src": {"text": "combination therapy", "char_start": 697, "char_end": 716, "token_start": 125, "token_end": 127}, "tgt": {"text": "Kombinationstherapie", "char_start": 778, "char_end": 798, "token_start": 107, "token_end": 108}}, {"src": {"text": "antiemetic", "char_start": 720, "char_end": 730, "token_start": 128, "token_end": 129}, "tgt": {"text": "Antiemetika", "char_start": 803, "char_end": 814, "token_start": 109, "token_end": 110}}, {"src": {"text": "pain-modulating drugs", "char_start": 735, "char_end": 756, "token_start": 130, "token_end": 134}, "tgt": {"text": "schmerzmodulierenden Medikamenten", "char_start": 819, "char_end": 852, "token_start": 111, "token_end": 113}}, {"src": {"text": "symptom control", "char_start": 770, "char_end": 785, "token_start": 137, "token_end": 139}, "tgt": {"text": "Symptomkontrolle", "char_start": 879, "char_end": 895, "token_start": 116, "token_end": 117}}, {"src": {"text": "therapy alternatives", "char_start": 823, "char_end": 843, "token_start": 147, "token_end": 149}, "tgt": {"text": "Therapiealternativen", "char_start": 928, "char_end": 948, "token_start": 123, "token_end": 124}}, {"src": {"text": "psychological strain", "char_start": 859, "char_end": 879, "token_start": 151, "token_end": 153}, "tgt": {"text": "Leidensdruck", "char_start": 971, "char_end": 983, "token_start": 127, "token_end": 128}}, {"src": {"text": "medical cannabis", "char_start": 907, "char_end": 923, "token_start": 157, "token_end": 159}, "tgt": {"text": "medizinischer Cannabis", "char_start": 1004, "char_end": 1026, "token_start": 131, "token_end": 133}}, {"src": {"text": "nausea symptoms", "char_start": 969, "char_end": 984, "token_start": 169, "token_end": 171}, "tgt": {"text": "\u00dcbelkeit-Symptomatik", "char_start": 1081, "char_end": 1101, "token_start": 142, "token_end": 145}}, {"src": {"text": "pain", "char_start": 503, "char_end": 507, "token_start": 92, "token_end": 93}, "tgt": {"text": "Schmerzen", "char_start": 562, "char_end": 571, "token_start": 78, "token_end": 79}}, {"src": {"text": "treatment option", "char_start": 1020, "char_end": 1036, "token_start": 178, "token_end": 180}, "tgt": {"text": "Behandlungsoption", "char_start": 1152, "char_end": 1169, "token_start": 153, "token_end": 154}}, {"src": {"text": "treatment-resistant symptoms", "char_start": 1041, "char_end": 1069, "token_start": 181, "token_end": 185}, "tgt": {"text": "therapieresistenten Beschwerden", "char_start": 1174, "char_end": 1205, "token_start": 155, "token_end": 157}}]}
{"idx": 5270, "pair_id": "34185109", "src": "Porphyrias are caused by enzyme defects along the heme biosynthetic pathway. The first line diagnosis of porphyria is based on specific biochemical patterns of elevated porphyrins and porphyrin precursors in urine, feces, and blood. In clinically active disease accumulated porphyrin precursors and/or porphyrins lead to abdominal, neurologic, psychiatric, endocrine and cardiovascular symptoms, liver damage and/or skin photosensitivity. Porphyrias are classified into acute and nonacute forms. Patients with symptomatic (clinically active) acute hepatic porphyria, e.g. acute intermittent porphyria, porphyria variegata, hereditary coproporphyria, and aminolevulinic acid dehydratase deficiency porphyria, display accumulation of porphyrin precursors, 5\u2011aminolevulinic acid and porphobilinogen due to regulation disorder. In the non-acute forms of porphyria, such as porphyria cutanea tarda, erythropoietic porphyria, X\u2011linked protoporphyria and congenital erythropoietic porphyria, accumulated porphyrins lead to skin photosensitivity and occasionally also to severe liver damage. Several different options for treatment, proven and innovative ones, are available for most porphyrias.", "tgt": "Porphyrien werden durch Enzymdefekte der H\u00e4mbiosynthese hervorgerufen und anhand spezifischer biochemischer Muster von Porphyrinen und deren Vorl\u00e4ufern in Urin, Stuhl und Blut diagnostiziert. Das jeweilige Muster der akkumulierten Porphyrine, Vorl\u00e4ufer und Derivate ist verbunden mit der klinischen Auspr\u00e4gung, die abdominale, neurologische, psychiatrische, endokrine, kardiovaskul\u00e4re Symptome, Leberschaden und/oder Lichtempfindlichkeit der Haut umfassen kann. Klinisch werden akute und nichtakute Porphyrien unterschieden. Bei symptomatischen (klinisch aktiven), akuten hepatischen Porphyrien \u2013\u00a0hierzu geh\u00f6ren akute intermittierende Porphyrie, Porphyria variegata, heredit\u00e4re Koproporphyrie und Doss-Porphyrie\u00a0\u2013 kommt es aufgrund einer Regulationsst\u00f6rung zur Kumulation der Porphyrinvorl\u00e4ufer 5\u2011Aminol\u00e4vulins\u00e4ure und Porphobilinogen. Bei den nichtakuten Formen \u2013\u00a0u.\u202fa. Porphyria cutanea tarda, erythropoetische und X\u2011chromosomale Protoporphyrie sowie kongenitale erythropoetische Porphyrie\u00a0\u2013 f\u00fchren akkumulierte Porphyrine zu Lichtempfindlichkeit (Fotodermatose) und mitunter auch zu schweren Lebersch\u00e4den. Zur Therapie der Porphyrien stehen sowohl bew\u00e4hrte und sichere als auch innovative Optionen zur Verf\u00fcgung.", "term_pairs": []}
{"idx": 5278, "pair_id": "34185219", "src": "For many years surgery, radiotherapy and chemotherapy dominated the treatment in head and neck malignancies. Refinements of the particular techniques, either in surgery or in radiooncology, brought some progress. However, clinical outcome data are still not satisfying and side effects and long term toxicities are significant. Apart of the improvement of overall results, the reduction of side effects stays a\u00a0main goal in this field. Targeted therapies as well as immune modulating therapies represent a\u00a0new generation in the treatment of cancer. The development of new and highly effective substances makes rapid progress and immunotherapy has become a\u00a0standard in the treatment of recurrent head and neck cancer. The following chapter will give you an actual review about the status quo of immunotherapy in head neck malignancies.", "tgt": "Chirurgie, Strahlentherapie und Chemotherapie dominierten \u00fcber Jahrzehnte die Behandlung von Kopf-Hals-Malignomen. Weiterentwicklungen in diesen Behandlungsabl\u00e4ufen, sei es in der Chirurgie oder in der Strahlentherapie, haben die onkologischen Ergebnisse verbessert. Das Langzeit\u00fcberleben ist aber nach wie vor nicht zufriedenstellend und das Nebenwirkungsprofil der Therapien ist hoch. Daher sind die Verbesserung des Gesamt\u00fcberlebens und die Reduktion von Nebenwirkungen nach wie vor das Hauptziel in der Behandlung von Kopf-Hals-Tumoren. Immunmodulierende und zielgerichtete Therapien stellen heute die neue Generation in der onkologischen Behandlung dar. Die Entwicklung neuer Substanzen, die durch ihre Beeinflussung des Immunsystems das Tumorwachstum beeinflussen k\u00f6nnen, hat sich in den letzten Jahren rasch beschleunigt und die Immuntherapie wurde zum Standard in der Behandlung von rezidivierten Kopf-Hals-Tumoren. Das folgende Kapitel stellt eine \u00dcbersicht \u00fcber den Status quo der Immuntherapie bei Kopf-Hals-Malignomen dar.", "term_pairs": [{"src": {"text": "surgery", "char_start": 15, "char_end": 22, "token_start": 3, "token_end": 4}, "tgt": {"text": "Chirurgie", "char_start": 0, "char_end": 9, "token_start": 0, "token_end": 1}}, {"src": {"text": "radiotherapy", "char_start": 24, "char_end": 36, "token_start": 5, "token_end": 6}, "tgt": {"text": "Strahlentherapie", "char_start": 11, "char_end": 27, "token_start": 2, "token_end": 3}}, {"src": {"text": "chemotherapy", "char_start": 41, "char_end": 53, "token_start": 7, "token_end": 8}, "tgt": {"text": "Chemotherapie", "char_start": 32, "char_end": 45, "token_start": 4, "token_end": 5}}, {"src": {"text": "head and neck malignancies", "char_start": 81, "char_end": 107, "token_start": 12, "token_end": 16}, "tgt": {"text": "Kopf-Hals-Malignomen", "char_start": 93, "char_end": 113, "token_start": 11, "token_end": 16}}, {"src": {"text": "side effects", "char_start": 273, "char_end": 285, "token_start": 44, "token_end": 46}, "tgt": {"text": "Nebenwirkungen", "char_start": 458, "char_end": 472, "token_start": 65, "token_end": 66}}, {"src": {"text": "targeted therapies", "char_start": 436, "char_end": 454, "token_start": 74, "token_end": 76}, "tgt": {"text": "zielgerichtete Therapien", "char_start": 563, "char_end": 587, "token_start": 83, "token_end": 85}}, {"src": {"text": "immune modulating therapies", "char_start": 466, "char_end": 493, "token_start": 79, "token_end": 82}, "tgt": {"text": "Immunmodulierende", "char_start": 541, "char_end": 558, "token_start": 81, "token_end": 82}}, {"src": {"text": "immunotherapy", "char_start": 629, "char_end": 642, "token_start": 104, "token_end": 105}, "tgt": {"text": "Immuntherapie", "char_start": 836, "char_end": 849, "token_start": 122, "token_end": 123}}, {"src": {"text": "head and neck cancer", "char_start": 695, "char_end": 715, "token_start": 114, "token_end": 118}, "tgt": {"text": "Kopf-Hals-Tumoren", "char_start": 522, "char_end": 539, "token_start": 75, "token_end": 80}}, {"src": {"text": "head neck malignancies", "char_start": 811, "char_end": 833, "token_start": 135, "token_end": 138}, "tgt": {"text": "Kopf-Hals-Malignomen", "char_start": 1009, "char_end": 1029, "token_start": 150, "token_end": 155}}]}
{"idx": 5411, "pair_id": "29017219", "src": "Recently, epidemiological data shows an increase of childhood tuberculosis in Germany. In addition to this, drug resistant tuberculosis becomes more frequent. Therefore, diagnosis, prevention and therapy in childhood and adolescence remain a challenge. Adult guidelines do not work for children, as there are age specific differences in manifestation, risk of progression and diagnostic as well as therapeutic pathways.The German Society for Pediatric Infectious Diseases (DGPI) has initiated a consensus-based (S2k) process and completed a paediatric guideline in order to improve and standardize care for children and adolescents with tuberculosis exposure, infection or disease.Updated dosage recommendations take age dependant pharmacokinetics in the treatment of drug sensitive but also drug resistant tuberculosis in account. In addition to this, there is a detailed chapter on perinatal exposure and disease as well as extrapulmonary manifestations.", "tgt": "Aktuelle epidemiologische Daten zeigen in den letzten Jahren einen Anstieg der Tuberkulose im Kindes- und Jugendalter. Es findet sich zudem auch in Deutschland ein Anstieg von Infektionen mit gegen\u00fcber Tuberkulosemedikamenten resistenten Erregern. In diesem Zusammenhang stellt die Diagnose, Pr\u00e4vention und Therapie der Tuberkulose vor allem im Kindesalter eine Herausforderung dar.Leitlinien f\u00fcr die Diagnostik und Therapie der Tuberkulose im Erwachsenenalter k\u00f6nnen nicht generell auf das Kindesalter \u00fcbertragen werden, da hier relevante altersabh\u00e4ngige Unterschiede bzgl. der Krankheitsprogression, Krankheitsmanifestation, Unterschiede in der Anwendung von diagnostischen Ma\u00dfnahmen und der Therapie bestehen.Unter Federf\u00fchrung der Deutschen Gesellschaft f\u00fcr P\u00e4diatrische Infektiologie (DGPI) e.\u200aV. wurde die S2k-Leitlinie f\u00fcr die Diagnostik, Pr\u00e4vention und Therapie der Tuberkulose im Kindes- und Jugendalter verfasst, um die ad\u00e4quate Versorgung von Kindern und Jugendlichen mit Tuberkulose-Exposition, Infektion oder Erkrankung nach neuesten wissenschaftlichen Erkenntnissen zu sichern.Aktualisierte Dosierungsempfehlungen ber\u00fccksichtigen die altersabh\u00e4ngige Pharmakokinetik in der Therapie der medikamentensensiblen, aber auch resistenten Tuberkulose. Dar\u00fcber hinaus werden die Themen perinatale Exposition und Erkrankung sowie die im Kindesalter h\u00e4ufigeren extrapulmonalen Manifestationsformen gesondert behandelt.", "term_pairs": [{"src": {"text": "childhood tuberculosis", "char_start": 52, "char_end": 74, "token_start": 8, "token_end": 10}, "tgt": {"text": "Tuberkulose im Kindes- und Jugendalter", "char_start": 79, "char_end": 117, "token_start": 11, "token_end": 17}}, {"src": {"text": "diagnosis", "char_start": 170, "char_end": 179, "token_start": 27, "token_end": 28}, "tgt": {"text": "Diagnose", "char_start": 282, "char_end": 290, "token_start": 40, "token_end": 41}}, {"src": {"text": "prevention", "char_start": 181, "char_end": 191, "token_start": 29, "token_end": 30}, "tgt": {"text": "Pr\u00e4vention", "char_start": 292, "char_end": 302, "token_start": 42, "token_end": 43}}, {"src": {"text": "therapy", "char_start": 196, "char_end": 203, "token_start": 31, "token_end": 32}, "tgt": {"text": "Therapie", "char_start": 307, "char_end": 315, "token_start": 44, "token_end": 45}}, {"src": {"text": "adult guidelines", "char_start": 253, "char_end": 269, "token_start": 40, "token_end": 42}, "tgt": {"text": "Leitlinien f\u00fcr die Diagnostik und Therapie der Tuberkulose im Erwachsenenalter", "char_start": 382, "char_end": 460, "token_start": 55, "token_end": 65}}, {"src": {"text": "German Society for Pediatric Infectious Diseases", "char_start": 423, "char_end": 471, "token_start": 69, "token_end": 75}, "tgt": {"text": "Deutschen Gesellschaft f\u00fcr P\u00e4diatrische Infektiologie", "char_start": 735, "char_end": 788, "token_start": 101, "token_end": 106}}, {"src": {"text": "DGPI", "char_start": 473, "char_end": 477, "token_start": 76, "token_end": 77}, "tgt": {"text": "DGPI", "char_start": 790, "char_end": 794, "token_start": 107, "token_end": 108}}, {"src": {"text": "paediatric guideline", "char_start": 541, "char_end": 561, "token_start": 91, "token_end": 93}, "tgt": {"text": "S2k-Leitlinie f\u00fcr die Diagnostik, Pr\u00e4vention und Therapie der Tuberkulose im Kindes- und Jugendalter", "char_start": 812, "char_end": 912, "token_start": 115, "token_end": 132}}, {"src": {"text": "tuberculosis exposure", "char_start": 637, "char_end": 658, "token_start": 105, "token_end": 107}, "tgt": {"text": "Tuberkulose-Exposition", "char_start": 983, "char_end": 1005, "token_start": 143, "token_end": 146}}, {"src": {"text": "infection", "char_start": 660, "char_end": 669, "token_start": 108, "token_end": 109}, "tgt": {"text": "Infektion", "char_start": 176, "char_end": 185, "token_start": 28, "token_end": 29}}, {"src": {"text": "disease", "char_start": 673, "char_end": 680, "token_start": 110, "token_end": 111}, "tgt": {"text": "Erkrankung", "char_start": 1022, "char_end": 1032, "token_start": 149, "token_end": 150}}, {"src": {"text": "dosage recommendations", "char_start": 689, "char_end": 711, "token_start": 113, "token_end": 115}, "tgt": {"text": "Dosierungsempfehlungen", "char_start": 1105, "char_end": 1127, "token_start": 158, "token_end": 159}}, {"src": {"text": "pharmacokinetics", "char_start": 731, "char_end": 747, "token_start": 118, "token_end": 119}, "tgt": {"text": "Pharmakokinetik", "char_start": 1164, "char_end": 1179, "token_start": 162, "token_end": 163}}, {"src": {"text": "drug sensitive", "char_start": 768, "char_end": 782, "token_start": 123, "token_end": 125}, "tgt": {"text": "medikamentensensiblen", "char_start": 1200, "char_end": 1221, "token_start": 167, "token_end": 168}}, {"src": {"text": "drug resistant", "char_start": 108, "char_end": 122, "token_start": 18, "token_end": 20}, "tgt": {"text": "resistenten", "char_start": 226, "char_end": 237, "token_start": 32, "token_end": 33}}, {"src": {"text": "perinatal exposure", "char_start": 884, "char_end": 902, "token_start": 144, "token_end": 146}, "tgt": {"text": "perinatale Exposition", "char_start": 1291, "char_end": 1312, "token_start": 179, "token_end": 181}}, {"src": {"text": "extrapulmonary manifestations", "char_start": 926, "char_end": 955, "token_start": 151, "token_end": 153}, "tgt": {"text": "extrapulmonalen Manifestationsformen", "char_start": 1364, "char_end": 1400, "token_start": 188, "token_end": 190}}]}
{"idx": 5433, "pair_id": "33086407", "src": "Since the U.S. adherence instruments VERITAS-PRO and VERITAS-PRN were developed in another healthcare system, we assumed that they are not appropriate for the German solidarity healthcare system. This study aims to evaluate the relevance of these instruments for the German healthcare system both by people with hemophilia (PWH) and by healthcare professionals (HCP). \u2003A total of 50 PWH (23 adult hemophilia patients and 27 parents of children with hemophilia) and 25 HCP rated the relevance of the single items of the VERITAS-PRO and VERITAS-PRN on a 5-point Likert scale. In addition, both groups were asked to make suggestions for additional adherence questions. To investigate the relevance of these instruments, the accordance between the raters' evaluations was determined calculating the content validity index (CVI) and the content validity ratio (CVR) based on the critical values of the CVR (CVR<sub>critical</sub>) to exclude chance and subjectivity. \u2003CVI (CVR) calculations revealed three (5) 'very important' items for PWH and six (11) items for HCP. Only two (3) 'very important' items were evaluated by both groups. Four domains were considered not important by both groups. Six PWH made 14 suggestions and 14 HCP made 24 suggestions for additional adherence questions. \u2003VERITAS-PRO and VERITAS-PRN have only very limited benefits for the German healthcare system. Since nonadherence has a great impact on the morbidity of PWH and on the costs for the healthcare system, there is a need for adherence instruments that are adapted to the specific needs of PWH in the German healthcare system.", "tgt": "ZIEL: \u2003Der Umstand, dass die Adh\u00e4renz-Messinstrumente VERITAS-PRO und VERITAS- PRN f\u00fcr das US-amerikanische Gesundheitssystem entwickelt wurden, l\u00e4sst vermuten, dass sie im solidarisch finanzierten deutschen Gesundheitssystem nur eingeschr\u00e4nkten Nutzen haben. Diese Studie zielt darauf ab, die Relevanz der beiden Instrumente f\u00fcr das deutsche Gesundheitssystem sowohl von Personen mit H\u00e4mophilie (PWH) als auch von Angeh\u00f6rigen der Gesundheitsberufe (HCP) evaluieren zu lassen. \u200350 PWH (23 erwachsene H\u00e4mophilie-Patienten und 27 Eltern von Kindern mit H\u00e4mophilie) und 25 HCP bewerteten die Relevanz der einzelnen VERITAS-PRO und VERITAS-PRN-Items auf einer 5-Punkt-Likert-Skala. Dar\u00fcber hinaus wurden beide Gruppen gebeten, Vorschl\u00e4ge f\u00fcr zus\u00e4tzliche Fragen zur Messung von Adh\u00e4renz zu machen. Um die Relevanz dieser Instrumente zu bestimmen, wurde die \u00dcbereinstimmung zwischen den Expertenurteilen anhand des Inhaltsvalidit\u00e4ts-Indexes (CVI) und des Inhaltsvalidit\u00e4ts-Verh\u00e4ltnisses (CVR) basierend auf den kritischen CVR-Werten (CVR<sub>critical</sub>) berechnet, um somit Zufall und Subjektivit\u00e4t ausschlie\u00dfen zu k\u00f6nnen. \u2003CVI (CVR) Berechnungen ergaben drei (5) \u201esehr wichtige\u201c Items f\u00fcr PWH und sechs (11) Items f\u00fcr HCP. Nur zwei (3) Items wurden von beiden Gruppen als \u201esehr wichtig\u201c bewertet. Vier Dom\u00e4nen wurden von beiden Gruppen als nicht wichtig erachtet. Sechs PWH machten 14 und vierzehn HCP machten 24 Vorschl\u00e4ge f\u00fcr zus\u00e4tzliche Adh\u00e4renz-Fragen. \u2003Im deutschen Gesundheitssystem haben der VERITAS-PRO und der VERITAS-PRN nur sehr eingeschr\u00e4nkten Nutzen. Da Nicht-Adh\u00e4renz deutlich negative Effekte sowohl auf die Morbidit\u00e4t der PWH als auch auf die Kostenentwicklung im deutschen Gesundheitssystem hat, gibt es einen Bedarf an Adh\u00e4renz-Messinstrumenten, die an die spezifischen Bed\u00fcrfnisse von PWH im deutschen Gesundheitssystem angepasst sind.", "term_pairs": [{"src": {"text": "VERITAS-PRO", "char_start": 37, "char_end": 48, "token_start": 8, "token_end": 11}, "tgt": {"text": "VERITAS-PRO", "char_start": 54, "char_end": 65, "token_start": 10, "token_end": 13}}, {"src": {"text": "VERITAS-PRN", "char_start": 53, "char_end": 64, "token_start": 12, "token_end": 15}, "tgt": {"text": "VERITAS-PRN", "char_start": 628, "char_end": 639, "token_start": 105, "token_end": 108}}, {"src": {"text": "hemophilia", "char_start": 312, "char_end": 322, "token_start": 55, "token_end": 56}, "tgt": {"text": "H\u00e4mophilie", "char_start": 385, "char_end": 395, "token_start": 60, "token_end": 61}}, {"src": {"text": "PWH", "char_start": 324, "char_end": 327, "token_start": 57, "token_end": 58}, "tgt": {"text": "PWH", "char_start": 397, "char_end": 400, "token_start": 62, "token_end": 63}}, {"src": {"text": "healthcare professionals", "char_start": 336, "char_end": 360, "token_start": 61, "token_end": 63}, "tgt": {"text": "Angeh\u00f6rigen der Gesundheitsberufe", "char_start": 415, "char_end": 448, "token_start": 67, "token_end": 70}}, {"src": {"text": "HCP", "char_start": 362, "char_end": 365, "token_start": 64, "token_end": 65}, "tgt": {"text": "HCP", "char_start": 450, "char_end": 453, "token_start": 71, "token_end": 72}}, {"src": {"text": "Likert scale", "char_start": 560, "char_end": 572, "token_start": 109, "token_end": 111}, "tgt": {"text": "Likert-Skala", "char_start": 664, "char_end": 676, "token_start": 116, "token_end": 119}}, {"src": {"text": "content validity index", "char_start": 795, "char_end": 817, "token_start": 146, "token_end": 149}, "tgt": {"text": "Inhaltsvalidit\u00e4ts-Indexes", "char_start": 909, "char_end": 934, "token_start": 154, "token_end": 157}}, {"src": {"text": "CVI", "char_start": 819, "char_end": 822, "token_start": 150, "token_end": 151}, "tgt": {"text": "CVI", "char_start": 936, "char_end": 939, "token_start": 158, "token_end": 159}}, {"src": {"text": "content validity ratio", "char_start": 832, "char_end": 854, "token_start": 154, "token_end": 157}, "tgt": {"text": "Inhaltsvalidit\u00e4ts-Verh\u00e4ltnisses", "char_start": 949, "char_end": 980, "token_start": 162, "token_end": 165}}, {"src": {"text": "CVR", "char_start": 856, "char_end": 859, "token_start": 158, "token_end": 159}, "tgt": {"text": "CVR", "char_start": 982, "char_end": 985, "token_start": 166, "token_end": 167}}, {"src": {"text": "CVR<sub>critical</sub>", "char_start": 902, "char_end": 924, "token_start": 169, "token_end": 178}, "tgt": {"text": "CVR<sub>critical</sub>", "char_start": 1028, "char_end": 1050, "token_start": 176, "token_end": 185}}, {"src": {"text": "morbidity", "char_start": 1425, "char_end": 1434, "token_start": 279, "token_end": 280}, "tgt": {"text": "Morbidit\u00e4t", "char_start": 1622, "char_end": 1632, "token_start": 295, "token_end": 296}}]}
{"idx": 5592, "pair_id": "29589364", "src": "Atopaxar, also known as E 5555 is a novel reversible protease-activated receptor-1 (PAR-1) thrombin receptor antagonist. To date, Atopaxar has been investigated in phase II trials with focus on safety and tolerability in patients with acute coronary syndromes or stable coronary artery disease on top of standard antiplatelet therapy. Atopaxar was generally well tolerated, however a rise in liver enzymes and prolongation of the QTcF interval were observed. The data suggest, that atopaxar administration may promote some minor bleeding complications, but does not seem to significantly increase the risk of major bleeding. Although not powered for efficacy, the currently available data suggest potential benefits in patients at high risk for recurrent ischemic events on top of standard antiplatelet therapy. In conclusion, more studies (e.g. phase III) are needed to evaluate efficacy and safety of atopaxar.", "tgt": "Atopaxar, auch bekannt als E 5555 ist ein neuer, reversibler Antagonist des Thrombin Protease-aktivierten Rezeptors-1 (PAR-1). Atopaxar wurde bisher in Phase-II-Studien in Hinblick auf Sicherheit und Vertr\u00e4glichkeit bei Patienten mit akutem Koronarsyndrom oder stabiler koronarer Herzkrankheit zus\u00e4tzlich zur antithrombozyt\u00e4ren Standardtherapie untersucht. Atopaxar wurde im Allgemeinen gut vertragen, jedoch waren eine Erh\u00f6hung der Leberenzyme und eine Verl\u00e4ngerung der QTZeit auff\u00e4llig. Die zus\u00e4tzliche Einnahme von Atopaxar scheint zu einer Zunahme leichter Blutungskomplikationen zu f\u00fchren, jedoch ohne das Auftreten schwerwiegender Blutungskomplikationen relevant zu erh\u00f6hen. Obwohl bisherige Studien nicht prim\u00e4r die Wirksamkeit von Atopaxar untersuchten, gibt es Hinweise daf\u00fcr dass Patienten mit hohem Risiko f\u00fcr das Auftreten isch\u00e4mischer Ereignisse von der zus\u00e4tzlichen Einnahme von Atopaxar prof\u00edtieren. Weitere (Phase-III-)Studien sind n\u00f6tig, die Wirksamkeit und Sicherheit von Atopaxar untersuchen.", "term_pairs": [{"src": {"text": "Atopaxar", "char_start": 0, "char_end": 8, "token_start": 0, "token_end": 1}, "tgt": {"text": "Atopaxar", "char_start": 0, "char_end": 8, "token_start": 0, "token_end": 1}}, {"src": {"text": "E 5555", "char_start": 24, "char_end": 30, "token_start": 5, "token_end": 7}, "tgt": {"text": "E 5555", "char_start": 27, "char_end": 33, "token_start": 5, "token_end": 7}}, {"src": {"text": "protease-activated receptor-1 (PAR-1)", "char_start": 53, "char_end": 90, "token_start": 11, "token_end": 22}, "tgt": {"text": "Protease-aktivierten Rezeptors-1 (PAR-1)", "char_start": 85, "char_end": 125, "token_start": 15, "token_end": 26}}, {"src": {"text": "thrombin receptor antagonist", "char_start": 91, "char_end": 119, "token_start": 22, "token_end": 25}, "tgt": {"text": "Antagonist des Thrombin", "char_start": 61, "char_end": 84, "token_start": 12, "token_end": 15}}, {"src": {"text": "phase II trials", "char_start": 164, "char_end": 179, "token_start": 34, "token_end": 37}, "tgt": {"text": "Phase-II-Studien", "char_start": 152, "char_end": 168, "token_start": 31, "token_end": 36}}, {"src": {"text": "acute coronary syndromes", "char_start": 235, "char_end": 259, "token_start": 46, "token_end": 49}, "tgt": {"text": "akutem Koronarsyndrom", "char_start": 234, "char_end": 255, "token_start": 45, "token_end": 47}}, {"src": {"text": "stable coronary artery disease", "char_start": 263, "char_end": 293, "token_start": 50, "token_end": 54}, "tgt": {"text": "stabiler koronarer Herzkrankheit", "char_start": 261, "char_end": 293, "token_start": 48, "token_end": 51}}, {"src": {"text": "antiplatelet therapy", "char_start": 313, "char_end": 333, "token_start": 58, "token_end": 60}, "tgt": {"text": "antithrombozyt\u00e4ren Standardtherapie", "char_start": 309, "char_end": 344, "token_start": 53, "token_end": 55}}, {"src": {"text": "liver enzymes", "char_start": 392, "char_end": 405, "token_start": 71, "token_end": 73}, "tgt": {"text": "Leberenzyme", "char_start": 433, "char_end": 444, "token_start": 69, "token_end": 70}}, {"src": {"text": "QTcF interval", "char_start": 430, "char_end": 443, "token_start": 77, "token_end": 79}, "tgt": {"text": "QTZeit", "char_start": 471, "char_end": 477, "token_start": 74, "token_end": 75}}, {"src": {"text": "bleeding complications", "char_start": 529, "char_end": 551, "token_start": 93, "token_end": 95}, "tgt": {"text": "Blutungskomplikationen", "char_start": 561, "char_end": 583, "token_start": 87, "token_end": 88}}, {"src": {"text": "major bleeding", "char_start": 609, "char_end": 623, "token_start": 106, "token_end": 108}, "tgt": {"text": "schwerwiegender Blutungskomplikationen", "char_start": 621, "char_end": 659, "token_start": 95, "token_end": 97}}, {"src": {"text": "phase III", "char_start": 846, "char_end": 855, "token_start": 148, "token_end": 150}, "tgt": {"text": "Phase-III", "char_start": 924, "char_end": 933, "token_start": 136, "token_end": 139}}]}
{"idx": 5926, "pair_id": "30516447", "src": "Preparedness to provide care in relation to the satisfaction with hospital discharge planning and level of knowledge of relatives to elderly patients Abstract. Relatives are a great resource for older people who are discharged after hospitalization. Studies have so far shown very little about the readiness of relatives to aid in caregiving. The study examined if relatives showed a relationship between readiness to provide care and satisfaction with hospital discharge management as well as group differences between well-informed and less informed relatives. In addition to demographic data, the preparedness to provide care, satisfaction and extent of knowledge of relatives were surveyed using a retrospective cross-sectional study. Analyses were made of the relationship between preparedness to provide care and satisfaction with hospital discharge management, as well as group differences between informed and less informed relatives in terms of their preparedness to provide care. Of the 111 relatives, the majority were adult offspring (55.9 %) and partners (32.4 %) that participated in the study. A weak correlation was detected between the satisfaction with the hospital discharge planning of relatives and their willingness to provide care (rs = -0.113, p = 0.267). The group differences between well-informed and less informed relatives were significant (t(102) = 2.301, p = 0.023). Relatives that evaluated themselves as well informed are more likely to be in the position to provide informal care. Therefore, it is necessary to involve relatives more in the planning of hospital discharges and to inform them better. Experimental studies are necessary to find out if the preparedness to provide care can be increased through good discharge planning and specific information provision.", "tgt": "Zusammenfassung. Hintergrund: Angeh\u00f6rige stellen f\u00fcr \u00e4ltere Menschen, die nach einer Hospitalisation entlassen werden, eine gro\u00dfe Ressource dar. Aus Studien ist bisher sehr wenig \u00fcber die Pflegebereitschaft von Angeh\u00f6rigen bekannt. Ziel: Die Studie untersuchte, ob es bei Angeh\u00f6rigen einen Zusammenhang zwischen der Bereitschaft zur Pflege und der Zufriedenheit mit dem Austrittsmanagement sowie Gruppenunterschiede zwischen gut informierten und weniger gut informierten Angeh\u00f6rigen gibt. Methode: Mittels einer retrospektiven Querschnittstudie wurden neben den demografischen Daten die Bereitschaft zur Pflege, die Zufriedenheit und Informiertheit von Angeh\u00f6rigen erhoben. Analysen wurden zum Zusammenhang zwischen der Bereitschaft und der Zufriedenheit sowie zu Gruppenunterschieden zwischen informierten und weniger informierten Angeh\u00f6rigen, in Bezug auf ihre Bereitschaft, Pflege zu \u00fcbernehmen, gemacht. Ergebnisse: 111 Angeh\u00f6rige, mehrheitlich erwachsene Nachkommen (55,9 %) und Partner (32,4 %), nahmen an der Studie teil. Es konnte eine schwache Korrelation zwischen der Zufriedenheit mit der Austrittsplanung von Angeh\u00f6rigen und deren Bereitschaft, Pflege zu \u00fcbernehmen, nachgewiesen werden (rs = \u22120,113, p = 0,267). Die Gruppenunterschiede zwischen gut informierten und weniger gut informierten Angeh\u00f6rigen waren signifikant (t(102) = 2,301, p = 0,023). Schlussfolgerung: Angeh\u00f6rige, die sich als besser informiert zeigten, f\u00fchlten sich auch eher in der Lage, Pflege zu \u00fcbernehmen. Deshalb ist es notwendig, Angeh\u00f6rige vermehrt in die Austrittsplanung einzubeziehen und besser zu informieren. Experimentelle Studien sind notwendig, um herauszufinden, ob die Pflegebereitschaft, mithilfe einer guten Austrittsplanung und gezielter Informationsabgabe, erh\u00f6ht werden kann.", "term_pairs": [{"src": {"text": "hospital discharge planning", "char_start": 66, "char_end": 93, "token_start": 10, "token_end": 13}, "tgt": {"text": "Austrittsplanung", "char_start": 1100, "char_end": 1116, "token_start": 165, "token_end": 166}}, {"src": {"text": "preparedness to provide care", "char_start": 0, "char_end": 28, "token_start": 0, "token_end": 4}, "tgt": {"text": "Bereitschaft zur Pflege", "char_start": 316, "char_end": 339, "token_start": 49, "token_end": 52}}, {"src": {"text": "satisfaction", "char_start": 48, "char_end": 60, "token_start": 8, "token_end": 9}, "tgt": {"text": "Zufriedenheit", "char_start": 348, "char_end": 361, "token_start": 54, "token_end": 55}}, {"src": {"text": "level of knowledge", "char_start": 98, "char_end": 116, "token_start": 14, "token_end": 17}, "tgt": {"text": "Informiertheit", "char_start": 634, "char_end": 648, "token_start": 89, "token_end": 90}}, {"src": {"text": "relatives", "char_start": 120, "char_end": 129, "token_start": 18, "token_end": 19}, "tgt": {"text": "Angeh\u00f6rige", "char_start": 30, "char_end": 40, "token_start": 4, "token_end": 5}}, {"src": {"text": "elderly patients", "char_start": 133, "char_end": 149, "token_start": 20, "token_end": 22}, "tgt": {"text": "\u00e4ltere Menschen", "char_start": 53, "char_end": 68, "token_start": 7, "token_end": 9}}, {"src": {"text": "hospital discharge management", "char_start": 453, "char_end": 482, "token_start": 71, "token_end": 74}, "tgt": {"text": "Austrittsmanagement", "char_start": 370, "char_end": 389, "token_start": 57, "token_end": 58}}, {"src": {"text": "retrospective cross-sectional study", "char_start": 702, "char_end": 737, "token_start": 111, "token_end": 116}, "tgt": {"text": "retrospektiven Querschnittstudie", "char_start": 512, "char_end": 544, "token_start": 74, "token_end": 76}}, {"src": {"text": "demographic data", "char_start": 578, "char_end": 594, "token_start": 91, "token_end": 93}, "tgt": {"text": "demografischen Daten", "char_start": 562, "char_end": 582, "token_start": 79, "token_end": 81}}, {"src": {"text": "group differences", "char_start": 494, "char_end": 511, "token_start": 77, "token_end": 79}, "tgt": {"text": "Gruppenunterschiede", "char_start": 396, "char_end": 415, "token_start": 59, "token_end": 60}}, {"src": {"text": "well-informed", "char_start": 520, "char_end": 533, "token_start": 80, "token_end": 83}, "tgt": {"text": "gut informierten", "char_start": 425, "char_end": 441, "token_start": 61, "token_end": 63}}, {"src": {"text": "less informed", "char_start": 538, "char_end": 551, "token_start": 84, "token_end": 86}, "tgt": {"text": "weniger gut informierten", "char_start": 446, "char_end": 470, "token_start": 64, "token_end": 67}}, {"src": {"text": "informal care", "char_start": 1500, "char_end": 1513, "token_start": 268, "token_end": 270}, "tgt": {"text": "Pflege", "char_start": 188, "char_end": 194, "token_start": 30, "token_end": 31}}, {"src": {"text": "experimental studies", "char_start": 1634, "char_end": 1654, "token_start": 292, "token_end": 294}, "tgt": {"text": "Experimentelle Studien", "char_start": 1602, "char_end": 1624, "token_start": 261, "token_end": 263}}]}
{"idx": 5942, "pair_id": "30522380", "src": "Possibilities for Suicide Prevention Through Architecture in Child and Adolescent Psychiatry Abstract. In Germany, departments of Child and Adolescent Psychiatry are responsible for the treatment of young people with acute suicidal tendencies. Therefore, it is important to consider means of preventing suicide already during the construction and business operations of these institutions. Approaches to structural suicide prevention can be divided into restrictive and atmospheric-therapeutic measures. The latter includes ways to create an antisuicidal environment and to establish a setting amenable to close support and care by mental-health professionals. Restrictive measures comprise security measures and means of avoiding potential hazards, for example, through life-threatening jumps (e. g., staircases) or intentional strangulation (e. g., employing materials with predetermined breaking points). In addition to security issues, architectural and creative aspects must be incorporated to enable a suicide-preventive atmosphere, that is, satisfying protective needs, creating positive distractions (panoramic views, activities, occupational therapy opportunities), and using positive physiological and natural influences (such as colors and light). Secure access to a pleasant and protected external area as well as exercise spaces is also essential. Architects and construction managers should work closely with the institution's health personnel (e. g., doctors, therapists, and psychiatric nursing staff) during the planning stages for Departments of Child and Adolescent Psychiatry in order to come up with solutions that comprise appropriate, practical, and functional requirements and safety-restrictive measures. Thus, an inviting and atmospherically pleasant space can be created that simultaneously provides suicide prevention and protection, where adolescents with psychiatric disorders can be treated by mental-health professionals.", "tgt": "Zusammenfassung. Da in Kliniken f\u00fcr Kinder- und Jugendpsychiatrie auch Jugendliche mit akuter Suizidalit\u00e4t behandelt werden, sind beim Bau und Unterhalt solcher Kliniken suizidpr\u00e4ventive Ma\u00dfnahmen zu ber\u00fccksichtigen. Die Ans\u00e4tze der baulichen Suizidpr\u00e4vention lassen sich in restriktive und atmosph\u00e4risch-therapeutische Ma\u00dfnahmen unterteilen. Letztere umfassen Ma\u00dfnahmen zur Schaffung eines antisuizidalen Milieus und zur engen Begleitung der Patienten und Patientinnen durch die Mitarbeiter. Unter restriktiven Ma\u00dfnahmen sind die Sicherung von potenziellen Sprung- sowie die Reduzierung von Strangulationsm\u00f6glichkeiten, zum Beispiel durch die Verwendung von Materialien mit Sollbruchstellen, zu verstehen. Neben suizidpr\u00e4ventiver sichernder Gestaltung sind zur Schaffung einer solchen suizidpr\u00e4ventiven Atmosph\u00e4re architektonisch-gestalterische Aspekte zu ber\u00fccksichtigen, wie zum Beispiel Befriedigung des Schutzbed\u00fcrfnisses, Schaffung positiver Ablenkung (Blick in Natur, Besch\u00e4ftigungsm\u00f6glichkeiten) und die Nutzung positiver physiologischer Wirkung (durch Licht, Farben). Ein gesicherter Zugang zu einem ansprechenden und gleichzeitig gesch\u00fctzten Au\u00dfenbereich sowie zu Bewegungsr\u00e4umen ist ebenfalls zu ber\u00fccksichtigen. Bereits in der Planung einer kinder- und jugendpsychiatrischen Klinik sollten sich Architekten und Bauplaner eng mit \u00c4rzten, Therapeuten und Mitarbeitern des Pflege- und Erziehungsdienstes austauschen und restriktive Ma\u00dfnahmen hinsichtlich Praktikabilit\u00e4t und funktionellen Abl\u00e4ufen abstimmen. So kann kooperativ ein suizidpr\u00e4ventiver, ebenso sichernder wie atmosph\u00e4risch ansprechender altersgerechter Ort entstehen, an dem Jugendliche mit psychischen St\u00f6rungen mit therapeutischer Unterst\u00fctzung und fachpflegerisch-p\u00e4dagogischer Begleitung behandelt werden k\u00f6nnen.", "term_pairs": []}
{"idx": 6111, "pair_id": "34255348", "src": "How parents think and feel about their young children has implications for the parent-child relationship. We examined prospective associations between prenatal descriptions of the unborn child's personality and later parenting behavior. Pregnant women (N = 120; mean age = 26.16, SD = 5.71) were recruited in their third trimester for a longitudinal study. The sample is demographically diverse and predominantly economically disadvantaged. During prenatal interviews, women described their unborn child's personality, from which positive and negative emotion words were coded. Parenting behavior was coded 12 months postpartum (n = 105 for longitudinal analyses). Use of positive and negative words was negatively correlated (r = -.34, p\u00a0<\u00a0.001). Greater use of positive words to describe the unborn child's personality was associated with higher observed sensitivity, warmth, and engagement during mother-infant interactions, whereas negative words were associated with higher interference and lower levels of sensitivity. Mothers who used anxiety- and/or anger-related words to describe their unborn child, relative to mothers who did not, demonstrated higher interference and lower warmth and sensitivity. Descriptions of a child's personality before the child is born were associated with postnatal parenting behavior. Prenatal interventions that address negative thoughts and feelings regarding the child may be beneficial for promoting positive parenting postnatally.", "tgt": "Die Emotionalit\u00e4t im Tonfall bei der Beschreibung von Kindern w\u00e4hrend der Schwangerschaft ist mit dem sp\u00e4teren Erziehungsverhalten assoziiert Einleitung: Wie Eltern \u00fcber ihre kleinen Kinder denken und f\u00fchlen, hat Auswirkungen auf die Eltern-Kind-Beziehung. Wir untersuchten prospektive Assoziationen zwischen pr\u00e4natalen Beschreibungen der Pers\u00f6nlichkeit des ungeborenen Kindes und sp\u00e4terem Erziehungsverhalten. Methoden: F\u00fcr die L\u00e4ngsschnittstudie wurden schwangere Frauen (N = 120; mittleres Alter = 26,16, SD = 5,71) im dritten Trimester rekrutiert. Die Stichprobe ist demographisch vielf\u00e4ltig und \u00fcberwiegend sozio\u00f6konomisch benachteiligt. In pr\u00e4natalen Interviews sollten die Frauen die Pers\u00f6nlichkeit ihres ungeborenen Kindes beschreiben. Daraus wurden positive und negative Emotionsw\u00f6rter kodiert. 12 Monate postpartum wurde das Erziehungsverhalten kodiert (n = 105 f\u00fcr L\u00e4ngsschnittanalysen). Ergebnisse: Der Gebrauch von positiven und negativen W\u00f6rtern war negativ korreliert (r = \u2212.34, p<.001). Eine st\u00e4rkere Verwendung positiver W\u00f6rter zur Beschreibung der Pers\u00f6nlichkeit des ungeborenen Kindes war mit h\u00f6herer beobachteter Sensibilit\u00e4t, W\u00e4rme und Engagement w\u00e4hrend der Mutter-Kind-Interaktionen assoziiert, w\u00e4hrend negative W\u00f6rter mit h\u00f6herer Interferenz und geringerer Sensibilit\u00e4t assoziiert waren. M\u00fctter, die \u00e4ngstliche und/oder \u00e4rgerliche W\u00f6rter zur Beschreibung ihres ungeborenen Kindes verwendeten, zeigten im Vergleich zu M\u00fcttern, die dies nicht taten, h\u00f6here Interferenz sowie geringere W\u00e4rme und Sensibilit\u00e4t. Schlussfolgerung: Beschreibungen der kindlichen Pers\u00f6nlichkeit vor der Geburt des Kindes waren mit dem postnatalen Erziehungsverhalten assoziiert. Pr\u00e4natale Interventionen, die auf negative Gedanken und Gef\u00fchle in Bezug auf das Kind abzielen, k\u00f6nnten f\u00fcr die F\u00f6rderung eines positiven Elternverhaltens nach der Geburt von Vorteil sein.", "term_pairs": [{"src": {"text": "parent-child relationship", "char_start": 79, "char_end": 104, "token_start": 13, "token_end": 17}, "tgt": {"text": "Eltern-Kind-Beziehung", "char_start": 234, "char_end": 255, "token_start": 34, "token_end": 39}}, {"src": {"text": "prenatal", "char_start": 151, "char_end": 159, "token_start": 23, "token_end": 24}, "tgt": {"text": "pr\u00e4natalen", "char_start": 309, "char_end": 319, "token_start": 45, "token_end": 46}}, {"src": {"text": "unborn child's personality", "char_start": 180, "char_end": 206, "token_start": 27, "token_end": 32}, "tgt": {"text": "Pers\u00f6nlichkeit des ungeborenen Kindes", "char_start": 339, "char_end": 376, "token_start": 48, "token_end": 52}}, {"src": {"text": "parenting behavior", "char_start": 217, "char_end": 235, "token_start": 34, "token_end": 36}, "tgt": {"text": "Erziehungsverhalten", "char_start": 111, "char_end": 130, "token_start": 16, "token_end": 17}}, {"src": {"text": "Pregnant women", "char_start": 237, "char_end": 251, "token_start": 37, "token_end": 39}, "tgt": {"text": "schwangere Frauen", "char_start": 455, "char_end": 472, "token_start": 62, "token_end": 64}}, {"src": {"text": "third trimester", "char_start": 315, "char_end": 330, "token_start": 61, "token_end": 63}, "tgt": {"text": "dritten Trimester", "char_start": 522, "char_end": 539, "token_start": 83, "token_end": 85}}, {"src": {"text": "longitudinal study", "char_start": 337, "char_end": 355, "token_start": 65, "token_end": 67}, "tgt": {"text": "L\u00e4ngsschnittstudie", "char_start": 429, "char_end": 447, "token_start": 60, "token_end": 61}}, {"src": {"text": "prenatal interviews", "char_start": 448, "char_end": 467, "token_start": 79, "token_end": 81}, "tgt": {"text": "pr\u00e4natalen Interviews", "char_start": 646, "char_end": 667, "token_start": 98, "token_end": 100}}, {"src": {"text": "positive and negative emotion words", "char_start": 530, "char_end": 565, "token_start": 93, "token_end": 98}, "tgt": {"text": "positive und negative Emotionsw\u00f6rter", "char_start": 758, "char_end": 794, "token_start": 112, "token_end": 116}}, {"src": {"text": "12 months postpartum", "char_start": 607, "char_end": 627, "token_start": 105, "token_end": 108}, "tgt": {"text": "12 Monate postpartum", "char_start": 804, "char_end": 824, "token_start": 118, "token_end": 121}}, {"src": {"text": "longitudinal analyses", "char_start": 641, "char_end": 662, "token_start": 113, "token_end": 115}, "tgt": {"text": "L\u00e4ngsschnittanalysen", "char_start": 876, "char_end": 896, "token_start": 130, "token_end": 131}}, {"src": {"text": "positive and negative words", "char_start": 672, "char_end": 699, "token_start": 119, "token_end": 123}, "tgt": {"text": "positiven und negativen W\u00f6rtern", "char_start": 928, "char_end": 959, "token_start": 138, "token_end": 142}}, {"src": {"text": "sensitivity", "char_start": 857, "char_end": 868, "token_start": 157, "token_end": 158}, "tgt": {"text": "Sensibilit\u00e4t", "char_start": 1133, "char_end": 1145, "token_start": 174, "token_end": 175}}, {"src": {"text": "warmth", "char_start": 870, "char_end": 876, "token_start": 159, "token_end": 160}, "tgt": {"text": "W\u00e4rme", "char_start": 1147, "char_end": 1152, "token_start": 176, "token_end": 177}}, {"src": {"text": "engagement", "char_start": 882, "char_end": 892, "token_start": 162, "token_end": 163}, "tgt": {"text": "Engagement", "char_start": 1157, "char_end": 1167, "token_start": 178, "token_end": 179}}, {"src": {"text": "mother-infant interactions", "char_start": 900, "char_end": 926, "token_start": 164, "token_end": 168}, "tgt": {"text": "Mutter-Kind-Interaktionen", "char_start": 1180, "char_end": 1205, "token_start": 181, "token_end": 186}}, {"src": {"text": "interference", "char_start": 979, "char_end": 991, "token_start": 176, "token_end": 177}, "tgt": {"text": "Interferenz", "char_start": 1254, "char_end": 1265, "token_start": 193, "token_end": 194}}, {"src": {"text": "anxiety- and/or anger-related words", "char_start": 1042, "char_end": 1077, "token_start": 186, "token_end": 195}, "tgt": {"text": "\u00e4ngstliche und/oder \u00e4rgerliche W\u00f6rter", "char_start": 1324, "char_end": 1361, "token_start": 203, "token_end": 209}}, {"src": {"text": "postnatal parenting behavior", "char_start": 1294, "char_end": 1322, "token_start": 232, "token_end": 235}, "tgt": {"text": "postnatalen Erziehungsverhalten", "char_start": 1634, "char_end": 1665, "token_start": 249, "token_end": 251}}, {"src": {"text": "Prenatal interventions", "char_start": 1324, "char_end": 1346, "token_start": 236, "token_end": 238}, "tgt": {"text": "Pr\u00e4natale Interventionen", "char_start": 1678, "char_end": 1702, "token_start": 253, "token_end": 255}}]}
{"idx": 6112, "pair_id": "34256390", "src": "There is evidence that health care professionals are uncertain about the legal framework when suspicion of child abuse or neglect is raised. This could result in inconsistent handling of such cases, putting children at risk in further danger. The present study was intended to provide an empirical basis for examining the knowledge of the legal framework among health care professionals. A survey of child and youth physicians, child surgeons, child and adolescent psychiatrists as well as psychotherapists working in Germany was carried out to obtain information on the general conditions. In all occupational groups, a majority of respondents feel insecure about the application of the legal framework on particular cases. Only a minority can correctly reflect the legal regulations of the Federal Child Protection Act ('Bundeskinderschutzgesetz'). Experience with child abuse cases doubled the odds to correctly understanding legal frameworks. Having attended training courses showed no impact. There is little knowledge of the legal framework in child protection. There is a need to improve training and provide low-threshold counselling services, especially for professionals with little experience in child protection cases.", "tgt": "Es gibt Hinweise, dass Fachkr\u00e4fte im Gesundheitswesen unsicher in Bezug auf die rechtlichen Rahmenbedingungen sind, wenn sie in Kontakt mit Kindern kommen, bei denen der Verdacht auf eine Kindeswohlgef\u00e4hrdung aufgekommen ist. Hieraus k\u00f6nnte sich ein inkonsistenter Umgang mit derartigen F\u00e4llen ergeben, der im schlimmsten Fall zu einer weiteren Gef\u00e4hrdung betroffener Kinder f\u00fchrt. Mit der vorliegenden Studie sollte eine empirische Grundlage geschaffen werden, um die Kenntnis des Rechtsrahmens bei Fachkr\u00e4ften im Gesundheitswesen zu untersuchen. Es erfolgte eine Befragung in Deutschland t\u00e4tiger Kinder- und Jugendmediziner, Kinderchirurgen, Kinder- und Jugendpsychiatern sowie psychologischer und Kinder- und Jugendlichenpsychotherapeuten zur Kenntnis der Rahmenbedingungen. In allen Berufsgruppen f\u00fchlt sich eine Mehrzahl der Befragten unsicher in der Anwendung des Rechtsrahmens im Alltag. Nur eine Minderheit kann die rechtlichen Regelungen des Bundeskinderschutzgesetzes korrekt wiedergeben. Erfahrung mit Kinderschutzf\u00e4llen verdoppelte die Wahrscheinlichkeit, den Rechtsrahmen korrekt wiederzugeben. Der Besuch von Fortbildungen zeigte hingegen keinen Einfluss. Die Kenntnisse zum rechtlichen Rahmen bei Kindswohlgef\u00e4hrdung sind gering. Es gilt, insbesondere f\u00fcr Fachkr\u00e4fte mit geringer Erfahrung in Kinderschutzf\u00e4llen, die Weiterbildung zu verbessern und niedrigschwellige Angebote zur Beratung anzubieten.", "term_pairs": [{"src": {"text": "health care professionals", "char_start": 23, "char_end": 48, "token_start": 4, "token_end": 7}, "tgt": {"text": "Fachkr\u00e4fte im Gesundheitswesen", "char_start": 23, "char_end": 53, "token_start": 5, "token_end": 8}}, {"src": {"text": "child abuse", "char_start": 107, "char_end": 118, "token_start": 16, "token_end": 18}, "tgt": {"text": "Kindeswohlgef\u00e4hrdung", "char_start": 188, "char_end": 208, "token_start": 31, "token_end": 32}}, {"src": {"text": "child and youth physicians", "char_start": 400, "char_end": 426, "token_start": 67, "token_end": 71}, "tgt": {"text": "Kinder- und Jugendmediziner", "char_start": 598, "char_end": 625, "token_start": 88, "token_end": 92}}, {"src": {"text": "child surgeons", "char_start": 428, "char_end": 442, "token_start": 72, "token_end": 74}, "tgt": {"text": "Kinderchirurgen", "char_start": 627, "char_end": 642, "token_start": 93, "token_end": 94}}, {"src": {"text": "child and adolescent psychiatrists", "char_start": 444, "char_end": 478, "token_start": 75, "token_end": 79}, "tgt": {"text": "Kinder- und Jugendpsychiatern", "char_start": 644, "char_end": 673, "token_start": 95, "token_end": 99}}, {"src": {"text": "psychotherapists", "char_start": 490, "char_end": 506, "token_start": 82, "token_end": 83}, "tgt": {"text": "psychologischer und Kinder- und Jugendlichenpsychotherapeuten", "char_start": 680, "char_end": 741, "token_start": 100, "token_end": 106}}, {"src": {"text": "Federal Child Protection Act", "char_start": 792, "char_end": 820, "token_start": 130, "token_end": 134}, "tgt": {"text": "Bundeskinderschutzgesetz", "char_start": 951, "char_end": 975, "token_start": 137, "token_end": 138}}, {"src": {"text": "child protection", "char_start": 1050, "char_end": 1066, "token_start": 171, "token_end": 173}, "tgt": {"text": "Kinderschutz", "char_start": 1013, "char_end": 1025, "token_start": 143, "token_end": 144}}]}
{"idx": 6192, "pair_id": "29558775", "src": "Chronic compartment syndromes are a rare, but frequently overlooked cause of pain in the locomotor system. Their aetiology is still not fully elucidated. There is an imbalance of muscle volume and space in the compartment. Thickening of the fascia and decreased elasticity lead to a pathological increase in pressure in the compartment under load. Chronic compartment syndromes are found in the foot, lower leg, thigh, forearm, hand, and even the spine. Bilateral compartment syndromes are very common (80\u200a%). The main symptoms are pain in the compartment under physical activity. Compartment pressure measurement is the gold standard examination. Other diagnostic procedures are near-infrared spectroscopy, MRI and ultrasound. As conse rvative treatment often fails, surgical treatment becomes necessary. Different techniques are described in the literature. We prefer an endoscopy-assisted minimally-invasive approach.", "tgt": "Das chronische Kompartmentsyndrom (CKS) ist eine seltene und vor allem h\u00e4ufig \u00fcbersehene Diagnose von chronischen Schmerzen am Bewegungsapparat. Ursache der Beschwerden ist ein Missverh\u00e4ltnis zwischen Kompartimentvolumen und Raumbedarf der Muskulatur. Durch eine Zunahme der Fasziendicke und eine Abnahme ihrer Elastizit\u00e4t kommt es unter Belastung zu einer pathologischen Drucksteigerung und damit verbunden zu Schmerzen. Der genaue Mechanismus ist jedoch immer noch unklar. Chronische Kompartmentsyndrome m\u00fcssen von akuten Kompartmentsyndromen differenziert werden. Sie treten vor allem am Unterschenkel auf, aber auch der Oberschenkel, der Fu\u00df, der Oberarm, der Vorderarm, die Hand und der R\u00fccken k\u00f6nnen betroffen sein. Ein bilaterales Auftreten ist sehr h\u00e4ufig (80\u200a%). Die Diagnosestellung basiert vor allem auf der Anamnese, der klinischen Untersuchung zur Abgrenzung der Differentialdiagnosen und der funktionellen Druckmessung. Weitere diagnostische Verfahren wie Nahinfrarotspektroskopie, MRI, Sonografie und Myotonometrie werden in der Literatur beschrieben. Die Therapie ist prim\u00e4r konservativ. Wenngleich meist erfolglos, sollte sie dennoch zun\u00e4chst eingesetzt werden um eine Operation zu vermeiden. Bei den operativen Therapieformen unterscheiden wir die offene Fasziotomie, halboffene Verfahren und seit geraumer Zeit auch endoskopisch assistierte, minimalinvasive Methoden.", "term_pairs": [{"src": {"text": "Chronic compartment syndromes", "char_start": 0, "char_end": 29, "token_start": 0, "token_end": 3}, "tgt": {"text": "Chronische Kompartmentsyndrome", "char_start": 475, "char_end": 505, "token_start": 67, "token_end": 69}}, {"src": {"text": "pain", "char_start": 77, "char_end": 81, "token_start": 12, "token_end": 13}, "tgt": {"text": "Schmerzen", "char_start": 114, "char_end": 123, "token_start": 17, "token_end": 18}}, {"src": {"text": "locomotor system", "char_start": 89, "char_end": 105, "token_start": 15, "token_end": 17}, "tgt": {"text": "Bewegungsapparat", "char_start": 127, "char_end": 143, "token_start": 19, "token_end": 20}}, {"src": {"text": "aetiology", "char_start": 113, "char_end": 122, "token_start": 19, "token_end": 20}, "tgt": {"text": "Ursache", "char_start": 145, "char_end": 152, "token_start": 21, "token_end": 22}}, {"src": {"text": "muscle volume", "char_start": 179, "char_end": 192, "token_start": 31, "token_end": 33}, "tgt": {"text": "Kompartimentvolumen", "char_start": 201, "char_end": 220, "token_start": 28, "token_end": 29}}, {"src": {"text": "fascia", "char_start": 241, "char_end": 247, "token_start": 42, "token_end": 43}, "tgt": {"text": "Faszie", "char_start": 275, "char_end": 281, "token_start": 38, "token_end": 39}}, {"src": {"text": "elasticity", "char_start": 262, "char_end": 272, "token_start": 45, "token_end": 46}, "tgt": {"text": "Elastizit\u00e4t", "char_start": 311, "char_end": 322, "token_start": 43, "token_end": 44}}, {"src": {"text": "pathological increase in pressure", "char_start": 283, "char_end": 316, "token_start": 49, "token_end": 53}, "tgt": {"text": "pathologischen Drucksteigerung", "char_start": 357, "char_end": 387, "token_start": 50, "token_end": 52}}, {"src": {"text": "foot", "char_start": 395, "char_end": 399, "token_start": 66, "token_end": 67}, "tgt": {"text": "Fu\u00df", "char_start": 642, "char_end": 645, "token_start": 90, "token_end": 91}}, {"src": {"text": "lower leg", "char_start": 401, "char_end": 410, "token_start": 68, "token_end": 70}, "tgt": {"text": "Unterschenkel", "char_start": 591, "char_end": 604, "token_start": 81, "token_end": 82}}, {"src": {"text": "thigh", "char_start": 412, "char_end": 417, "token_start": 71, "token_end": 72}, "tgt": {"text": "Oberschenkel", "char_start": 624, "char_end": 636, "token_start": 87, "token_end": 88}}, {"src": {"text": "forearm", "char_start": 419, "char_end": 426, "token_start": 73, "token_end": 74}, "tgt": {"text": "Vorderarm", "char_start": 664, "char_end": 673, "token_start": 96, "token_end": 97}}, {"src": {"text": "hand", "char_start": 428, "char_end": 432, "token_start": 75, "token_end": 76}, "tgt": {"text": "Hand", "char_start": 679, "char_end": 683, "token_start": 99, "token_end": 100}}, {"src": {"text": "spine", "char_start": 447, "char_end": 452, "token_start": 80, "token_end": 81}, "tgt": {"text": "R\u00fccken", "char_start": 692, "char_end": 698, "token_start": 102, "token_end": 103}}, {"src": {"text": "Bilateral compartment syndromes", "char_start": 454, "char_end": 485, "token_start": 82, "token_end": 85}, "tgt": {"text": "bilaterales Auftreten", "char_start": 726, "char_end": 747, "token_start": 108, "token_end": 110}}, {"src": {"text": "compartment pressure measurement", "char_start": 581, "char_end": 613, "token_start": 105, "token_end": 108}, "tgt": {"text": "funktionellen Druckmessung", "char_start": 906, "char_end": 932, "token_start": 136, "token_end": 138}}, {"src": {"text": "near-infrared spectroscopy", "char_start": 680, "char_end": 706, "token_start": 118, "token_end": 122}, "tgt": {"text": "Nahinfrarotspektroskopie", "char_start": 970, "char_end": 994, "token_start": 143, "token_end": 144}}, {"src": {"text": "MRI", "char_start": 708, "char_end": 711, "token_start": 123, "token_end": 124}, "tgt": {"text": "MRI", "char_start": 996, "char_end": 999, "token_start": 145, "token_end": 146}}, {"src": {"text": "ultrasound", "char_start": 716, "char_end": 726, "token_start": 125, "token_end": 126}, "tgt": {"text": "Sonografie", "char_start": 1001, "char_end": 1011, "token_start": 147, "token_end": 148}}, {"src": {"text": "surgical treatment", "char_start": 768, "char_end": 786, "token_start": 134, "token_end": 136}, "tgt": {"text": "Operation", "char_start": 1186, "char_end": 1195, "token_start": 174, "token_end": 175}}, {"src": {"text": "endoscopy-assisted minimally-invasive approach", "char_start": 873, "char_end": 919, "token_start": 150, "token_end": 157}, "tgt": {"text": "endoskopisch assistierte, minimalinvasive Methoden", "char_start": 1335, "char_end": 1385, "token_start": 195, "token_end": 200}}]}
{"idx": 6226, "pair_id": "31842237", "src": "A comparison of inter-professional communication within the core therapeutic teams including nurses in 5 neurological early rehabilitation hospitals of one non-profit organization was supposed to indicate factors facilitating and impairing cooperation. Data collection was conducted through analysis of architecture plans, passive participating observation in 10 wards and through partly standardized interviews (N=39). Participants were nurses, physio-, occupational and speech therapists. Data analysis used the method of Thick Description [1]. A permanent team, daily team conferences, treatments in cooperation, ward based training and informal talks influence interprofessional communication. Organizational and structural preconditions have effects on the quality of communication. Daily inter-professional briefings and the organization of training sessions within the team improve inter-professional communication, a confrontation nurses vs. therapists impairs it.", "tgt": "ZIEL: Durch einen Vergleich der Kommunikation in pflegerisch-therapeutischen Teams von 5 neurologischen Fr\u00fchrehabilitationskliniken eines gemeinn\u00fctzigen Tr\u00e4gers mit \u00e4hnlichem Profil sollen f\u00f6rdernde und hindernde Faktoren der Kooperation identifiziert werden. Vergleich der interprofessionellen Kommunikation in 5 funktional \u00e4quivalenten Kliniken mit den Methoden der Dichten Beschreibung [1], also Architekturpl\u00e4nen,: passiv teilnehmender mitgehender ganzt\u00e4giger Beobachtungen f\u00fcr je eine Woche in 10 Fr\u00fchrehabilitationsstationen, dokumentiert in Memos (Beobachtungsaufzeichnungen). Erg\u00e4nzt wurden diese Beobachtungen durch teilstrukturierte Leitfadeninterviews (n=39), in denen die Beobachtungen besprochen wurden. Teilnehmende waren Berufsangeh\u00f6rige der Pflege, Physiotherapie, Ergotherapie und Logop\u00e4die. Feste Teams, werkt\u00e4gliche auch informelle Teambesprechungen, gemeinsame interprofessionelle Behandlungseinheiten, stationsbezogene Fortbildungen und informelle Gespr\u00e4che beeinflussen die interprofessionelle Kommunikation positiv oder negativ (Fraktionsbildung, Kooperationsl\u00fccken). Dabei haben organisatorische und bauliche Bedingungen einen vermutlich nicht zu untersch\u00e4tzenden Einfluss auf die Qualit\u00e4t der Kommunikation zwischen den Berufsgruppen. Kurze t\u00e4gliche Teambesprechungen und die Organisation von Fortbildungen auf Teamebene f\u00f6rdern die interprofessionelle Kommunikation, eine auch baulich und organisatorisch verst\u00e4rkte Fraktionsbildung Pflege vs. Therapie beeintr\u00e4chtigt sie.", "term_pairs": [{"src": {"text": "inter-professional communication", "char_start": 16, "char_end": 48, "token_start": 3, "token_end": 7}, "tgt": {"text": "interprofessionellen Kommunikation", "char_start": 274, "char_end": 308, "token_start": 34, "token_end": 36}}, {"src": {"text": "nurses", "char_start": 93, "char_end": 99, "token_start": 13, "token_end": 14}, "tgt": {"text": "Pflege", "char_start": 49, "char_end": 55, "token_start": 8, "token_end": 9}}, {"src": {"text": "neurological early rehabilitation hospitals", "char_start": 105, "char_end": 148, "token_start": 16, "token_end": 20}, "tgt": {"text": "neurologischen Fr\u00fchrehabilitationskliniken", "char_start": 89, "char_end": 131, "token_start": 14, "token_end": 16}}, {"src": {"text": "non-profit organization", "char_start": 156, "char_end": 179, "token_start": 22, "token_end": 26}, "tgt": {"text": "gemeinn\u00fctzigen Tr\u00e4gers", "char_start": 138, "char_end": 160, "token_start": 17, "token_end": 19}}, {"src": {"text": "interviews", "char_start": 401, "char_end": 411, "token_start": 56, "token_end": 57}, "tgt": {"text": "Interviews", "char_start": 652, "char_end": 662, "token_start": 81, "token_end": 82}}, {"src": {"text": "physio-, occupational and speech therapists", "char_start": 446, "char_end": 489, "token_start": 67, "token_end": 74}, "tgt": {"text": "Physiotherapie, Ergotherapie und Logop\u00e4die", "char_start": 765, "char_end": 807, "token_start": 101, "token_end": 106}}, {"src": {"text": "Thick Description", "char_start": 524, "char_end": 541, "token_start": 81, "token_end": 83}, "tgt": {"text": "Dichten Beschreibung", "char_start": 368, "char_end": 388, "token_start": 45, "token_end": 47}}, {"src": {"text": "team conferences", "char_start": 571, "char_end": 587, "token_start": 92, "token_end": 94}, "tgt": {"text": "Teambesprechungen", "char_start": 851, "char_end": 868, "token_start": 113, "token_end": 114}}, {"src": {"text": "treatments in cooperation", "char_start": 589, "char_end": 614, "token_start": 95, "token_end": 98}, "tgt": {"text": "gemeinsame interprofessionelle Behandlungseinheiten", "char_start": 870, "char_end": 921, "token_start": 115, "token_end": 118}}, {"src": {"text": "informal talks", "char_start": 640, "char_end": 654, "token_start": 103, "token_end": 105}, "tgt": {"text": "informelle Gespr\u00e4che", "char_start": 958, "char_end": 978, "token_start": 122, "token_end": 124}}, {"src": {"text": "organizational and structural preconditions", "char_start": 698, "char_end": 741, "token_start": 109, "token_end": 113}, "tgt": {"text": "organisatorische und bauliche Bedingungen", "char_start": 1103, "char_end": 1144, "token_start": 139, "token_end": 143}}, {"src": {"text": "daily inter-professional briefings", "char_start": 788, "char_end": 822, "token_start": 121, "token_end": 126}, "tgt": {"text": "t\u00e4gliche Teambesprechungen", "char_start": 1266, "char_end": 1292, "token_start": 159, "token_end": 161}}, {"src": {"text": "training sessions", "char_start": 847, "char_end": 864, "token_start": 130, "token_end": 132}, "tgt": {"text": "Fortbildungen", "char_start": 940, "char_end": 953, "token_start": 120, "token_end": 121}}, {"src": {"text": "nurses vs. therapists", "char_start": 939, "char_end": 960, "token_start": 143, "token_end": 147}, "tgt": {"text": "Pflege vs. Therapie", "char_start": 1459, "char_end": 1478, "token_start": 180, "token_end": 184}}]}
{"idx": 6260, "pair_id": "34666400", "src": "Several recent meta-analyses have identified the retromuscular plane as the preferred mesh position in ventral hernia repair. Open surgery used to be the standard technique for these procedures. However, new minimally invasive techniques with totally extraperitoneal access and mesh positioning in the retromuscular plane have evolved. Between September 2018 and March 2019, 18 consecutive patients with ventral hernia were treated endoscopically in the totally extraperitoneal technique. Depending on the localisation and size of the hernia, the appropriate access was chosen and an uncoated mesh was placed in the retromuscular space in all patients. Data of patients' characteristics as well as peri- and postoperative parameters were collected. One year after surgery, patients were asked about recurrence, pain and complications, using the questionnaire of the herniamed data base. No intraoperative complications were noted. Postoperatively, there was one retromuscular seroma that did not need treatment, one temporary paralysis of the radial nerve and one pulmonary embolism. None of these complications led to persistent problems. 17 of 18 patients were available for follow-up. One year follow-up showed no hernia recurrence. One patient had pain at rest requiring treatment. Totally extraperitoneal endoscopic hernia surgery is a safe and promising new technique that is also feasible in complex hernias and with satisfactory 1 year results. This technique can combine the advantages of minimally invasive surgery with those of extraperitoneal mesh placement.", "tgt": "Mehrere in den letzten Jahren publizierte Metaanalysen zeigten, dass der Retromuskul\u00e4rraum die bevorzugte Netzposition in der Versorgung von Ventralhernien ist. Operationen mit retromuskul\u00e4rer Netzplatzierung wurde bislang haupts\u00e4chlich offen durchgef\u00fchrt. In den letzten Jahren wurden neue minimalinvasive Verfahren mit total extraperitonealem Zugang und retromuskul\u00e4rer Netzeinlage beschrieben. Von September 2018 bis M\u00e4rz 2019 wurden 18 Patienten endoskopisch in total extraperitonealer Technik an einer Ventralhernie operiert. In Abh\u00e4ngigkeit der Hernienlokalisation und -gr\u00f6\u00dfe wurden verschiedene extraperitoneale Zugangswege gew\u00e4hlt und bei allen Patienten ein unbeschichtetes Netz im Retromuskul\u00e4rraum platziert. Patientencharakteristika, peri- und postoperative Parameter wurden erhoben. Mithilfe des Herniamed-Fragebogens wurden die Patienten 1 Jahr nach Operation nach Rezidiv, Komplikationen und Schmerzen befragt. Intraoperative Komplikationen traten nicht auf. Postoperativ wurden ein nicht behandlungsbed\u00fcrftiges Serom im Bereich des Netzlagers, eine passagere Radialisparese und eine Lungenembolie beobachtet, die alle ohne Langzeitfolgen f\u00fcr die Patienten blieben. 17 von 18 Patienten konnten nachverfolgt werden. Im 1-Jahres-Follow-up zeigte sich kein Hernienrezidiv. Ein Patient hatte behandlungsbed\u00fcrftige Schmerzen in Ruhe. Die total extraperitoneale eTEP-Technik ist eine neue vielversprechende Operationsmethode, mit der sich auch komplexe Ventralhernien mit akzeptablem 1-Jahres-Ergebnis versorgen lassen. Durch diese Technik lassen sich die Vorteile der minimalinvasiven Chirurgie mit denen der extraperitonealen Netzplatzierung kombinieren.", "term_pairs": [{"src": {"text": "retromuscular plane", "char_start": 49, "char_end": 68, "token_start": 8, "token_end": 10}, "tgt": {"text": "Retromuskul\u00e4rraum", "char_start": 73, "char_end": 90, "token_start": 11, "token_end": 12}}, {"src": {"text": "ventral hernia", "char_start": 103, "char_end": 117, "token_start": 16, "token_end": 18}, "tgt": {"text": "Ventralhernie", "char_start": 141, "char_end": 154, "token_start": 19, "token_end": 20}}, {"src": {"text": "mesh", "char_start": 86, "char_end": 90, "token_start": 13, "token_end": 14}, "tgt": {"text": "Netz", "char_start": 106, "char_end": 110, "token_start": 14, "token_end": 15}}, {"src": {"text": "open surgery", "char_start": 126, "char_end": 138, "token_start": 20, "token_end": 22}, "tgt": {"text": "offen", "char_start": 237, "char_end": 242, "token_start": 29, "token_end": 30}}, {"src": {"text": "minimally invasive techniques", "char_start": 208, "char_end": 237, "token_start": 35, "token_end": 38}, "tgt": {"text": "minimalinvasive Verfahren", "char_start": 291, "char_end": 316, "token_start": 38, "token_end": 40}}, {"src": {"text": "totally extraperitoneal", "char_start": 243, "char_end": 266, "token_start": 39, "token_end": 41}, "tgt": {"text": "total extraperitoneal", "char_start": 321, "char_end": 342, "token_start": 41, "token_end": 43}}, {"src": {"text": "uncoated mesh", "char_start": 584, "char_end": 597, "token_start": 91, "token_end": 93}, "tgt": {"text": "unbeschichtetes Netz", "char_start": 667, "char_end": 687, "token_start": 85, "token_end": 87}}, {"src": {"text": "retromuscular space", "char_start": 616, "char_end": 635, "token_start": 97, "token_end": 99}, "tgt": {"text": "Retromuskul\u00e4rraum", "char_start": 691, "char_end": 708, "token_start": 88, "token_end": 89}}, {"src": {"text": "postoperative", "char_start": 708, "char_end": 721, "token_start": 114, "token_end": 115}, "tgt": {"text": "postoperative", "char_start": 756, "char_end": 769, "token_start": 96, "token_end": 97}}, {"src": {"text": "herniamed", "char_start": 866, "char_end": 875, "token_start": 139, "token_end": 140}, "tgt": {"text": "Herniamed", "char_start": 809, "char_end": 818, "token_start": 103, "token_end": 104}}, {"src": {"text": "intraoperative complications", "char_start": 890, "char_end": 918, "token_start": 144, "token_end": 146}, "tgt": {"text": "Intraoperative Komplikationen", "char_start": 926, "char_end": 955, "token_start": 121, "token_end": 123}}, {"src": {"text": "retromuscular seroma", "char_start": 962, "char_end": 982, "token_start": 154, "token_end": 156}, "tgt": {"text": "Serom im Bereich des Netzlagers", "char_start": 1027, "char_end": 1058, "token_start": 132, "token_end": 137}}, {"src": {"text": "radial nerve", "char_start": 1043, "char_end": 1055, "token_start": 167, "token_end": 169}, "tgt": {"text": "Radialisparese", "char_start": 1075, "char_end": 1089, "token_start": 140, "token_end": 141}}, {"src": {"text": "pulmonary embolism", "char_start": 1064, "char_end": 1082, "token_start": 171, "token_end": 173}, "tgt": {"text": "Lungenembolie", "char_start": 1099, "char_end": 1112, "token_start": 143, "token_end": 144}}, {"src": {"text": "hernia recurrence", "char_start": 1217, "char_end": 1234, "token_start": 201, "token_end": 203}, "tgt": {"text": "Hernienrezidiv", "char_start": 1269, "char_end": 1283, "token_start": 174, "token_end": 175}}, {"src": {"text": "pain", "char_start": 811, "char_end": 815, "token_start": 130, "token_end": 131}, "tgt": {"text": "Schmerzen", "char_start": 907, "char_end": 916, "token_start": 118, "token_end": 119}}, {"src": {"text": "follow-up", "char_start": 1177, "char_end": 1186, "token_start": 190, "token_end": 193}, "tgt": {"text": "Follow-up", "char_start": 1242, "char_end": 1251, "token_start": 168, "token_end": 171}}, {"src": {"text": "extraperitoneal mesh placement", "char_start": 1539, "char_end": 1569, "token_start": 252, "token_end": 255}, "tgt": {"text": "extraperitonealen Netzplatzierung", "char_start": 1619, "char_end": 1652, "token_start": 225, "token_end": 227}}]}
{"idx": 6559, "pair_id": "33588491", "src": "The objective of this study was to evaluate the outcome of a special interdisciplinary hand therapy program depending on the time interval between trauma and rehabilitation. With use of self-assessed scores (Disability of the Arm, Shoulder and Hand Score [DASH-Score], European Quality of Life 5 Dimensions [EQ-5D]) and objective functional parameters (TAM = Total Active Motion for finger injuries, ROM = Range of Motion for wrist injuries, grip strength) the outcome of 76 patients with injuries of the fingers, wrist or a complex regional pain syndrome (CRPS) was analysed at the begin and end of an inpatient rehabilitation and at a follow-up examination after 12 to 16 weeks. The patients were divided into groups with an early (< 120 days after trauma) or late beginning of their rehabilitation. At the follow-up examination early beginners had a significant better DASH-Score as well as a ROM. At the end of the rehabilitation program and at the time of the follow-up examination significant more patients with an early as patients with a late start of the rehabilitation were back to work. Especially patients with CRPS and finger injuries benefit from an early start of the rehabilitation. Compared to a late start an early start of a rehabilitation program after finger and hand injuries and a CRPS leads to better functional with special benefit for patients with a CRPS.", "tgt": "ZIEL: Ziel der Studie war die Auswertung der Ergebnisse einer spezialisierten interdisziplin\u00e4ren Handrehabilitation in Abh\u00e4ngigkeit vom zeitlichen Abstand zwischen der Verletzung und dem Beginn der Rehabilitation. Mit Hilfe von punktebasierten Frageb\u00f6gen (Disability of the Arm, Shoulder and Hand Score [DASH-Score], European Quality of Life 5 Dimensions [EQ-5D]) und objektiven Messparametern (TAM = Total Active Motion bei Fingerverletzungen, ROM = Range of Motion bei Handgelenksverletzungen, Grobkraft) wurden die Ergebnisse von 76 Patienten mit Verletzungen von Fingern und Handgelenken oder einem komplexen regionalen Schmerzsyndrom (CRPS) zu Beginn, am Ende und bei der Nachuntersuchung 12\u201316 Wochen nach Ende der semistation\u00e4ren Rehabilitation analysiert. Die Patienten wurden in Gruppen mit einem fr\u00fchen (< 120 Tage nach Trauma) bzw. sp\u00e4ten Beginn der Rehabilitation aufgeteilt. Patienten mit fr\u00fchem Beginn der Rehabilitation hatten bei der Nachuntersuchung signifikant bessere Ergebnisse beim DASH-Score als auch beim Bewegungsausma\u00df des Handgelenkes. Auch waren signifikant mehr Patienten mit fr\u00fchem Rehabilitationsbeginn zum Ende der Rehabilitation als auch bei der Nachuntersuchung arbeitsf\u00e4hig als Patienten mit sp\u00e4tem Beginn der Rehabilitation. Insbesondere Patienten mit Fingerverletzungen und CRPS profitierten von einem fr\u00fchen Beginn der Rehabilitation. Ein fr\u00fcher Beginn der Rehabilitation nach Finger- und Handverletzungen sowie bei einem CRPS f\u00fchrt zu funktionell besseren Ergebnissen, wobei vor allem Patienten mit CRPS von einem fr\u00fchen Beginn profitieren.", "term_pairs": [{"src": {"text": "Disability of the Arm, Shoulder and Hand Score", "char_start": 208, "char_end": 254, "token_start": 35, "token_end": 44}, "tgt": {"text": "Disability of the Arm, Shoulder and Hand Score", "char_start": 256, "char_end": 302, "token_start": 34, "token_end": 43}}, {"src": {"text": "DASH-Score", "char_start": 256, "char_end": 266, "token_start": 45, "token_end": 48}, "tgt": {"text": "DASH-Score", "char_start": 304, "char_end": 314, "token_start": 44, "token_end": 47}}, {"src": {"text": "European Quality of Life 5 Dimensions", "char_start": 269, "char_end": 306, "token_start": 50, "token_end": 56}, "tgt": {"text": "European Quality of Life 5 Dimensions", "char_start": 317, "char_end": 354, "token_start": 49, "token_end": 55}}, {"src": {"text": "EQ-5D", "char_start": 308, "char_end": 313, "token_start": 57, "token_end": 60}, "tgt": {"text": "EQ-5D", "char_start": 356, "char_end": 361, "token_start": 56, "token_end": 59}}, {"src": {"text": "TAM", "char_start": 353, "char_end": 356, "token_start": 67, "token_end": 68}, "tgt": {"text": "TAM", "char_start": 395, "char_end": 398, "token_start": 65, "token_end": 66}}, {"src": {"text": "Total Active Motion", "char_start": 359, "char_end": 378, "token_start": 69, "token_end": 72}, "tgt": {"text": "Total Active Motion", "char_start": 401, "char_end": 420, "token_start": 67, "token_end": 70}}, {"src": {"text": "ROM", "char_start": 400, "char_end": 403, "token_start": 76, "token_end": 77}, "tgt": {"text": "ROM", "char_start": 445, "char_end": 448, "token_start": 73, "token_end": 74}}, {"src": {"text": "Range of Motion", "char_start": 406, "char_end": 421, "token_start": 78, "token_end": 81}, "tgt": {"text": "Range of Motion", "char_start": 451, "char_end": 466, "token_start": 75, "token_end": 78}}, {"src": {"text": "grip strength", "char_start": 442, "char_end": 455, "token_start": 85, "token_end": 87}, "tgt": {"text": "Grobkraft", "char_start": 496, "char_end": 505, "token_start": 81, "token_end": 82}}, {"src": {"text": "complex regional pain syndrome", "char_start": 525, "char_end": 555, "token_start": 102, "token_end": 106}, "tgt": {"text": "komplexen regionalen Schmerzsyndrom", "char_start": 603, "char_end": 638, "token_start": 97, "token_end": 100}}, {"src": {"text": "CRPS", "char_start": 557, "char_end": 561, "token_start": 107, "token_end": 108}, "tgt": {"text": "CRPS", "char_start": 640, "char_end": 644, "token_start": 101, "token_end": 102}}]}
{"idx": 6593, "pair_id": "33598900", "src": "Dyspnoea is a frequent and compromising symptom in patients with advanced and metastatic lung cancer. Exogenous as well as endogenous factors contribute to development of shortness of breath. Knowledge of these influences is essential for effective treatment of this important symptom. In our study, we evaluated the influence of cofactors and comorbidity on development of dyspnoea in lung cancer patients for the purpose of effective therapy of shortness of breath in this target group. \u2002In this prospective monocentric study, we registered severity of dyspnoea in advanced lung cancer patients using the modified Medical Research Council-Scale (mMRC-scale). Patients' history of COPD and cardiopulmonary comorbidity was recorded using a standardized questionnaire. Moreover, cofactors such as pain or cancer-induced mental stress were documented by visual rating scale. \u200225 (48,1\u200a%) of 52 recruited lung cancer-patients reported moderate or severe dyspnoea. In logistic regression analysis history of COPD or cardiopulmonary comorbidity, severe pain, airway obstruction or pleural effusion were associated with severe dyspnoea (mMRC-scale \u2265\u200a3). Furthermore, in our study cohort lower cancer level III UICC and absence of metastasis correlated with severe dyspnoea. \u2002Our findings confirm the relevance of dyspnoea in patients with advanced lung cancer. Probability of occurrence is influenced by comorbidity and cofactors. The knowledge of these factors contributes to better understanding of occurrence and treatment of dyspnoea.", "tgt": "ZIEL: \u2002Dyspnoe ist ein h\u00e4ufiges und schwer beeintr\u00e4chtigendes Krankheitssymptom bei Patienten mit fortgeschrittenem Lungenkarzinom. Exogene wie endogene Faktoren tragen zum subjektiven Symptom Luftnot bei. Um eine effektive Therapie einleiten zu k\u00f6nnen, ist die Kenntnis von beeinflussbaren Faktoren essenziell. Mit dem Ziel, die Atemnot gezielter behandeln zu k\u00f6nnen, wurde in dieser Arbeit die Auswirkung von Begleitfaktoren und Komorbidit\u00e4ten auf den Schweregrad von Luftnot bei Patienten mit Lungenkarzinom untersucht. \u2002Im Rahmen einer prospektiven, monozentrischen Beobachtungsstudie wurde der Schweregrad der Atemnot bei Patienten mit fortgeschrittenem Lungenkarzinom anhand des mMRC-Scores abgefragt und standardisiert nach kardialer oder pulmonaler Komorbidit\u00e4t befragt. Zudem wurden Schmerzsymptomatik und psychische Belastung der Patienten durch die Tumorerkrankung anhand numerischer Ratingskalen (NRS) abgefragt. \u200225 (48,1\u200a%) von 52 eingeschlossenen Lungenkarzinompatienten gaben m\u00e4\u00dfige bis starke Dyspnoe an. Vorbekannte COPD, kardiopulmonale Begleiterkrankungen, starke Schmerzen, eine obstruktive Ventilationsst\u00f6rung in der Lungenfunktion sowie nachweisbare Pleuraerg\u00fcsse korrelierten in der logistischen Regressionsanalyse mit dem Auftreten von Dyspnoeschweregraden \u2265\u200a\u200a3 in der mMRC-Skala. In dieser Untersuchung war auch das niedrigere UICC-Stadium III bzw. eine M0-Situation mit einer h\u00f6heren Wahrscheinlichkeit einer schweren Dyspnoe korreliert als ein h\u00f6heres Stadium IV nach UICC. \u2002Unsere Untersuchung best\u00e4tigt die klinische Relevanz von Dyspnoe bei Lungenkarzinompatienten. Die Wahrscheinlichkeit f\u00fcr das Auftreten dyspnoeischer Beschwerden wird durch Begleitsymptome wie starke Schmerzen und insbesondere durch das Vorhandensein von kardialen oder pulmonalen Komorbidit\u00e4ten wesentlich beeinflusst. Eine effektive Behandlung von Luftnot sollte daher diese begleitenden Faktoren in der Therapie ber\u00fccksichtigen.", "term_pairs": [{"src": {"text": "Dyspnoea", "char_start": 0, "char_end": 8, "token_start": 0, "token_end": 1}, "tgt": {"text": "Dyspnoe", "char_start": 7, "char_end": 14, "token_start": 2, "token_end": 3}}, {"src": {"text": "lung cancer", "char_start": 89, "char_end": 100, "token_start": 13, "token_end": 15}, "tgt": {"text": "Lungenkarzinom", "char_start": 116, "char_end": 130, "token_start": 14, "token_end": 15}}, {"src": {"text": "shortness of breath", "char_start": 171, "char_end": 190, "token_start": 26, "token_end": 29}, "tgt": {"text": "Luftnot", "char_start": 193, "char_end": 200, "token_start": 24, "token_end": 25}}, {"src": {"text": "COPD", "char_start": 682, "char_end": 686, "token_start": 113, "token_end": 114}, "tgt": {"text": "COPD", "char_start": 1034, "char_end": 1038, "token_start": 145, "token_end": 146}}, {"src": {"text": "comorbidity", "char_start": 344, "char_end": 355, "token_start": 55, "token_end": 56}, "tgt": {"text": "Komorbidit\u00e4t", "char_start": 431, "char_end": 443, "token_start": 63, "token_end": 64}}, {"src": {"text": "pain", "char_start": 796, "char_end": 800, "token_start": 129, "token_end": 130}, "tgt": {"text": "Schmerzen", "char_start": 1084, "char_end": 1093, "token_start": 151, "token_end": 152}}, {"src": {"text": "airway obstruction", "char_start": 1054, "char_end": 1072, "token_start": 177, "token_end": 179}, "tgt": {"text": "obstruktive Ventilationsst\u00f6rung", "char_start": 1100, "char_end": 1131, "token_start": 154, "token_end": 156}}, {"src": {"text": "pleural effusion", "char_start": 1076, "char_end": 1092, "token_start": 180, "token_end": 182}, "tgt": {"text": "Pleuraerg\u00fcsse", "char_start": 1173, "char_end": 1186, "token_start": 161, "token_end": 162}}, {"src": {"text": "UICC", "char_start": 1204, "char_end": 1208, "token_start": 205, "token_end": 206}, "tgt": {"text": "UICC", "char_start": 1353, "char_end": 1357, "token_start": 187, "token_end": 188}}, {"src": {"text": "mMRC-scale", "char_start": 648, "char_end": 658, "token_start": 104, "token_end": 107}, "tgt": {"text": "mMRC-Skala", "char_start": 1294, "char_end": 1304, "token_start": 176, "token_end": 179}}, {"src": {"text": "dyspnoea", "char_start": 374, "char_end": 382, "token_start": 59, "token_end": 60}, "tgt": {"text": "Dyspnoe", "char_start": 1010, "char_end": 1017, "token_start": 141, "token_end": 142}}, {"src": {"text": "dyspnoea", "char_start": 555, "char_end": 563, "token_start": 89, "token_end": 90}, "tgt": {"text": "Atemnot", "char_start": 330, "char_end": 337, "token_start": 48, "token_end": 49}}, {"src": {"text": "shortness of breath", "char_start": 447, "char_end": 466, "token_start": 71, "token_end": 74}, "tgt": {"text": "Atemnot", "char_start": 615, "char_end": 622, "token_start": 86, "token_end": 87}}]}
{"idx": 6856, "pair_id": "32544918", "src": "Oncological second opinions are becoming increasingly important given more complex treatment strategies, simultaneously more patients use complementary and alternative medicine (CAM), and many comprehensive cancer centers initiate integrative medicine programs. The present study focuses on analyzing the effects of a second opinion in relation to attitudes toward CAM. In this prospective study patients (n = 97) with a diagnosis of breast cancer or gynecological malignancies who had requested a second opinion received a questionnaire before and after the second opinion concerning their attitudes toward CAM. The majority of patients had breast cancer (72.2%, n = 70). Only 6.2% (n = 6) stated that they had been informed about CAM by the doctors who treated them first, 21.6% (n = 21) had received information about it when seeking the second opinion. After the first opinion, 42.3% (n = 41) wanted to try CAM, the same proportion trusted orthodox medicine alone. After the second opinion, 24 patients (24.7%) wanted to try CAM, while 38.1% (n = 37) relied exclusively on orthodox medicine. There was a significant correlation between an increased patients' need for information and interest in CAM (p = 0.02). Today, aspects of CAM still are very often no part of oncological first and second opinions. This might hence lead to discouraging patients to try out CAM and therefore integrative medicine programs in comprehensive cancer centers might be problem-solving.", "tgt": "Hintergrund und Ziele: Im Zeitalter der komplexeren Krebstherapien gewinnt zum einen die onkologische Zweitmeinung zunehmend an Bedeutung, zum anderen nutzen immer mehr Patientinnen komplement\u00e4re und alternativmedizinische Verfahren und in vielen zertifizierten Onkologischen Zentren entstehen Sprechstunden f\u00fcr Komplement\u00e4r- und Alternativmedizin. Eine Ana\u00adlyse der Effekte einer onkologischen Zweitmeinung in Bezug auf die Einstellung zur Komplement\u00e4r- und Alternativmedizin war somit Fokus der vorliegenden Studie. Patientinnen und Methoden: In der prospektiven Untersuchung wurden onkologische Zweitmeinungen evalu\u00adiert. Patientinnen (n = 97) mit der Diagnose eines Mammakarzinoms oder eines gyn\u00e4kologischen Malignoms erhielten vor und zwei Monate nach der onkologischen Zweitmeinung einen Fragebogen zu ihrer Einstellung zur Komplement\u00e4r- und Alternativmedizin. Ergebnisse und Beobachtungen: Die Mehrheit der Patientinnen wies ein Mammakarzinom auf (72,2%, n = 70). Nur 6,2% (n = 6) der Patientinnen gaben an von den erstbehandelnden \u00c4rzten bzw. 21,6 % (n = 21) im Rahmen der Zweitmeinung zur Komplement\u00e4r- und Alternativmedizin informiert worden zu sein. Nach der Erstmeinung wollten 42,3% (n = 41) Komplement\u00e4r- und Alternativmedizin ausprobieren und genau der gleiche Anteil vertraute nur auf Schulmedizin (42,3%, n = 41). Nach der Zweitmeinung wollten 24 Patientinnen (24,7%) Komplement\u00e4r- und Alternativme\u00addizin ausprobieren, und 38,1% (n = 37) vertrauten aus\u00adschlie\u00dflich auf Schulmedizin. Es zeigte sich eine signifikante Korrelation zwischen einem erh\u00f6hten Informations-bed\u00fcrfnis der Patientinnen und dem Interesse an Komplement\u00e4r- und Alternativmedizin (p = 0,02). Schlussfolgerung: Im Rahmen der onkologischen Erst- oder Zweitmeinung wird auch heute noch in vielen F\u00e4llen nicht auf Aspekte der Komplement\u00e4r- und Alternativmedizin ein\u00adgegangen, was dazu f\u00fchren kann, dass Patientinnen von der Komplement\u00e4r- und Alternativmedizin Abstand neh\u00admen. Der Aufbau von Sprechstunden f\u00fcr Komplement\u00e4r- und Alternativmedizin in zertifizierten Onkologischen Zentren k\u00f6nnte hier hilfreich sein.", "term_pairs": [{"src": {"text": "oncological second opinions", "char_start": 0, "char_end": 27, "token_start": 0, "token_end": 3}, "tgt": {"text": "onkologische Zweitmeinung", "char_start": 89, "char_end": 114, "token_start": 13, "token_end": 15}}, {"src": {"text": "complementary and alternative medicine", "char_start": 138, "char_end": 176, "token_start": 17, "token_end": 21}, "tgt": {"text": "Komplement\u00e4r- und Alternativmedizin", "char_start": 312, "char_end": 347, "token_start": 38, "token_end": 42}}, {"src": {"text": "CAM", "char_start": 178, "char_end": 181, "token_start": 22, "token_end": 23}, "tgt": {"text": "Komplement\u00e4r- und Alternativmedizin", "char_start": 441, "char_end": 476, "token_start": 58, "token_end": 62}}, {"src": {"text": "integrative medicine programs", "char_start": 231, "char_end": 260, "token_start": 31, "token_end": 34}, "tgt": {"text": "Sprechstunden f\u00fcr Komplement\u00e4r- und Alternativmedizin", "char_start": 1974, "char_end": 2027, "token_start": 340, "token_end": 346}}, {"src": {"text": "breast cancer", "char_start": 434, "char_end": 447, "token_start": 68, "token_end": 70}, "tgt": {"text": "Mammakarzinom", "char_start": 670, "char_end": 683, "token_start": 94, "token_end": 95}}, {"src": {"text": "gynecological malignancies", "char_start": 451, "char_end": 477, "token_start": 71, "token_end": 73}, "tgt": {"text": "gyn\u00e4kologischen Malignoms", "char_start": 696, "char_end": 721, "token_start": 97, "token_end": 99}}, {"src": {"text": "prospective study", "char_start": 378, "char_end": 395, "token_start": 56, "token_end": 58}, "tgt": {"text": "prospektiven Untersuchung", "char_start": 552, "char_end": 577, "token_start": 75, "token_end": 77}}, {"src": {"text": "second opinion", "char_start": 318, "char_end": 332, "token_start": 45, "token_end": 47}, "tgt": {"text": "Zweitmeinung", "char_start": 395, "char_end": 407, "token_start": 51, "token_end": 52}}, {"src": {"text": "orthodox medicine", "char_start": 944, "char_end": 961, "token_start": 181, "token_end": 183}, "tgt": {"text": "Schulmedizin", "char_start": 1301, "char_end": 1313, "token_start": 211, "token_end": 212}}, {"src": {"text": "comprehensive cancer centers", "char_start": 193, "char_end": 221, "token_start": 27, "token_end": 30}, "tgt": {"text": "zertifizierten Onkologischen Zentren", "char_start": 247, "char_end": 283, "token_start": 32, "token_end": 35}}]}
{"idx": 6955, "pair_id": "29409082", "src": "The prevalence of oropharyngeal dysphagia in older persons is high. Because it is frequently undetected, screening tests should be applied in risk groups. If the screening test is positive or typical risk factors are present, an instrumental assessment should be utilized. Objective diagnostic tools such as endoscopic evaluation and videofluoroscopy allow the description of the individual dysphagia pattern, which is the basis for an individualized treatment. The endoscopic evaluation of swallowing is increasingly used because it includes several advantages. Potential therapeutic strategies are multifaceted. The evidence for the effectiveness of adaptive, compensatory and rehabilitative strategies is growing, supporting the evolution of dysphagia therapy to an evidence based treatment.", "tgt": "Aufgrund unspezifischer Symptome wird die oropharyngeale Dysphagie oft nicht als solche diagnostiziert und damit h\u00e4ufig \u00fcbersehen. Da die Pr\u00e4valenz der Dysphagie im Alter hoch ist, muss gerade bei dieser Patientengruppe aktiv danach gesucht werden. H\u00e4UFIGE BEFUNDE: \u2002Die oropharyngeale Dysphagie ist durch eine Vielzahl unterschiedlicher Befunde in variabler Konstellation charakterisiert, die im folgenden Artikel dargestellt werden. Als Presbyphagie wird die Beeintr\u00e4chtigung des Schluckakts durch altersassoziierte Ver\u00e4nderungen bezeichnet. Durch die Presbyphagie wird die Sch\u00e4digungsschwelle gesenkt, ab der eine Dysphagie auftritt. In den letzten Jahren hat sich die flexible endoskopische Evaluation des Schluckaktes (FEES) in vielen Kliniken und Disziplinen etabliert. Durch eine h\u00f6here Bildaufl\u00f6sung und neue Kontrastverfahren wurde diese Methode erheblich weiterentwickelt. Die FEES bietet viele Vorteile gegen\u00fcber der radiologischen Videofluoroskopie (VFS), ist jedoch weiterhin komplement\u00e4r zur VFS zu sehen. Eine neue Leitlinie der Europ\u00e4ischen Gesellschaft f\u00fcr klinische Ern\u00e4hrung und Stoffwechsel (ESPEN) fasst die wesentlichen Aspekte der Therapie und ihre Evidenz zusammen. Mittlerweile gibt es zunehmende Evidenz f\u00fcr bestimmte Trainingsverfahren, kompensatorische Man\u00f6ver und Stimulationsverfahren.", "term_pairs": [{"src": {"text": "oropharyngeal dysphagia", "char_start": 18, "char_end": 41, "token_start": 3, "token_end": 5}, "tgt": {"text": "oropharyngeale Dysphagie", "char_start": 42, "char_end": 66, "token_start": 5, "token_end": 7}}, {"src": {"text": "prevalence", "char_start": 4, "char_end": 14, "token_start": 1, "token_end": 2}, "tgt": {"text": "Pr\u00e4valenz", "char_start": 138, "char_end": 147, "token_start": 19, "token_end": 20}}, {"src": {"text": "dysphagia", "char_start": 391, "char_end": 400, "token_start": 61, "token_end": 62}, "tgt": {"text": "Dysphagie", "char_start": 152, "char_end": 161, "token_start": 21, "token_end": 22}}, {"src": {"text": "endoscopic evaluation", "char_start": 308, "char_end": 329, "token_start": 51, "token_end": 53}, "tgt": {"text": "endoskopische Evaluation", "char_start": 681, "char_end": 705, "token_start": 95, "token_end": 97}}, {"src": {"text": "videofluoroscopy", "char_start": 334, "char_end": 350, "token_start": 54, "token_end": 55}, "tgt": {"text": "Videofluoroskopie", "char_start": 943, "char_end": 960, "token_start": 130, "token_end": 131}}, {"src": {"text": "treatment", "char_start": 451, "char_end": 460, "token_start": 71, "token_end": 72}, "tgt": {"text": "Therapie", "char_start": 1154, "char_end": 1162, "token_start": 163, "token_end": 164}}, {"src": {"text": "evidence", "char_start": 618, "char_end": 626, "token_start": 94, "token_end": 95}, "tgt": {"text": "Evidenz", "char_start": 1172, "char_end": 1179, "token_start": 166, "token_end": 167}}]}
{"idx": 7097, "pair_id": "30536261", "src": "Maternal emergencies during pregnancy are characterized by a concomitant threat to 2 patients. These emergencies can occur during or even before a hospital stay. Due to the rarity of the latter cases, sustainable methods of knowledge transfer should be implemented so emergency teams have sufficient obstetrical information to provide emergency care during pregnancy. In a series of articles, launched here, individual competencies for prehospital emergency management of pregnant women are described. Part one addresses prehospital emergency care of pregnant women, their emergency transport, handover management on hospital admission, and a team approach to perinatal emergency care.", "tgt": "Gesundheitliche Notfallsituationen w\u00e4hrend einer Schwangerschaft sind durch die Gleichzeitigkeit einer potenziellen Bedrohung von mindestens 2 Patienten charakterisiert. Diese Notf\u00e4lle k\u00f6nnen dabei w\u00e4hrend eines Krankenhausaufenthaltes aber auch als pr\u00e4hospitales Ereignis auftreten. Aufgrund ihrer Seltenheit sind zur hinreichenden diagnostisch/therapeutischen Bef\u00e4higung des not\u00e4rztlichen/rettungsdienstlichen Personals nachhaltige Methoden der geburtshilflichen Wissensvermittlung/-sicherung zum Einsatz zu bringen. Durch die Vermittlung situationsangemessener Handlungsempfehlungen werden pr\u00e4hospitale Notfallteams ohne gesonderte geburtshilfliche Ausbildung so in die Lage zu versetzt, sich der geburtshilflichen Notfallversorgung kompetent stellen zu k\u00f6nnen. Diesem Anspruch folgend, wird in der hier beginnenden Artikelserie individuelle Kompetenz zur pr\u00e4hospitalen Notfalleinsch\u00e4tzung gemeinsam mit Kenntnissen zu sich daraus ableitenden Ma\u00dfnahmen in, dem Notfallsetting angepasster inhaltlicher Tiefe vermittelt. Dies umfasst im ersten Teil die pr\u00e4hospitale Notfallversorgung der Schwangeren, den Notfalltransport, das Schnittstellenmanagement zwischen ambulanter und station\u00e4rer Notfallmedizin bei Einlieferung in das Krankenhaus und den innerklinischen perinatologischen Notfallplan.", "term_pairs": [{"src": {"text": "Maternal emergencies", "char_start": 0, "char_end": 20, "token_start": 0, "token_end": 2}, "tgt": {"text": "Gesundheitliche Notfallsituationen", "char_start": 0, "char_end": 34, "token_start": 0, "token_end": 2}}, {"src": {"text": "pregnancy", "char_start": 28, "char_end": 37, "token_start": 3, "token_end": 4}, "tgt": {"text": "Schwangerschaft", "char_start": 49, "char_end": 64, "token_start": 4, "token_end": 5}}, {"src": {"text": "hospital stay", "char_start": 147, "char_end": 160, "token_start": 23, "token_end": 25}, "tgt": {"text": "Krankenhausaufenthaltes", "char_start": 212, "char_end": 235, "token_start": 24, "token_end": 25}}, {"src": {"text": "emergency teams", "char_start": 268, "char_end": 283, "token_start": 44, "token_end": 46}, "tgt": {"text": "Notfallteams", "char_start": 606, "char_end": 618, "token_start": 67, "token_end": 68}}, {"src": {"text": "obstetrical information", "char_start": 300, "char_end": 323, "token_start": 48, "token_end": 50}, "tgt": {"text": "geburtshilflichen Wissensvermittlung", "char_start": 447, "char_end": 483, "token_start": 50, "token_end": 52}}, {"src": {"text": "emergency care", "char_start": 335, "char_end": 349, "token_start": 52, "token_end": 54}, "tgt": {"text": "Notfallversorgung", "char_start": 718, "char_end": 735, "token_start": 82, "token_end": 83}}, {"src": {"text": "pregnant women", "char_start": 472, "char_end": 486, "token_start": 73, "token_end": 75}, "tgt": {"text": "Schwangeren", "char_start": 1089, "char_end": 1100, "token_start": 129, "token_end": 130}}, {"src": {"text": "prehospital emergency management", "char_start": 436, "char_end": 468, "token_start": 69, "token_end": 72}, "tgt": {"text": "pr\u00e4hospitalen Notfalleinsch\u00e4tzung", "char_start": 859, "char_end": 892, "token_start": 101, "token_end": 103}}, {"src": {"text": "prehospital emergency care", "char_start": 521, "char_end": 547, "token_start": 81, "token_end": 84}, "tgt": {"text": "pr\u00e4hospitale Notfallversorgung", "char_start": 1054, "char_end": 1084, "token_start": 126, "token_end": 128}}, {"src": {"text": "emergency transport", "char_start": 573, "char_end": 592, "token_start": 89, "token_end": 91}, "tgt": {"text": "Notfalltransport", "char_start": 1106, "char_end": 1122, "token_start": 132, "token_end": 133}}, {"src": {"text": "handover management", "char_start": 594, "char_end": 613, "token_start": 92, "token_end": 94}, "tgt": {"text": "Schnittstellenmanagement", "char_start": 1128, "char_end": 1152, "token_start": 135, "token_end": 136}}, {"src": {"text": "hospital admission", "char_start": 617, "char_end": 635, "token_start": 95, "token_end": 97}, "tgt": {"text": "Einlieferung in das Krankenhaus", "char_start": 1208, "char_end": 1239, "token_start": 142, "token_end": 146}}, {"src": {"text": "perinatal emergency care", "char_start": 660, "char_end": 684, "token_start": 103, "token_end": 106}, "tgt": {"text": "perinatologischen Notfallplan", "char_start": 1264, "char_end": 1293, "token_start": 149, "token_end": 151}}]}
{"idx": 7112, "pair_id": "30537792", "src": "In Germany, widespread use is made of dietary supplements (DS) to improve the individual health status, especially among patients diagnosed with certain conditions, elderly people and athletes. Legal aspects as well as health risks related to DS purchased via the internet are rarely analysed in Germany. \u2002We aim to provide a review of the respective literature focusing on health risks, legal aspects und consumer information related to the internet retailing of DS. \u2002A review of the literature including reference tracking was conducted between January 2017 and January 2018 and combined with the results of an analysis of legal regulations in Germany. \u2002Using the internet to research into health-related aspects is common among patients. However, this is often associated with a lack of individual and professional counselling regarding the potential risks and benefits of using DS.\u00a0Potential side-effects are often not declared, and there is a high prevalence of contamination with harmful substances, especially among DS marketed as 'natural health products'. Athletes must be aware of the risk of being tested positive due to contamination of a DS with a WADA-banned substance. \u2002Questions regarding the use of DS in patients as well as in healthy athletes should be implemented into the medical history records by physicians. The use of DS should be carefully documented. A thorough cost-benefit analysis is recommended, and athletes should consider the risk of being tested positive.", "tgt": "Die Einnahme von Nahrungserg\u00e4nzungsmitteln (NEM) mit dem Ziel, den Gesundheitszustand zu verbessern, ist in Deutschland weit verbreitet, insbesondere bei Patienten mit entsprechenden Diagnosen, \u00c4lteren und Sportlern. Rechtsunsicherheiten und gesundheitliche Risiken, die speziell mit dem Interneteinkauf von NEM assoziiert sein k\u00f6nnen, sind in Deutschland wenig untersucht. ZIEL: \u2002Ziel der Arbeit ist ein literaturbasierter \u00dcberblick \u00fcber das gesundheitliche Gef\u00e4hrdungspotenzial, die rechtlichen Rahmenbedingungen sowie die Verbraucherinformationen von \u00fcber den Internethandel bezogenen NEM. \u2002Literaturrecherche (Pubmed) inklusive Reference-tracking (01/2017\u200a\u2013\u200a01/2018) und Sichtung von Ver\u00f6ffentlichungen des Bundesinstituts f\u00fcr Risikobewertung und deutscher Verbraucherzentralen sowie \u00fcberschl\u00e4gige Sichtung der gesetzlichen Regelungen auf Bundes- und L\u00e4nderebene und teilweise Gesetzesexegese. \u2002Patienten nutzen zunehmend das Internet zur gesundheitsbezogenen Information, wobei die pers\u00f6nliche, fachlich einschl\u00e4gige Beratung zu Nutzen und Risiken eines Produkts in der Regel entf\u00e4llt. Auf potenzielle Nebenwirkungen wird h\u00e4ufig nicht hingewiesen. Verunreinigungen mit toxischen Substanzen wie Schwermetallen oder Beimengungen von pharmakologischen Substanzen werden geh\u00e4uft bei als nat\u00fcrlich beworbenen NEM nachgewiesen und k\u00f6nnen ein erhebliches Gesundheitsrisiko darstellen. Im Gegensatz zu Arzneimitteln unterliegen NEM keiner beh\u00f6rdlichen Zulassungspflicht, bei der die Unbedenklichkeit des Produkts \u00fcberpr\u00fcft wird. AthletInnen sollten das nicht unerhebliche Risiko positiver Dopingbefunde infolge einer NEM-Einnahme ber\u00fccksichtigen. Derzeit sind 6\u200a\u2013\u200a9\u200a% der Dopingf\u00e4lle auf NEM zur\u00fcckzuf\u00fchren. \u2002\u00c4rztInnen wird empfohlen, ihre PatientInnen gezielt nach der Einnahme von NEM zu fragen, diese zu dokumentieren und in einen individuellen Substanzpass aufzunehmen. Bei AthletInnen sollte das Risiko dopingrelevanter Verunreinigungen in die individuelle Nutzen-Risiko-Analyse einbezogen werden.", "term_pairs": [{"src": {"text": "dietary supplements", "char_start": 38, "char_end": 57, "token_start": 8, "token_end": 10}, "tgt": {"text": "Nahrungserg\u00e4nzungsmitteln", "char_start": 17, "char_end": 42, "token_start": 3, "token_end": 4}}, {"src": {"text": "DS", "char_start": 59, "char_end": 61, "token_start": 11, "token_end": 12}, "tgt": {"text": "NEM", "char_start": 44, "char_end": 47, "token_start": 5, "token_end": 6}}, {"src": {"text": "health risks", "char_start": 219, "char_end": 231, "token_start": 38, "token_end": 40}, "tgt": {"text": "gesundheitliche Risiken", "char_start": 242, "char_end": 265, "token_start": 35, "token_end": 37}}, {"src": {"text": "legal aspects", "char_start": 194, "char_end": 207, "token_start": 33, "token_end": 35}, "tgt": {"text": "rechtlichen Rahmenbedingungen", "char_start": 485, "char_end": 514, "token_start": 70, "token_end": 72}}, {"src": {"text": "patients", "char_start": 121, "char_end": 129, "token_start": 22, "token_end": 23}, "tgt": {"text": "Patienten", "char_start": 154, "char_end": 163, "token_start": 24, "token_end": 25}}, {"src": {"text": "elderly people", "char_start": 165, "char_end": 179, "token_start": 28, "token_end": 30}, "tgt": {"text": "\u00c4lteren", "char_start": 194, "char_end": 201, "token_start": 29, "token_end": 30}}, {"src": {"text": "athletes", "char_start": 184, "char_end": 192, "token_start": 31, "token_end": 32}, "tgt": {"text": "Sportlern", "char_start": 206, "char_end": 215, "token_start": 31, "token_end": 32}}, {"src": {"text": "internet retailing", "char_start": 442, "char_end": 460, "token_start": 76, "token_end": 78}, "tgt": {"text": "Internethandel", "char_start": 563, "char_end": 577, "token_start": 78, "token_end": 79}}, {"src": {"text": "side-effects", "char_start": 896, "char_end": 908, "token_start": 151, "token_end": 154}, "tgt": {"text": "Nebenwirkungen", "char_start": 1107, "char_end": 1121, "token_start": 154, "token_end": 155}}, {"src": {"text": "contamination", "char_start": 967, "char_end": 980, "token_start": 166, "token_end": 167}, "tgt": {"text": "Verunreinigungen", "char_start": 1153, "char_end": 1169, "token_start": 160, "token_end": 161}}, {"src": {"text": "natural health products", "char_start": 1039, "char_end": 1062, "token_start": 177, "token_end": 180}, "tgt": {"text": "nat\u00fcrlich beworbenen NEM", "char_start": 1288, "char_end": 1312, "token_start": 175, "token_end": 178}}, {"src": {"text": "WADA-banned substance", "char_start": 1161, "char_end": 1182, "token_start": 201, "token_end": 205}, "tgt": {"text": "dopingrelevanter Verunreinigungen", "char_start": 1905, "char_end": 1938, "token_start": 262, "token_end": 264}}, {"src": {"text": "medical history records", "char_start": 1293, "char_end": 1316, "token_start": 225, "token_end": 228}, "tgt": {"text": "Substanzpass", "char_start": 1845, "char_end": 1857, "token_start": 254, "token_end": 255}}, {"src": {"text": "cost-benefit analysis", "char_start": 1389, "char_end": 1410, "token_start": 242, "token_end": 246}, "tgt": {"text": "Nutzen-Risiko-Analyse", "char_start": 1959, "char_end": 1980, "token_start": 267, "token_end": 272}}]}
{"idx": 7199, "pair_id": "33710361", "src": "In many cases primary hyperparathyroidism (PHPT) remains asymptomatic for years and is only detected by abnormalities in routine diagnostics. While symptomatic disease almost always requires surgical treatment, in symptom-free patients the question of whether and in what form treatment should be carried out is particularly important. The aim of this review is to summarize the current recommendations regarding the diagnostics and treatment of asymptomatic PHPT, taking the existing evidence into account. The diagnostics of asymptomatic PHPT is the same as for symptomatic disease. The diagnosis is made in the presence of elevated parathyroid hormone and balanced vitamin\u00a0D levels when a\u00a0combination of hypercalcemia, hypophosphatemia and hypercalciuria is present. Borderline laboratory findings occur especially in asymptomatic PHPT and the differential diagnosis of familial hypocalciuric hypercalcemia must be considered. Once the diagnosis is made sonography, radiography or computed tomography (CT) is used to search for nephrolithiasis or nephrocalcinosis. Regarding bone mineral density (BMD) measurements, in addition to routine measurements at the lumbar spine and femur, measurement at the distal radius is important as it is the most sensitive site for detecting osteoporosis in PHPT. An indication for parathyroidectomy is confirmed in the case of hypercalcemia >\u202f1.0\u202fmg/dl (>0.25\u202fmmol/l) above the upper limit of normal, hypercalciuria >\u202f400\u202fmg/day (>10\u202fmmol/day), renal insufficiency, proven osteoporosis or age <\u202f50\u00a0years. If none of these criteria are fulfilled and surgery is not desired by the patient, annual laboratory check-ups and assessment of BMD every 1-2\u00a0years are recommended.", "tgt": "HINTERGRUND: Der prim\u00e4re Hyperparathyreoidismus (pHPT) bleibt in vielen F\u00e4llen \u00fcber Jahre asymptomatisch und wird lediglich durch Auff\u00e4lligkeiten in der Routinediagnostik erkannt. W\u00e4hrend die symptomatische Erkrankung fast immer eine operative Therapie nach sich zieht, stellt sich bei symptomfreien PatientInnen im Besonderen die Frage, ob und in welcher Form eine Therapie erfolgen soll. Ziel dieser \u00dcbersicht ist es, die aktuellen Empfehlungen bez\u00fcglich Diagnostik und Therapie des asymptomatischen pHPT unter Ber\u00fccksichtigung der bestehenden Evidenz zusammenzufassen. Die Diagnostik des asymptomatischen pHPT entspricht der bei einer symptomatischen Erkrankung. Die Diagnose wird bei erh\u00f6htem Parathormon- und ausgeglichenem Vitamin-D-Spiegel gestellt, wenn eine Kombination von Hyperkalz\u00e4mie, Hypophosphat\u00e4mie und Hyperkalzurie vorliegt. Gerade beim asymptomatischen pHPT kommen grenzwertige Laborbefunde vor; die Differenzialdiagnose der famili\u00e4ren hypokalzurischen Hyperkalz\u00e4mie muss beachtet werden. Nach erfolgter Diagnose wird mithilfe von Sonographie, R\u00f6ntgen oder CT-Untersuchung nach Nierensteinen gesucht. In der Knochendichtemessung ist neben den Routinemessungen an LWS und Femur die Messung am distalen Radius wichtig, die bei pHPT als sensitivstem Messort eine Osteoporose erfasst. Eine Indikation zur Parathyreoidektomie ergibt sich bei einer Hyperkalz\u00e4mie >\u202f1,0\u202fmg/dl (>0,25\u202fmmol/l) \u00fcber dem oberen Normwert, bei einer Hyperkalzurie >\u202f400\u202fmg/Tag (>10\u202fmmol/Tag), einer Niereninsuffizienz, einer nachgewiesenen Osteoporose oder einem Alter <\u202f50\u00a0Jahren. Wird keines dieser Kriterien erf\u00fcllt und von dem Patienten/der Patientin keine Operation gew\u00fcnscht, sind j\u00e4hrliche Laborkontrollen sowie ein- bis 2\u2011j\u00e4hrliche Kontrollen der Knochendichte empfohlen.", "term_pairs": []}
{"idx": 7223, "pair_id": "24568763", "src": "Health related behaviour is a main determinant of chronic disease. Family physicians have an important role in the support of patients to improve their health behaviour, but relevant barriers should be addressed. In the new 'Health Coaching KHM' program, patients and physicians are working as a team in four steps (sensitize - create motivation - plan - act). In this process, physicians' communication skills (which are trained within the program) are of utmost importance. In a pilot study with 20 family physicians and 1045 patients acceptance and feasibility were excellent: Every second participant improved her or his behaviour in the area of choice by at least one (of two possible) categories. For dissemination improving framework is crucial.", "tgt": "Das gesundheitsrelevante Verhalten ist eine wichtige Determinante chronischer Krankheiten. Haus\u00e4rzten kommt dabei die bedeutende Rolle zu, Patienten bei der Verbesserung ihres Gesundheitsverhaltens zu unterst\u00fctzen; Hindernisse m\u00fcssen aber ber\u00fccksichtigt werden. Im neuen Beratungsprogramm \u00abGesundheitscoaching KHM\u00bb (www.gesundheitscoaching-khm.ch) arbeiten Patient und Arzt als Team in vier Schritten (sensibilisieren \u2013 Motivation aufbauen \u2013 planen \u2013 ausf\u00fchren und begleiten) daran, ein selbstgew\u00e4hltes Ziel der Verhaltens\u00e4nderung zu erreichen. Entscheidend sind dabei kommunikative Fertigkeiten des Arztes, die im Programm trainiert werden. Ein Pilottest mit 20 \u00c4rzten und 1045 Patienten zeigte eine hervorragende Akzeptanz und Praktikabilit\u00e4t des Programmes; nach vier Beratungssitzungen verbesserte jeder zweite Teilnehmer sein Gesundheitsverhalten im gew\u00e4hlten Ziel um mindestens eine (von zwei m\u00f6glichen) Kategorien. F\u00fcr die Weiterverbreitung ist die Schaffung von g\u00fcnstigen Rahmenbedingungen essenziell.", "term_pairs": [{"src": {"text": "chronic disease", "char_start": 50, "char_end": 65, "token_start": 8, "token_end": 10}, "tgt": {"text": "chronischer Krankheiten", "char_start": 66, "char_end": 89, "token_start": 7, "token_end": 9}}, {"src": {"text": "Family physicians", "char_start": 67, "char_end": 84, "token_start": 11, "token_end": 13}, "tgt": {"text": "Haus\u00e4rzten", "char_start": 91, "char_end": 101, "token_start": 10, "token_end": 11}}, {"src": {"text": "Health Coaching KHM", "char_start": 225, "char_end": 244, "token_start": 39, "token_end": 42}, "tgt": {"text": "Gesundheitscoaching KHM", "char_start": 290, "char_end": 313, "token_start": 37, "token_end": 39}}, {"src": {"text": "pilot study", "char_start": 481, "char_end": 492, "token_start": 90, "token_end": 92}, "tgt": {"text": "Pilottest", "char_start": 646, "char_end": 655, "token_start": 95, "token_end": 96}}, {"src": {"text": "family physicians", "char_start": 501, "char_end": 518, "token_start": 94, "token_end": 96}, "tgt": {"text": "\u00c4rzten", "char_start": 663, "char_end": 669, "token_start": 98, "token_end": 99}}, {"src": {"text": "patients", "char_start": 126, "char_end": 134, "token_start": 21, "token_end": 22}, "tgt": {"text": "Patienten", "char_start": 139, "char_end": 148, "token_start": 18, "token_end": 19}}, {"src": {"text": "physicians", "char_start": 268, "char_end": 278, "token_start": 47, "token_end": 48}, "tgt": {"text": "Arzt", "char_start": 369, "char_end": 373, "token_start": 52, "token_end": 53}}, {"src": {"text": "communication skills", "char_start": 390, "char_end": 410, "token_start": 73, "token_end": 75}, "tgt": {"text": "kommunikative Fertigkeiten", "char_start": 569, "char_end": 595, "token_start": 83, "token_end": 85}}]}
{"idx": 7445, "pair_id": "30397405", "src": "Neuroendocrine carcinoma of the breast is a rare disease. We present a 65-yearold female patient with an enlarged breast mass within 2 months. Solid neuroendocrine carcinoma of the breast was diagnosed by excision biopsy and histopathological analysis. A lumpectomy with the right axillary sentinel lymph node biopsy was performed, and the mass was completely resected. The literature on neuroendocrine carcinoma of the breast is reviewed. Due to the diversity of imaging findings from primary breast neuroendocrine carcinomas, the diagnosis is based on immunohistochemical staining of neuroendocrine markers. Surgery has turned out to be the first-line treatment and subsequently radiation may play a role in palliative treatment.", "tgt": "Neuroendokrine Mammakarzinome sind eine seltene Krankheit. Wir stellen eine 65 Jahre alte Frau mit einem innerhalb von 2 Monaten vergr\u00f6\u00dferten Tumor vor. Ein solides neuroendokrines Karzinom der Brust wurde mittels Exzisionsbiopsie und histopathologischer Analyse diagnostiziert. Eine Lumpektomie wurde mit einer Sentinel-Lymphknotenbiopsie in der rechten Achsel durchgef\u00fchrt und die Wucherung komplett entfernt. Die Literatur zum neuroendokrinen Mammakarzinom wird dargestellt. Aufgrund der Vielf\u00e4ltigkeit der Ergebnisse bei der Bildgebung des prim\u00e4ren neuroendokrinen Mammakarzinoms basiert die Diagnose auf immunohistochemischer F\u00e4rbung von neuroendokrinen Markern. Die chirurgische Entfernung hat sich als First-line-Behandlung herausgestellt und nachfolgend kann Bestrahlung eine Rolle in der palliativen Behandlung einnehmen.", "term_pairs": [{"src": {"text": "rare disease", "char_start": 44, "char_end": 56, "token_start": 7, "token_end": 9}, "tgt": {"text": "seltene Krankheit", "char_start": 40, "char_end": 57, "token_start": 4, "token_end": 6}}, {"src": {"text": "65-yearold female patient", "char_start": 71, "char_end": 96, "token_start": 13, "token_end": 18}, "tgt": {"text": "65 Jahre alte Frau", "char_start": 76, "char_end": 94, "token_start": 10, "token_end": 14}}, {"src": {"text": "breast mass", "char_start": 114, "char_end": 125, "token_start": 21, "token_end": 23}, "tgt": {"text": "Tumor", "char_start": 142, "char_end": 147, "token_start": 21, "token_end": 22}}, {"src": {"text": "Solid neuroendocrine carcinoma of the breast", "char_start": 143, "char_end": 187, "token_start": 27, "token_end": 33}, "tgt": {"text": "solides neuroendokrines Karzinom der Brust", "char_start": 157, "char_end": 199, "token_start": 25, "token_end": 30}}, {"src": {"text": "excision biopsy", "char_start": 205, "char_end": 220, "token_start": 36, "token_end": 38}, "tgt": {"text": "Exzisionsbiopsie", "char_start": 214, "char_end": 230, "token_start": 32, "token_end": 33}}, {"src": {"text": "histopathological analysis", "char_start": 225, "char_end": 251, "token_start": 39, "token_end": 41}, "tgt": {"text": "histopathologischer Analyse", "char_start": 235, "char_end": 262, "token_start": 34, "token_end": 36}}, {"src": {"text": "lumpectomy", "char_start": 255, "char_end": 265, "token_start": 43, "token_end": 44}, "tgt": {"text": "Lumpektomie", "char_start": 284, "char_end": 295, "token_start": 39, "token_end": 40}}, {"src": {"text": "axillary sentinel lymph node biopsy", "char_start": 281, "char_end": 316, "token_start": 47, "token_end": 52}, "tgt": {"text": "Sentinel-Lymphknotenbiopsie in der rechten Achsel", "char_start": 312, "char_end": 361, "token_start": 43, "token_end": 50}}, {"src": {"text": "neuroendocrine carcinoma of the breast", "char_start": 0, "char_end": 38, "token_start": 0, "token_end": 5}, "tgt": {"text": "neuroendokrinen Mammakarzinom", "char_start": 430, "char_end": 459, "token_start": 60, "token_end": 62}}, {"src": {"text": "primary breast neuroendocrine carcinomas", "char_start": 486, "char_end": 526, "token_start": 81, "token_end": 85}, "tgt": {"text": "prim\u00e4ren neuroendokrinen Mammakarzinoms", "char_start": 544, "char_end": 583, "token_start": 74, "token_end": 77}}, {"src": {"text": "immunohistochemical staining", "char_start": 554, "char_end": 582, "token_start": 91, "token_end": 93}, "tgt": {"text": "immunohistochemischer F\u00e4rbung", "char_start": 609, "char_end": 638, "token_start": 81, "token_end": 83}}, {"src": {"text": "neuroendocrine markers", "char_start": 586, "char_end": 608, "token_start": 94, "token_end": 96}, "tgt": {"text": "neuroendokrinen Markern", "char_start": 643, "char_end": 666, "token_start": 84, "token_end": 86}}, {"src": {"text": "Surgery", "char_start": 610, "char_end": 617, "token_start": 97, "token_end": 98}, "tgt": {"text": "chirurgische Entfernung", "char_start": 672, "char_end": 695, "token_start": 88, "token_end": 90}}, {"src": {"text": "first-line treatment", "char_start": 643, "char_end": 663, "token_start": 104, "token_end": 108}, "tgt": {"text": "First-line-Behandlung", "char_start": 709, "char_end": 730, "token_start": 93, "token_end": 98}}, {"src": {"text": "radiation", "char_start": 681, "char_end": 690, "token_start": 110, "token_end": 111}, "tgt": {"text": "Bestrahlung", "char_start": 767, "char_end": 778, "token_start": 102, "token_end": 103}}, {"src": {"text": "palliative treatment", "char_start": 710, "char_end": 730, "token_start": 116, "token_end": 118}, "tgt": {"text": "palliativen Behandlung", "char_start": 797, "char_end": 819, "token_start": 107, "token_end": 109}}]}
{"idx": 7629, "pair_id": "34570266", "src": "Since older adults spend much time in their home environment (HE), frailty may occur as a\u00a0consequence of a\u00a0maladaptation to the HE. The aim of this study was to describe the prevalence of frailty in the very old population of North Rhine-Westphalia, and to examine the association between the HE and the frailty levels of these individuals. Data from a\u00a0cross-sectional representative study were used, including data on 1577 community-dwelling individuals and nursing home residents aged \u2265\u202f80\u00a0years. Objective and subjective HE aspects were included. Frailty was defined according to four criteria: exhaustion, unintentional weight loss, weakness, and low physical activity. Adjusted multinomial regression modelling was used to analyze the link between the HE and frailty levels. Of the very old individuals, 24.3% were robust, 57.0% were prefrail, and 18.7% were frail. Adjusting for relevant sociodemographic and health characteristics, being not closely attached to the HE was linked with an increased probability of being prefrail and frail. An improvement of the residential area was associated with a\u00a0decrease in odds of being frail. Living in communities with less than 50,000 and with 100,000-499,999 inhabitants decreased the odds of being frail. Frailty prevalence is shown to be higher in the very old population than in the younger age groups in Germany. Early identification of frailty and tailored interventions focused on improving objective and subjective attributes of the HE are needed to reduce the risk of frailty.", "tgt": "HINTERGRUND: Da \u00e4ltere Menschen viel Zeit in ihrer Wohnumgebung (HE) verbringen, kann als Folge einer Fehlanpassung an HE Gebrechlichkeit auftreten. Das Ziel der Studie war, die Gebrechlichkeitspr\u00e4valenz in der Hochaltrigenpopulation Nordrhein-Westfalens zu beschreiben und den Zusammenhang zwischen dem HE und Gebrechlichkeitsniveau zu untersuchen. Es wurden Daten aus einer repr\u00e4sentativen Querschnittsstudie verwendet. Insgesamt wurden Daten von 1577 in Privathaushalten und Heimen lebenden Personen im Alter von \u2265\u202f80\u00a0Jahren analysiert. Einbezogen wurden objektive und subjektive Aspekte von HE. Gebrechlichkeit wurde anhand von vier Kriterien definiert: Ersch\u00f6pfung, unabsichtlicher Gewichtsverlust, Schw\u00e4che, niedrige k\u00f6rperliche Aktivit\u00e4t. Mit einem adjustierten multinomialen Regressionsmodell wurde der Zusammenhang zwischen HE und Gebrechlichkeitsniveau gesch\u00e4tzt. In der Hochaltrigenpopulation waren 24,3\u202f% robust, 57,0\u202f% pr\u00e4gebrechlich und 18,7\u202f% gebrechlich. Unter Ber\u00fccksichtigung relevanter soziodemographischer und gesundheitlicher Merkmale war die fehlende Verbundenheit mit HE mit einer erh\u00f6hten Wahrscheinlichkeit assoziiert, pr\u00e4gebrechlich und gebrechlich zu sein. Eine Verbesserung der Wohngegend war mit einer verminderten Wahrscheinlichkeit des Auftretens von Gebrechlichkeit verbunden. Der Wohnsitz in Gemeinden mit weniger als 50.000 und 100.000 bis 499.999 Einwohnern reduzierte die Wahrscheinlichkeit, gebrechlich zu sein. Die Gebrechlichkeitspr\u00e4valenz war in der Hochaltrigenpopulation h\u00f6her als in den j\u00fcngeren Altersgruppen in Deutschland. Fr\u00fchzeitige Identifikation und gezielte Interventionen, die sich mit Verbesserungen objektiver und subjektiver Merkmale von HE befassen, sind erforderlich, um das Gebrechlichkeitsrisiko zu senken.", "term_pairs": [{"src": {"text": "frailty", "char_start": 67, "char_end": 74, "token_start": 14, "token_end": 15}, "tgt": {"text": "Gebrechlichkeit", "char_start": 122, "char_end": 137, "token_start": 22, "token_end": 23}}, {"src": {"text": "home environment (HE)", "char_start": 44, "char_end": 65, "token_start": 8, "token_end": 13}, "tgt": {"text": "Wohnumgebung (HE)", "char_start": 51, "char_end": 68, "token_start": 9, "token_end": 13}}, {"src": {"text": "exhaustion", "char_start": 598, "char_end": 608, "token_start": 110, "token_end": 111}, "tgt": {"text": "Ersch\u00f6pfung", "char_start": 658, "char_end": 669, "token_start": 97, "token_end": 98}}, {"src": {"text": "unintentional weight loss", "char_start": 610, "char_end": 635, "token_start": 112, "token_end": 115}, "tgt": {"text": "unabsichtlicher Gewichtsverlust", "char_start": 671, "char_end": 702, "token_start": 99, "token_end": 101}}, {"src": {"text": "weakness", "char_start": 637, "char_end": 645, "token_start": 116, "token_end": 117}, "tgt": {"text": "Schw\u00e4che", "char_start": 704, "char_end": 712, "token_start": 102, "token_end": 103}}, {"src": {"text": "low physical activity", "char_start": 651, "char_end": 672, "token_start": 119, "token_end": 122}, "tgt": {"text": "niedrige k\u00f6rperliche Aktivit\u00e4t", "char_start": 714, "char_end": 744, "token_start": 104, "token_end": 107}}, {"src": {"text": "prefrail", "char_start": 839, "char_end": 847, "token_start": 158, "token_end": 159}, "tgt": {"text": "pr\u00e4gebrechlich", "char_start": 932, "char_end": 946, "token_start": 136, "token_end": 137}}, {"src": {"text": "frail", "char_start": 188, "char_end": 193, "token_start": 38, "token_end": 39}, "tgt": {"text": "gebrechlich", "char_start": 178, "char_end": 189, "token_start": 32, "token_end": 33}}, {"src": {"text": "robust", "char_start": 820, "char_end": 826, "token_start": 151, "token_end": 152}, "tgt": {"text": "robust", "char_start": 917, "char_end": 923, "token_start": 130, "token_end": 131}}, {"src": {"text": "cross-sectional representative study", "char_start": 353, "char_end": 389, "token_start": 69, "token_end": 74}, "tgt": {"text": "repr\u00e4sentativen Querschnittsstudie", "char_start": 376, "char_end": 410, "token_start": 57, "token_end": 59}}, {"src": {"text": "nursing home residents", "char_start": 459, "char_end": 481, "token_start": 86, "token_end": 89}, "tgt": {"text": "Heimen lebenden Personen", "char_start": 478, "char_end": 502, "token_start": 69, "token_end": 72}}, {"src": {"text": "multinomial regression modelling", "char_start": 683, "char_end": 715, "token_start": 124, "token_end": 127}, "tgt": {"text": "multinomialen Regressionsmodell", "char_start": 769, "char_end": 800, "token_start": 111, "token_end": 113}}, {"src": {"text": "residential area", "char_start": 1068, "char_end": 1084, "token_start": 199, "token_end": 201}, "tgt": {"text": "Wohngegend", "char_start": 1206, "char_end": 1216, "token_start": 172, "token_end": 173}}, {"src": {"text": "frailty prevalence", "char_start": 1256, "char_end": 1274, "token_start": 238, "token_end": 240}, "tgt": {"text": "Gebrechlichkeitspr\u00e4valenz", "char_start": 1453, "char_end": 1478, "token_start": 212, "token_end": 213}}, {"src": {"text": "very old population", "char_start": 203, "char_end": 222, "token_start": 41, "token_end": 44}, "tgt": {"text": "Hochaltrigenpopulation", "char_start": 211, "char_end": 233, "token_start": 35, "token_end": 36}}, {"src": {"text": "North Rhine-Westphalia", "char_start": 226, "char_end": 248, "token_start": 45, "token_end": 49}, "tgt": {"text": "Nordrhein-Westfalens", "char_start": 234, "char_end": 254, "token_start": 36, "token_end": 39}}]}
{"idx": 7650, "pair_id": "30481835", "src": "People who have become victims of domestic or public violence often suffer long-term physical, psychological and social impairment. Due to physical injury, the first contact with the health care system is frequently an A\u200a&\u200aE Department. Thus, physicians and especially surgeons play a key role in detecting victims of domestic or public violence. The specific needs of victims are adequate medical treatment of injuries, forensic documentation, as well as interdisciplinary medical support to prevent further morbidity and violence. To take this into account, so-called expertise centres for victims of violence have been established at several locations in Germany in recent years. In this study: I. We tried to define the characteristics of victims of domestic and public violence to ensure better identification by physicians/surgeons. II. We elucidate the acceptance and effectiveness of such an expertise centre one year after its implementation and for a period of three years (2007\u200a-\u200a2009) and for a follow-up period of three years (2014\u200a-\u200a2016) after establishment. Patients were prospectively classified as victims of violence by the attending physician at the A\u200a&\u200aE Department and further treatment was initiated by the expertise centre for victims of violence. Medical reports from the A\u200a&\u200aE Department were analysed anonymously and compared with the number of patients of the expertise centre for victims of violence who had been referred from A\u200a&\u200aE Department. Orthopaedic and trauma surgery is the main referring discipline for the expertise centre for victims of violence. 0.9% of patients (2007\u200a-\u200a2009) and in the follow-up period (2014\u200a-\u200a2016) even 1.6% of patients were identified as victims of violence. However, the acceptance of such a centre fell from 22.2% (2007\u200a-\u200a2009) to 17.2% (2014\u200a-\u200a2016). Physicians and especially trauma surgeons are responsible for identifying victims of domestic or public violence and ensuring further treatment. Accordingly, it is crucial that the expertise centre should characterise the victims of violence and be aware of their different needs, if the expertise centre is to be accepted. The results of this study indicate that interdisciplinary training and close cooperation between traumatology and legal medicine are the main prerequisites for continuous improvement in the treatment of victims of violence.", "tgt": "Die erste Anlaufstelle eines Opfers nach k\u00f6rperlicher Gewalt ist zumeist die zentrale Notaufnahme eines Krankenhauses. Die Behandlung beschr\u00e4nkt sich dabei in der Regel auf die vordringliche chirurgische Versorgung der Verletzungsfolgen. Der Status \u201eGewaltopfer\u201c wird als solcher oft nicht erkannt. Deren Erkennung und Notfallversorgung durch den Unfallchirurgen vorausgesetzt, beinhaltet die ad\u00e4quate Versorgung eines Gewaltopfers idealerweise eine forensisch aussagekr\u00e4ftige Dokumentation sowie eine interdisziplin\u00e4re Weiterbehandlung. Unter diesem Aspekt wurden in Deutschland an mehreren Standorten sogenannte Gewaltopferambulanzen etabliert, die mit den Angeboten der notfallmedizinischen Versorgungsinstitutionen eine interdisziplin\u00e4re Gewaltopferversorgung anbieten. Ziele dieser Studie waren: I. Erfassung und Charakterisierung von Gewaltopfern in einer unfallchirurgischen Notaufnahme. II. Dokumentation des Inanspruchnahmeverhaltens in der angebundenen rechtsmedizinischen Gewaltopferambulanz. Die Datenauswertung umfasste auf der einen Seite einen Zeitraum von 3 Jahren (2007\u200a\u2013\u200a2009), dem die Implementierung der Gewaltopferambulanz am Institut f\u00fcr Rechtsmedizin im Universit\u00e4tsklinikum voranging, auf der anderen Seite 3 weitere Jahre (2014\u200a\u2013\u200a2016) nach mehrj\u00e4hriger routinem\u00e4\u00dfiger Arbeit der erfolgreich etablierten Gewaltopferambulanz. Im Patientenkontakt wurde durch den erstbehandelnden Unfallchirurgen eine Wertung \u201eGewaltopfer\u201c oder \u201ekein Gewaltopfer\u201c vorgenommen, die Informationen anonymisiert gesammelt und die empfohlene Weiterleitung an die rechtsmedizinische Gewaltopferambulanz dokumentiert. Diese Daten wurden der Anzahl der Patienten gegen\u00fcbergestellt, die durch die Empfehlung der Unfallchirurgie in der rechtsmedizinischen Ambulanz betreut wurden. Zus\u00e4tzlich wurde die Relation zu anderen Einweisern bestimmt. Die Unfallchirurgie war unter den medizinischen Zuweisern am st\u00e4rksten vertreten. Im Vergleich zum Zeitraum 2007\u200a\u2013\u200a2009 mit 0,9% konnte im Follow-up-Zeitraum 2014\u200a\u2013\u200a2016 mit 1,6% eine h\u00f6here Patientenzahl als Gewaltopfer identifiziert werden. Die Inanspruchnahme der Gewaltopferambulanz war im Zeitraum 2007\u200a\u2013\u200a2009 mit 22,2% jedoch deutlich niedriger als im Folgezeitraum 2014\u200a\u2013\u200a2016 mit 17,2%. Als Hauptzuweiser f\u00fcr die rechtsmedizinische Gewaltopferambulanz obliegt insbesondere der Unfallchirurgie die Aufgabe, Gewaltopfer zu identifizieren und die Dunkelziffer an Gewaltopfern gering zu halten. Neben der Identifikation eines Gewaltopfers liegt die Verantwortung des erstbehandelnden Arztes auch in der F\u00f6rderung der Inanspruchnahme nachgelagerter Hilfeangebote. Dementsprechend sind die Charakterisierung unfallchirurgischer Gewaltopfer sowie die Kenntnis \u00fcber deren unterschiedliches Inanspruchnahmeverhalten f\u00fcr eine zuk\u00fcnftig bessere Gewaltopferidentifikation und Versorgung von entscheidender Bedeutung. Durch entsprechend empathisches Handeln der Erstbehandler, Information der Betroffenen und Ermutigung zur Inanspruchnahme psychosozialer Hilfen k\u00f6nnen nachgeschaltete Institutionen deutlich wirksamer t\u00e4tig werden.", "term_pairs": [{"src": {"text": "forensic documentation", "char_start": 421, "char_end": 443, "token_start": 74, "token_end": 76}, "tgt": {"text": "forensisch aussagekr\u00e4ftige Dokumentation", "char_start": 450, "char_end": 490, "token_start": 61, "token_end": 64}}, {"src": {"text": "interdisciplinary medical support", "char_start": 456, "char_end": 489, "token_start": 80, "token_end": 83}, "tgt": {"text": "interdisziplin\u00e4re Weiterbehandlung", "char_start": 502, "char_end": 536, "token_start": 66, "token_end": 68}}, {"src": {"text": "expertise centres for victims of violence", "char_start": 570, "char_end": 611, "token_start": 99, "token_end": 105}, "tgt": {"text": "Gewaltopferambulanzen", "char_start": 614, "char_end": 635, "token_start": 79, "token_end": 80}}, {"src": {"text": "victims of violence", "char_start": 1116, "char_end": 1135, "token_start": 198, "token_end": 201}, "tgt": {"text": "Gewaltopfer", "char_start": 250, "char_end": 261, "token_start": 35, "token_end": 36}}, {"src": {"text": "trauma surgery", "char_start": 1490, "char_end": 1504, "token_start": 263, "token_end": 265}, "tgt": {"text": "Unfallchirurgie", "char_start": 1709, "char_end": 1724, "token_start": 221, "token_end": 222}}, {"src": {"text": "traumatology", "char_start": 2239, "char_end": 2251, "token_start": 411, "token_end": 412}, "tgt": {"text": "Unfallchirurgie", "char_start": 1843, "char_end": 1858, "token_start": 239, "token_end": 240}}, {"src": {"text": "legal medicine", "char_start": 2256, "char_end": 2270, "token_start": 413, "token_end": 415}, "tgt": {"text": "Rechtsmedizin", "char_start": 963, "char_end": 976, "token_start": 119, "token_end": 120}}, {"src": {"text": "follow-up period", "char_start": 1007, "char_end": 1023, "token_start": 178, "token_end": 182}, "tgt": {"text": "Follow-up-Zeitraum", "char_start": 1978, "char_end": 1996, "token_start": 263, "token_end": 268}}]}
{"idx": 7680, "pair_id": "34852370", "src": "To determine whether the prefrontal space ratio (PSFR), inferior facial (IFA) and maxilla-nasion-mandible angle (MNM), and the fetal profile line (FPL) are helpful in identifying fetuses with Robin sequence (RS) in cases with isolated retrognathia, and thus better predict the likelihood of immediate need for postnatal respiratory support. This was a retrospective matched case-control study of fetuses/infants with isolated retrognathia with or without RS receiving pre- and postnatal treatment at the University Hospital of T\u00fcbingen, Germany between 2008 and 2020. The PFSR, IFA, MNM, and FPL were measured in affected and normal fetuses according to standardized protocols. Cases were stratified into isolated retrognathia and RS. 21 (n=7 isolated retrognathia, n=14 RS) affected fetuses and 252 normal fetuses were included. Their median gestational age at ultrasound examination was 23.6 and 24.1 weeks, respectively. In fetuses with isolated retrognathia and RS, the PSFR, IFA, and FPL were significantly different from the normal population. At a false-positive rate of 5%, the detection rate was 76.2% for the PFSR, 85.7% for the IFA, and 90.5% for both parameters combined. However, all parameters failed to distinguish between isolated retrognathia and RS. PSFR and IFA are simple markers for identifying retrognathia prenatally. However, they are not helpful for the detection of RS in fetuses with isolated retrognathia. Therefore, delivery should take place in a center experienced with RS and potentially life-threatening airway obstruction immediately after birth.", "tgt": "Es sollte bestimmt werden, ob das pr\u00e4frontale Raumverh\u00e4ltnis (PSFR), der inferiore faziale Winkel (IFA) und der Maxilla-Nasion-Mandibula-Winkel (MNM) oder die fetale Profillinie (FPL) bei der Identifizierung von F\u00f6ten mit Robin-Sequenz (RS) in F\u00e4llen mit isolierter Retrognathie hilfreich sind, um so die Wahrscheinlichkeit eines unmittelbaren Bedarfs an postnataler Atmungsunterst\u00fctzung besser vorherzusagen zu k\u00f6nnen. Dies war eine retrospektive, gematchte Fall-Kontroll-Studie von F\u00f6ten/Kindern mit isolierter Retrognathie mit oder ohne RS, die zwischen 2008 und 2020 im Universit\u00e4tsklinikum T\u00fcbingen, Deutschland pr\u00e4- und postnatal behandelt wurden. Die PFSR, IFA, MNM und FPL wurden bei betroffenen und normalen F\u00f6ten nach standardisierten Protokollen gemessen. Die Patienten wurden in isolierte Retrognathie und RS unterteilt. 21 (n=7 isolierte Retrognathie, n=14 RS) betroffene und 252 normale F\u00f6ten wurden eingeschlossen. Das mediane Gestationsalter bei der Ultraschalluntersuchung betrug 23,6 bzw. 24,1 Wochen. Bei F\u00f6ten mit isolierter Retrognathie und RS unterschieden sich die PSFR, IFA und FPL signifikant von der normalen Population. Bei einer Falsch-Positiv-Rate von 5% betrug die Erkennungsrate 76,2% f\u00fcr die PFSR, 85,7% f\u00fcr die IFA und 90,5% f\u00fcr beide Parameter zusammen. Alle Parameter konnten jedoch nicht zwischen isolierter Retrognathie und RS unterscheiden. PSFR und IFA sind einfache Marker zur pr\u00e4natalen Identifizierung von Retrognathien. Sie sind jedoch nicht hilfreich f\u00fcr die Erkennung von RS bei F\u00f6ten mit isolierter Retrognathie. Daher sollte die Entbindung in einem Zentrum erfolgen, das Erfahrung mit RS und einer potenziell lebensbedrohlichen Atemwegsobstruktion unmittelbar nach der Geburt hat.", "term_pairs": [{"src": {"text": "prefrontal space ratio", "char_start": 25, "char_end": 47, "token_start": 4, "token_end": 7}, "tgt": {"text": "pr\u00e4frontale Raumverh\u00e4ltnis", "char_start": 34, "char_end": 60, "token_start": 7, "token_end": 9}}, {"src": {"text": "PSFR", "char_start": 49, "char_end": 53, "token_start": 8, "token_end": 9}, "tgt": {"text": "PSFR", "char_start": 62, "char_end": 66, "token_start": 10, "token_end": 11}}, {"src": {"text": "inferior facial", "char_start": 56, "char_end": 71, "token_start": 11, "token_end": 13}, "tgt": {"text": "inferiore faziale", "char_start": 73, "char_end": 90, "token_start": 14, "token_end": 16}}, {"src": {"text": "IFA", "char_start": 73, "char_end": 76, "token_start": 14, "token_end": 15}, "tgt": {"text": "IFA", "char_start": 99, "char_end": 102, "token_start": 18, "token_end": 19}}, {"src": {"text": "maxilla-nasion-mandible angle", "char_start": 82, "char_end": 111, "token_start": 17, "token_end": 23}, "tgt": {"text": "Maxilla-Nasion-Mandibula-Winkel", "char_start": 112, "char_end": 143, "token_start": 22, "token_end": 29}}, {"src": {"text": "MNM", "char_start": 113, "char_end": 116, "token_start": 24, "token_end": 25}, "tgt": {"text": "MNM", "char_start": 145, "char_end": 148, "token_start": 30, "token_end": 31}}, {"src": {"text": "fetal profile line", "char_start": 127, "char_end": 145, "token_start": 29, "token_end": 32}, "tgt": {"text": "fetale Profillinie", "char_start": 159, "char_end": 177, "token_start": 34, "token_end": 36}}, {"src": {"text": "FPL", "char_start": 147, "char_end": 150, "token_start": 33, "token_end": 34}, "tgt": {"text": "FPL", "char_start": 179, "char_end": 182, "token_start": 37, "token_end": 38}}, {"src": {"text": "Robin sequence", "char_start": 192, "char_end": 206, "token_start": 41, "token_end": 43}, "tgt": {"text": "Robin-Sequenz", "char_start": 222, "char_end": 235, "token_start": 45, "token_end": 48}}, {"src": {"text": "RS", "char_start": 208, "char_end": 210, "token_start": 44, "token_end": 45}, "tgt": {"text": "RS", "char_start": 237, "char_end": 239, "token_start": 49, "token_end": 50}}, {"src": {"text": "retrognathia", "char_start": 235, "char_end": 247, "token_start": 50, "token_end": 51}, "tgt": {"text": "Retrognathie", "char_start": 266, "char_end": 278, "token_start": 55, "token_end": 56}}, {"src": {"text": "respiratory support", "char_start": 320, "char_end": 339, "token_start": 63, "token_end": 65}, "tgt": {"text": "Atmungsunterst\u00fctzung", "char_start": 367, "char_end": 387, "token_start": 68, "token_end": 69}}, {"src": {"text": "retrospective matched case-control study", "char_start": 352, "char_end": 392, "token_start": 69, "token_end": 75}, "tgt": {"text": "retrospektive, gematchte Fall-Kontroll-Studie", "char_start": 434, "char_end": 479, "token_start": 77, "token_end": 85}}, {"src": {"text": "University Hospital of T\u00fcbingen", "char_start": 504, "char_end": 535, "token_start": 94, "token_end": 98}, "tgt": {"text": "Universit\u00e4tsklinikum T\u00fcbingen", "char_start": 574, "char_end": 603, "token_start": 103, "token_end": 105}}, {"src": {"text": "gestational age", "char_start": 843, "char_end": 858, "token_start": 159, "token_end": 161}, "tgt": {"text": "Gestationsalter", "char_start": 942, "char_end": 957, "token_start": 166, "token_end": 167}}, {"src": {"text": "ultrasound examination", "char_start": 862, "char_end": 884, "token_start": 162, "token_end": 164}, "tgt": {"text": "Ultraschalluntersuchung", "char_start": 966, "char_end": 989, "token_start": 169, "token_end": 170}}, {"src": {"text": "false-positive rate", "char_start": 1055, "char_end": 1074, "token_start": 201, "token_end": 205}, "tgt": {"text": "Falsch-Positiv-Rate", "char_start": 1157, "char_end": 1176, "token_start": 204, "token_end": 209}}, {"src": {"text": "detection rate", "char_start": 1086, "char_end": 1100, "token_start": 210, "token_end": 212}, "tgt": {"text": "Erkennungsrate", "char_start": 1195, "char_end": 1209, "token_start": 214, "token_end": 215}}, {"src": {"text": "airway obstruction", "char_start": 1537, "char_end": 1555, "token_start": 297, "token_end": 299}, "tgt": {"text": "Atemwegsobstruktion", "char_start": 1675, "char_end": 1694, "token_start": 297, "token_end": 298}}]}
{"idx": 7689, "pair_id": "34860267", "src": "Presentation of a 16-year-old male patient due to a cycling accident while mountain biking 14\u00a0days after primary treatment after open epiphyseal injury. Metaphyseal intraosseous stones within the anatomically reduced distal radius fracture were misinterpreted as an incidental osteoma.", "tgt": "Vorstellung eines 16-j\u00e4hrigen Patienten nach Fahrradsturz beim Mountainbiken 14\u00a0Tage nach prim\u00e4rer Versorgung nach offener Epiphysenverletzung. Metaphys\u00e4r intraoss\u00e4r liegende Steine wurden bei anatomischer Reposition der Fraktur als nebenbefundliches Osteom fehlinterpretiert.", "term_pairs": [{"src": {"text": "cycling accident", "char_start": 52, "char_end": 68, "token_start": 13, "token_end": 15}, "tgt": {"text": "Fahrradsturz", "char_start": 45, "char_end": 57, "token_start": 7, "token_end": 8}}, {"src": {"text": "mountain biking", "char_start": 75, "char_end": 90, "token_start": 16, "token_end": 18}, "tgt": {"text": "Mountainbiken", "char_start": 63, "char_end": 76, "token_start": 9, "token_end": 10}}, {"src": {"text": "primary treatment", "char_start": 105, "char_end": 122, "token_start": 21, "token_end": 23}, "tgt": {"text": "prim\u00e4rer Versorgung", "char_start": 90, "char_end": 109, "token_start": 13, "token_end": 15}}, {"src": {"text": "open epiphyseal injury", "char_start": 129, "char_end": 151, "token_start": 24, "token_end": 27}, "tgt": {"text": "offener Epiphysenverletzung", "char_start": 115, "char_end": 142, "token_start": 16, "token_end": 18}}, {"src": {"text": "Metaphyseal intraosseous stones", "char_start": 153, "char_end": 184, "token_start": 28, "token_end": 31}, "tgt": {"text": "Metaphys\u00e4r intraoss\u00e4r liegende Steine", "char_start": 144, "char_end": 181, "token_start": 19, "token_end": 23}}, {"src": {"text": "osteoma", "char_start": 277, "char_end": 284, "token_start": 43, "token_end": 44}, "tgt": {"text": "Osteom", "char_start": 251, "char_end": 257, "token_start": 31, "token_end": 32}}]}
{"idx": 7757, "pair_id": "34491367", "src": "Since the start of the global pandemic, a\u00a0number of publications have suggested using ionising radiation to diagnose a\u00a0COVID-19 infection. Some proposals call for the use of computed tomography (CT) to screen for presymptomatic SARS-CoV-2-infections. With these proposals in mind, the German Commission on Radiological Protection (SSK) agreed during its 307th meeting on 2 and 3\u00a0July 2020 to establish a\u00a0working group aimed at evaluating the use of ionising radiation in connection with a\u00a0COVID-19 infection. The working group focussed on radiological protection aspects with a\u00a0view to using computed tomography to diagnose COVID-19. The group started its work on 5\u00a0October 2020. Although not commissioned by the Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (BMU), representatives of the BMU and the Federal Office for Radiation Protection (BfS) were involved in the consultations. The SSK issues the following statement: 1.\u00a0The use of CT in asymptomatic persons to diagnose COVID-19 outside of approved studies is not evidentially justified. 2.\u00a0Pursuant to Section\u00a083\u00a0(3) of the German Radiation Protection Act, a\u00a0CT scan for the diagnosis or follow-up of a\u00a0COVID-19 pneumonia requires the prior justifying indication from a\u00a0doctor with the requisite specialist knowledge in radiation protection. To this end, specialist medical associations provide recommendations based on up-to-date findings.", "tgt": "PROBLEM: Seit dem Auftreten der COVID-19-Pandemie wurde in einigen Ver\u00f6ffentlichungen vorgeschlagen, ionisierende Strahlung zur Diagnose einer COVID-19-Infektion einzusetzen. So soll die Computertomographie (CT) daf\u00fcr eingesetzt werden, dass eine SARS-CoV-2-Infektion schon vor der symptomatischen Phase entdeckt wird. Die Strahlenschutzkommission beschloss daher in ihrer 307.\u00a0Sitzung am 2./3.\u00a0Juli 2020 die Einsetzung einer SSK-Arbeitsgruppe, die sich mit den Strahlenschutzfragen im Zusammenhang mit einer COVID-19-Infektion befassen soll. Hierbei sollten insbesondere f\u00fcr den Strahlenschutz relevante Aspekte beim Einsatz einer Computertomographie zur Diagnostik einer COVID-19-Erkrankung er\u00f6rtert werden. Der Beratung dieser Arbeitsgruppe, die ihre Arbeit am 5.\u00a0Oktober 2020 aufnahm, liegt kein Beratungsauftrag des Bundesministeriums f\u00fcr Umwelt, Naturschutz und nukleare Sicherheit (BMU) zu Grunde, aber Vertreter des BMU und des Bundesamtes f\u00fcr Strahlenschutz begleiteten die Beratung unterst\u00fctzend. Die SSK nimmt wie folgt Stellung: 1.\u00a0Die Anwendung einer CT bei asymptomatischen Personen zur Diagnose einer COVID-19-Erkrankung ist au\u00dferhalb von genehmigten Studien medizinisch nicht gerechtfertigt. 2.\u00a0Gem\u00e4\u00df \u00a7\u00a083 Abs.\u00a03 Strahlenschutzgesetz erfordert auch eine CT zur Diagnostik und Verlaufskontrolle einer COVID-19-Pneumonie die vorherige Stellung der rechtfertigenden Indikation durch einen Arzt oder eine \u00c4rztin mit der erforderlichen Fachkunde im Strahlenschutz. Diesbez\u00fcglich bieten die Empfehlungen der Fachgesellschaften aktuelle Hilfestellung.", "term_pairs": [{"src": {"text": "ionising radiation", "char_start": 86, "char_end": 104, "token_start": 15, "token_end": 17}, "tgt": {"text": "ionisierende Strahlung", "char_start": 101, "char_end": 123, "token_start": 17, "token_end": 19}}, {"src": {"text": "COVID-19 infection", "char_start": 119, "char_end": 137, "token_start": 20, "token_end": 24}, "tgt": {"text": "COVID-19-Infektion", "char_start": 143, "char_end": 161, "token_start": 22, "token_end": 27}}, {"src": {"text": "computed tomography", "char_start": 174, "char_end": 193, "token_start": 32, "token_end": 34}, "tgt": {"text": "Computertomographie", "char_start": 187, "char_end": 206, "token_start": 32, "token_end": 33}}, {"src": {"text": "CT", "char_start": 195, "char_end": 197, "token_start": 35, "token_end": 36}, "tgt": {"text": "CT", "char_start": 208, "char_end": 210, "token_start": 34, "token_end": 35}}, {"src": {"text": "SARS-CoV-2-infections", "char_start": 228, "char_end": 249, "token_start": 41, "token_end": 48}, "tgt": {"text": "SARS-CoV-2-Infektion", "char_start": 247, "char_end": 267, "token_start": 42, "token_end": 49}}, {"src": {"text": "German Commission on Radiological Protection", "char_start": 285, "char_end": 329, "token_start": 56, "token_end": 61}, "tgt": {"text": "Strahlenschutzkommission", "char_start": 323, "char_end": 347, "token_start": 58, "token_end": 59}}, {"src": {"text": "SSK", "char_start": 331, "char_end": 334, "token_start": 62, "token_end": 63}, "tgt": {"text": "SSK", "char_start": 426, "char_end": 429, "token_start": 77, "token_end": 78}}, {"src": {"text": "Federal Ministry for the Environment, Nature Conservation and Nuclear Safety", "char_start": 713, "char_end": 789, "token_start": 133, "token_end": 144}, "tgt": {"text": "Bundesministeriums f\u00fcr Umwelt, Naturschutz und nukleare Sicherheit", "char_start": 821, "char_end": 887, "token_start": 140, "token_end": 148}}, {"src": {"text": "BMU", "char_start": 791, "char_end": 794, "token_start": 145, "token_end": 146}, "tgt": {"text": "BMU", "char_start": 889, "char_end": 892, "token_start": 149, "token_end": 150}}, {"src": {"text": "Federal Office for Radiation Protection", "char_start": 832, "char_end": 871, "token_start": 154, "token_end": 159}, "tgt": {"text": "Bundesamtes f\u00fcr Strahlenschutz", "char_start": 936, "char_end": 966, "token_start": 160, "token_end": 163}}, {"src": {"text": "COVID-19", "char_start": 489, "char_end": 497, "token_start": 92, "token_end": 95}, "tgt": {"text": "COVID-19", "char_start": 32, "char_end": 40, "token_start": 6, "token_end": 9}}, {"src": {"text": "COVID-19 pneumonia", "char_start": 1191, "char_end": 1209, "token_start": 226, "token_end": 230}, "tgt": {"text": "COVID-19-Pneumonie", "char_start": 1316, "char_end": 1334, "token_start": 219, "token_end": 224}}, {"src": {"text": "German Radiation Protection Act", "char_start": 1112, "char_end": 1143, "token_start": 209, "token_end": 213}, "tgt": {"text": "Strahlenschutzgesetz", "char_start": 1229, "char_end": 1249, "token_start": 209, "token_end": 210}}]}
{"idx": 7939, "pair_id": "33528860", "src": "Topical corticosteroids are commonly used in the management of allergic otitis externa to diminish inflammation. A common strategy is to make compounded solutions of dexamethasone in ear cleaner. The objective of this study was to determine the stability of dexamethasone when added to four commercial ear cleaners (ec): designated ecA, ecB, ecC and ecD. Two concentrations (0.1 and 0.25\u00a0mg/mL) of dexamethasone were formulated for each cleaner solution from a 2\u00a0mg/mL solution and stored in the original manufacturers' bottles at two temperatures: room (22\u00a0\u02daC) and refrigerated (4\u00a0\u02daC). Samples were evaluated in triplicate, using liquid chromatography-tandem mass spectrometry at 10 time points over 90\u00a0days. The mean and standard deviation were calculated for each time point. A solution was considered stable if the dexamethasone value remained >90% of the target concentration. All dexamethasone solution values were stable to 90 days, except two solutions for ecA; the 0.25 mg/mL dexamethasone concentration was only stable to 14 (4\u00a0\u02daC) and 21 days (22\u00a0\u02daC). These results provide preliminary evidence in support of pharmaceutical stability data for dexamethasone when included in the above compounded solutions at the noted concentrations and temperatures.", "tgt": "Topisch verabreichte Cortikosteroide werden h\u00e4ufig beim Management von allergischer Otitis externa eingesetzt, um die Entz\u00fcndung abzuschw\u00e4chen. Eine h\u00e4ufige Strategie besteht darin, gemischte L\u00f6sungen von Dexamethason im Ohrreiniger herzustellen. Das objektive Ziel dieser Studie war es, die Stabilit\u00e4t von Dexamethason zu bestimmen, wenn es zu vier kommerziellen Ohrreinigern (ec) zugesetzt wurde: ecA, ecB, ecC und ecD. Zwei Konzentrationen (0,2 und 0,25 mg/mL) an Dexamethason wurden f\u00fcr jeden Ohrreiniger aus einer 2 mg/mL L\u00f6sung gemischt und in der Originalflasche des Herstellers bei zwei Temperaturen gelagert: Raumtemperatur (22\u00b0 C) und gek\u00fchlt (4\u00b0 C). Proben wurden im Triplet evaluiert, wobei die Fl\u00fcssigkeitschromatografie im Tandem mit Massenspektrometrie zu 10 Zeitpunkten \u00fcber einen Zeitraum von 90 Tagen zum Einsatz kam. Die durchschnittliche und Standardabweichung wurde f\u00fcr jeden Zeitpunkt kalkuliert. Eine L\u00f6sung wurde als stabil betrachtet, wenn der Wert des Dexamethasons bei >90% der Zielkonzentration blieb. Alle Dexamethason-L\u00f6sungen waren 90 Tage lang stabil, au\u00dfer zweier L\u00f6sungen f\u00fcr ecA; die 0,25 mg/mL Dexamethason Konzentration war nur stabil bis 14 (4\u00b0 C) und 21 Tage (22\u00b0 C). Diese Ergebnisse zeigten eine vorl\u00e4ufige Evidenz zur Unterst\u00fctzung der Daten der pharmazeutischen Stabilit\u00e4t f\u00fcr Dexamethason, wenn es in die oben genannten gemischten L\u00f6sungen zu den genannten Konzentrationen und Temperaturen inkludiert wurde.", "term_pairs": [{"src": {"text": "Topical corticosteroids", "char_start": 0, "char_end": 23, "token_start": 0, "token_end": 2}, "tgt": {"text": "Topisch verabreichte Cortikosteroide", "char_start": 0, "char_end": 36, "token_start": 0, "token_end": 3}}, {"src": {"text": "allergic otitis externa", "char_start": 63, "char_end": 86, "token_start": 9, "token_end": 12}, "tgt": {"text": "allergischer Otitis externa", "char_start": 71, "char_end": 98, "token_start": 8, "token_end": 11}}, {"src": {"text": "dexamethasone", "char_start": 166, "char_end": 179, "token_start": 25, "token_end": 26}, "tgt": {"text": "Dexamethason", "char_start": 205, "char_end": 217, "token_start": 27, "token_end": 28}}, {"src": {"text": "ear cleaners", "char_start": 302, "char_end": 314, "token_start": 47, "token_end": 49}, "tgt": {"text": "Ohrreinigern", "char_start": 364, "char_end": 376, "token_start": 52, "token_end": 53}}, {"src": {"text": "liquid chromatography-tandem mass spectrometry", "char_start": 631, "char_end": 677, "token_start": 124, "token_end": 130}, "tgt": {"text": "Fl\u00fcssigkeitschromatografie im Tandem mit Massenspektrometrie", "char_start": 707, "char_end": 767, "token_start": 128, "token_end": 133}}, {"src": {"text": "standard deviation", "char_start": 723, "char_end": 741, "token_start": 141, "token_end": 143}, "tgt": {"text": "Standardabweichung", "char_start": 862, "char_end": 880, "token_start": 149, "token_end": 150}}]}
{"idx": 7971, "pair_id": "34338809", "src": "This article investigates the question of how forensic toxicologists established the credibility of chemical analytical methods in poisoning lawsuits in the nineteenth century. After encountering the problem of laypersons in court, forensic toxicologists attempted to find strategies to make their evidence compelling to an untrained audience. Three of these strategies are discussed here: redundancy, standard methods, and intuitive comprehensibility. Whereas redundancy was not very practical and legally prescribed standard methods were not very popular with most forensic toxicologists, intuitive comprehensibility proved effective and popular. This strategy relied on employing methods which did not require chemical knowledge to be understandable. The methods aimed to generate a\u00a0visual aid and to be obvious in their results. Two forms of this strategy are discussed here: the presentation of the actual material and explicit comparison. I\u00a0argue that this shift towards presenting forensic toxicology expertise as evident represents an important step in the history of forensic expertise.", "tgt": "In diesem Artikel wird der Frage nachgegangen, wie im 19.\u00a0Jahrhundert bei Vergiftungsf\u00e4llen die Anwendung analytisch-chemischer Methoden Glaubw\u00fcrdigkeit erlangte. Nachdem forensische Toxikologen Laien vor Gericht als ein ernstzunehmendes Problem identifiziert hatten, versuchten sie, Strategien der Anpassungen zu finden, um kritische Fragen vor Gericht zu vermeiden. Drei Strategien werden hier diskutiert: Redundanz, Normalmethoden und Anschaulichkeit. W\u00e4hrend Redundanz an praktischen Problemen scheiterte und staatlich verordnete Normalmethoden bei den meisten forensischen Toxikologen unbeliebt blieben, hatte die Anschaulichkeit keines dieser Probleme. Die Idee dieser Strategie war es, Methoden zu nutzen, die kein chemisches Wissen voraussetzten, um nachvollziehbar zu sein. Sie dienten als eine Form der Visualisierung und f\u00fchrten zu auch f\u00fcr Laien recht offensichtlich wirkenden Schlussfolgerungen. Zwei Formen dieser Strategie werden hier vorgestellt: die Darstellung der eigentlich gesuchten Substanz und der explizite Vergleich. Ich werde argumentieren, dass diese Strategie, die eigene Expertise als evident zu pr\u00e4sentieren, einen wichtigen Schritt in der Geschichte der Forensik darstellte.", "term_pairs": [{"src": {"text": "forensic toxicologists", "char_start": 46, "char_end": 68, "token_start": 7, "token_end": 9}, "tgt": {"text": "forensische Toxikologen", "char_start": 171, "char_end": 194, "token_start": 25, "token_end": 27}}, {"src": {"text": "poisoning lawsuits", "char_start": 131, "char_end": 149, "token_start": 17, "token_end": 19}, "tgt": {"text": "Vergiftungsf\u00e4llen", "char_start": 74, "char_end": 91, "token_start": 14, "token_end": 15}}, {"src": {"text": "redundancy", "char_start": 390, "char_end": 400, "token_start": 57, "token_end": 58}, "tgt": {"text": "Redundanz", "char_start": 408, "char_end": 417, "token_start": 60, "token_end": 61}}, {"src": {"text": "standard methods", "char_start": 402, "char_end": 418, "token_start": 59, "token_end": 61}, "tgt": {"text": "Normalmethoden", "char_start": 419, "char_end": 433, "token_start": 62, "token_end": 63}}, {"src": {"text": "intuitive comprehensibility", "char_start": 424, "char_end": 451, "token_start": 63, "token_end": 65}, "tgt": {"text": "Anschaulichkeit", "char_start": 438, "char_end": 453, "token_start": 64, "token_end": 65}}, {"src": {"text": "chemical knowledge", "char_start": 713, "char_end": 731, "token_start": 103, "token_end": 105}, "tgt": {"text": "chemisches Wissen", "char_start": 722, "char_end": 739, "token_start": 104, "token_end": 106}}, {"src": {"text": "visual aid", "char_start": 786, "char_end": 796, "token_start": 115, "token_end": 117}, "tgt": {"text": "Visualisierung", "char_start": 813, "char_end": 827, "token_start": 119, "token_end": 120}}, {"src": {"text": "explicit comparison", "char_start": 924, "char_end": 943, "token_start": 141, "token_end": 143}, "tgt": {"text": "explizite Vergleich", "char_start": 1021, "char_end": 1040, "token_start": 147, "token_end": 149}}, {"src": {"text": "forensic expertise", "char_start": 1076, "char_end": 1094, "token_start": 164, "token_end": 166}, "tgt": {"text": "Forensik", "char_start": 1185, "char_end": 1193, "token_start": 173, "token_end": 174}}]}
{"idx": 8037, "pair_id": "34351485", "src": "The term frailty describes a\u00a0complex syndrome of reduced resistance to stress factors as a\u00a0consequence of age-related degeneration in various organ systems.In the general population frailty is associated with poor clinical outcomes, including an increased risk of falls, hospitalization, functional impairment and mortality. Frailty occurs earlier and its prevalence is higher in patients with chronic kidney disease (CKD) compared to the general population. Frail patients with CKD, on dialysis or not, have reduced quality of life and increased hospitalization and mortality rates, regardless of age, sex or comorbidities.The identification of frailty in patients with CKD can lead to the detection of important and potentially modifiable risk factors. Early nephrological evaluation coupled with an interdisciplinary approach including primary care physicians, geriatricians, physiotherapists, occupational therapists and nutritionists, is fundamental in the prevention of frailty as well as in the management of frail patients with CKD.Several instruments have been developed to screen for and assess the degree of frailty; however, there is currently no recommendation as to which should be used in nephrology and how to manage frail patients with CKD. In this article we suggest an approach based on a\u00a0multidimensional, interdisciplinary evaluation aimed at the early identification and management of frail CKD patients independent of the clinical setting of admission; however, more important than the method used is the need to identify and follow-up on frail CKD patients.", "tgt": "Frailty beschreibt einen Zustand reduzierter Belastbarkeit gegen\u00fcber Stressfaktoren, welcher u.\u202fa. Folge altersbedingter Abbauprozesse verschiedener Organsysteme ist und mit einem erh\u00f6hten Risiko f\u00fcr St\u00fcrze, Hospitalisationen, funktionelle Einschr\u00e4nkung und Mortalit\u00e4t assoziiert ist. Frailty tritt bei Patienten mit CKD fr\u00fcher und h\u00e4ufiger auf als in der Allgemeinbev\u00f6lkerung und ist ein wichtiger und potenziell modifizierbarer Risikofaktor f\u00fcr eine erh\u00f6hte Sterblichkeit und Hospitalisationsrate sowie eine reduzierte Lebensqualit\u00e4t. Die Erkennung von Frailty bei Patienten mit CKD erm\u00f6glicht eine Identifikation von wichtigen und potenziell modifizierbaren Risikofaktoren.Eine fr\u00fchzeitige nephrologische Beurteilung sowie eine interdisziplin\u00e4re Zusammenarbeit mit Geriatern, Allgemeinmedizinern, Physiotherapeuten, Ergotherapeuten und Ern\u00e4hrungsberatung sind essenzielle Bausteine in der Pr\u00e4vention und Therapie von Frailty.Zur Messung von Frailty existieren verschiedene Instrumente, wobei keines in der Erkennung von Frailty bei CKD-Patienten als \u00fcberlegen identifiziert wurde. Die Auswahl des Screeninginstruments sollte daher unter Ber\u00fccksichtigung der klinischen Rahmenbedingungen und der verf\u00fcgbaren Ressourcen erfolgen. In diesem Artikel wird eine Strategie zur fr\u00fchen Identifikation von gebrechlichen Patienten mit CKD vorgeschlagen, welche auf einer multidiemensionalen und interdisziplin\u00e4ren Einsch\u00e4tzung beruht. Wichtiger als die Methode ist jedoch die Notwendigkeit, Patienten mit Frailty zu identifizieren.", "term_pairs": [{"src": {"text": "frailty", "char_start": 9, "char_end": 16, "token_start": 2, "token_end": 3}, "tgt": {"text": "Frailty", "char_start": 0, "char_end": 7, "token_start": 0, "token_end": 1}}, {"src": {"text": "chronic kidney disease", "char_start": 394, "char_end": 416, "token_start": 63, "token_end": 66}, "tgt": {"text": "CKD", "char_start": 317, "char_end": 320, "token_start": 42, "token_end": 43}}, {"src": {"text": "CKD", "char_start": 418, "char_end": 421, "token_start": 67, "token_end": 68}, "tgt": {"text": "CKD", "char_start": 581, "char_end": 584, "token_start": 77, "token_end": 78}}, {"src": {"text": "falls", "char_start": 264, "char_end": 269, "token_start": 43, "token_end": 44}, "tgt": {"text": "St\u00fcrze", "char_start": 200, "char_end": 206, "token_start": 26, "token_end": 27}}, {"src": {"text": "hospitalization", "char_start": 271, "char_end": 286, "token_start": 45, "token_end": 46}, "tgt": {"text": "Hospitalisationen", "char_start": 208, "char_end": 225, "token_start": 28, "token_end": 29}}, {"src": {"text": "mortality", "char_start": 314, "char_end": 323, "token_start": 50, "token_end": 51}, "tgt": {"text": "Mortalit\u00e4t", "char_start": 258, "char_end": 268, "token_start": 33, "token_end": 34}}, {"src": {"text": "functional impairment", "char_start": 288, "char_end": 309, "token_start": 47, "token_end": 49}, "tgt": {"text": "funktionelle Einschr\u00e4nkung", "char_start": 227, "char_end": 253, "token_start": 30, "token_end": 32}}, {"src": {"text": "geriatricians", "char_start": 864, "char_end": 877, "token_start": 139, "token_end": 140}, "tgt": {"text": "Geriatern", "char_start": 768, "char_end": 777, "token_start": 97, "token_end": 98}}, {"src": {"text": "primary care physicians", "char_start": 839, "char_end": 862, "token_start": 135, "token_end": 138}, "tgt": {"text": "Allgemeinmedizinern", "char_start": 779, "char_end": 798, "token_start": 99, "token_end": 100}}, {"src": {"text": "physiotherapists", "char_start": 879, "char_end": 895, "token_start": 141, "token_end": 142}, "tgt": {"text": "Physiotherapeuten", "char_start": 800, "char_end": 817, "token_start": 101, "token_end": 102}}, {"src": {"text": "occupational therapists", "char_start": 897, "char_end": 920, "token_start": 143, "token_end": 145}, "tgt": {"text": "Ergotherapeuten", "char_start": 819, "char_end": 834, "token_start": 103, "token_end": 104}}, {"src": {"text": "nutritionists", "char_start": 925, "char_end": 938, "token_start": 146, "token_end": 147}, "tgt": {"text": "Ern\u00e4hrungsberatung", "char_start": 839, "char_end": 857, "token_start": 105, "token_end": 106}}, {"src": {"text": "nephrology", "char_start": 1204, "char_end": 1214, "token_start": 196, "token_end": 197}, "tgt": {"text": "nephrologische", "char_start": 693, "char_end": 707, "token_start": 90, "token_end": 91}}, {"src": {"text": "multidimensional", "char_start": 1308, "char_end": 1324, "token_start": 216, "token_end": 217}, "tgt": {"text": "multidiemensionalen", "char_start": 1363, "char_end": 1382, "token_start": 177, "token_end": 178}}, {"src": {"text": "interdisciplinary", "char_start": 802, "char_end": 819, "token_start": 132, "token_end": 133}, "tgt": {"text": "interdisziplin\u00e4ren", "char_start": 1387, "char_end": 1405, "token_start": 179, "token_end": 180}}]}
{"idx": 8159, "pair_id": "33242119", "src": "Advanced and metastatic stages of bladder cancer are associated with a\u00a0poor prognosis. Therapy options are currently limited to systemic therapy with chemo- and immunotherapeutics. In order to improve individual therapy and especially to achieve a\u00a0more favorable prognosis for these patients, intrinsic molecular subtypes have recently been identified in urothelial carcinoma of the bladder. This review article presents the latest developments, background, and clinical relevance of molecular subtypes in urothelial carcinoma of the bladder. The existing literature and current study data were analyzed to present and evaluate the different molecular classification systems. A\u00a0focus was placed on the possible therapeutic implications of these molecular subtypes. Although promising progress has been made in the molecular subtyping of urothelial carcinoma, this classification has not yet found its way into clinical application. Multicenter prospective studies with standardized study protocols are still lacking. Previous studies differ in molecular markers, sample collection and preparation procedures, and analytical protocols. Standardization is urgently needed before guidelines can be established and targeted treatment regimens implemented. In principle, the aim should be to develop a\u00a0stable and as simple as possible methodology, enabling personalized treatment based on molecular subtypes to be broadly applied, and not just in specialized expert centers.", "tgt": "Das Urothelkarzinom der Harnblase hat im fortgeschrittenen und metastasierten Stadium oft eine eingeschr\u00e4nkte Prognose. Chemotherapie und Immuntherapie bilden derzeit die Standardbehandlungsoptionen im systemischen Erkrankungsmanagement. Mit dem Ziel der Pr\u00e4zisionsmedizin und Prognoseverbesserung wurden in den vergangenen Jahren durch mehrere Gruppen intrinsische molekularen Subtypen des Urothelkarzinoms der Harnblase definiert. Die vorliegende Arbeit gibt einen \u00dcberblick \u00fcber die Hintergr\u00fcnde und die klinische Relevanz dieser molekularen Subtypen des Urothelkarzinoms der Harnblase und bildet den aktuellen Standard sowie j\u00fcngste Entwicklungen ab. Dabei wurden die relevante Literatur und aktuelle Studiendaten ausgewertet, eine Kongruenz der verschiedenen publizierten Klassifikationsans\u00e4tze diskutiert und die m\u00f6glichen therapeutischen Implikationen der molekularen Subtypen zusammengestellt. Obwohl gro\u00dfe und vielversprechende Fortschritte auf dem Gebiet der molekularen Charakterisierung des Urothelkarzinom der Harnblase in den vergangenen Jahren erreicht wurden, scheint die \u201eprime time\u201c f\u00fcr den klinischen Einsatz der bislang definierten Subtypen noch nicht gekommen. Hierzu fehlen bis dato immer noch prospektive und multizentrische Studien mit einheitlichen molekularen Definitionen, sowie Standardisierungen bei der Probenaufarbeitung, einfache Analyseprotokolle mit reduzierten Genpanels und die Entwicklung einer Leitlinie f\u00fcr zielgerichtete Therapieregime. Grunds\u00e4tzlich ist die Generalisierbarkeit der Methodik gefragt, um personalisierte Therapiekonzepte nicht nur an wenigen ausgew\u00e4hlten Expertenzentren, sondern auch in der breiteren Anwendung durchf\u00fchren zu k\u00f6nnen.", "term_pairs": [{"src": {"text": "bladder cancer", "char_start": 34, "char_end": 48, "token_start": 5, "token_end": 7}, "tgt": {"text": "Urothelkarzinom der Harnblase", "char_start": 4, "char_end": 33, "token_start": 1, "token_end": 4}}, {"src": {"text": "metastatic stages", "char_start": 13, "char_end": 30, "token_start": 2, "token_end": 4}, "tgt": {"text": "metastasierten Stadium", "char_start": 63, "char_end": 85, "token_start": 8, "token_end": 10}}, {"src": {"text": "poor prognosis", "char_start": 71, "char_end": 85, "token_start": 11, "token_end": 13}, "tgt": {"text": "eingeschr\u00e4nkte Prognose", "char_start": 95, "char_end": 118, "token_start": 12, "token_end": 14}}, {"src": {"text": "systemic therapy", "char_start": 128, "char_end": 144, "token_start": 20, "token_end": 22}, "tgt": {"text": "systemischen Erkrankungsmanagement", "char_start": 202, "char_end": 236, "token_start": 23, "token_end": 25}}, {"src": {"text": "chemo- and immunotherapeutics", "char_start": 150, "char_end": 179, "token_start": 23, "token_end": 27}, "tgt": {"text": "Chemotherapie und Immuntherapie", "char_start": 120, "char_end": 151, "token_start": 15, "token_end": 18}}, {"src": {"text": "molecular subtypes", "char_start": 303, "char_end": 321, "token_start": 47, "token_end": 49}, "tgt": {"text": "molekularen Subtypen", "char_start": 366, "char_end": 386, "token_start": 42, "token_end": 44}}, {"src": {"text": "urothelial carcinoma of the bladder", "char_start": 355, "char_end": 390, "token_start": 54, "token_end": 59}, "tgt": {"text": "Urothelkarzinom der Harnblase", "char_start": 1003, "char_end": 1032, "token_start": 119, "token_end": 122}}, {"src": {"text": "clinical relevance", "char_start": 462, "char_end": 480, "token_start": 71, "token_end": 73}, "tgt": {"text": "klinische Relevanz", "char_start": 507, "char_end": 525, "token_start": 61, "token_end": 63}}, {"src": {"text": "molecular classification systems", "char_start": 642, "char_end": 674, "token_start": 98, "token_end": 101}, "tgt": {"text": "Klassifikationsans\u00e4tze", "char_start": 777, "char_end": 799, "token_start": 95, "token_end": 96}}, {"src": {"text": "therapeutic implications", "char_start": 711, "char_end": 735, "token_start": 109, "token_end": 111}, "tgt": {"text": "therapeutischen Implikationen", "char_start": 829, "char_end": 858, "token_start": 100, "token_end": 102}}, {"src": {"text": "molecular subtyping", "char_start": 814, "char_end": 833, "token_start": 124, "token_end": 126}, "tgt": {"text": "molekularen Charakterisierung", "char_start": 969, "char_end": 998, "token_start": 116, "token_end": 118}}, {"src": {"text": "clinical application", "char_start": 910, "char_end": 930, "token_start": 139, "token_end": 141}, "tgt": {"text": "klinischen Einsatz", "char_start": 1109, "char_end": 1127, "token_start": 137, "token_end": 139}}, {"src": {"text": "multicenter prospective studies", "char_start": 932, "char_end": 963, "token_start": 142, "token_end": 145}, "tgt": {"text": "multizentrische Studien", "char_start": 1232, "char_end": 1255, "token_start": 155, "token_end": 157}}, {"src": {"text": "standardized study protocols", "char_start": 969, "char_end": 997, "token_start": 146, "token_end": 149}, "tgt": {"text": "einheitlichen molekularen Definitionen", "char_start": 1260, "char_end": 1298, "token_start": 158, "token_end": 161}}, {"src": {"text": "sample collection and preparation procedures", "char_start": 1063, "char_end": 1107, "token_start": 160, "token_end": 165}, "tgt": {"text": "Probenaufarbeitung", "char_start": 1333, "char_end": 1351, "token_start": 166, "token_end": 167}}, {"src": {"text": "analytical protocols", "char_start": 1113, "char_end": 1133, "token_start": 167, "token_end": 169}, "tgt": {"text": "Analyseprotokolle", "char_start": 1362, "char_end": 1379, "token_start": 169, "token_end": 170}}, {"src": {"text": "guidelines", "char_start": 1177, "char_end": 1187, "token_start": 175, "token_end": 176}, "tgt": {"text": "Leitlinie", "char_start": 1432, "char_end": 1441, "token_start": 177, "token_end": 178}}, {"src": {"text": "targeted treatment regimens", "char_start": 1211, "char_end": 1238, "token_start": 180, "token_end": 183}, "tgt": {"text": "zielgerichtete Therapieregime", "char_start": 1446, "char_end": 1475, "token_start": 179, "token_end": 181}}, {"src": {"text": "personalized treatment", "char_start": 1352, "char_end": 1374, "token_start": 204, "token_end": 206}, "tgt": {"text": "personalisierte Therapiekonzepte", "char_start": 1544, "char_end": 1576, "token_start": 191, "token_end": 193}}, {"src": {"text": "expert centers", "char_start": 1454, "char_end": 1468, "token_start": 220, "token_end": 222}, "tgt": {"text": "Expertenzentren", "char_start": 1611, "char_end": 1626, "token_start": 198, "token_end": 199}}]}
{"idx": 8286, "pair_id": "33346852", "src": "Emergency care in Germany is in transition. Emergency departments (EDs) treat their patients based on symptoms and acuity. However, this perspective is not reflected in claims data. The aim of the AKTIN project was to establish an Emergency Department Data Registry as a\u00a0data privacy-compliant infrastructure for the use of routine medical data. Data from the respective documentation systems are continuously transmitted to local data warehouses using a\u00a0standardized interface. They are available for several applications such as internal reports but also multicentre studies, in compliance with data privacy regulations. Based on a\u00a012-months period we evaluate the population with focus on acuity assessment (triage) and vital parameters in combination with presenting complaints. For the period April\u00a02018 to March\u00a02019, 436,149\u00a0cases from 15\u00a0EDs were available. A\u00a0triage level is documented in 86.0% of cases, and 70.5% were triaged within 10\u202fmin of arrival. Ten\u00a0EDs collected a\u00a0presenting complaint regularly (82.3%). The respective documentation of vital signs shows plausible patterns. The AKTIN registry provides an almost real-time insight into German EDs, regardless of the primary documentation system and health insurance claims data. The Federal Joint Committee's requirements are largely met. Standardized presenting complaints allow for symptom-based analyses as well as health surveillance.", "tgt": "HINTERGRUND: Die Notfallversorgung befindet sich im Umbruch. In Notaufnahmen werden Patienten ausgehend von Symptomen und Dringlichkeit versorgt; dies bildet sich jedoch in den etablierten Routinedaten der gesetzlichen Sozialversicherung nicht ab. Ziel des AKTIN-Projekts war der Aufbau einer datenschutzkonformen Registerinfrastruktur zur Nutzung von klinischen Routinedaten aus Notaufnahmen. \u00dcber eine standardisierte Schnittstelle werden aus den verschiedenen Dokumentationssystemen kontinuierlich Daten der Notaufnahmebehandlung in ein lokales Data Warehouse exportiert. Dort stehen sie sowohl f\u00fcr lokale Nutzungen, wie interne Berichte und Qualit\u00e4tsmanagement, als auch gleichzeitig datenschutzkonform f\u00fcr multizentrische Auswertungen zur Verf\u00fcgung. Anhand der Registerpopulation wird die Ersteinsch\u00e4tzung sowie die Erhebung von Vitalparametern in Abh\u00e4ngigkeit von Vorstellungsgr\u00fcnden f\u00fcr einen 12-Monats-Zeitraum analysiert. F\u00fcr den Zeitraum 04/2018 bis 03/2019 wurden 436.149 g\u00fcltige F\u00e4lle aus 15\u00a0Notaufnahmen \u00fcbermittelt. In 86,0\u202f% der F\u00e4lle ist eine Ersteinsch\u00e4tzung dokumentiert. Diese fand in 70,5\u202f% innerhalb von 10\u202fmin nach Ankunft des Patienten statt. In 10\u00a0Kliniken wird regelhaft (82,3\u202f%) ein Vorstellungsgrund erfasst. Die Erfassung von Vitalparametern variiert plausibel zwischen den Vorstellungsgr\u00fcnden. Das AKTIN-Notaufnahmeregister bietet einen zeitnahen Einblick in das Versorgungsgeschehen der Notaufnahmen ohne zus\u00e4tzlichen Dokumentationsaufwand und unabh\u00e4ngig vom prim\u00e4ren IT-System, Kostentr\u00e4ger, Fallart und Abrechnungsmodus. Die Vorgaben des Gemeinsamen Bundesausschusses zur Ersteinsch\u00e4tzung werden weitgehend umgesetzt. Durch die Etablierung von standardisierten Vorstellungsgr\u00fcnden werden symptombasierte Analysen und Gesundheitssurveillance erm\u00f6glicht.", "term_pairs": []}
{"idx": 8326, "pair_id": "30602185", "src": "We report of three pregnancies, two with renal insufficiency and one with a history of renal transplantation. Pat.1 is a 32y at 20 weeks of gestation with acute renal failure, nephrotic syndrome and history of familial Mediterranean fever. Case 2 is a 23y with cirrhotic kidneys, stage 5\u00a0of chronic kidney disease and dialysis treatment 3\u200a\u00d7 a week. The pregnancy was an incidental finding. Pat. 3 is a 29y I/0 with history of renal transplantation years ago. In pat. 1a renal biopsy confirmed the suspected diagnosis of AA amyloidosis. Due to deterioration of the kidney function, she required dialysis up to 6\u200a\u00d7 a week. In Case 2 the dialysis increased to 6\u200a\u00d7 a week as well. In both patients, we indicated delivery at 35 weeks of gestational age. Pat. 3 delivered at term without complications. A close interdisciplinary cooperation improves neonatal outcome in pregnant women with CKD. Counseling and risk assessment of these patients should be initiated before pregnancy. The care of these high-risk pregnancies needs to be performed at a tertiary care center with the above-mentioned specialists.", "tgt": "Wir berichten \u00fcber drei\u00a0Schwangere: zwei in verschiedenen Stadien der Niereninsuffizienz und eine Nierentransplantierte. Pat. 1 ist eine 32-J\u00e4hrige I/0 in der 20. SSW mit akutem Nierenversagen, nephrotischem Syndrom und famili\u00e4rem Mittelmeerfieber in der Anamnese. Pat. 2 ist eine 23-J\u00e4hrige mit Schrumpfnieren bds. und Niereninsuffizienz Stad. V unter Dialyse 3\u200a\u00d7 w\u00f6chentlich, die Schwangerschaft war eine Zufallsdiagnose. Pat. 3 ist eine 29-J\u00e4hrige im Z.\u200an. Nierentransplantation vor mehreren Jahren. Bei Pat. 1 wurde die Verdachtsdiagnose einer AA-Amyloidose durch Nierenbiopsie best\u00e4tigt. Im Verlauf wurde sie zunehmend dialysepflichtig. Bei Pat. 2 musste die Dialyse ebenfalls eskaliert werden. Beide Schwangerschaften wurden vorzeitig beendet. Die transplantierte Pat. 3 wurde am Termin ohne Komplikationen im Verlauf entbunden. Die Verbesserung des fetalen Outcomes ist v.\u200aa. auf die interdisziplin\u00e4re Zusammenarbeit zur\u00fcckzuf\u00fchren. Ziel sollte sein, junge nierenkranke Frauen bereits vor einer Schwangerschaft umfassend \u00fcber Risiken und Erfolgsaussichten zu beraten und zu betreuen.", "term_pairs": [{"src": {"text": "renal insufficiency", "char_start": 41, "char_end": 60, "token_start": 8, "token_end": 10}, "tgt": {"text": "Niereninsuffizienz", "char_start": 70, "char_end": 88, "token_start": 11, "token_end": 12}}, {"src": {"text": "renal transplantation", "char_start": 87, "char_end": 108, "token_start": 16, "token_end": 18}, "tgt": {"text": "Nierentransplantation", "char_start": 460, "char_end": 481, "token_start": 87, "token_end": 88}}, {"src": {"text": "chronic kidney disease", "char_start": 291, "char_end": 313, "token_start": 56, "token_end": 59}, "tgt": {"text": "Niereninsuffizienz", "char_start": 320, "char_end": 338, "token_start": 58, "token_end": 59}}, {"src": {"text": "dialysis", "char_start": 318, "char_end": 326, "token_start": 60, "token_end": 61}, "tgt": {"text": "Dialyse", "char_start": 353, "char_end": 360, "token_start": 63, "token_end": 64}}, {"src": {"text": "renal biopsy", "char_start": 470, "char_end": 482, "token_start": 95, "token_end": 97}, "tgt": {"text": "Nierenbiopsie", "char_start": 568, "char_end": 581, "token_start": 104, "token_end": 105}}, {"src": {"text": "AA amyloidosis", "char_start": 520, "char_end": 534, "token_start": 102, "token_end": 104}, "tgt": {"text": "AA-Amyloidose", "char_start": 548, "char_end": 561, "token_start": 100, "token_end": 103}}, {"src": {"text": "gestational age", "char_start": 732, "char_end": 747, "token_start": 148, "token_end": 150}, "tgt": {"text": "SSW", "char_start": 163, "char_end": 166, "token_start": 31, "token_end": 32}}]}
{"idx": 8389, "pair_id": "30838946", "src": "Antitest Revolt? On the Pros and Cons of Psychological Testing With regard to international student assessments, efforts of inclusion in society, as well as social and economic participation, this article deals with fundamental arguments against the use of psychological tests. Taking into account the antitest revolt of the 1960s to 1980s in the US and Europe the author ventilates Anne Anastasis classical paper Psychology, psychologists, and psychological testing of 1967. Anastasis point of view is illustrated by means of seven objections against psychological testing as a basis of selection decisions. It becomes clear that a critique of tests as a means of obtaining information has to be clearly distinguished from the ends - the purpose and objective of diagnostics - and the general framework.", "tgt": "Zusammenfassung Mit Bezug auf internationale Schulleistungsvergleiche, gesamtgesellschaftliche Inklusionsbem\u00fchungen sowie soziale und \u00f6konomische Teilhabe setzt sich der vorliegende Artikel mit grunds\u00e4tzlichen Argumenten gegen den Einsatz psychologischer Testverfahren auseinander. Ankn\u00fcpfend an die Anti-Test-Bewegung der 1960er bis 1980er Jahre in den USA und Europa ventiliert der Autor den als klassisch zu bezeichnenden Beitrag Anne Anastasis Psychology, psychologists and psychological testing von 1967. Dabei wird Anastasis Argumentation anhand von sieben nach wie vor aktuellen Einw\u00e4nden gegen eine psychologische Testdiagnostik als Grundlage von Selektionsentscheidungen dargestellt. Es wird deutlich, dass eine Kritik am Diagnostikum als Mittel der Informationsgewinnung vom Zweck \u2013 der diagnostischen Zielsetzung \u2013 und den entsprechenden Rahmenbedingungen unterschieden werden muss.", "term_pairs": [{"src": {"text": "psychological testing", "char_start": 41, "char_end": 62, "token_start": 9, "token_end": 11}, "tgt": {"text": "psychologischer Testverfahren", "char_start": 239, "char_end": 268, "token_start": 25, "token_end": 27}}, {"src": {"text": "antitest revolt", "char_start": 0, "char_end": 15, "token_start": 0, "token_end": 2}, "tgt": {"text": "Anti-Test-Bewegung", "char_start": 300, "char_end": 318, "token_start": 32, "token_end": 37}}, {"src": {"text": "psychological tests", "char_start": 257, "char_end": 276, "token_start": 42, "token_end": 44}, "tgt": {"text": "psychologische Testdiagnostik", "char_start": 607, "char_end": 636, "token_start": 81, "token_end": 83}}, {"src": {"text": "selection decisions", "char_start": 588, "char_end": 607, "token_start": 96, "token_end": 98}, "tgt": {"text": "Selektionsentscheidungen", "char_start": 655, "char_end": 679, "token_start": 86, "token_end": 87}}, {"src": {"text": "diagnostics", "char_start": 764, "char_end": 775, "token_start": 127, "token_end": 128}, "tgt": {"text": "Diagnostikum", "char_start": 731, "char_end": 743, "token_start": 97, "token_end": 98}}]}
{"idx": 8474, "pair_id": "31096293", "src": "Dear Colleagues,it is an extraordinary pleasure for me to present this really interesting booklet that was created at the occasion of the 90<sup>th</sup> Annual Meeting of the German Society of Oto-Rhino-Laryngology, Head & Neck Surgery. The highly significant scientific contributions from nine universities discuss different aspects of the meeting's motto entitled 'Digitization in Oto-Rhino-Laryngology' and show important fields for developing and securing the future of our discipline.During the last years, digitization and <i>artificial intelligence</i> gain increasingly in importance for the German healthcare landscape and thus also for the field of oto-rhino-laryngology. With regard to future developments in healthcare services it is essential to impart digital competences to physicians, medical staff, but also to patients in a well-structured way. At the same time, the legal and ethical issues resulting from medical-technological progresses have to be thoroughly discussed.", "tgt": "Liebe Kolleginnen, liebe Kollegen,es freut mich au\u00dferordentlich, den aus meiner Sicht sehr spannenden Referateband zur 90. Jahresversammlung der Deutschen Gesellschaft f\u00fcr Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie vorzustellen. Die hochinteressanten wissenschaftlichen Abhandlungen aus neun Universit\u00e4ten bearbeiten unterschiedliche Bereiche zum Kongressthema \u201eDigitalisierung in der HNO-Heilkunde\u201c und zeigen wichtige Aspekte f\u00fcr die Weiterentwicklung und Zukunftssicherung unseres Fachgebietes auf.", "term_pairs": [{"src": {"text": "Oto-Rhino-Laryngology", "char_start": 194, "char_end": 215, "token_start": 40, "token_end": 45}, "tgt": {"text": "HNO-Heilkunde", "char_start": 395, "char_end": 408, "token_start": 58, "token_end": 61}}, {"src": {"text": "Head & Neck Surgery", "char_start": 217, "char_end": 236, "token_start": 46, "token_end": 50}, "tgt": {"text": "Kopf- und Hals-Chirurgie", "char_start": 200, "char_end": 224, "token_start": 34, "token_end": 40}}]}
{"idx": 8496, "pair_id": "29719895", "src": "Approximately 5\u2005% of the general population is affected by functional anosmia. An additional 15\u2005% exhibit decreased olfactory function. Many of these individuals ask ENT-doctors or neurologists for help. A cornerstone of the counselling process is the assessment of olfactory function. The aim of this work is to give a differentiated overview about the administration of commonly used psychophysical tests for olfactory and gustatory function including their normative data. The use of standardized, reliable and validated tools is mandatory to provide patients with state-of the-art counseling on treatment options.", "tgt": "Etwa 5\u2005% der Bev\u00f6lkerung leiden unter einer funktionellen Anosmie, bei weiteren 15\u2005% ist die Riechfunktion eingeschr\u00e4nkt. Ein Grundpfeiler der Behandlung durch den HNO-Arzt ist die Beurteilung der chemosensorischen Funktion durch psychophysische Riech- und Schmecktests. Die Verwendung standardisierter validierter Instrumente ist zwingend erforderlich, um Patienten nach dem neuesten wissenschaftlichen Stand \u00fcber Therapieverfahren beraten zu k\u00f6nnen.", "term_pairs": [{"src": {"text": "functional anosmia", "char_start": 59, "char_end": 77, "token_start": 10, "token_end": 12}, "tgt": {"text": "funktionellen Anosmie", "char_start": 44, "char_end": 65, "token_start": 8, "token_end": 10}}, {"src": {"text": "olfactory function", "char_start": 116, "char_end": 134, "token_start": 19, "token_end": 21}, "tgt": {"text": "Riechfunktion", "char_start": 93, "char_end": 106, "token_start": 17, "token_end": 18}}, {"src": {"text": "ENT-doctors", "char_start": 166, "char_end": 177, "token_start": 27, "token_end": 30}, "tgt": {"text": "HNO-Arzt", "char_start": 164, "char_end": 172, "token_start": 26, "token_end": 29}}, {"src": {"text": "psychophysical tests", "char_start": 386, "char_end": 406, "token_start": 65, "token_end": 67}, "tgt": {"text": "psychophysische Riech- und Schmecktests", "char_start": 230, "char_end": 269, "token_start": 36, "token_end": 41}}, {"src": {"text": "standardized", "char_start": 487, "char_end": 499, "token_start": 80, "token_end": 81}, "tgt": {"text": "standardisierter", "char_start": 286, "char_end": 302, "token_start": 44, "token_end": 45}}, {"src": {"text": "validated", "char_start": 514, "char_end": 523, "token_start": 84, "token_end": 85}, "tgt": {"text": "validierter", "char_start": 303, "char_end": 314, "token_start": 45, "token_end": 46}}]}
{"idx": 8615, "pair_id": "30776843", "src": "Buckling techniques are used for rhegmatogenous (break-induced) retinal detachment. The aim is to achieve a functional closure of the retinal breakwith permanent retinal attachment by scleral indentation and coagulation of retinal holes. The surgery is primarily extraocular. The use of different buckling methods depends on various factors. The success rates are high at 54\u200a-\u200a97% after the initial procedure, but decrease as the macula is detached. When the possibilities of the scleral buckling procedures are exhausted, pars plana vitrectomy is the next therapeutical option. In recent years, however, there is a trend to primarily address even a simple rhegmatogenic retinal detachment with vitreous surgical methods.", "tgt": "Ein hoher Anteil der prim\u00e4r lochbedingten Netzhautabl\u00f6sungen kann durch eindellende chirurgische Verfahren behandelt werden. Dieser Artikel stellt diese Operationsmethoden vor, die \u2013 bei prinzipiell gleichem Konzept \u2013 erheblich variieren. Die Erfolgsraten betragen 54\u200a\u2013\u200a97%. Re-Operationen werden in der Regel als Vitrektomie durchgef\u00fchrt, diese werden in einem folgenden Artikel beschrieben.", "term_pairs": [{"src": {"text": "success rates", "char_start": 346, "char_end": 359, "token_start": 56, "token_end": 58}, "tgt": {"text": "Erfolgsraten", "char_start": 243, "char_end": 255, "token_start": 33, "token_end": 34}}, {"src": {"text": "vitrectomy", "char_start": 534, "char_end": 544, "token_start": 91, "token_end": 92}, "tgt": {"text": "Vitrektomie", "char_start": 314, "char_end": 325, "token_start": 48, "token_end": 49}}]}
{"idx": 8749, "pair_id": "27273176", "src": "Early diagnosis and treatment of leprosy and leprosy reactions are essential to prevent stigmatizing deformities and disability. Although the incidence of leprosy has decreased enormously, grade 2 disability due to nerve injury has remained the same. New tools are needed to better diagnose and monitor leprosy reactions and associated neuritis and this study assessed whether high-resolution sonography (HRUS) can be used as such a tool. During a prospective follow-up period of 2 years at regular intervals, we performed clinical examination to assess sensory and motor function and HRUS\u00a0of the four main peripheral nerves in 57 patients, of whom 36 were with reactions and 21 were without reactions. Normative data of the cross-sectional area (CSA) of these nerves were obtained from 55 healthy subjects (HS). Color Doppler (CD) was used to study blood flow in the nerves. At the baseline visit and during follow-up, all four nerves were significantly thicker in patients with leprosy reactions in comparison to HS (p\u200a<\u200a0.0001) and to a lesser extent also in comparison to patients without reactions ranging from a p-value of <\u200a0.05 to <\u200a0.0001 in the different nerves tested. During follow-up, the nerve size did not change significantly in patients without reactions, while it decreased significantly in patients with reactions. At baseline, endoneural blood flow was present only in patients with reactions. This\u00a0occurred in 20 of the 36 (55\u200a%) patients (49 nerves) and decreased to only 1 patient (2.7\u200a%) at the end of the follow-up period. This prospective study demonstrates the ability of HRUS to monitor disease activity and the effect of treatment in patients with leprosy reactions by determining changes in nerve size and vascularity, which are indicators of peripheral nerve involvement and damage.", "tgt": "ZIEL: \u2002Fr\u00fche Diagnose und Therapie der Lepra und der Lepra-Reaktionen ist entscheidend, um stigmatisierende Entstellungen und Behinderungen zu verhindern. Obwohl die Lepra-Inzidenz immens gesunken ist, ist eine Behinderung 2. Grades aufgrund der Nervensch\u00e4digung gleich h\u00e4ufig geblieben. Neue Verfahren f\u00fcr eine bessere Diagnose und \u00dcberwachung der Lepra-Reaktionen und der assoziierten Neuritis sind erforderlich, daher \u00fcberpr\u00fcft diese Studie, ob HRUS hierf\u00fcr eingesetzt werden kann. W\u00e4hrend eines prospektiven Nachuntersuchungszeitraums von 2 Jahren mit gleichm\u00e4\u00dfigen Intervallen f\u00fchrten wir bei 57 Patienten eine klinische Untersuchung der sensorischen und motorischen Funktionen und HRUS der vier peripheren Hauptnerven durch, von denen 36 Reaktionen und 21 keine Reaktionen zeigten. Die normativen Werte der Querschnittsregion (CSA) dieser Nerven wurden bei 55 Gesunden erhoben. Farbdopplersonografie wurde durchgef\u00fchrt, um den Blutfluss in den Nerven zu ermitteln. Beim Erstbesuch und w\u00e4hrend der Folgeuntersuchungen waren bei allen Patienten mit Lepra-Reaktionen im Vergleich zu gesunden alle vier Nerven signifikant dicker (p\u200a<\u200a0,0001) und in geringerem Ma\u00dfe auch im Vergleich zu Patienten ohne Reaktionen, die in einem p-Wert-Bereich zwischen <\u200a0,05 und <\u200a0,0001 f\u00fcr die verschiedenen untersuchten Nerven lagen. W\u00e4hrend der Folgeuntersuchungen ver\u00e4nderte sich bei Patienten ohne Reaktion die Gr\u00f6\u00dfe der\u00a0Nerven kaum, w\u00e4hrend sie bei Patienten mit Reaktionen signifikant kleiner wurden. Bei Erstaufnahme war der endoneurale Blutfluss nur bei Patienten mit Reaktionen vorhanden, dies traf f\u00fcr 20 (55\u200a%) der 36 Patienten zu (49 Nerven) und sank auf nur einen Patienten (2,7\u200a%) am Ende des Nachsorgezeitraums ab. Diese prospektive Studie zeigt die M\u00f6glichkeit des HRUS, die Erkrankungsaktivit\u00e4t und den Therapieerfolg bei Patienten mit Lepra-Reaktionen zu\u00a0\u00fcberwachen, indem die Ver\u00e4nderungen der Nervengr\u00f6\u00dfe und Durchblutung bestimmt werden, welche Hinweise auf eine Beteilung der peripheren Nerven und deren Sch\u00e4digung geben.", "term_pairs": [{"src": {"text": "leprosy", "char_start": 33, "char_end": 40, "token_start": 5, "token_end": 6}, "tgt": {"text": "Lepra", "char_start": 39, "char_end": 44, "token_start": 7, "token_end": 8}}, {"src": {"text": "leprosy reactions", "char_start": 45, "char_end": 62, "token_start": 7, "token_end": 9}, "tgt": {"text": "Lepra-Reaktionen", "char_start": 53, "char_end": 69, "token_start": 10, "token_end": 13}}, {"src": {"text": "grade 2 disability", "char_start": 189, "char_end": 207, "token_start": 27, "token_end": 30}, "tgt": {"text": "Behinderung 2. Grades", "char_start": 211, "char_end": 232, "token_start": 35, "token_end": 39}}, {"src": {"text": "nerve injury", "char_start": 215, "char_end": 227, "token_start": 32, "token_end": 34}, "tgt": {"text": "Nervensch\u00e4digung", "char_start": 246, "char_end": 262, "token_start": 41, "token_end": 42}}, {"src": {"text": "neuritis", "char_start": 336, "char_end": 344, "token_start": 52, "token_end": 53}, "tgt": {"text": "Neuritis", "char_start": 387, "char_end": 395, "token_start": 61, "token_end": 62}}, {"src": {"text": "high-resolution sonography", "char_start": 377, "char_end": 403, "token_start": 58, "token_end": 62}, "tgt": {"text": "HRUS", "char_start": 448, "char_end": 452, "token_start": 71, "token_end": 72}}, {"src": {"text": "HRUS", "char_start": 405, "char_end": 409, "token_start": 63, "token_end": 64}, "tgt": {"text": "HRUS", "char_start": 687, "char_end": 691, "token_start": 101, "token_end": 102}}, {"src": {"text": "prospective follow-up", "char_start": 448, "char_end": 469, "token_start": 75, "token_end": 79}, "tgt": {"text": "prospektiven Nachuntersuchungszeitraums", "char_start": 499, "char_end": 538, "token_start": 79, "token_end": 81}}, {"src": {"text": "peripheral nerves", "char_start": 607, "char_end": 624, "token_start": 103, "token_end": 105}, "tgt": {"text": "peripheren Hauptnerven", "char_start": 701, "char_end": 723, "token_start": 104, "token_end": 106}}, {"src": {"text": "cross-sectional area", "char_start": 725, "char_end": 745, "token_start": 125, "token_end": 129}, "tgt": {"text": "Querschnittsregion", "char_start": 813, "char_end": 831, "token_start": 122, "token_end": 123}}, {"src": {"text": "CSA", "char_start": 747, "char_end": 750, "token_start": 130, "token_end": 131}, "tgt": {"text": "CSA", "char_start": 833, "char_end": 836, "token_start": 124, "token_end": 125}}, {"src": {"text": "Color Doppler", "char_start": 813, "char_end": 826, "token_start": 145, "token_end": 147}, "tgt": {"text": "Farbdopplersonografie", "char_start": 884, "char_end": 905, "token_start": 134, "token_end": 135}}, {"src": {"text": "blood flow", "char_start": 850, "char_end": 860, "token_start": 154, "token_end": 156}, "tgt": {"text": "Blutfluss", "char_start": 933, "char_end": 942, "token_start": 140, "token_end": 141}}, {"src": {"text": "endoneural blood flow", "char_start": 1347, "char_end": 1368, "token_start": 255, "token_end": 258}, "tgt": {"text": "endoneurale Blutfluss", "char_start": 1518, "char_end": 1539, "token_start": 243, "token_end": 245}}, {"src": {"text": "disease activity", "char_start": 1615, "char_end": 1631, "token_start": 314, "token_end": 316}, "tgt": {"text": "Erkrankungsaktivit\u00e4t", "char_start": 1777, "char_end": 1797, "token_start": 296, "token_end": 297}}, {"src": {"text": "treatment", "char_start": 20, "char_end": 29, "token_start": 3, "token_end": 4}, "tgt": {"text": "Therapie", "char_start": 26, "char_end": 34, "token_start": 5, "token_end": 6}}, {"src": {"text": "nerve size", "char_start": 1202, "char_end": 1212, "token_start": 232, "token_end": 234}, "tgt": {"text": "Nervengr\u00f6\u00dfe", "char_start": 1899, "char_end": 1910, "token_start": 313, "token_end": 314}}, {"src": {"text": "vascularity", "char_start": 1736, "char_end": 1747, "token_start": 333, "token_end": 334}, "tgt": {"text": "Durchblutung", "char_start": 1915, "char_end": 1927, "token_start": 315, "token_end": 316}}]}
{"idx": 8950, "pair_id": "32131128", "src": "There is only limited information available on the effects of physical exercise on the posterior pole. Retinal circulation is autoregulated similarly to the brain vasculature in order to provide constant flow and thus constant nutrition of the inner retinal structures while the choroid is mostly controlled by the sympathetic nervous system. The available data show that physical exercise may indeed have a positive effect on the retina and visual function. The assessment of retinal structure could serve as a marker in sports medicine, whereas physical activity could exert a positive protective effect against diseases such as diabetic retinopathy or age-related macular degeneration. According to our theory, similar to the term 'trained heart' used in cardiology and sports medicine, the term 'trained eye' could also be coined. This latter term would help to further emphasize the beneficial effects of physical exercise that works protectively not only for the cardiovascular but for the visual system as well, and thus could further help in the fight against avoidable blindness worldwide.", "tgt": "Es ist nur relativ wenig Information \u00fcber die Wirkung der k\u00f6rperlichen Aktivit\u00e4t auf den hinteren Augenabschnitt vorhanden. Die Netzhautzirkulation wurde \u00e4hnlich zum Gehirn durch Autoregulation geregelt, welche die Ern\u00e4hrung der inneren Netzhautschichten erm\u00f6glicht, wobei die Aderhaut prim\u00e4r durch die sympathetische Innervation gesteuert wurde. Die zur Verf\u00fcgung stehenden Informationen zeigen, dass k\u00f6rperliche Aktivit\u00e4t eine positive Auswirkung auf die Netzhaut und Sehleistung haben kann. Die strukturellen Angaben der Netzhaut k\u00f6nnten als Marker in der Sportmedizin dienen und k\u00f6rperliche Aktivit\u00e4t wirkt vermutlich sehr stark protektiv bei Krankheiten wie diabetischer Retinopathie und altersbedingter Makuladegeneration. Nach unserer Theorie, \u00e4hnlich zum \u201etrainierten Herz\u201c in der Sportmedizin und Kardiologie, k\u00f6nnte man auch das \u201etrainierte Auge\u201c als Definition einf\u00fchren, welche auf die positive, protektive Wirkung der k\u00f6rperlichen Aktivit\u00e4t bei verschiedenen Krankheiten hinweist. Dies k\u00f6nnte den Kampf gegen die vermeidbare Erblindung weiter unterst\u00fctzen.", "term_pairs": [{"src": {"text": "posterior pole", "char_start": 87, "char_end": 101, "token_start": 14, "token_end": 16}, "tgt": {"text": "hinteren Augenabschnitt", "char_start": 89, "char_end": 112, "token_start": 14, "token_end": 16}}, {"src": {"text": "retinal circulation", "char_start": 103, "char_end": 122, "token_start": 17, "token_end": 19}, "tgt": {"text": "Netzhautzirkulation", "char_start": 128, "char_end": 147, "token_start": 19, "token_end": 20}}, {"src": {"text": "brain vasculature", "char_start": 157, "char_end": 174, "token_start": 24, "token_end": 26}, "tgt": {"text": "Gehirn", "char_start": 166, "char_end": 172, "token_start": 23, "token_end": 24}}, {"src": {"text": "inner retinal structures", "char_start": 244, "char_end": 268, "token_start": 38, "token_end": 41}, "tgt": {"text": "inneren Netzhautschichten", "char_start": 229, "char_end": 254, "token_start": 32, "token_end": 34}}, {"src": {"text": "choroid", "char_start": 279, "char_end": 286, "token_start": 43, "token_end": 44}, "tgt": {"text": "Aderhaut", "char_start": 277, "char_end": 285, "token_start": 38, "token_end": 39}}, {"src": {"text": "sympathetic nervous system", "char_start": 315, "char_end": 341, "token_start": 49, "token_end": 52}, "tgt": {"text": "sympathetische Innervation", "char_start": 303, "char_end": 329, "token_start": 42, "token_end": 44}}, {"src": {"text": "retina", "char_start": 431, "char_end": 437, "token_start": 68, "token_end": 69}, "tgt": {"text": "Netzhaut", "char_start": 457, "char_end": 465, "token_start": 62, "token_end": 63}}, {"src": {"text": "visual function", "char_start": 442, "char_end": 457, "token_start": 70, "token_end": 72}, "tgt": {"text": "Sehleistung", "char_start": 470, "char_end": 481, "token_start": 64, "token_end": 65}}, {"src": {"text": "retinal structure", "char_start": 477, "char_end": 494, "token_start": 76, "token_end": 78}, "tgt": {"text": "strukturellen Angaben der Netzhaut", "char_start": 498, "char_end": 532, "token_start": 69, "token_end": 73}}, {"src": {"text": "sports medicine", "char_start": 522, "char_end": 537, "token_start": 84, "token_end": 86}, "tgt": {"text": "Sportmedizin", "char_start": 559, "char_end": 571, "token_start": 78, "token_end": 79}}, {"src": {"text": "diabetic retinopathy", "char_start": 631, "char_end": 651, "token_start": 100, "token_end": 102}, "tgt": {"text": "diabetischer Retinopathie", "char_start": 663, "char_end": 688, "token_start": 91, "token_end": 93}}, {"src": {"text": "age-related macular degeneration", "char_start": 655, "char_end": 687, "token_start": 103, "token_end": 108}, "tgt": {"text": "altersbedingter Makuladegeneration", "char_start": 693, "char_end": 727, "token_start": 94, "token_end": 96}}, {"src": {"text": "trained heart", "char_start": 735, "char_end": 748, "token_start": 119, "token_end": 121}, "tgt": {"text": "trainierten Herz", "char_start": 764, "char_end": 780, "token_start": 104, "token_end": 106}}, {"src": {"text": "cardiology", "char_start": 758, "char_end": 768, "token_start": 124, "token_end": 125}, "tgt": {"text": "Kardiologie", "char_start": 806, "char_end": 817, "token_start": 111, "token_end": 112}}, {"src": {"text": "trained eye", "char_start": 800, "char_end": 811, "token_start": 132, "token_end": 134}, "tgt": {"text": "trainierte Auge", "char_start": 840, "char_end": 855, "token_start": 118, "token_end": 120}}, {"src": {"text": "blindness", "char_start": 1078, "char_end": 1087, "token_start": 180, "token_end": 181}, "tgt": {"text": "Erblindung", "char_start": 1038, "char_end": 1048, "token_start": 147, "token_end": 148}}]}
{"idx": 8983, "pair_id": "32289847", "src": "The extensive use of antibiotics is reflected by an increasing prevalence of infections with multidrug-resistant bacteria, including third-generation cephalosporin-resistant bacteria (3GCRB). For neonatal intensive care units screening and enhanced barrier precautions are recommended to control the spread of multidrug-resistant Gram-negative bacteria, while evidence for efficacy of barrier precautions remains scarce in a non-outbreak setting. To determine the impact of a screening program for maternal 3GCRB colonization and the effects of contact precautions and cohort nursing, concerning the risk of neonatal late-onset sepsis (LOS) and antibiotic use rates (AURs). In a retrospective matched-pair cohort study, data of neonates exposed to maternal 3GCRB colonization were compared with findings in non-exposed neonates. Of 3,144 neonates admitted, 184 neonates born to 3GCRB-positive mothers were eligible. Among them, 37 (20%) became 3GCRB positive during hospital stay. 3GCRB-exposed infants had a lower rate of LOS (6.5 vs. 14.1%, p=0.03) and lower AURs in that time period compared to controls (mean 0.009 vs. 0.025, p=0.006). When started within the first 72h after birth, days of therapy with meropenem were significantly lower in non-exposed vs. 3GCRB-exposed infants (mean 0.13 vs. 0.42; p=0.002). No invasive infections with 3GCRB occurred. Neonates of 3GCRB-positive mothers do not have an increased a priori risk for invasive 3GCRB infection and may benefit from enhanced contact precautions measures.", "tgt": "Der zunehmende Einsatz von Antibiotika f\u00fchrt zu einem Anstieg von Infektionen mit multiresistenten Erregern wie z.\u2009B. Drittgeneration Cephalosporin-resistenten Bakterien (3GCRB). Empfehlungen zu Screening- und Kohortierungsma\u00dfnahmen auf neonatologischen Intensivstationen zielen auf die Pr\u00e4vention von horizontaler Transmission und invasiven Infektionen ab. F\u00fcr Nicht-Ausbruchssituationen ist die Evidenz f\u00fcr Hygienema\u00dfnahmen und Screeningprogrammen unzureichend. ZIEL: Evaluation eines Screening f\u00fcr m\u00fctterliche 3GCRB-Besiedlung mit nachfolgender Isolation bzw. Kohortenpflege des Neugeborenen (NG) unter Bezug auf das Risiko einer Late-Onset-Sepsis (LOS) und die Anzahl der Antibiotika-Tage (AUR). In einer retrospektiven Fall-Kontroll-Kohortenstudie wurden Daten von NG mit maternaler 3GCRB-Besiedelung im Vergleich zu einer Kontrollgruppe mit unauff\u00e4lligem Screening analysiert. In einer Kohorte von 3144 NG fanden sich 184 NG von 3GCRB-besiedelten M\u00fcttern. Bei 37 (20%) wurde im Verlauf eine Besiedelung mit 3GCRB nachgewiesen. In der Gruppe der 3GCRB-exponierten NG kam es seltener zu einer LOS (6,5 vs. 14,1%, p=0,03). Zwischen dem 4. Lebenstag und der Entlassung hatten 3GCRB-exponierte NG eine niedrigere AUR (Mittelwert 0,009 vs. 0,025, p=0,006) als die Kontrollgruppe. Die Behandlungstage mit Meropenem (Start in den ersten 3 Lebenstagen), war in der Kontrollgruppe signifikant geringer als in der 3GCRB-exponierten Gruppe (Mittelwert 0,13 vs. 0,43 Tage; p=0,002). In beiden Gruppen trat keine invasive Infektion mit 3GCRB auf. Neugeborene, deren M\u00fctter 3GCRB besiedelt sind, haben kein erh\u00f6htes a priori Risiko f\u00fcr eine invasive Infektion mit 3GCRB Erregern und profitieren wahrscheinlich von erweiterten Kohortierungs- und Isolationsma\u00dfnahmen.", "term_pairs": []}
{"idx": 9318, "pair_id": "32659839", "src": "The high-throughput method of 'Next Generation Sequencing' (NGS) allows cost-effective decoding of the nucleotide sequences of millions of RNA molecules in a sample. This makes it possible to determine the number of distinct RNA molecules in tissues or cells and to use these data to draw conclusions. The entirety of RNAs, in particular mRNAs (messenger RNAs) as potential precursors of proteins, provides a comprehensive insight into the functional state of the cells and tissues under investigation. In addition to cell cultures or unfixed tissue, formalin-fixed and paraffin-embedded (FFPE) tissue can also be analysed for this purpose using specific methods. In this overview, the methodological strategy and its application to the field of ophthalmic histopathology are presented.", "tgt": "Hochdurchsatzverfahren des \u201eNext Generation Sequencing\u201c (NGS) erlauben es, kosteng\u00fcnstig die Nukleotidsequenzen von Millionen von RNA-Molek\u00fclen in einer Probe zu entschl\u00fcsseln. Dies erm\u00f6glicht, die Anzahl unterschiedlicher RNA-Molek\u00fcle in Gewebeverb\u00e4nden oder Einzelzellen zu bestimmen und daraus R\u00fcckschl\u00fcsse zu ziehen. Dabei gibt die Gesamtheit der RNAs, insbesondere der mRNAs (messenger RNAs) als potenzielle Vorlagen f\u00fcr die Proteinexpression, einen umfassenden Einblick in den Funktionszustand der untersuchten Zellen und Gewebe. Hierf\u00fcr k\u00f6nnen neben Zellkulturen oder frischem Gewebe mit speziellen Methoden auch formalinfixierte und in Paraffin (FFPE) eingebettete Pr\u00e4parate genutzt werden. In dieser \u00dcbersicht werden die methodische Strategie und ihr Einsatz im Bereich der ophthalmologischen Histopathologie dargestellt.", "term_pairs": [{"src": {"text": "Next Generation Sequencing", "char_start": 31, "char_end": 57, "token_start": 7, "token_end": 10}, "tgt": {"text": "Next Generation Sequencing", "char_start": 28, "char_end": 54, "token_start": 3, "token_end": 6}}, {"src": {"text": "NGS", "char_start": 60, "char_end": 63, "token_start": 12, "token_end": 13}, "tgt": {"text": "NGS", "char_start": 57, "char_end": 60, "token_start": 8, "token_end": 9}}, {"src": {"text": "RNA", "char_start": 139, "char_end": 142, "token_start": 26, "token_end": 27}, "tgt": {"text": "RNA", "char_start": 130, "char_end": 133, "token_start": 19, "token_end": 20}}, {"src": {"text": "mRNAs", "char_start": 338, "char_end": 343, "token_start": 64, "token_end": 65}, "tgt": {"text": "mRNAs", "char_start": 374, "char_end": 379, "token_start": 58, "token_end": 59}}, {"src": {"text": "messenger RNAs", "char_start": 345, "char_end": 359, "token_start": 66, "token_end": 68}, "tgt": {"text": "messenger RNAs", "char_start": 381, "char_end": 395, "token_start": 60, "token_end": 62}}, {"src": {"text": "FFPE", "char_start": 589, "char_end": 593, "token_start": 108, "token_end": 109}, "tgt": {"text": "FFPE", "char_start": 654, "char_end": 658, "token_start": 98, "token_end": 99}}, {"src": {"text": "ophthalmic histopathology", "char_start": 746, "char_end": 771, "token_start": 136, "token_end": 138}, "tgt": {"text": "ophthalmologischen Histopathologie", "char_start": 783, "char_end": 817, "token_start": 118, "token_end": 120}}]}
{"idx": 9438, "pair_id": "30005443", "src": "In recent years an increased comorbidity of schizophrenic disorders with anxiety disorders has been reported. Thus, among patients with a disorder from the schizophrenia spectrum, a general anxiety disorder was found in 38.3\u200a% of patients, with 14.9\u200a% of these with social phobia (SP). Especially social anxiety (SA) is of particular importance because it is often associated with depression and can contribute to psychosocial disabilities in patients with psychosis.Anxiety disorders already seem to occur prior to the first psychotic manifestation in the clinical high-risk state (CHR). Therefore, the questions arise as to whether this comorbidity is also dominated by SP in this patient group and, if so, what its consequences are on early detection and prevention of psychotic disorders. To clarify these questions, the present paper provides a systematic review of all published studies on social anxiety (SA) in the CHR.A total of 124 studies were included comprising 1702 CHR individuals, 445 healthy controls, 67 relatives / siblings of patients with psychotic disorders and 95 patients with a psychosis. In the most meaningful study, anxiety disorders were generally highly significant in CHR individuals (51\u200a%) compared to control subjects from the normal population (4\u200a%). Among those with anxiety disorders, 14.4\u200a% suffered from SP compared to 0.36\u200a% in normal controls and thus SP was almost as frequent as the prevalence of this type of anxiety disorders in the schizophrenic spectrum (14.9\u200a%). Also, the degree of SA in CHR individuals (SIAS score\u2006=\u200634.4, SD\u2006=\u20066.11) (SIAS-Score\u2006=\u200622.1, SD\u2006=\u20068.7), measured with the Social Interaction and Anxiety Scale (SIAS) in 9 studies, was almost as high as in psychotic patients (SIAS score =\u200635.0, SD\u2006=\u20069.56) and healthy controls (SIAS score\u2006=\u200614.,6; SD\u2006=\u20067,28). This degree of SA was also related to the attenuated psychotic symptomatology of the CHR individuals. However, the only study investigating the relationship between SA and a possible transition to a first psychotic manifestation did not reveal any predictive power. The feared psychosocial loss of function, which is already present in CHR, seems to be connected not only to the strong SA, but also to the similarly frequent comorbid depressive disorders.Moreover, one study has already provided some evidence that it is promising to address the SA as well as functional impairments in the CHR through newly developed specialized cognitive behavioural therapies.", "tgt": "In den letzten Jahren wird zunehmend \u00fcber die Komorbidit\u00e4t von schizophrenen St\u00f6rungen mit Angsterkrankungen berichtet. So wurde bei Patienten mit einer St\u00f6rung aus dem Schizophrenie-Spektrum in 38,3\u200a% eine Angsterkrankung und darunter mit 14,9\u200a% am h\u00e4ufigsten eine soziale Phobie (SP) gefunden. Gerade sozialer Angst kommt bei Patienten mit Psychose eine besondere Bedeutung zu, weil sie sich oft mit Depressivit\u00e4t verbindet und zur Entstehung von psychosozialen Behinderungen beitragen kann. Auch im Hochrisikostadium f\u00fcr Psychosen (\u201eClinical High- Risk State for Psychosis\u201c, HRP) treten Angsterkrankungen bereits geh\u00e4uft auf. Daher stellen sich die Fragen, ob auch hier die soziale Angstst\u00f6rung dominiert und welche Bedeutung dies f\u00fcr die Arbeit in den Fr\u00fcherkennungs- und Pr\u00e4ventivzentren h\u00e4tte. Um diese Fragen zu kl\u00e4ren, gibt diese Arbeit erstmals einen systematischen \u00dcberblick \u00fcber alle bisher publizierten Untersuchungen zu sozialen \u00c4ngste im klinischen HRP.Insgesamt wurden 124 Studien eingeschlossen. Nach der aussagekr\u00e4ftigsten dieser Arbeiten kamen Angsterkrankungen bei den HRP-Probanden mit knapp 51\u200a% hochsignifikant h\u00e4ufiger als bei Kontrollpersonen mit nur knapp 4\u200a% vor. Die SP dominierte und war mit einer Pr\u00e4valenz 14,4\u200a% gegen\u00fcber nur 0,36\u200a% bei den Kontrollpersonen fast genauso h\u00e4ufig vertreten, wie man sie unter den Angstst\u00f6rungen im Schizophrenie-Spektrum (14,9\u200a%) gefunden hat. Der in 9 Studien mit Hilfe der Social Interaction and Anxiety Scale (SIAS) ermittelte Auspr\u00e4gungsgrad sozialer \u00c4ngstlichkeit (S\u00c4) lag im Mittel bei den HRP Gruppen nahezu genauso hoch (SIAS-Score\u2006=\u200634,4; SD\u2006=\u20066,11) wie bei den bereits an einer Psychose erkrankten Patienten (SIAS-Score\u2006=\u200635,0; SD\u2006=\u20069,56) und hob sich deutlich von den Werten f\u00fcr Angeh\u00f6rige von Psychosekranken (SIAS-Score\u2006=\u200622,1; SD\u2006=\u20068,7) und Kontrollen (SIAS Score\u2006=\u2006 14,6; SD\u2006=\u20067,28) ab. Der Auspr\u00e4gungsgrad der S\u00c4 stand zwar mit der f\u00fcr das HRP ma\u00dfgeblichen attenuierten psychotischen Symptomatik im Zusammenhang, lie\u00df aber keine Vorhersagekraft f\u00fcr den \u00dcbergang in die psychotische Erstmanifestation erkennen. Die psychosozialen Funktionsverluste im HRP scheinen zudem nicht nur mit der S\u00c4, sondern auch mit den ebenfalls h\u00e4ufigen komorbiden depressiven St\u00f6rungen in Verbindung zu stehen. Ferner konnte eine Studie zeigen, dass es erfolgversprechend ist, die S\u00c4 im HRP durch neu entwickelte spezialisierte kognitive Verhaltenstherapien anzugehen.", "term_pairs": [{"src": {"text": "schizophrenic disorders", "char_start": 44, "char_end": 67, "token_start": 7, "token_end": 9}, "tgt": {"text": "schizophrenen St\u00f6rungen", "char_start": 63, "char_end": 86, "token_start": 10, "token_end": 12}}, {"src": {"text": "anxiety disorders", "char_start": 73, "char_end": 90, "token_start": 10, "token_end": 12}, "tgt": {"text": "Angsterkrankungen", "char_start": 91, "char_end": 108, "token_start": 13, "token_end": 14}}, {"src": {"text": "schizophrenia spectrum", "char_start": 156, "char_end": 178, "token_start": 25, "token_end": 27}, "tgt": {"text": "Schizophrenie-Spektrum", "char_start": 169, "char_end": 191, "token_start": 25, "token_end": 28}}, {"src": {"text": "social phobia", "char_start": 266, "char_end": 279, "token_start": 50, "token_end": 52}, "tgt": {"text": "soziale Phobie", "char_start": 266, "char_end": 280, "token_start": 45, "token_end": 47}}, {"src": {"text": "social anxiety", "char_start": 297, "char_end": 311, "token_start": 57, "token_end": 59}, "tgt": {"text": "soziale Angst", "char_start": 677, "char_end": 690, "token_start": 115, "token_end": 117}}, {"src": {"text": "psychosis", "char_start": 457, "char_end": 466, "token_start": 82, "token_end": 83}, "tgt": {"text": "Psychose", "char_start": 342, "char_end": 350, "token_start": 59, "token_end": 60}}, {"src": {"text": "clinical high-risk state", "char_start": 557, "char_end": 581, "token_start": 98, "token_end": 103}, "tgt": {"text": "Hochrisikostadium f\u00fcr Psychosen", "char_start": 502, "char_end": 533, "token_start": 83, "token_end": 86}}, {"src": {"text": "Social Interaction and Anxiety Scale", "char_start": 1632, "char_end": 1668, "token_start": 325, "token_end": 330}, "tgt": {"text": "Social Interaction and Anxiety Scale", "char_start": 1437, "char_end": 1473, "token_start": 244, "token_end": 249}}, {"src": {"text": "SIAS", "char_start": 1553, "char_end": 1557, "token_start": 293, "token_end": 294}, "tgt": {"text": "SIAS", "char_start": 1475, "char_end": 1479, "token_start": 250, "token_end": 251}}, {"src": {"text": "depressive disorders", "char_start": 2253, "char_end": 2273, "token_start": 453, "token_end": 455}, "tgt": {"text": "depressiven St\u00f6rungen", "char_start": 2220, "char_end": 2241, "token_start": 403, "token_end": 405}}, {"src": {"text": "cognitive behavioural therapies", "char_start": 2449, "char_end": 2480, "token_start": 485, "token_end": 488}, "tgt": {"text": "kognitive Verhaltenstherapien", "char_start": 2384, "char_end": 2413, "token_start": 429, "token_end": 431}}]}
{"idx": 9663, "pair_id": "33652488", "src": "The satirical story describes how the first person became 'conscious'.", "tgt": "In einer satirischen Geschichte wird geschildert, wie der erste Mensch sein \u201eBewusstsein\u201c erlangte.", "term_pairs": [{"src": {"text": "conscious", "char_start": 59, "char_end": 68, "token_start": 10, "token_end": 11}, "tgt": {"text": "Bewusstsein", "char_start": 77, "char_end": 88, "token_start": 13, "token_end": 14}}]}
{"idx": 9713, "pair_id": "32728768", "src": "In view of the globally evolving coronavirus disease (COVID-19) pandemic, German hospitals rapidly expanded their intensive care capacities. However, it is possible that even with an optimal use of the increased resources, these will not suffice for all patients in need. Therefore, recommendations for the allocation of intensive care resources in the context of the COVID-19 pandemic have been developed by a multidisciplinary group of authors with the support of eight scientific medical societies. The recommendations for procedures and criteria for prioritisations in case of resource scarcity are based on scientific evidence, ethicolegal considerations and practical experience. Medical decisions must always be based on the need and the treatment preferences of the individual patient. In addition to this patient-centred approach, prioritisations in case of resource scarcity require a supraindividual perspective. In such situations, prioritisations should be based on the criterion of clinical prospect of success in order to minimize the number of preventable deaths due to resource scarcity and to avoid discrimination based on age, disabilities or social factors. The assessment of the clinical prospect of success should take into account the severity of the current illness, severe comorbidities and the patient's general health status prior to the current illness.", "tgt": "Angesichts der beginnenden COVID-19-Pandemie haben die deutschen Krankenh\u00e4user ihre intensivmedizinischen Kapazit\u00e4ten erh\u00f6ht. Trotz optimaler Nutzung erscheint es m\u00f6glich, dass die intensivmedizinischen Ressourcen nicht mehr f\u00fcr alle Patienten ausreichen, die ihrer bed\u00fcrfen. Vor diesem Hintergrund wurden von einer multidisziplin\u00e4ren Autorengruppe und mit Unterst\u00fctzung von acht medizinisch-wissenschaftlichen Fachgesellschaften Empfehlungen zur Verteilung intensivmedizinischer Ressourcen im Kontext der COVID-19-Pandemie erarbeitet. Die Empfehlungen zu Verfahren und Kriterien f\u00fcr Priorisierungsentscheidungen bei Ressourcenknappheit wurden auf Grundlage der verf\u00fcgbaren wissenschaftlichen Evidenz, ethischer und rechtlicher \u00dcberlegungen sowie praktischen Erfahrungen erstellt. Medizinische Entscheidungen m\u00fcssen sich immer am Bedarf und den Behandlungspr\u00e4ferenzen des einzelnen Patienten orientieren. Erg\u00e4nzend zu dieser patientenzentrierten Betrachtung kommt mit der Priorisierung bei absoluter Mittelknappheit eine \u00fcberindividuelle Perspektive hinzu. In dieser Situation sollte die Priorisierung anhand des Kriteriums der Erfolgsaussicht einer Behandlung erfolgen, um die Anzahl der vermeidbaren Todesf\u00e4lle zu minimieren und eine Diskriminierung von Patienten aufgrund des Alters, von Behinderungen oder des sozialen Status zu vermeiden. Die Einsch\u00e4tzung der klinischen Erfolgsaussicht ber\u00fccksichtigt den Schweregrad der aktuellen Erkrankung, das Vorliegen schwerer Komorbidit\u00e4ten und den allgemeinen pr\u00e4morbiden Gesundheitsstatus des Patienten.", "term_pairs": [{"src": {"text": "coronavirus disease (COVID-19) pandemic", "char_start": 33, "char_end": 72, "token_start": 6, "token_end": 14}, "tgt": {"text": "COVID-19-Pandemie", "char_start": 27, "char_end": 44, "token_start": 3, "token_end": 8}}, {"src": {"text": "intensive care capacities", "char_start": 114, "char_end": 139, "token_start": 20, "token_end": 23}, "tgt": {"text": "intensivmedizinischen Kapazit\u00e4ten", "char_start": 84, "char_end": 117, "token_start": 13, "token_end": 15}}, {"src": {"text": "intensive care resources", "char_start": 321, "char_end": 345, "token_start": 57, "token_end": 60}, "tgt": {"text": "intensivmedizinischen Ressourcen", "char_start": 181, "char_end": 213, "token_start": 26, "token_end": 28}}, {"src": {"text": "COVID-19 pandemic", "char_start": 368, "char_end": 385, "token_start": 65, "token_end": 69}, "tgt": {"text": "COVID-19-Pandemie", "char_start": 506, "char_end": 523, "token_start": 64, "token_end": 69}}, {"src": {"text": "resource scarcity", "char_start": 581, "char_end": 598, "token_start": 98, "token_end": 100}, "tgt": {"text": "Ressourcenknappheit", "char_start": 617, "char_end": 636, "token_start": 80, "token_end": 81}}, {"src": {"text": "clinical prospect of success", "char_start": 996, "char_end": 1024, "token_start": 162, "token_end": 166}, "tgt": {"text": "klinischen Erfolgsaussicht", "char_start": 1365, "char_end": 1391, "token_start": 174, "token_end": 176}}, {"src": {"text": "severe comorbidities", "char_start": 1291, "char_end": 1311, "token_start": 211, "token_end": 213}, "tgt": {"text": "schwerer Komorbidit\u00e4ten", "char_start": 1463, "char_end": 1486, "token_start": 185, "token_end": 187}}]}
{"idx": 9745, "pair_id": "32325500", "src": "In 2019, one novel pharmaceutical agent for horses or food-producing animals was released on the German market: An injection suspension for horses containing chondrogenic-induced equine allogeneic peripheral blood-derived mesenchymal stem cells as the active ingredient (ArtiCell<sup>\u00ae</sup> Forte) is now available. Two established veterinary active pharmaceutical ingredients became accessible for additional species: a salicylanilide anthelmintic oxyclozanide (Distocur<sup>\u00ae</sup>) for the treatment and control of fascioliasis in sheep as well as a type-I synthetic pyrethroid permethrin (Z-Itch<sup>\u00ae</sup>), which now has additionally been authorized for donkeys. Additionally, one veterinary drug with a new combination of active ingredients (toltrazuril + gleptoferron), 2 drugs (permethrin, omeprazole) in a new pharmaceutical formulation, one drug (lidocaine) with a novel route of administration, one drug (amprolium) with a higher content of the active ingredient, as well as one active substance (butylscopolaminium bromide) in mono-preparation have been launched on the market for horses and food-producing animals.", "tgt": "Im Jahr 2019 kam f\u00fcr Pferde und landwirtschaftliche Nutztiere ein neuer Wirkstoff auf den deutschen Tierarzneimittelmarkt. So steht erstmalig f\u00fcr Pferde eine Injektionssuspension mit chondrogen induzierten allogenen peripheren mesenchymalen Stammzellen aus dem Blut vom Pferd zur Verf\u00fcgung (ArtiCell<sup>\u00ae</sup> Forte). Zwei Wirkstoffe erhielten eine Tierartenerweiterung. So wurde das Fasziolizid Oxyclozanid (Distocur<sup>\u00ae</sup>) aus der Gruppe der Salicyls\u00e4ureanilide auch f\u00fcr Schafe und das synthetische Typ-I-Pyrethroid Permethrin (Z-Itch<sup>\u00ae</sup>) auch f\u00fcr Esel zugelassen. Au\u00dferdem kamen eine neue Wirkstoffkombination (Toltrazuril + Gleptoferron), 2 Wirkstoffe (Permethrin, Omeprazol) in einer neuen Darreichungsform, ein Wirkstoff (Lidocain) in einer neuen Anwendungsart, ein Wirkstoff (Amprolium) mit einem h\u00f6heren Wirkstoffgehalt und ein Wirkstoff (Butylscopolaminiumbromid) in Monozubereitung f\u00fcr Pferde und landwirtschaftliche Nutztiere auf den Markt.", "term_pairs": [{"src": {"text": "chondrogenic-induced equine allogeneic peripheral blood-derived mesenchymal stem cells", "char_start": 158, "char_end": 244, "token_start": 27, "token_end": 39}, "tgt": {"text": "chondrogen induzierten allogenen peripheren mesenchymalen Stammzellen aus dem Blut vom Pferd", "char_start": 183, "char_end": 275, "token_start": 25, "token_end": 36}}, {"src": {"text": "ArtiCell<sup>\u00ae</sup> Forte", "char_start": 271, "char_end": 297, "token_start": 44, "token_end": 54}, "tgt": {"text": "ArtiCell<sup>\u00ae</sup> Forte", "char_start": 291, "char_end": 317, "token_start": 39, "token_end": 49}}, {"src": {"text": "oxyclozanide", "char_start": 450, "char_end": 462, "token_start": 74, "token_end": 75}, "tgt": {"text": "Oxyclozanid", "char_start": 398, "char_end": 409, "token_start": 61, "token_end": 62}}, {"src": {"text": "Distocur<sup>\u00ae</sup>", "char_start": 464, "char_end": 484, "token_start": 76, "token_end": 85}, "tgt": {"text": "Distocur<sup>\u00ae</sup>", "char_start": 411, "char_end": 431, "token_start": 63, "token_end": 72}}, {"src": {"text": "fascioliasis", "char_start": 519, "char_end": 531, "token_start": 92, "token_end": 93}, "tgt": {"text": "Fasziolizid", "char_start": 386, "char_end": 397, "token_start": 60, "token_end": 61}}, {"src": {"text": "permethrin", "char_start": 582, "char_end": 592, "token_start": 104, "token_end": 105}, "tgt": {"text": "Permethrin", "char_start": 526, "char_end": 536, "token_start": 89, "token_end": 90}}, {"src": {"text": "Z-Itch<sup>\u00ae</sup>", "char_start": 594, "char_end": 612, "token_start": 106, "token_end": 117}, "tgt": {"text": "Z-Itch<sup>\u00ae</sup>", "char_start": 538, "char_end": 556, "token_start": 91, "token_end": 102}}, {"src": {"text": "toltrazuril", "char_start": 751, "char_end": 762, "token_start": 141, "token_end": 142}, "tgt": {"text": "Toltrazuril", "char_start": 631, "char_end": 642, "token_start": 114, "token_end": 115}}, {"src": {"text": "gleptoferron", "char_start": 765, "char_end": 777, "token_start": 143, "token_end": 144}, "tgt": {"text": "Gleptoferron", "char_start": 645, "char_end": 657, "token_start": 116, "token_end": 117}}, {"src": {"text": "omeprazole", "char_start": 801, "char_end": 811, "token_start": 151, "token_end": 152}, "tgt": {"text": "Omeprazol", "char_start": 686, "char_end": 695, "token_start": 124, "token_end": 125}}, {"src": {"text": "lidocaine", "char_start": 860, "char_end": 869, "token_start": 162, "token_end": 163}, "tgt": {"text": "Lidocain", "char_start": 745, "char_end": 753, "token_start": 134, "token_end": 135}}, {"src": {"text": "amprolium", "char_start": 919, "char_end": 928, "token_start": 174, "token_end": 175}, "tgt": {"text": "Amprolium", "char_start": 800, "char_end": 809, "token_start": 144, "token_end": 145}}, {"src": {"text": "butylscopolaminium bromide", "char_start": 1011, "char_end": 1037, "token_start": 192, "token_end": 194}, "tgt": {"text": "Butylscopolaminiumbromid", "char_start": 864, "char_end": 888, "token_start": 154, "token_end": 155}}]}
{"idx": 9871, "pair_id": "30952174", "src": "Organizational health services research is still a relatively young field of research in Germany which is of increasing interest. The German Network Health Services Research e.V. (DNVF e.V.) published in 2009 - supported by expert associations and individual members of the DNVF - a guide on 'Methods for organizational health services research' of the Memorandum III, part 1 [1]. Originating from this publication and facilitated by the increasing relevance of the field, a necessity to refine the conceptual and methodological basis became evident. The update and extension of the publication from 2009 consists of three chapters: (1) Definition and concept of organizational health services research, (2) Methodological approaches in organizational health services research: indicators, data sources, data collection and data analysis, (3) Methodological approaches for the design, evaluation and implementation of complex interventions in health care organizations. The aim of the third chapter is to present methods for intervention design, evaluation of effectiveness and efficacy as well as implementation research with particular regard to the organizational context of interventions to improve health care.", "tgt": "Das Forschungsfeld der organisationsbezogenen Versorgungsforschung ist in Deutschland noch relativ jung und von zunehmendem Interesse. Das Deutsche Netzwerk Versorgungsforschung e. V. (DNVF e. V.) hat im Jahr 2009 \u2013 getragen von den im DNVF organisierten Fachgesellschaften und Mitgliedern \u2013 eine Vertiefung zu \u201eMethoden der organisationsbezogenen Versorgungsforschung\u201c des Memorandums III, Teil 1 konsentiert [1]. Ausgehend von dieser Ver\u00f6ffentlichung und dem gegenw\u00e4rtigen Bedeutungsgewinn des Forschungsfeldes ist eine Weiterentwicklung der konzeptionellen und methodischen Grundlage erforderlich. Die Neuauflage und Erweiterung der Ver\u00f6ffentlichung aus dem Jahr 2009 gliedert sich in 3 Kapitel: (1) Definition und Konzept der organisationsbezogenen Versorgungsforschung, (2) Methodische Ans\u00e4tze der organisationsbezogenen Versorgungsforschung: Zielgr\u00f6\u00dfen, Datenquellen, Datenerhebung, und Datenanalyse, (3) Methodische Ans\u00e4tze zur Konzeption, Evaluation und Implementierung komplexer Interventionen in Versorgungsorganisationen. Ziel des dritten Kapitels ist es, Methoden f\u00fcr das Design von Interventionen, f\u00fcr die Wirkungs- und Wirksamkeitsforschung sowie f\u00fcr die Implementierungsforschung unter besonderer Ber\u00fccksichtigung des organisationalen Kontextes, in dem Versorgungsinterventionen stattfinden, vorzustellen.", "term_pairs": [{"src": {"text": "Organizational health services research", "char_start": 0, "char_end": 39, "token_start": 0, "token_end": 4}, "tgt": {"text": "organisationsbezogenen Versorgungsforschung", "char_start": 23, "char_end": 66, "token_start": 3, "token_end": 5}}, {"src": {"text": "German Network Health Services Research e.V. (DNVF e.V.)", "char_start": 134, "char_end": 190, "token_start": 21, "token_end": 37}, "tgt": {"text": "Deutsche Netzwerk Versorgungsforschung e. V. (DNVF e. V.)", "char_start": 139, "char_end": 196, "token_start": 17, "token_end": 31}}, {"src": {"text": "Memorandum III, part 1", "char_start": 353, "char_end": 375, "token_start": 65, "token_end": 70}, "tgt": {"text": "Memorandums III, Teil 1", "char_start": 374, "char_end": 397, "token_start": 56, "token_end": 61}}, {"src": {"text": "Definition and concept of organizational health services research", "char_start": 637, "char_end": 702, "token_start": 117, "token_end": 125}, "tgt": {"text": "Definition und Konzept der organisationsbezogenen Versorgungsforschung", "char_start": 703, "char_end": 773, "token_start": 105, "token_end": 111}}, {"src": {"text": "Methodological approaches in organizational health services research", "char_start": 708, "char_end": 776, "token_start": 129, "token_end": 136}, "tgt": {"text": "Methodische Ans\u00e4tze der organisationsbezogenen Versorgungsforschung", "char_start": 779, "char_end": 846, "token_start": 115, "token_end": 120}}, {"src": {"text": "indicators", "char_start": 778, "char_end": 788, "token_start": 137, "token_end": 138}, "tgt": {"text": "Zielgr\u00f6\u00dfen", "char_start": 848, "char_end": 858, "token_start": 121, "token_end": 122}}, {"src": {"text": "data sources", "char_start": 790, "char_end": 802, "token_start": 139, "token_end": 141}, "tgt": {"text": "Datenquellen", "char_start": 860, "char_end": 872, "token_start": 123, "token_end": 124}}, {"src": {"text": "data collection", "char_start": 804, "char_end": 819, "token_start": 142, "token_end": 144}, "tgt": {"text": "Datenerhebung", "char_start": 874, "char_end": 887, "token_start": 125, "token_end": 126}}, {"src": {"text": "data analysis", "char_start": 824, "char_end": 837, "token_start": 145, "token_end": 147}, "tgt": {"text": "Datenanalyse", "char_start": 893, "char_end": 905, "token_start": 128, "token_end": 129}}, {"src": {"text": "design", "char_start": 877, "char_end": 883, "token_start": 155, "token_end": 156}, "tgt": {"text": "Konzeption", "char_start": 544, "char_end": 554, "token_start": 80, "token_end": 81}}, {"src": {"text": "evaluation", "char_start": 885, "char_end": 895, "token_start": 157, "token_end": 158}, "tgt": {"text": "Evaluation", "char_start": 947, "char_end": 957, "token_start": 138, "token_end": 139}}, {"src": {"text": "implementation", "char_start": 900, "char_end": 914, "token_start": 159, "token_end": 160}, "tgt": {"text": "Implementierung", "char_start": 962, "char_end": 977, "token_start": 140, "token_end": 141}}, {"src": {"text": "complex interventions", "char_start": 918, "char_end": 939, "token_start": 161, "token_end": 163}, "tgt": {"text": "komplexer Interventionen", "char_start": 978, "char_end": 1002, "token_start": 141, "token_end": 143}}, {"src": {"text": "health care organizations", "char_start": 943, "char_end": 968, "token_start": 164, "token_end": 167}, "tgt": {"text": "Versorgungsorganisationen", "char_start": 1006, "char_end": 1031, "token_start": 144, "token_end": 145}}, {"src": {"text": "intervention design", "char_start": 1025, "char_end": 1044, "token_start": 179, "token_end": 181}, "tgt": {"text": "Design von Interventionen", "char_start": 1084, "char_end": 1109, "token_start": 156, "token_end": 159}}, {"src": {"text": "evaluation of effectiveness and efficacy", "char_start": 1046, "char_end": 1086, "token_start": 182, "token_end": 187}, "tgt": {"text": "Wirkungs- und Wirksamkeitsforschung", "char_start": 1119, "char_end": 1154, "token_start": 162, "token_end": 166}}, {"src": {"text": "implementation research", "char_start": 1098, "char_end": 1121, "token_start": 190, "token_end": 192}, "tgt": {"text": "Implementierungsforschung", "char_start": 1169, "char_end": 1194, "token_start": 169, "token_end": 170}}, {"src": {"text": "organizational context", "char_start": 1152, "char_end": 1174, "token_start": 197, "token_end": 199}, "tgt": {"text": "organisationalen Kontextes", "char_start": 1233, "char_end": 1259, "token_start": 174, "token_end": 176}}]}
{"idx": 9985, "pair_id": "34729632", "src": "The goal of the modified Ellison operation as a\u00a0supplement to a\u00a0conventional anterior cruciate ligament (ACL) reconstruction is to decrease anterolateral rotational instability of a\u00a0knee joint after ACL rupture, to improve the stability and prevent ACL re-rupture. An ACL rupture with high risk of re-rupture (young age, high-performance sport, hyperlaxity, contralateral ACL rupture in history), increased subjective and objective anterolateral rotational instability of the knee after ACL rupture, ACL re-rupture. Gonarthrosis, additive instabilities (e.g. posterolateral, medial), non-anatomical ACL reconstruction with persistent instability, general contraindications to surgery (e.g. infections), chronic irritation of the knee joint. Supine position. Mark the typical landmarks. Incision from Gerdy's tubercle extending proximally along the iliotibial tract (ITT) to the lateral collateral ligament (approx. 5\u202fcm). Incise the ITT in the line of its fibers about 10\u202fmm anterior to its posterior border and continue the incision proximally to 5\u202fmm proximal to the LCL. Make a\u00a0parallel incision 10-12\u202fmm anterior to the first incision. Use sharp subperiosteal dissection to elevate the strip of the ITT from Gerdy's tubercle. Secure the distal end of the ITT strip with a\u00a0nonabsorbable suture (e.g. FiberWire No. 2, Arthrex, Naples, USA). Expose the LCL and pass the ITT strip deep to the LCL from proximal to distal and back to Gerdy's tubercle. Reattach the distal end of the strip of the ITT to its original position at Gerdy's tubercle with a\u00a0bone anchor. The defect in the ITT can be closed with an absorbable suture (e.g. Vicryl, Ethicon, USA) in the proximal part. Layered closure. Knee brace for at least 6\u00a0weeks, movement limitation of 0\u20110-90\u00b0 for 6\u00a0weeks, 2\u00a0weeks 20\u202fkg partial weight bearing. A total of 36\u00a0patients (mean age 18.9 years) with a high risk of ACL re-rupture have been treated with ACL reconstruction and modified Ellison procedure. Follow-up over 2\u00a0years. Of the patients 35\u00a0returned to the previous sports level, 1 patient suffered a re-rupture, 2 patients had cyclops resection and 1 patient contralateral ACL rupture.", "tgt": "OPERATIONSZIEL: Ziel der modifizierten Operation nach Ellison als Erg\u00e4nzung einer konventionellen VKB-Rekonstruktion ist die gezielte Erh\u00f6hung der anterolateralen Rotationsstabilit\u00e4t eines Kniegelenks nach VKB-Ruptur zur Verbesserung der Stabilit\u00e4t und Verminderung des Rerupturrisikos. VKB-Ruptur mit erh\u00f6htem Rerupturrisiko (junges Alter <25\u00a0Jahre, R\u00fcckkehr zu Risikosportarten, Hyperlaxit\u00e4t, kontralaterale VKB-Ruptur in der Anamnese), erh\u00f6hte subjektive und objektive anterolaterale Rotationsinstabilit\u00e4t des Kniegelenks nach VKB-Ruptur, Rerupturen des VKB. Relative: Gonarthrose, additive Instabilit\u00e4ten (z.\u202fB. posterolateral, medial), nichtanatomische VKB-Rekonstruktion mit persistierender Instabilit\u00e4t. Absolute: Allgemeine Kontraindikationen gegen eine Operation (z.\u202fB. Infektionen etc.), Reizzustand des Kniegelenks. Durchf\u00fchrung in R\u00fcckenlagerung. Anzeichnen der typischen Landmarken. Schnittf\u00fchrung des Hautschnitts vom Tuberculum Gerdyi nach proximal im Verlauf des Tractus iliotibialis bis zur Kreuzungsstelle des lateralen Kollateralbands (ca.\u00a05\u202fcm). Darstellung des Tractus iliotibialis im Bereich des Tuberculum Gerdyi bis etwa 10\u202fmm oberhalb der Kreuzungsstelle mit dem LCL. Anzeichnen der Breite (10\u201312\u202fmm) des Transplantats \u00fcber dem Tuberculum Gerdyi. Scharfes periostales Abl\u00f6sen des 10\u201312\u202fmm breiten Traktusstreifens am Tuberculum Gerdyi mit dem Skalpell. Verl\u00e4ngerung des Traktusstreifens mit 10\u201312\u202fmm Breite bis 8\u202fmm proximal der Kreuzungsstelle mit dem LCL mit Hilfe einer Schere. Armieren des distalen Endes des Traktusstreifens mit Hilfe eines nichtresorbierbaren Fadens (z.\u202fB. FiberWire No2, Arthrex, Naples, USA). Unterminieren des lateralen Kollateralbands. Der Traktusstreifen wird dann anschlie\u00dfend von proximal unter dem LCL durchgeshuttelt und wieder zum Tuberculum Gerdyi gef\u00fchrt. Am Tuberculum Gerdyi wird der Traktus in urspr\u00fcnglicher Position mit Hilfe eines Knochenankers refixiert. Der Entnahmedefekt des Traktus wird mittels Vicrylnaht im proximalen Teil verschlossen. Schichtweiser Verschluss. Hartrahmen Kniegelenkorthese mindestens 6\u00a0Wochen, Bewegungslimitierung von 0\u20110-90\u00b0 f\u00fcr 6\u00a0Wochen, 2\u00a0Wochen 20\u202fkg Teilbelastung. Insgesamt 36\u00a0Patienten (mittleres Alter: 18,9 Jahre) mit erh\u00f6htem Rerupturrisiko wurden neben der VKB-Rekonstruktion mit einer modifizierten Ellison-Rekonstruktion versorgt. Follow-up von 2\u00a0Jahren.; 35\u00a0Patienten erreichten das vorherige Sportlevel. Ein Patient mit Reruptur, 2\u00a0Zyklopsresektionen und 3\u00a0kontralaterale VKB-Rupturen.", "term_pairs": []}
{"idx": 10015, "pair_id": "34734298", "src": "For intensive care patients the return to normal life is usually a\u00a0long and strenuous journey. In addition to the severity of the underlying disease, possible comorbidities, sedation and pain management as well as the use of various drugs together with the length of stay in the intensive care unit are factors that strongly influence the course of early rehabilitation and thus the functional outcome. Intensive care patients in particular are exposed to extreme stress during mobilization and often reach their cardiopulmonary stress limit. In order to determine such limits, lactate measurement is used in the performance diagnostics of athletes. In a\u00a0retrospective study 20\u00a0intensive care patients were mobilized up to their subjective maximum load capacity during physiotherapy (sitting on the edge of the bed n\u202f=\u20096, standing n\u202f=\u200912 and walking n\u202f=\u20092). The lactate value was determined from the routine arterial blood gas analysis and then an attempt was made to establish a\u00a0correlation between the subjectively perceived change in exercise load (Borg CR10) and the changes in lactate measurements. Changes in the sense of an increase in stress occurred in both in the Borg scale and in the lactate measurements. The subjective maximum load capacity increased on average by 4.85\u00a0points (p\u202f=\u20090.13, 95% confidence interval, CI 4.58-5.12). In addition, a\u00a0significant mean increase in lactate by 10.8\u202fmg/dl (p\u202f<\u20090.001, 95% CI 9.73-11.87) was observed. No positive correlation between the load-induced changes in Borg values and the development of lactate values was shown (Pearson correlation: r\u202f=\u20090.123). The subjective load increase in the Borg CR10 observed in all 20\u00a0intensive care patients included in the study and the associated significant increase in lactate after mobilization, suggest that an efficient load in the sense of a\u00a0training-desired supercompensation was achieved through mobilization. The tendency towards a\u00a0correlation between the changes in Borg CR10 and the lactate values can be interpreted as an indication that the development of lactate values can also be used in intensive care patients to avoid overloading of patients in early rehabilitation.", "tgt": "HINTERGRUND: F\u00fcr IntensivpatientInnen ist die R\u00fcckkehr ins gewohnte Leben meist ein langer und anstrengender Weg. Neben der Schwere der Grunderkrankung beeinflussen etwaige Komorbidit\u00e4ten, das Sedierungs- und Schmerzmanagement sowie diverse Medikamente und die Aufenthaltsdauer auf der Intensivstation den Verlauf der Fr\u00fchrehabilitation und damit das funktionelle Outcome. Insbesondere IntensivpatientInnen sind w\u00e4hrend der Mobilisation extremen Belastungen ausgesetzt und kommen dabei an ihre kardiopulmonale Belastungsgrenze. Um derartige Limits zu erfassen, wird in der Leistungsdiagnostik bei SportlerInnen die Laktatmessung eingesetzt. Im Rahmen einer retrospektiven Untersuchung wurden bei 20\u00a0IntensivpatientInnen, die bis zu ihrer subjektiven maximalen Belastbarkeit im Rahmen der Physiotherapie mobilisiert wurden (Querbettsitz [n\u202f=\u20096], Stehen [n\u202f=\u200912] bzw. Gehen [n\u202f=\u20092]), mittels routinem\u00e4\u00dfiger arterieller Blutgasanalyse die Laktatwerte erhoben. Die Werte wurden bez\u00fcglich eines Zusammenhangs zwischen der subjektiv empfundenen Belastungs\u00e4nderung (Borg-Category-Ratio-10[CR10]-Skala) und den Ver\u00e4nderungen der Laktatmessungen untersucht. Sowohl auf der Borg-Skala als auch bei den Laktatmessungen kam es zu Ver\u00e4nderungen im Sinne einer Belastungssteigerung. Die subjektiv empfundene Anstrengung w\u00e4hrend der Mobilisation erh\u00f6hte sich im Mittel um 4,85\u00a0Punkte (p\u202f=\u20090,13; 95\u202f%-Konfidenzintervall [KI] 4,58\u20135,12). Eine signifikante mittlere Zunahme des Laktats um 10,8\u202fmg/dl (p\u202f<\u20090,001; 95\u202f%-KI 9,73\u201311,87) wurde festgestellt. Es zeigte sich kein statistisch signifikanter Zusammenhang zwischen den belastungsinduzierten Ver\u00e4nderungen der Borg-Werte und der Entwicklung der Laktatwerte (Pearson-Korrelation: r\u202f=\u20090,123). Bei allen\u00a020 in die Untersuchung einbezogenen IntensivpatientInnen konnten eine subjektive Belastungssteigerung auf der Borg-CR10-Skala und eine signifikante Steigerung des Laktats nach der Mobilisation festgestellt werden. Durch die Mobilisation konnte eine effiziente Belastung im Sinne einer trainingserw\u00fcnschten Superkompensation erreicht werden. Die Korrelationstendenz zwischen den Ver\u00e4nderungen auf der Borg-CR10-Skala und den Laktatwerten kann als Hinweis daf\u00fcr gewertet werden, dass die Entwicklung der Laktatwerte bei IntensivpatientInnen zur Vermeidung einer \u00dcberbelastung in der Fr\u00fchrehabilitation eingesetzt werden k\u00f6nnte.", "term_pairs": [{"src": {"text": "intensive care patients", "char_start": 4, "char_end": 27, "token_start": 1, "token_end": 4}, "tgt": {"text": "IntensivpatientInnen", "char_start": 17, "char_end": 37, "token_start": 3, "token_end": 4}}, {"src": {"text": "comorbidities", "char_start": 159, "char_end": 172, "token_start": 28, "token_end": 29}, "tgt": {"text": "Komorbidit\u00e4ten", "char_start": 173, "char_end": 187, "token_start": 24, "token_end": 25}}, {"src": {"text": "sedation", "char_start": 174, "char_end": 182, "token_start": 30, "token_end": 31}, "tgt": {"text": "Sedierungs", "char_start": 193, "char_end": 203, "token_start": 27, "token_end": 28}}, {"src": {"text": "pain management", "char_start": 187, "char_end": 202, "token_start": 32, "token_end": 34}, "tgt": {"text": "Schmerzmanagement", "char_start": 209, "char_end": 226, "token_start": 30, "token_end": 31}}, {"src": {"text": "drugs", "char_start": 233, "char_end": 238, "token_start": 41, "token_end": 42}, "tgt": {"text": "Medikamente", "char_start": 241, "char_end": 252, "token_start": 33, "token_end": 34}}, {"src": {"text": "intensive care unit", "char_start": 279, "char_end": 298, "token_start": 50, "token_end": 53}, "tgt": {"text": "Intensivstation", "char_start": 286, "char_end": 301, "token_start": 39, "token_end": 40}}, {"src": {"text": "early rehabilitation", "char_start": 349, "char_end": 369, "token_start": 61, "token_end": 63}, "tgt": {"text": "Fr\u00fchrehabilitation", "char_start": 318, "char_end": 336, "token_start": 43, "token_end": 44}}, {"src": {"text": "functional outcome", "char_start": 383, "char_end": 401, "token_start": 66, "token_end": 68}, "tgt": {"text": "funktionelle Outcome", "char_start": 351, "char_end": 371, "token_start": 47, "token_end": 49}}, {"src": {"text": "mobilization", "char_start": 478, "char_end": 490, "token_start": 80, "token_end": 81}, "tgt": {"text": "Mobilisation", "char_start": 424, "char_end": 436, "token_start": 55, "token_end": 56}}, {"src": {"text": "cardiopulmonary stress limit", "char_start": 513, "char_end": 541, "token_start": 85, "token_end": 88}, "tgt": {"text": "kardiopulmonale Belastungsgrenze", "char_start": 494, "char_end": 526, "token_start": 64, "token_end": 66}}, {"src": {"text": "lactate measurement", "char_start": 578, "char_end": 597, "token_start": 96, "token_end": 98}, "tgt": {"text": "Laktatmessung", "char_start": 615, "char_end": 628, "token_start": 80, "token_end": 81}}, {"src": {"text": "performance diagnostics", "char_start": 613, "char_end": 636, "token_start": 102, "token_end": 104}, "tgt": {"text": "Leistungsdiagnostik", "char_start": 573, "char_end": 592, "token_start": 76, "token_end": 77}}, {"src": {"text": "retrospective study", "char_start": 655, "char_end": 674, "token_start": 109, "token_end": 111}, "tgt": {"text": "retrospektiven Untersuchung", "char_start": 657, "char_end": 684, "token_start": 86, "token_end": 88}}, {"src": {"text": "physiotherapy", "char_start": 769, "char_end": 782, "token_start": 125, "token_end": 126}, "tgt": {"text": "Physiotherapie", "char_start": 788, "char_end": 802, "token_start": 103, "token_end": 104}}, {"src": {"text": "arterial blood gas analysis", "char_start": 908, "char_end": 935, "token_start": 157, "token_end": 161}, "tgt": {"text": "arterieller Blutgasanalyse", "char_start": 905, "char_end": 931, "token_start": 132, "token_end": 134}}, {"src": {"text": "Borg CR10", "char_start": 1052, "char_end": 1061, "token_start": 180, "token_end": 182}, "tgt": {"text": "Borg-Category-Ratio-10[CR10]-Skala", "char_start": 1059, "char_end": 1093, "token_start": 150, "token_end": 162}}, {"src": {"text": "Borg scale", "char_start": 1174, "char_end": 1184, "token_start": 204, "token_end": 206}, "tgt": {"text": "Borg-Skala", "char_start": 1164, "char_end": 1174, "token_start": 173, "token_end": 176}}, {"src": {"text": "confidence interval", "char_start": 1306, "char_end": 1325, "token_start": 234, "token_end": 236}, "tgt": {"text": "Konfidenzintervall", "char_start": 1385, "char_end": 1403, "token_start": 216, "token_end": 217}}, {"src": {"text": "CI", "char_start": 757, "char_end": 759, "token_start": 123, "token_end": 124}, "tgt": {"text": "KI", "char_start": 1405, "char_end": 1407, "token_start": 218, "token_end": 219}}, {"src": {"text": "Pearson correlation", "char_start": 1574, "char_end": 1593, "token_start": 305, "token_end": 307}, "tgt": {"text": "Pearson-Korrelation", "char_start": 1694, "char_end": 1713, "token_start": 285, "token_end": 288}}, {"src": {"text": "supercompensation", "char_start": 1855, "char_end": 1872, "token_start": 357, "token_end": 358}, "tgt": {"text": "Superkompensation", "char_start": 2043, "char_end": 2060, "token_start": 338, "token_end": 339}}]}
{"idx": 10078, "pair_id": "34749411", "src": "The etiology of keratoconus (KC) is probably multifactorial but remains essentially unknown. Previous scientific observations have suggested that hypothyroidism might play a role in the development and progression of KC. The purpose of this study was to analyze the tomographic and biomechanical parameters in KC patients with or without hypothyroidism. Twenty-eight patients with KC and hypothyroidism (HT group) and fifty-six KC patients without thyroid dysfunction (WHT group) with matching gender and age were analyzed. Mean age was 40.3 years (range 14\u200a-\u200a57) in the HT group and 40.3 years (range 14\u200a-\u200a57) in the WHT group. Routine ophthalmic examinations consisted of corneal tomography and biomechanical parameters. We extracted the following KC parameters from the Pentacam (Pentacam HR, Oculus, Wetzlar, Germany): Keratoconus Index (KI), maximum keratometry (K<sub>max</sub>), astigmatism, and thinnest pachymetry (TP). From the ocular response analyzer (ORA, Reichert Ophthalmic Instruments, Depew, NY, USA), we extracted corneal hysteresis (CH), corneal resistance factor (CRF), and KC match index (KMI). The comparison of the tomographic and biomechanical values from cross-sectional and longitudinal analyses showed no significant differences between the HT and WHT groups. The severity of KC based on tomographical and biomechanical parameters does not seem to depend on the presence of hypothyroidism.", "tgt": "Die \u00c4tiologie des Keratokonus (KK) ist multifaktoriell, letztendlich aber bislang unklar. Einige fr\u00fchere klinische Beobachtungen legen nahe, dass die Hypothyreose eine Rolle bei der Entstehung und Auspr\u00e4gung des KK spielt. Das Ziel unserer Studie war es, die tomografischen und biomechanischen Parameter zwischen KK-Patienten mit und ohne Hypothyreose zu vergleichen. 28 Patienten mit KK und Hypothyreose (Gruppe HT) und 56 KK-Patienten ohne Schilddr\u00fcsenfunktionsst\u00f6rung (Gruppe WHT), die geschlechts- und altersm\u00e4\u00dfig \u00fcbereinstimmten, wurden analysiert. Das Durchschnittsalter betrug 40,3 Jahre (von 14 bis 57) in der Gruppe HT und 40,3 Jahre (von 14 bis 57) in der Gruppe WHT. Die ophthalmologischen Routineuntersuchungen bestanden aus Hornhauttomografie und biomechanischen Parametern. Wir analysierten die folgenden KK-Parameter aus der Pentacam (Pentacam HR, Oculus, Wetzlar, Deutschland): Keratokonusindex (KI), steilster Kr\u00fcmmungsradius (K<sub>max</sub>), Astigmatismus und minimale Hornhautdicke sowie aus dem Ocular Response Analyzer (ORA, Reichert Ophthalmic Instruments, Depew, NY, USA) die korneale Hysterese (CH), den kornealen Resistance-Faktor (CRF) sowie den Keratokonus-Match-Index (KMI). Die Ergebnisse der tomografischen und biomechanischen Werte zeigten sowohl in der Querschnitts- als auch in der L\u00e4ngsschnittanalyse keine signifikanten Unterschiede zwischen der HT- und WHT-Gruppe. Die Schwere des KK scheint, basierend auf biomechanischen und tomografischen Parametern, nicht von der Hypothyreose beeinflusst zu sein.", "term_pairs": [{"src": {"text": "keratoconus", "char_start": 16, "char_end": 27, "token_start": 3, "token_end": 4}, "tgt": {"text": "Keratokonus", "char_start": 18, "char_end": 29, "token_start": 3, "token_end": 4}}, {"src": {"text": "KC", "char_start": 29, "char_end": 31, "token_start": 5, "token_end": 6}, "tgt": {"text": "KK", "char_start": 31, "char_end": 33, "token_start": 5, "token_end": 6}}, {"src": {"text": "hypothyroidism", "char_start": 146, "char_end": 160, "token_start": 21, "token_end": 22}, "tgt": {"text": "Hypothyreose", "char_start": 150, "char_end": 162, "token_start": 24, "token_end": 25}}, {"src": {"text": "tomographic", "char_start": 266, "char_end": 277, "token_start": 43, "token_end": 44}, "tgt": {"text": "tomografischen", "char_start": 259, "char_end": 273, "token_start": 44, "token_end": 45}}, {"src": {"text": "biomechanical", "char_start": 282, "char_end": 295, "token_start": 45, "token_end": 46}, "tgt": {"text": "biomechanischen", "char_start": 278, "char_end": 293, "token_start": 46, "token_end": 47}}, {"src": {"text": "HT group", "char_start": 404, "char_end": 412, "token_start": 64, "token_end": 66}, "tgt": {"text": "Gruppe HT", "char_start": 406, "char_end": 415, "token_start": 66, "token_end": 68}}, {"src": {"text": "WHT group", "char_start": 469, "char_end": 478, "token_start": 77, "token_end": 79}, "tgt": {"text": "Gruppe WHT", "char_start": 472, "char_end": 482, "token_start": 77, "token_end": 79}}, {"src": {"text": "corneal tomography", "char_start": 674, "char_end": 692, "token_start": 126, "token_end": 128}, "tgt": {"text": "Hornhauttomografie", "char_start": 737, "char_end": 755, "token_start": 129, "token_end": 130}}, {"src": {"text": "Pentacam", "char_start": 773, "char_end": 781, "token_start": 140, "token_end": 141}, "tgt": {"text": "Pentacam", "char_start": 840, "char_end": 848, "token_start": 143, "token_end": 144}}, {"src": {"text": "Keratoconus Index", "char_start": 823, "char_end": 840, "token_start": 152, "token_end": 154}, "tgt": {"text": "Keratokonusindex", "char_start": 894, "char_end": 910, "token_start": 155, "token_end": 156}}, {"src": {"text": "KI", "char_start": 842, "char_end": 844, "token_start": 155, "token_end": 156}, "tgt": {"text": "KI", "char_start": 912, "char_end": 914, "token_start": 157, "token_end": 158}}, {"src": {"text": "maximum keratometry", "char_start": 847, "char_end": 866, "token_start": 158, "token_end": 160}, "tgt": {"text": "steilster Kr\u00fcmmungsradius", "char_start": 917, "char_end": 942, "token_start": 160, "token_end": 162}}, {"src": {"text": "K<sub>max</sub>", "char_start": 868, "char_end": 883, "token_start": 161, "token_end": 170}, "tgt": {"text": "K<sub>max</sub>", "char_start": 944, "char_end": 959, "token_start": 163, "token_end": 172}}, {"src": {"text": "astigmatism", "char_start": 886, "char_end": 897, "token_start": 172, "token_end": 173}, "tgt": {"text": "Astigmatismus", "char_start": 962, "char_end": 975, "token_start": 174, "token_end": 175}}, {"src": {"text": "thinnest pachymetry", "char_start": 903, "char_end": 922, "token_start": 175, "token_end": 177}, "tgt": {"text": "minimale Hornhautdicke", "char_start": 980, "char_end": 1002, "token_start": 176, "token_end": 178}}, {"src": {"text": "ocular response analyzer", "char_start": 938, "char_end": 962, "token_start": 183, "token_end": 186}, "tgt": {"text": "Ocular Response Analyzer", "char_start": 1017, "char_end": 1041, "token_start": 181, "token_end": 184}}, {"src": {"text": "ORA", "char_start": 964, "char_end": 967, "token_start": 187, "token_end": 188}, "tgt": {"text": "ORA", "char_start": 1043, "char_end": 1046, "token_start": 185, "token_end": 186}}, {"src": {"text": "corneal hysteresis", "char_start": 1032, "char_end": 1050, "token_start": 202, "token_end": 204}, "tgt": {"text": "korneale Hysterese", "char_start": 1101, "char_end": 1119, "token_start": 198, "token_end": 200}}, {"src": {"text": "CH", "char_start": 488, "char_end": 490, "token_start": 81, "token_end": 82}, "tgt": {"text": "CH", "char_start": 66, "char_end": 68, "token_start": 10, "token_end": 11}}, {"src": {"text": "corneal resistance factor", "char_start": 1057, "char_end": 1082, "token_start": 208, "token_end": 211}, "tgt": {"text": "kornealen Resistance-Faktor", "char_start": 1130, "char_end": 1157, "token_start": 205, "token_end": 209}}, {"src": {"text": "CRF", "char_start": 1084, "char_end": 1087, "token_start": 212, "token_end": 213}, "tgt": {"text": "CRF", "char_start": 1159, "char_end": 1162, "token_start": 210, "token_end": 211}}, {"src": {"text": "KC match index", "char_start": 1094, "char_end": 1108, "token_start": 216, "token_end": 219}, "tgt": {"text": "Keratokonus-Match-Index", "char_start": 1174, "char_end": 1197, "token_start": 214, "token_end": 219}}, {"src": {"text": "KMI", "char_start": 1110, "char_end": 1113, "token_start": 220, "token_end": 221}, "tgt": {"text": "KMI", "char_start": 1199, "char_end": 1202, "token_start": 220, "token_end": 221}}]}
{"idx": 10456, "pair_id": "31659766", "src": "This paper gives an overview of psychoanalytic process research, which brings to light the complexity of psychotherapy sessions. This complexity is so rich that many instruments intended to make the process measurable failed in the past because they initially used a strategy of complexity reduction. This method however did not help to further our understanding of the complexity involved. Three former presidents of the Society for Psychotherapy Research (Stiles, Hill, Elliot 2015) decided to solve the following equivalence paradox: many therapies work successfully though they all follow different theories, produce a heterogeneity of processes and often enough a misfit between what theories maintain to be a good process and their realization in the treatment room. As theories are often compared to maps, a driver would wonder which route to take. But therapists-as-drivers go undaunted - and nevertheless achieve their goals together with their patients. Norcross and Wampold (2018) found that good therapists invent new therapies with every new patient. They hypothesize that it is because of conversation. This is in accord with the 3 former presidents' proposal to return to detailed single case analyses including the micro-analytic power of conversation analysis of which a few insights are outlined in this article.", "tgt": "Dieser Artikel vermittelt einen \u00dcberblick \u00fcber die psychoanalytische Proze\u00dfforschung, was die Komplexit\u00e4t von Psychotherapiesitzungen beleuchtet. Diese Komplexit\u00e4t ist so hoch, da\u00df viele Instrumente, die den Proze\u00df me\u00dfbar machen sollen, in der Vergangenheit versagten, weil sie urspr\u00fcnglich eine Strategie der Komplexit\u00e4tsreduzierung verfolgten. Diese Methode trug jedoch nicht zu unserem besseren Verst\u00e4ndnis der vorfindlichen Komplexit\u00e4t bei. Drei ehemalige Pr\u00e4sidenten der Gesellschaft f\u00fcr Psychotherapieforschung (Stiles, Hill, Elliot 2015) beschlossen, das folgende \u00c4quivalenzparadoxon zu l\u00f6sen: viele Therapien funktionieren erfolgreich, obwohl sie alle unterschiedlichen Theorien folgen, eine Heterogenit\u00e4t der Prozesse erzeugen und oft genug ein Mi\u00dfverh\u00e4ltnis zwischen dem produzieren, was Theorien st\u00fctzt, um einen guten Proze\u00dfverlauf auszuweisen und ihre Verwirklichung im Behandlungsraum. Da Theorien oft mit Landkarten verglichen werden w\u00fcrde sich ein Fahrer fragen, welchen Weg er nehmen soll. Therapeuten als Fahrer bleiben jedoch unverzagt - und erreichen ihre Ziele dennoch gemeinsam mit ihren Patienten. Norcross und Wampold (2018) stellten fest, da\u00df gute Therapeuten mit jedem neuen Patienten neue Therapien erfinden. Sie nehmen an, da\u00df diese aus der Kommunikation heraus entstehen. Das steht im Einklang mit dem Vorschlag der drei ehemaligen Pr\u00e4sidenten, zu detaillierten Einzelfallanalysen zur\u00fcckzukehren, einschlie\u00dflich der mikroanalytischen F\u00e4higkeit der Gespr\u00e4chsanalyse, in die in diesem Artikel einige Einblicke vermittelt werden.", "term_pairs": [{"src": {"text": "psychoanalytic process research", "char_start": 32, "char_end": 63, "token_start": 6, "token_end": 9}, "tgt": {"text": "psychoanalytische Proze\u00dfforschung", "char_start": 51, "char_end": 84, "token_start": 7, "token_end": 9}}, {"src": {"text": "psychotherapy sessions", "char_start": 105, "char_end": 127, "token_start": 17, "token_end": 19}, "tgt": {"text": "Psychotherapiesitzungen", "char_start": 110, "char_end": 133, "token_start": 14, "token_end": 15}}, {"src": {"text": "complexity reduction", "char_start": 279, "char_end": 299, "token_start": 45, "token_end": 47}, "tgt": {"text": "Komplexit\u00e4tsreduzierung", "char_start": 310, "char_end": 333, "token_start": 45, "token_end": 46}}, {"src": {"text": "Society for Psychotherapy Research", "char_start": 422, "char_end": 456, "token_start": 68, "token_end": 72}, "tgt": {"text": "Gesellschaft f\u00fcr Psychotherapieforschung", "char_start": 476, "char_end": 516, "token_start": 66, "token_end": 69}}, {"src": {"text": "equivalence paradox", "char_start": 516, "char_end": 535, "token_start": 85, "token_end": 87}, "tgt": {"text": "\u00c4quivalenzparadoxon", "char_start": 571, "char_end": 590, "token_start": 81, "token_end": 82}}, {"src": {"text": "single case analyses", "char_start": 1196, "char_end": 1216, "token_start": 204, "token_end": 207}, "tgt": {"text": "Einzelfallanalysen", "char_start": 1391, "char_end": 1409, "token_start": 208, "token_end": 209}}, {"src": {"text": "conversation analysis", "char_start": 1255, "char_end": 1276, "token_start": 214, "token_end": 216}, "tgt": {"text": "Gespr\u00e4chsanalyse", "char_start": 1477, "char_end": 1493, "token_start": 216, "token_end": 217}}]}
{"idx": 10629, "pair_id": "34459939", "src": "Since fall of 2020, the first Digital Health Applications (DiGA) have been available as a service of the statutory health insurance. The National Association of Statutory Health Insurance Funds considers digital applications to have the potential to improve health care, e.g., for people with chronic diseases, and to consolidate the interconnectedness of the provided offers. DiGA can empower the insured persons to help shape their health care actively and to self-contribute to a\u00a0successful treatment. At the same time, statutory health insurance identifies a\u00a0number of basic and substantial critical issues regarding the legal requirements for the authorization of DiGA for reimbursement by insurance and the conceptional design of the fast-track process from the Federal Institute for Drugs and Medical Devices (BfArM).This article examines the DiGA, which have been listed in the BfArM directory up to this point, and takes stock after six months of the fast-track process being in place. According to this, the requirements and legal specifications for directory listings and reimbursement via the fast-track process are insufficient from the point of view of the statutory health insurance regarding proven medical effectiveness and economically efficient health care. At present, most of the authorized DiGA, which so far could not provide sufficient evidence about positive healthcare effects, are subsequently only listed provisionally. At the same time, the requirements for proof of medical benefit do not ensure the generation of valid results in studies or clinical trials with regards to routine everyday care. So far, there has been only a\u00a0moderate qualitative reliability of results. Furthermore, in the context of free pricing by manufacturers, significant price increases can be observed in some cases compared to prices before the BfArM listing.This paper gives recommendations towards further development of the legal basis for the fast-track process, particularly in the subject areas of benefit and patient safety as well as cost effectiveness.", "tgt": "Seit Herbst 2020 stehen die ersten digitalen Gesundheitsanwendungen (DiGA) fl\u00e4chendeckend als Leistung der gesetzlichen Krankenversicherung (GKV) zur Verf\u00fcgung. Der GKV-Spitzenverband sieht in ihnen Potenzial zur Verbesserung der medizinischen Versorgung beispielsweise von Menschen mit chronischen Erkrankungen und zur st\u00e4rkeren Vernetzung der Angebote. DiGA k\u00f6nnen die Versicherten dazu bef\u00e4higen, ihre Versorgung aktiv mitzugestalten und zu Behandlungserfolgen selbst beizutragen. Gleichzeitig besteht aus GKV-Sicht erhebliche und grunds\u00e4tzliche Kritik an den gesetzlichen Vorgaben f\u00fcr die Zulassung von DiGA zur GKV-Erstattung und an der Konzeption des Fast-Track-Bewertungsverfahrens durch das Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (BfArM).Der vorliegende Artikel betrachtet die bisher im BfArM-Verzeichnis zugelassenen DiGA und zieht eine erste bewertende Bilanz nach 6 Monaten Fast Track. Demnach sind die Anforderungen zur Bewertung f\u00fcr die Erstattung aus Sicht der GKV im Sinne einer nachweislich nutzenstiftenden und wirtschaftlichen Versorgung ungen\u00fcgend. So sind die meisten der bisher zugelassenen DiGA solche, die einen Nutzen noch nicht hinreichend belegen konnten und deshalb nur vorbehaltlich zugelassen sind. Gleichzeitig gew\u00e4hrleisten die Anforderungen an den Nachweis des medizinischen Nutzens nicht, dass Studienergebnisse mit verl\u00e4sslichen Nutzenaussagen in Bezug auf den Versorgungsalltag entstehen. Bisher ist nur eine m\u00e4\u00dfige qualitative Ergebnissicherheit gegeben. Des Weiteren sind im Rahmen der freien Preisbildung durch die Hersteller zum Teil deutliche Preissteigerungen im Vergleich zu Preisen vor der BfArM-Listung zu beobachten.Der Beitrag gibt Empfehlungen zur Weiterentwicklung der Gesetzesgrundlage zur Fast-Track-Bewertung, insbesondere in den Themenbereichen Nutzen- und Patientensicherheit sowie Wirtschaftlichkeit.", "term_pairs": [{"src": {"text": "DiGA", "char_start": 59, "char_end": 63, "token_start": 11, "token_end": 12}, "tgt": {"text": "DiGA", "char_start": 69, "char_end": 73, "token_start": 9, "token_end": 10}}, {"src": {"text": "statutory health insurance", "char_start": 105, "char_end": 131, "token_start": 21, "token_end": 24}, "tgt": {"text": "gesetzlichen Krankenversicherung", "char_start": 107, "char_end": 139, "token_start": 15, "token_end": 17}}, {"src": {"text": "National Association of Statutory Health Insurance Funds", "char_start": 137, "char_end": 193, "token_start": 26, "token_end": 33}, "tgt": {"text": "GKV-Spitzenverband", "char_start": 165, "char_end": 183, "token_start": 24, "token_end": 27}}, {"src": {"text": "chronic diseases", "char_start": 293, "char_end": 309, "token_start": 53, "token_end": 55}, "tgt": {"text": "chronischen Erkrankungen", "char_start": 287, "char_end": 311, "token_start": 40, "token_end": 42}}, {"src": {"text": "Federal Institute for Drugs and Medical Devices", "char_start": 768, "char_end": 815, "token_start": 131, "token_end": 138}, "tgt": {"text": "Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte", "char_start": 699, "char_end": 750, "token_start": 101, "token_end": 106}}, {"src": {"text": "BfArM", "char_start": 817, "char_end": 822, "token_start": 139, "token_end": 140}, "tgt": {"text": "BfArM", "char_start": 752, "char_end": 757, "token_start": 107, "token_end": 108}}, {"src": {"text": "fast-track process", "char_start": 740, "char_end": 758, "token_start": 125, "token_end": 129}, "tgt": {"text": "Fast-Track-Bewertungsverfahrens", "char_start": 657, "char_end": 688, "token_start": 94, "token_end": 99}}, {"src": {"text": "clinical trials", "char_start": 1572, "char_end": 1587, "token_start": 270, "token_end": 272}, "tgt": {"text": "Studienergebnisse", "char_start": 1340, "char_end": 1357, "token_start": 195, "token_end": 196}}, {"src": {"text": "patient safety", "char_start": 2023, "char_end": 2037, "token_start": 347, "token_end": 349}, "tgt": {"text": "Patientensicherheit", "char_start": 1822, "char_end": 1841, "token_start": 264, "token_end": 265}}]}
{"idx": 10773, "pair_id": "28628931", "src": "The German Institute for Quality and Efficiency in Health Care (IQWiG) recommends the concept of the efficiency frontier to assess health care interventions. The efficiency frontier supports regulatory decisions on reimbursement prices for the appropriate allocation of health care resources. Until today this cost-benefit assessment framework has only been applied on the basis of individual patient-relevant endpoints. This contradicts the reality of a multi-dimensional patient benefit. The objective of this study was to illustrate the operationalization of multi-dimensional benefit considering the uncertainty in clinical effects and preference data in order to calculate the efficiency of different treatment options for hepatitis C (HCV). This case study shows how methodological challenges could be overcome in order to use the efficiency frontier for economic analysis and health care decision-making. The operationalization of patient benefit was carried out on several patient-relevant endpoints. Preference data from a discrete choice experiment (DCE) study and clinical data based on clinical trials, which reflected the patient and the clinical perspective, respectively, were used for the aggregation of an overall benefit score. A probabilistic efficiency frontier was constructed in a Monte Carlo simulation with 10000 random draws. Patient-relevant endpoints were modeled with a beta distribution and preference data with a normal distribution. The assessment of overall benefit and costs provided information about the adequacy of the treatment prices. The parameter uncertainty was illustrated by the price-acceptability-curve and the net monetary benefit. Based on the clinical and preference data in Germany, the interferon-free treatment options proved to be efficient for the current price level. The interferon-free therapies of the latest generation achieved a positive net cost-benefit. Within the decision model, these therapies showed a maximum overall benefit. Due to their high additional benefit and approved prices, the therapies lie above of the extrapolated efficiency frontier, which suggests that these options have efficient reimbursement prices. Considering uncertainty, even a higher price would have resulted in a positive cost-benefit ratio. IQWiG's efficiency frontier was used to assess the value of different treatment options in HCV. This study demonstrates that the probabilistic efficiency frontier, price-acceptability-curve and the net monetary benefit can contribute essential information to reimbursement decisions and price negotiations.", "tgt": "Das IQWiG entwickelte die Methodik der Effizienzgrenze, um den gesetzlichen Vorgaben \u00fcber die Bewertung der Wirtschaftlichkeit von Gesundheitstechnologien nachzukommen. Bislang wurden Effizienzgrenzen nur auf Basis einzelner Endpunkte berechnet. Dies widerspricht der Realit\u00e4t eines multidimensionalen Patientennutzens. ZIEL: Zielsetzung der Studie war die Operationalisierung eines multidimensionalen Nutzens und die Berechnung einer Effizienzgrenze unter Ber\u00fccksichtigung der Unsicherheit bei klinischen Effekt- und Pr\u00e4ferenzdaten. Die Fallstudie sollte dokumentieren, wie die methodischen Herausforderungen \u00fcberwunden werden k\u00f6nnen, um die Effizienzgrenze zur Wirtschaftlichkeitsanalyse und Entscheidungsfindung im Bereich der Hepatitis C sinnvoll zu nutzen. Die Operationalisierung des Patientennutzes erfolgte \u00fcber mehrere patientenrelevante Zielkriterien. F\u00fcr die Aggregation des Gesamtnutzens wurden Pr\u00e4ferenzdaten herangezogen. In einer Monte-Carlo-Simulation mit 10000 Zufallsziehungen wurden patientenrelevante Endpunkte mit einer Beta-Verteilung und Pr\u00e4ferenzdaten mit einer Normalverteilung ber\u00fccksichtigt. Der Gesamtnutzen in Relation zu den Kosten informierte \u00fcber die Angemessenheit der Preise. Die Parameterunsicherheit wurde mithilfe der Preis-Akzeptanz-Kurve und des Netto-Kosten-Vorteils dargestellt. Seit Beginn der antiviralen Therapien zur Behandlung von Hepatitis C wurden gro\u00dfe Nutzen- bzw. Effizienzspr\u00fcnge vollzogen. Auf Basis der hier ber\u00fccksichtigten Effekt- und Pr\u00e4ferenzdaten erwiesen sich die interferonfreien Behandlungsoptionen zum derzeitigen Preisniveau als effizient. Die Therapien der neuesten Generation erzielten einen positiven Netto-Kosten-Vorteil. Die vom IQWiG beschriebene Methodik zur Berechnung der Effizienzgrenze und der Unsicherheit konnte f\u00fcr den Bereich der HCV Therapie praktisch umgesetzt werden. Die Effizienzgrenze, die Preis-Akzeptanz-Kurve und der Netto-Kosten-Vorteil k\u00f6nnen im Rahmen der Erstattungsentscheidungen bzw. der Preisverhandlungen wesentliche Informationen beisteuern.", "term_pairs": [{"src": {"text": "efficiency frontier", "char_start": 101, "char_end": 120, "token_start": 18, "token_end": 20}, "tgt": {"text": "Effizienzgrenze", "char_start": 39, "char_end": 54, "token_start": 6, "token_end": 7}}, {"src": {"text": "patient-relevant endpoints", "char_start": 393, "char_end": 419, "token_start": 61, "token_end": 65}, "tgt": {"text": "patientenrelevante Endpunkte", "char_start": 1002, "char_end": 1030, "token_start": 125, "token_end": 127}}, {"src": {"text": "multi-dimensional patient benefit", "char_start": 455, "char_end": 488, "token_start": 72, "token_end": 77}, "tgt": {"text": "multidimensionalen Patientennutzens", "char_start": 283, "char_end": 318, "token_start": 36, "token_end": 38}}, {"src": {"text": "Monte Carlo simulation", "char_start": 1303, "char_end": 1325, "token_start": 210, "token_end": 213}, "tgt": {"text": "Monte-Carlo-Simulation", "char_start": 945, "char_end": 967, "token_start": 116, "token_end": 121}}, {"src": {"text": "beta distribution", "char_start": 1398, "char_end": 1415, "token_start": 226, "token_end": 228}, "tgt": {"text": "Beta-Verteilung", "char_start": 1041, "char_end": 1056, "token_start": 129, "token_end": 132}}, {"src": {"text": "normal distribution", "char_start": 1443, "char_end": 1462, "token_start": 233, "token_end": 235}, "tgt": {"text": "Normalverteilung", "char_start": 1086, "char_end": 1102, "token_start": 136, "token_end": 137}}, {"src": {"text": "price-acceptability-curve", "char_start": 1622, "char_end": 1647, "token_start": 260, "token_end": 265}, "tgt": {"text": "Preis-Akzeptanz-Kurve", "char_start": 1255, "char_end": 1276, "token_start": 158, "token_end": 163}}, {"src": {"text": "net monetary benefit", "char_start": 1656, "char_end": 1676, "token_start": 267, "token_end": 270}, "tgt": {"text": "Netto-Kosten-Vorteil", "char_start": 1285, "char_end": 1305, "token_start": 165, "token_end": 170}}, {"src": {"text": "hepatitis C", "char_start": 728, "char_end": 739, "token_start": 113, "token_end": 115}, "tgt": {"text": "Hepatitis C", "char_start": 730, "char_end": 741, "token_start": 89, "token_end": 91}}, {"src": {"text": "HCV", "char_start": 741, "char_end": 744, "token_start": 116, "token_end": 117}, "tgt": {"text": "HCV", "char_start": 1809, "char_end": 1812, "token_start": 242, "token_end": 243}}, {"src": {"text": "interferon-free treatment options", "char_start": 1736, "char_end": 1769, "token_start": 282, "token_end": 287}, "tgt": {"text": "interferonfreien Behandlungsoptionen", "char_start": 1524, "char_end": 1560, "token_start": 203, "token_end": 205}}, {"src": {"text": "overall benefit", "char_start": 1223, "char_end": 1238, "token_start": 198, "token_end": 200}, "tgt": {"text": "Gesamtnutzens", "char_start": 886, "char_end": 899, "token_start": 109, "token_end": 110}}, {"src": {"text": "preference data", "char_start": 640, "char_end": 655, "token_start": 100, "token_end": 102}, "tgt": {"text": "Pr\u00e4ferenzdaten", "char_start": 518, "char_end": 532, "token_start": 64, "token_end": 65}}, {"src": {"text": "clinical data", "char_start": 1075, "char_end": 1088, "token_start": 173, "token_end": 175}, "tgt": {"text": "Effekt- und Pr\u00e4ferenzdaten", "char_start": 1479, "char_end": 1505, "token_start": 196, "token_end": 200}}]}
{"idx": 10816, "pair_id": "34609609", "src": "Good visibility over the entire fundus is mandatory for optimal diagnostics and treatment of retinal pathologies. If an IOL implantation is planned in the context of retinal pathologies, a\u00a0model with an enlarged optic diameter offers various advantages. The two most important benefits are an enhanced view at the fundus periphery and an improvement of the IOL positional stability especially with combined vitrectomy and the use of gas or silicone oil tamponades. The purpose of this study was to evaluate the performance and positional stability of a\u00a0new 7\u202fmm IOL. This prospective study included 55\u00a0eyes of 39\u00a0patients who were scheduled for standardized cataract surgery and received a\u00a0monofocal 7.0\u202fmm optic IOL (Aspira-aXA, HumanOptics). An incision size of 2.0\u202fmm was chosen. Follow-up visits were performed 1 week (1W), 1 month (1M), 4 months (4M) and 1.5\u00a0years (1.5J) postoperatively. Measurements included subjective refraction, uncorrected and corrected distance visual acuity (UDVA and CDVA) as well as IOL stability regarding decentration, tilt and rotation (IOLs had a\u00a0pseudomarking on the periphery of the optics). Except for the postoperative occurrence of an Irvine-Gass syndrome in one eye, no intraoperative or postoperative complications were reported. The CDVA did not change significantly (p\u202f=\u20090.40) within the postoperative course from 1\u00a0month (median 0.00 logMAR; -0.10 to 0.22 logMAR) to 1.5\u00a0years (median 0.00 logMAR; -0.10 to 0.10 logMAR). The IOL was found to be stable over the postoperative course as decentration was <\u202f0.02\u202fmm and tilt <\u202f5.5\u00b0. There was a\u00a0median rotation of 1.8\u00b0 (0.0-13.4\u00b0) within the first postoperative week, which was not significantly different from the rotation between surgery and 1.5\u00a0years (median 1.4\u00b0; 0.0-10.9\u00b0). With comparable functional performance and the same small incision size as with usual 6.0\u202fmm IOLs, the Aspira-aXA offers the advantages of a\u00a07.0\u202fmm optic in the diagnostics and treatment of peripheral retinal pathologies. In addition, the lens shows good position stability in the capsular bag.", "tgt": "HINTERGRUND: F\u00fcr eine bestm\u00f6gliche Diagnostik und Behandlung von Netzhautpathologien sind gute Sichtverh\u00e4ltnisse auf den Augenhintergrund ein wesentlicher Faktor. Ist bei einem Patienten mit einer kontroll- bzw. behandlungsw\u00fcrdigen Netzhautver\u00e4nderung die Implantation einer intraokularen Kunstlinse (IOL) geplant, kann ein Modell mit vergr\u00f6\u00dfertem Optikdurchmesser mehrere Vorteile bieten. Die beiden wesentlichen Vorz\u00fcge sind ein verbesserter Einblick in die Fundusperipherie sowie eine optimierte Positionsstabilit\u00e4t der IOL v.\u202fa. bei kombinierten Vitrektomien mit Verwendung von Gas- oder Silikon\u00f6ltamponaden. Ziel dieser Arbeit war die Evaluation der funktionellen Performance sowie der Positionsstabilit\u00e4t einer neuen 7\u2011mm-Intraokularlinse. In einer prospektiven Studie wurden 55\u00a0Augen von 39\u00a0Patienten im Rahmen geplanter Kataraktoperationen mit einer monofokalen IOL mit 7,0\u202fmm Optikdurchmesser (Aspira-aXA, HumanOptics, Erlangen, Deutschland) versorgt. Die Implantation erfolgte \u00fcber eine 2\u2011mm-Inzision. Eine Woche, 1\u00a0Monat, 4\u00a0Monate und 1,5\u00a0Jahre postoperativ erfolgten Kontrollvisiten mit Bestimmung der Refraktion, des unkorrigierten und korrigierten Visus (UDVA und CDVA) sowie einer Beurteilung der Linsenstabilit\u00e4t hinsichtlich Dezentrierung, Verkippung und Rotation (mittels Markierung einer Pseudoachse am Optikrand). Bis auf ein postoperatives Irvine-Gass-Syndrom an einem Auge wurden weder intra- noch postoperative Komplikationen beobachtet. Die postoperativ erreichte CDVA blieb im Verlauf stabil (nach 1\u00a0Monat: Median 0,00 logMAR; \u22120,10 bis 0,22; nach 1,5\u00a0Jahren: Median 0,00 logMAR; \u22120,10 bis 0,10; p\u202f=\u20090,40). Die Linsenposition war mit einer mittleren Dezentrierung <\u202f0,2\u202fmm und einem mittleren Tilt <\u202f5,5\u00b0 ebenfalls stabil im Nachkontrollzeitraum. Nach 1\u00a0Woche lag die Rotation im Median bei 1,8\u00b0 (0,0 bis 13,4) und zeigte keine signifikanten \u00c4nderungen im Vergleich zwischen Implantationszeitpunkt und nach 1,5\u00a0Jahren (Median 1,4\u00b0; 0,0 bis 10,9\u00b0). Bei vergleichbarer funktioneller Leistung sowie gleicher Inzisionsgr\u00f6\u00dfe gegen\u00fcber sonst \u00fcblichen 6,0-mm-IOL bietet die Aspira-aXA die Vorteile einer 7\u2011mm-Optik v.\u202fa. bei der Diagnostik und Therapie peripherer retinaler Pathologien. Zudem zeigt die Linse eine hohe Stabilit\u00e4t hinsichtlich ihrer Position im Kapselsack.", "term_pairs": []}
{"idx": 10855, "pair_id": "34623482", "src": "An individual's everyday practice in very old age is based on stable dispositions and on the living conditions associated with the person's stage of life. Age-associated changes in living conditions can cause discrepancies between the person's dispositions and actual everyday practice that have consequences for the quality of life. The aim of this paper is to look more closely at such discrepancies and their associations with living conditions in very old age (long-term care needs, multimorbidity, care tasks) as well as with the feeling of autonomy as an aspect of quality of life. A\u00a0cross-sectional analysis was conducted using data from the first wave of the NRW80+-study on the quality of life of people aged\u00a080 years and over. Data on the subjective importance of five areas of everyday practice and on the frequency of translating these dispositions into practice were used. The analysis focuses on the occurrence of large discrepancies that arise if the subjective importance of an everyday practice deviates considerably from the frequency of performing it. Among the very old population surveyed, solitary activities are considered the most important, and they are carried out most often. Multimorbidity, long-term care needs, and private care responsibilities are significantly associated with the experience of large discrepancies. Finally, very old adults with large discrepancies report feelings of reduced autonomy. These initial results show that age-associated changes in living conditions can be accompanied by difficulties for very old adults to put their dispositions into practice. Attention should be paid to such discrepancies to avoid negative consequences for quality of life.", "tgt": "HINTERGRUND: Die Alltagspraxis hochaltriger Menschen basiert auf stabilen Dispositionen, aber auch auf den aktuellen, mit der Lebenssituation verbundenen Lebensbedingungen. Mit dem hohen Alter assoziierte Ver\u00e4nderungen der Lebensbedingungen k\u00f6nnen zu Diskrepanzen zwischen den Dispositionen einer Person und ihrer tats\u00e4chlichen Alltagspraxis f\u00fchren und sich auf die Lebensqualit\u00e4t auswirken. ZIEL: Der Beitrag untersucht diese Diskrepanzen und deren Zusammenh\u00e4nge mit Lebensbedingungen im hohen Alter (Pflegebed\u00fcrftigkeit, Multimorbidit\u00e4t, private Pfleget\u00e4tigkeit) sowie mit Autonomieempfinden als ein Aspekt von Lebensqualit\u00e4t. Es wurde eine Querschnittsanalyse mit Daten der ersten Welle der NRW80+-Studie zur Lebensqualit\u00e4t von Menschen ab 80\u00a0Jahren durchgef\u00fchrt. Es werden Daten zur subjektiven Bedeutung von f\u00fcnf Bereichen allt\u00e4glicher Praxis sowie Angaben zur H\u00e4ufigkeit der Umsetzung dieser Dispositionen in die Praxis genutzt. Die Analyse fokussiert das Auftreten starker Diskrepanzen, die entstehen, wenn die subjektive Bedeutung der Alltagspraxis von der H\u00e4ufigkeit ihrer Aus\u00fcbung deutlich abweicht. In der befragten hochaltrigen Bev\u00f6lkerung sind solit\u00e4re T\u00e4tigkeiten subjektiv am wichtigsten; sie werden auch am h\u00e4ufigsten ausgef\u00fchrt. Multimorbidit\u00e4t, Pflegebedarf und private Pfleget\u00e4tigkeiten stehen in einem signifikanten Zusammenhang mit dem Auftreten starker Diskrepanzen. Schlie\u00dflich berichten hochaltrige Menschen mit starken Diskrepanzen ein geringeres Autonomieempfinden. Diese ersten Ergebnisse zeigen, dass altersassoziierte Ver\u00e4nderungen der Lebensbedingungen mit Schwierigkeiten f\u00fcr sehr alte Menschen einhergehen k\u00f6nnen, ihre Dispositionen in Alltagspraxis umzusetzen. Auf solche Diskrepanzen sollte geachtet werden, um negative Auswirkungen auf die Lebensqualit\u00e4t zu vermeiden.", "term_pairs": [{"src": {"text": "multimorbidity", "char_start": 487, "char_end": 501, "token_start": 89, "token_end": 90}, "tgt": {"text": "Multimorbidit\u00e4t", "char_start": 523, "char_end": 538, "token_start": 69, "token_end": 70}}, {"src": {"text": "long-term care needs", "char_start": 465, "char_end": 485, "token_start": 83, "token_end": 88}, "tgt": {"text": "Pflegebedarf", "char_start": 1263, "char_end": 1275, "token_start": 176, "token_end": 177}}, {"src": {"text": "care tasks", "char_start": 503, "char_end": 513, "token_start": 91, "token_end": 93}, "tgt": {"text": "private Pfleget\u00e4tigkeit", "char_start": 540, "char_end": 563, "token_start": 71, "token_end": 73}}, {"src": {"text": "autonomy", "char_start": 546, "char_end": 554, "token_start": 101, "token_end": 102}, "tgt": {"text": "Autonomieempfinden", "char_start": 575, "char_end": 593, "token_start": 76, "token_end": 77}}, {"src": {"text": "quality of life", "char_start": 317, "char_end": 332, "token_start": 55, "token_end": 58}, "tgt": {"text": "Lebensqualit\u00e4t", "char_start": 366, "char_end": 380, "token_start": 48, "token_end": 49}}, {"src": {"text": "cross-sectional analysis", "char_start": 590, "char_end": 614, "token_start": 111, "token_end": 115}, "tgt": {"text": "Querschnittsanalyse", "char_start": 643, "char_end": 662, "token_start": 86, "token_end": 87}}, {"src": {"text": "NRW80+-study", "char_start": 667, "char_end": 679, "token_start": 125, "token_end": 129}, "tgt": {"text": "NRW80+-Studie", "char_start": 694, "char_end": 707, "token_start": 93, "token_end": 97}}, {"src": {"text": "discrepancies", "char_start": 209, "char_end": 222, "token_start": 39, "token_end": 40}, "tgt": {"text": "Diskrepanzen", "char_start": 251, "char_end": 263, "token_start": 33, "token_end": 34}}, {"src": {"text": "everyday practice", "char_start": 16, "char_end": 33, "token_start": 4, "token_end": 6}, "tgt": {"text": "Alltagspraxis", "char_start": 17, "char_end": 30, "token_start": 3, "token_end": 4}}, {"src": {"text": "living conditions", "char_start": 93, "char_end": 110, "token_start": 18, "token_end": 20}, "tgt": {"text": "Lebensbedingungen", "char_start": 154, "char_end": 171, "token_start": 21, "token_end": 22}}, {"src": {"text": "very old age", "char_start": 37, "char_end": 49, "token_start": 7, "token_end": 10}, "tgt": {"text": "hohen Alter", "char_start": 181, "char_end": 192, "token_start": 25, "token_end": 27}}, {"src": {"text": "dispositions", "char_start": 69, "char_end": 81, "token_start": 14, "token_end": 15}, "tgt": {"text": "Dispositionen", "char_start": 74, "char_end": 87, "token_start": 9, "token_end": 10}}]}
{"idx": 10865, "pair_id": "34633503", "src": "The Apple and Google app stores offer a\u00a0wide range of health apps. It is still a\u00a0challenge to find valuable and qualified apps. Can German language apps be identified using the 'semiautomated retrospective app store analysis' (SARASA) method for the field of rheumatology? The SARASA is a\u00a0semiautomated method to select and characterize apps listed in the app store. After the first application in February 2018 SARASA was applied again to the Apple app store in February 2020. In February 2018 it was possible to acquire metadata for 103,046 apps and in February 2020 data for 94,735 apps that were listed in the category 'health and fitness' or 'medicine' in Apple's app store frontend for Germany. After applying the search terms 59\u00a0apps with a\u00a0German language app description were identified for the field of rheumatology in 2018 and 53\u00a0apps in 2020. For these, more detailed manual reviews seem worthwhile. In 2018, the apps found were more likely to address patients than physicians and this was more balanced in 2020. In addition, it became apparent that for certain diseases there was no app developer activity. The percentage breakdown of matches by search term revealed substantial fluctuations in the app market when comparing 2018 to 2020. The SARASA method provides a\u00a0useful tool to identify apps from app stores that meet predefined, formal criteria. Subsequent manual checks of the quality of the contents are still necessary. Further development of the SARASA method and consensus and standardization of quality criteria are worthwhile. Quality criteria should be considered for offers of mobile health apps in app stores.", "tgt": "HINTERGRUND: Die App Stores von Apple und Google bieten eine Vielzahl von Gesundheits-Apps an. Das Auffinden qualitativ hochwertiger Apps ist immer noch eine Herausforderung. Lassen sich unter Anwendung der SARASA(\u201esemiautomated retrospective App Store analysis\u201c)-Methode f\u00fcr das Fachgebiet Rheumatologie deutschsprachige Apps identifizieren? SARASA ist eine Methode zur teilautomatisierten Auswahl und Charakterisierung von App Store-gelisteten Apps nach formalen Kriterien. Nach der ersten Anwendung in 02/2018 wurde SARASA 02/2020 erneut auf den Apple App Store angewendet. In 02/2018 konnten f\u00fcr Apps in den Store-Kategorien \u201eMedizin\u201c oder \u201eGesundheit und Fitness\u201c Metadaten zu 103.046\u00a0Apps und bei einer erneuten Erhebung in 02/2020 Daten zu 94.735\u00a0Apps \u00fcber das deutsche Frontend des Apple App Stores ausgelesen werden. Im Jahr 2018 wurden nach Anwendung der Suchbegriffe 59\u00a0Apps mit einer deutschsprachigen Beschreibung f\u00fcr das Fachgebiet Rheumatologie identifiziert, 2020 waren dies 53\u00a0Apps, die jeweils manuell weiter \u00fcberpr\u00fcft wurden; 2018 waren noch mehr der gefundenen Apps f\u00fcr Patienten als f\u00fcr \u00c4rzte vorgesehen, dies war 2020 ausgeglichener. Zudem zeigte sich, dass bei bestimmten Krankheitsbildern von den App-Entwicklern keine Bearbeitungen erfolgten. Die prozentuale Verteilung von Treffern nach Suchbegriffen zeigte im Vergleich von 2018 zu 2020 gro\u00dfe Schwankungen. Die SARASA-Methode stellt ein hilfreiches Werkzeug dar, um Gesundheits-Apps teilautomatisiert zu identifizieren, die vordefinierten, formalen Kriterien entsprechen. Die inhaltliche Qualit\u00e4t muss anschlie\u00dfend manuell \u00fcberpr\u00fcft werden. Weiterentwicklungen der SARASA-Methode und die weitere Konsentierung und Standardisierung von Qualit\u00e4tskriterien sind sinnvoll. Qualit\u00e4tskriterien sollten beim Angebot von Gesundheits-Apps in den App-Stores ber\u00fccksichtigt werden.", "term_pairs": [{"src": {"text": "SARASA", "char_start": 227, "char_end": 233, "token_start": 42, "token_end": 43}, "tgt": {"text": "SARASA", "char_start": 207, "char_end": 213, "token_start": 34, "token_end": 35}}, {"src": {"text": "semiautomated retrospective app store analysis", "char_start": 178, "char_end": 224, "token_start": 35, "token_end": 40}, "tgt": {"text": "semiautomated retrospective App Store analysis", "char_start": 215, "char_end": 261, "token_start": 37, "token_end": 42}}, {"src": {"text": "rheumatology", "char_start": 259, "char_end": 271, "token_start": 49, "token_end": 50}, "tgt": {"text": "Rheumatologie", "char_start": 291, "char_end": 304, "token_start": 49, "token_end": 50}}, {"src": {"text": "Apple app store", "char_start": 444, "char_end": 459, "token_start": 81, "token_end": 84}, "tgt": {"text": "Apple App Store", "char_start": 549, "char_end": 564, "token_start": 89, "token_end": 92}}, {"src": {"text": "health and fitness", "char_start": 624, "char_end": 642, "token_start": 119, "token_end": 122}, "tgt": {"text": "Gesundheit und Fitness", "char_start": 645, "char_end": 667, "token_start": 111, "token_end": 114}}, {"src": {"text": "medicine", "char_start": 648, "char_end": 656, "token_start": 125, "token_end": 126}, "tgt": {"text": "Medizin", "char_start": 630, "char_end": 637, "token_start": 107, "token_end": 108}}, {"src": {"text": "German language", "char_start": 132, "char_end": 147, "token_start": 27, "token_end": 29}, "tgt": {"text": "deutschsprachige", "char_start": 305, "char_end": 321, "token_start": 50, "token_end": 51}}, {"src": {"text": "metadata", "char_start": 522, "char_end": 530, "token_start": 96, "token_end": 97}, "tgt": {"text": "Metadaten", "char_start": 669, "char_end": 678, "token_start": 115, "token_end": 116}}, {"src": {"text": "apps", "char_start": 61, "char_end": 65, "token_start": 12, "token_end": 13}, "tgt": {"text": "Apps", "char_start": 86, "char_end": 90, "token_start": 15, "token_end": 16}}]}
{"idx": 10985, "pair_id": "30900235", "src": "Amputations reduce irreversibly the quality of life. Health care always aims at avoiding amputations, and the quality of such care provided nationwide should be the same. This study aims to display rates of amputations at the county level and to uncover differences in health care. Using German nationwide hospital discharge data, amputations between 2011 and 2015 were identified. Regional variation is displayed using raw and risk-standardized rates per 100,000 persons. Furthermore, the Systematic Component of Variation (SCV) was computed and Funnel Plots display the Standardized Morbidity Ratio (SMR). The median amputation rate during the observation period was 67 cases per 100,000 persons with a 6-fold variation between counties. Variation between counties remained independent of demographic differences. Higher rates got visible especially within counties in the East and Southeast. The highest systematic variation was seen in amputation heights toe/foot ray (SCV 11.8) and foot complete and mid-/forefoot (SCV 11.7). In Germany, there are significant regional variations of amputation rates at the county level. The systematic variation is strongest within peripheral amputation heights. Especially in the East and Southeast of Germany, clusters of high amputation rates give insights in the potential regional need for improvement.", "tgt": "Amputationen vermindern irreversibel die Lebensqualit\u00e4t. Das Ziel vorangehender Versorgung ist stets eine Amputation zu verhindern. Diese Versorgung sollte bundesweit mit derselben Ergebnisqualit\u00e4t gew\u00e4hrleistet sein. Ziel dieser Arbeit ist es, regionale Versorgungsunterschiede sichtbar zu machen, indem Amputationsfallzahlen nach Amputationsh\u00f6hen auf Kreisebene analysiert werden. In den deutschlandweiten Krankenhausabrechnungsdaten (DRG-Statistik) wurden alle Behandlungsf\u00e4lle mit Amputation an der unteren Extremit\u00e4t zwischen 2011 und 2015 identifiziert. Auf Kreisebene wurden rohe Raten sowie alters- und geschlechtsstandardisierte Raten pro 100\u2009000 Einwohner dargestellt. Daneben wurde die systematische Variationskomponente (SCV) zwischen den Kreisen betrachtet und das standardisierte Morbidit\u00e4tsverh\u00e4ltnis (SMR) in Funnel Plots dargestellt. Im Beobachtungszeitraum belief sich die mediane j\u00e4hrliche Amputationsrate auf 67 F\u00e4lle pro 100\u2009000 Einwohner. Auf Kreisebene variierte die rohe Rate um das 6-fache. Unabh\u00e4ngig von demografischen Unterschieden zeigten sich Variationen zwischen den Kreisen. Erh\u00f6hte Amputationsraten wurden \u00fcberwiegend im Osten und S\u00fcdosten beobachtet. Die Variationen waren bei den Amputationsh\u00f6hen Zeh/Zehenstrahl (SCV 11,8) und Fu\u00df komplett & Mittel-/Vorfu\u00df (SCV 11,7) am st\u00e4rksten ausgepr\u00e4gt. Es bestehen deutliche regionale Unterschiede in den Amputationsraten. Bei peripheren Amputationsh\u00f6hen ist die systematische Variation am st\u00e4rksten. Insbesondere im Osten und S\u00fcdosten sind regionale Cluster erkennbar, die Anhaltspunkte f\u00fcr einen m\u00f6glichen regionalen Verbesserungsbedarf in der Versorgung liefern.", "term_pairs": [{"src": {"text": "amputations", "char_start": 0, "char_end": 11, "token_start": 0, "token_end": 1}, "tgt": {"text": "Amputationen", "char_start": 0, "char_end": 12, "token_start": 0, "token_end": 1}}, {"src": {"text": "quality of life", "char_start": 36, "char_end": 51, "token_start": 4, "token_end": 7}, "tgt": {"text": "Lebensqualit\u00e4t", "char_start": 41, "char_end": 55, "token_start": 4, "token_end": 5}}, {"src": {"text": "Systematic Component of Variation", "char_start": 490, "char_end": 523, "token_start": 84, "token_end": 88}, "tgt": {"text": "systematische Variationskomponente", "char_start": 697, "char_end": 731, "token_start": 92, "token_end": 94}}, {"src": {"text": "SCV", "char_start": 525, "char_end": 528, "token_start": 89, "token_end": 90}, "tgt": {"text": "SCV", "char_start": 733, "char_end": 736, "token_start": 95, "token_end": 96}}, {"src": {"text": "Funnel Plots", "char_start": 547, "char_end": 559, "token_start": 94, "token_end": 96}, "tgt": {"text": "Funnel Plots", "char_start": 825, "char_end": 837, "token_start": 109, "token_end": 111}}, {"src": {"text": "Standardized Morbidity Ratio", "char_start": 572, "char_end": 600, "token_start": 98, "token_end": 101}, "tgt": {"text": "standardisierte Morbidit\u00e4tsverh\u00e4ltnis", "char_start": 778, "char_end": 815, "token_start": 103, "token_end": 105}}, {"src": {"text": "SMR", "char_start": 602, "char_end": 605, "token_start": 102, "token_end": 103}, "tgt": {"text": "SMR", "char_start": 817, "char_end": 820, "token_start": 106, "token_end": 107}}, {"src": {"text": "amputation rate", "char_start": 619, "char_end": 634, "token_start": 107, "token_end": 109}, "tgt": {"text": "Amputationsrate", "char_start": 909, "char_end": 924, "token_start": 120, "token_end": 121}}, {"src": {"text": "county", "char_start": 226, "char_end": 232, "token_start": 39, "token_end": 40}, "tgt": {"text": "Kreisebene", "char_start": 353, "char_end": 363, "token_start": 44, "token_end": 45}}, {"src": {"text": "toe/foot ray", "char_start": 959, "char_end": 971, "token_start": 161, "token_end": 165}, "tgt": {"text": "Zeh/Zehenstrahl", "char_start": 1232, "char_end": 1247, "token_start": 168, "token_end": 171}}, {"src": {"text": "foot complete and mid-/forefoot", "char_start": 987, "char_end": 1018, "token_start": 172, "token_end": 179}, "tgt": {"text": "Fu\u00df komplett & Mittel-/Vorfu\u00df", "char_start": 1263, "char_end": 1292, "token_start": 178, "token_end": 185}}]}
{"idx": 11005, "pair_id": "30925595", "src": "Oncology has experienced a massive growth in knowledge over the last years. However, the growing amount of knowledge and data increases the complexity of clinical decisions and presents oncologists with new challenges. Currently, oncology-specific IT solutions are being developed with the aim to improve survival of cancer patients.The complexity of treatment decisions in oncology has greatly increased due to introduction of novel biomarkers and targeted therapeutics. First 'intelligent' systems that suggest therapies based on available data have been developed, however, these systems are not yet widely adopted and lack sufficient clinical validation.Increasing implementation of electronic health records enables structured collection and analysis of data from routine patient care. These real-world data are used for post marketing surveillance and can help to develop therapy guidelines. Currently it is being discussed if real world data can provide sufficient evidence for regulatory decisions.Broad availability of internet access and smartphones provides an opportunity to involve patients in surveillance and control of cancer treatments. Early reporting of symptoms and side effects is likely to improve treatment and compliance. In addition, patient reported outcomes can be employed for data collection in clinical trials and for quality surveillance. First randomized trials suggest that collection of patient reported outcomes can improve symptoms and survival of cancer patients.", "tgt": "In der Onkologie kam es zuletzt zu einem rasanten Wissenszuwachs. Neue Entwicklungen in Diagnostik und Therapie von Tumorerkrankungen haben die Grundlagen f\u00fcr individualisierte Therapiekonzepte geschaffen. Aktuell werden innovative Onkologie-spezifische IT-L\u00f6sungen entwickelt mit dem Ziel, die Heilungschancen f\u00fcr Patienten mit Tumorerkrankungen langfristig zu verbessern. Die Komplexit\u00e4t onkologischer Therapieentscheidungen hat durch Einf\u00fchrung neuer Biomarker und zielgerichteter Therapeutika stark zugenommen. Erste \u201eintelligente\u201c Systeme, die aktiv Therapieoptionen auf Basis von vorhandenen Daten vorschlagen, sind verf\u00fcgbar, aber noch nicht weit verbreitet und unzureichend klinisch validiert. Durch die zunehmende Verbreitung von elektronischen Gesundheitsakten wird eine strukturierte Sammlung und Auswertung von Daten aus der onkologischen Routineversorgung m\u00f6glich. Real World Data werden eingesetzt, um die Sicherheit und Nebenwirkungen von onkologischen Medikamenten zu \u00fcberwachen und k\u00f6nnen helfen, onkologische Therapieleitlinien zu entwickeln. Die fr\u00fche Meldung von Symptomen und Nebenwirkungen (Patient Reported Outcomes) verspricht eine verbesserte Behandlung und eine gesteigerte Therapieadh\u00e4renz. Patient Reported Outcomes k\u00f6nnen auch im Rahmen von klinischen Studien und zur Qualit\u00e4tssicherung eingesetzt werden. Erste Studien zeigen, dass eine IT-gest\u00fctzte Erfassung von Patient Reported Outcomes Symptome und \u00dcberleben von Patienten mit Tumorerkrankungen positiv beeinflussen kann.", "term_pairs": [{"src": {"text": "Oncology", "char_start": 0, "char_end": 8, "token_start": 0, "token_end": 1}, "tgt": {"text": "Onkologie", "char_start": 7, "char_end": 16, "token_start": 2, "token_end": 3}}, {"src": {"text": "oncology-specific IT solutions", "char_start": 230, "char_end": 260, "token_start": 37, "token_end": 42}, "tgt": {"text": "Onkologie-spezifische IT-L\u00f6sungen", "char_start": 232, "char_end": 265, "token_start": 30, "token_end": 36}}, {"src": {"text": "cancer patients", "char_start": 317, "char_end": 332, "token_start": 52, "token_end": 54}, "tgt": {"text": "Patienten mit Tumorerkrankungen", "char_start": 315, "char_end": 346, "token_start": 44, "token_end": 47}}, {"src": {"text": "biomarkers", "char_start": 434, "char_end": 444, "token_start": 70, "token_end": 71}, "tgt": {"text": "Biomarker", "char_start": 454, "char_end": 463, "token_start": 59, "token_end": 60}}, {"src": {"text": "targeted therapeutics", "char_start": 449, "char_end": 470, "token_start": 72, "token_end": 74}, "tgt": {"text": "zielgerichteter Therapeutika", "char_start": 468, "char_end": 496, "token_start": 61, "token_end": 63}}, {"src": {"text": "electronic health records", "char_start": 687, "char_end": 712, "token_start": 109, "token_end": 112}, "tgt": {"text": "elektronischen Gesundheitsakten", "char_start": 739, "char_end": 770, "token_start": 100, "token_end": 102}}, {"src": {"text": "real-world data", "char_start": 797, "char_end": 812, "token_start": 125, "token_end": 129}, "tgt": {"text": "Real World Data", "char_start": 878, "char_end": 893, "token_start": 116, "token_end": 119}}, {"src": {"text": "patient reported outcomes", "char_start": 1259, "char_end": 1284, "token_start": 199, "token_end": 202}, "tgt": {"text": "Patient Reported Outcomes", "char_start": 1113, "char_end": 1138, "token_start": 149, "token_end": 152}}, {"src": {"text": "clinical trials", "char_start": 1324, "char_end": 1339, "token_start": 209, "token_end": 211}, "tgt": {"text": "klinischen Studien", "char_start": 1270, "char_end": 1288, "token_start": 170, "token_end": 172}}, {"src": {"text": "symptoms", "char_start": 1173, "char_end": 1181, "token_start": 184, "token_end": 185}, "tgt": {"text": "Symptome", "char_start": 1083, "char_end": 1091, "token_start": 145, "token_end": 146}}, {"src": {"text": "side effects", "char_start": 1186, "char_end": 1198, "token_start": 186, "token_end": 188}, "tgt": {"text": "Nebenwirkungen", "char_start": 935, "char_end": 949, "token_start": 126, "token_end": 127}}]}
{"idx": 11035, "pair_id": "29966145", "src": "Caregiving relatives of dementia patients are exposed to considerable burdens. A multimodal rehabilitation concept which enables the inpatient treatment of caregiving relatives together with the dementia patients was evaluated. Questionnaire survey including 121 caring relatives at 3 times of measurement. Indicators of subjective health and the use of nursing and psychosocial support services were measured during the course of the study. Relevant improvements in health can be seen after rehabilitation. Six months after rehabilitation, the effects decrease, but do not reach the baseline value before rehabilitation for any of the variables measured. The multimodal rehabilitation concept shows sustainable effects, at least in some variables. In connection with the high level of satisfaction of the participants, the results indicate that the rehabilitation concept is successful and is associated with a large health benefit.", "tgt": "Pflegende Angeh\u00f6rige von Demenzerkrankten sind erheblichen Belastungen ausgesetzt. Ein multimodales Rehabilitationskonzept, welches die station\u00e4re Behandlung von pflegerisch t\u00e4tigen Angeh\u00f6rigen zusammen mit den Demenzkranken erm\u00f6glicht, wurde evaluiert. Schriftliche Befragung von 121 pflegenden Angeh\u00f6rigen zu 3 Messzeitpunkten. Erfasst wurden Parameter der subjektiven Gesundheit sowie die Inanspruchnahme von pflegerischen und psychosozialen Unterst\u00fctzungsangeboten im Verlauf. Es zeigen sich deutliche gesundheitliche Verbesserungen am Ende der Rehabilitation. Sechs Monate nach der Rehabilitation gehen die Effekte zur\u00fcck, erreichen jedoch bei keinem der erfassten Merkmale den Ausgangswert vor der Reha. Das multimodale Rehabilitationskonzept zeigt zumindest in Teilbereichen nachhaltige Effekte. Diese sowie die hohe Zufriedenheit der Teilnehmer sprechen daf\u00fcr, dass sich das Rehabilitationskonzept bew\u00e4hrt und mit einem hohen gesundheitlichen Gewinn verbunden ist.", "term_pairs": [{"src": {"text": "Caregiving relatives", "char_start": 0, "char_end": 20, "token_start": 0, "token_end": 2}, "tgt": {"text": "Pflegende Angeh\u00f6rige", "char_start": 0, "char_end": 20, "token_start": 0, "token_end": 2}}, {"src": {"text": "dementia patients", "char_start": 24, "char_end": 41, "token_start": 3, "token_end": 5}, "tgt": {"text": "Demenzerkrankten", "char_start": 25, "char_end": 41, "token_start": 3, "token_end": 4}}, {"src": {"text": "multimodal rehabilitation concept", "char_start": 81, "char_end": 114, "token_start": 12, "token_end": 15}, "tgt": {"text": "multimodales Rehabilitationskonzept", "char_start": 87, "char_end": 122, "token_start": 10, "token_end": 12}}, {"src": {"text": "inpatient treatment", "char_start": 133, "char_end": 152, "token_start": 18, "token_end": 20}, "tgt": {"text": "station\u00e4re Behandlung", "char_start": 136, "char_end": 157, "token_start": 15, "token_end": 17}}, {"src": {"text": "Questionnaire survey", "char_start": 228, "char_end": 248, "token_start": 31, "token_end": 33}, "tgt": {"text": "Schriftliche Befragung", "char_start": 254, "char_end": 276, "token_start": 30, "token_end": 32}}, {"src": {"text": "subjective health", "char_start": 321, "char_end": 338, "token_start": 45, "token_end": 47}, "tgt": {"text": "subjektiven Gesundheit", "char_start": 359, "char_end": 381, "token_start": 44, "token_end": 46}}, {"src": {"text": "nursing and psychosocial support services", "char_start": 354, "char_end": 395, "token_start": 51, "token_end": 56}, "tgt": {"text": "pflegerischen und psychosozialen Unterst\u00fctzungsangeboten", "char_start": 412, "char_end": 468, "token_start": 50, "token_end": 54}}, {"src": {"text": "rehabilitation", "char_start": 492, "char_end": 506, "token_start": 73, "token_end": 74}, "tgt": {"text": "Rehabilitation", "char_start": 549, "char_end": 563, "token_start": 66, "token_end": 67}}, {"src": {"text": "baseline value", "char_start": 584, "char_end": 598, "token_start": 89, "token_end": 91}, "tgt": {"text": "Ausgangswert", "char_start": 683, "char_end": 695, "token_start": 86, "token_end": 87}}, {"src": {"text": "health benefit", "char_start": 918, "char_end": 932, "token_start": 141, "token_end": 143}, "tgt": {"text": "gesundheitlichen Gewinn", "char_start": 934, "char_end": 957, "token_start": 120, "token_end": 122}}]}
{"idx": 11148, "pair_id": "30286500", "src": "Case 1: admission to hospital of a 72-year-old male patient due to suspect tumor at the pulmonary valve. At admission the patient was hemodynamically stable with known coronary one vessel heart disease and arterial hypertension.Case 2: admission to hospital of a 74-year-old female patient due to symptoms of de novo angina pectoris with known coronary three vessel heart disease. In both patients suspect tumors could have been detected at the pulmonary- and tricuspid valve by transthoracic echocardiography. In case 1 coronary angiography showed a complex coronary three vessel heart disease with indication for surgery. In case 2 coronary angiography showed a subtotal stenosis of the RCA which could have been treated by percutaneous coronary intervention (PCI). In both cases the tumor were highly suspective to be benigne. Despite of the certain risk of embolism, surgery was only recommended in case 1 because the patient needed surgical revascularisation anyway due to the complex coronary three vessel heart disease. In case 2 the RCA stenosis has been treated by PCI and surgery has not been recommended. Echocardiography can help to detect cardiac tumors whereas the diagnosis can only be confirmed by biopsy. Further therapeutic procedures should be defined individually.", "tgt": "Kasuistik 1: 72-j\u00e4hriger kardio-pulmonal stabiler Patient mit Einweisung zur weiteren Abkl\u00e4rung einer unklaren Raumforderung an der Pulmonalklappe. Anamnestisch vorbeschrieben waren eine koronare Ein-Gef\u00e4\u00dferkrankung und ein arterieller Hypertonus.Kasuistik 2: 74-j\u00e4hrige Patientin mit eigeninitiierter Vorstellung bei erneuten pektangin\u00f6sen Beschwerden bei vorbeschriebener koronarer Drei-Gef\u00e4\u00dferkrankung. Echokardiografisch konnte bei beiden Patienten eine suspekte Raumforderung an der Pulmonal- bzw. Trikuspidalklappe diagnostiziert werden. Bei Kasuistik 1 ergab die Koronarangiografie eine koronare 3-Gef\u00e4\u00dferkrankung mit Indikation zur operativen Revaskularisation. Bei Kasuistik 2 eine subtotale Stenose der rechten Koronararterie (RCA) mit interventionellem Therapieansatz. In beiden F\u00e4llen bestand der Verdacht auf einen gutartigen Tumor. Trotz des prinzipiell bestehenden Embolierisikos wurde bei Kasuistik 1 \u2013 aufgrund der notwendigen operativen Koronarrevaskularisation \u2013 eine operative Entfernung des Tumors empfohlen, wohingegen sich bei Kasuistik 2 \u2013 aufgrund der interventionellen Therapiem\u00f6glichkeit der RCA-Stenose \u2013 f\u00fcr ein konservatives Prozedere entschieden wurde. Mithilfe der Echokardiografie k\u00f6nnen suspekte kardiale Raumforderungen detektiert werden, wobei die endg\u00fcltige Diagnose nur histologisch gesichert werden kann. Das weitere Therapieregime sollte jeweils individuell festgelegt werden.", "term_pairs": [{"src": {"text": "tumor", "char_start": 75, "char_end": 80, "token_start": 18, "token_end": 19}, "tgt": {"text": "Tumor", "char_start": 839, "char_end": 844, "token_start": 117, "token_end": 118}}, {"src": {"text": "pulmonary valve", "char_start": 88, "char_end": 103, "token_start": 21, "token_end": 23}, "tgt": {"text": "Pulmonalklappe", "char_start": 132, "char_end": 146, "token_start": 21, "token_end": 22}}, {"src": {"text": "coronary one vessel heart disease", "char_start": 168, "char_end": 201, "token_start": 33, "token_end": 38}, "tgt": {"text": "koronare Ein-Gef\u00e4\u00dferkrankung", "char_start": 187, "char_end": 215, "token_start": 27, "token_end": 31}}, {"src": {"text": "arterial hypertension", "char_start": 206, "char_end": 227, "token_start": 39, "token_end": 41}, "tgt": {"text": "arterieller Hypertonus", "char_start": 224, "char_end": 246, "token_start": 33, "token_end": 35}}, {"src": {"text": "angina pectoris", "char_start": 317, "char_end": 332, "token_start": 63, "token_end": 65}, "tgt": {"text": "pektangin\u00f6sen Beschwerden", "char_start": 327, "char_end": 352, "token_start": 48, "token_end": 50}}, {"src": {"text": "tricuspid valve", "char_start": 460, "char_end": 475, "token_start": 87, "token_end": 89}, "tgt": {"text": "Trikuspidalklappe", "char_start": 503, "char_end": 520, "token_start": 71, "token_end": 72}}, {"src": {"text": "transthoracic echocardiography", "char_start": 479, "char_end": 509, "token_start": 90, "token_end": 92}, "tgt": {"text": "Echokardiografie", "char_start": 1197, "char_end": 1213, "token_start": 166, "token_end": 167}}, {"src": {"text": "coronary angiography", "char_start": 521, "char_end": 541, "token_start": 96, "token_end": 98}, "tgt": {"text": "Koronarangiografie", "char_start": 570, "char_end": 588, "token_start": 80, "token_end": 81}}, {"src": {"text": "stenosis", "char_start": 673, "char_end": 681, "token_start": 119, "token_end": 120}, "tgt": {"text": "Stenose", "char_start": 701, "char_end": 708, "token_start": 97, "token_end": 98}}, {"src": {"text": "RCA", "char_start": 689, "char_end": 692, "token_start": 122, "token_end": 123}, "tgt": {"text": "RCA", "char_start": 737, "char_end": 740, "token_start": 102, "token_end": 103}}, {"src": {"text": "percutaneous coronary intervention", "char_start": 726, "char_end": 760, "token_start": 129, "token_end": 132}, "tgt": {"text": "interventionellem Therapieansatz", "char_start": 746, "char_end": 778, "token_start": 105, "token_end": 107}}, {"src": {"text": "PCI", "char_start": 762, "char_end": 765, "token_start": 133, "token_end": 134}, "tgt": {"text": "interventionellen Therapie", "char_start": 1077, "char_end": 1103, "token_start": 150, "token_end": 152}}, {"src": {"text": "embolism", "char_start": 861, "char_end": 869, "token_start": 154, "token_end": 155}, "tgt": {"text": "Embolierisikos", "char_start": 880, "char_end": 894, "token_start": 123, "token_end": 124}}, {"src": {"text": "surgical revascularisation", "char_start": 937, "char_end": 963, "token_start": 167, "token_end": 169}, "tgt": {"text": "operativen Revaskularisation", "char_start": 640, "char_end": 668, "token_start": 89, "token_end": 91}}, {"src": {"text": "biopsy", "char_start": 1214, "char_end": 1220, "token_start": 213, "token_end": 214}, "tgt": {"text": "histologisch", "char_start": 1308, "char_end": 1320, "token_start": 179, "token_end": 180}}]}
